Intervention_type,intervention,Study_count,Date of First Study,N/A,Phase 1,Phase 2,Phase 3,Phase 4,sponsor_counts,Score,NUmber_of_sponsors,NUmber_of_Publications
Other,standard care,189,2020-05-07,33,5,74,64,13,"Grifols Therapeutics LLC ( 5 )|Assistance Publique - HÃ´pitaux de Paris ( 3 )|Gilead Sciences ( 3 )|Indonesia University ( 3 )|Ampio Pharmaceuticals. Inc. ( 2 )|Applied Biology, Inc. ( 2 )|Baqiyatallah Medical Sciences University ( 2 )|Cadila Healthcare Limited ( 2 )|Cambridge University Hospitals NHS Foundation Trust ( 2 )|Corvus Pharmaceuticals, Inc. ( 2 )|Edesa Biotech Inc. ( 2 )|Emory University ( 2 )|Fundacion Clinic per a la Recerca BiomÃ©dica ( 2 )|Hamad Medical Corporation ( 2 )|Laboratorio Elea Phoenix S.A. ( 2 )|Postgraduate Institute of Medical Education and Research ( 2 )|Royal College of Surgeons in Ireland - Medical University of Bahrain ( 2 )|Rutgers, The State University of New Jersey ( 2 )|Stanford University ( 2 )|University of Catanzaro ( 2 )|University of the Philippines ( 2 )|West Virginia University ( 2 )|Aarogyam UK ( 1 )|Abu Dhabi Stem Cells Center ( 1 )|Academic and Community Cancer Research United ( 1 )|Ain Shams University ( 1 )|Alkarkh Health Directorate-Baghdad ( 1 )|All Natural Medicine Clinic, LLC ( 1 )|Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) ( 1 )|Amgen ( 1 )|Andalusian Network for Design and Translation of Advanced Therapies ( 1 )|Angion Biomedica Corp ( 1 )|Atrium Health ( 1 )|Ayub Teaching Hospital ( 1 )|Azienda Policlinico Umberto I ( 1 )|Bangladesh Medical Research Council (BMRC) ( 1 )|Baylor College of Medicine ( 1 )|BerGenBio ASA ( 1 )|Beximco Pharmaceuticals Ltd. ( 1 )|Bharat Serums and Vaccines Limited ( 1 )|Boehringer Ingelheim ( 1 )|Bosnalijek D.D ( 1 )|Boston University ( 1 )|Burnasyan Federal Medical Biophysical Center ( 1 )|Cairo University ( 1 )|Catalysis SL ( 1 )|Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ( 1 )|Centre Leon Berard ( 1 )|Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva ( 1 )|Charite University, Berlin, Germany ( 1 )|Chelsea and Westminster NHS Foundation Trust ( 1 )|Chinese University of Hong Kong ( 1 )|Chong Kun Dang Pharmaceutical ( 1 )|Chromis LLC ( 1 )|Clear Creek Bio, Inc. ( 1 )|Composite Interceptive Med Science ( 1 )|D'Or Institute for Research and Education ( 1 )|Dhaka Medical College ( 1 )|DompÃ© Farmaceutici S.p.A ( 1 )|Duke University ( 1 )|Entera Health, Inc ( 1 )|Epitech Group SpA ( 1 )|Estudios ClÃ­nicos Latino AmÃ©rica ( 1 )|Federal State Budgetary Institution, Pulmonology Scientific Research Institute ( 1 )|Fondation Ophtalmologique Adolphe de Rothschild ( 1 )|Fraser Health ( 1 )|Frederiksberg University Hospital ( 1 )|Fujifilm Pharmaceuticals U.S.A., Inc. ( 1 )|FundaciÃ³n de InvestigaciÃ³n BiomÃ©dica - Hospital Universitario de La Princesa ( 1 )|FundaciÃ³n de investigaciÃ³n HM ( 1 )|FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 1 )|FundaciÃ³n PÃºblica Andaluza para la gestiÃ³n de la InvestigaciÃ³n en Sevilla ( 1 )|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia ( 1 )|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal ( 1 )|GlaxoSmithKline ( 1 )|Guangzhou Institute of Respiratory Disease ( 1 )|HÃ´pital de Verdun ( 1 )|HaEmek Medical Center, Israel ( 1 )|Hebrew University of Jerusalem ( 1 )|Heinrich-Heine University, Duesseldorf ( 1 )|Hofseth Biocare ASA ( 1 )|Hospital Son Llatzer ( 1 )|Hospital Universitari de Bellvitge ( 1 )|Hospital Universitario Infanta Leonor ( 1 )|Humanigen, Inc. ( 1 )|Icahn School of Medicine at Mount Sinai ( 1 )|Imperial College London ( 1 )|InflaRx GmbH ( 1 )|Innovation Pharmaceuticals, Inc. ( 1 )|Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )|Institut universitaire de cardiologie et de pneumologie de QuÃ©bec, University Laval ( 1 )|Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus ( 1 )|Institute of Liver and Biliary Sciences, India ( 1 )|Instituto de InvestigaciÃ³n Sanitaria de la FundaciÃ³n JimÃ©nez DÃ­az ( 1 )|IRCCS San Raffaele ( 1 )|Istanbul University ( 1 )|Ivano-Frankivsk National Medical University ( 1 )|Janssen Pharmaceutica N.V., Belgium ( 1 )|Janssen Research & Development, LLC ( 1 )|Jena University Hospital ( 1 )|Johns Hopkins University ( 1 )|Karolinska University Hospital ( 1 )|Kermanshah University of Medical Sciences ( 1 )|King Edward Medical University ( 1 )|KK Women's and Children's Hospital ( 1 )|Klinikum Bremen-Mitte, gGmbH ( 1 )|Korle-Bu Teaching Hospital, Accra, Ghana ( 1 )|Lazarski University ( 1 )|Lowell General Hospital ( 1 )|MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 )|Maimonides Medical Center ( 1 )|Max Healthcare Insititute Limited ( 1 )|Medical University of Vienna ( 1 )|Misr University for Science and Technology ( 1 )|National and Kapodistrian University of Athens ( 1 )|Nektar Therapeutics ( 1 )|NeuroRx, Inc. ( 1 )|Northwell Health ( 1 )|Novartis ( 1 )|Obafemi Awolowo University ( 1 )|Oslo University Hospital ( 1 )|Partner Therapeutics, Inc. ( 1 )|Peking Union Medical College Hospital ( 1 )|Promomed, LLC ( 1 )|PTC Therapeutics ( 1 )|Puerta de Hierro University Hospital ( 1 )|R-Pharm ( 1 )|Rhizen Pharmaceuticals SA ( 1 )|Ruijin Hospital ( 1 )|Saisei Pharma ( 1 )|Science Valley Research Institute ( 1 )|Senhwa Biosciences, Inc. ( 1 )|Shahid Beheshti University of Medical Sciences ( 1 )|Sharp HealthCare ( 1 )|Shin Poong Pharmaceutical Co. Ltd. ( 1 )|Soroka University Medical Center ( 1 )|Sorrento Therapeutics, Inc. ( 1 )|South African National Blood Service ( 1 )|Tanta University ( 1 )|The Cleveland Clinic ( 1 )|Thirty Respiratory Limited ( 1 )|UKK Institute ( 1 )|UMC Utrecht ( 1 )|Universidad del Rosario ( 1 )|Universidad Nacional de Colombia ( 1 )|Universidad PÃºblica de Navarra ( 1 )|Universidade Federal de Sao Carlos ( 1 )|Universitaire Ziekenhuizen Leuven ( 1 )|University College Hospital Galway ( 1 )|University Hospital Southampton NHS Foundation Trust ( 1 )|University Hospital, Ghent ( 1 )|University of Alabama at Birmingham ( 1 )|University of Chicago ( 1 )|University of Edinburgh ( 1 )|University of Liege ( 1 )|University of Pennsylvania ( 1 )|University of Sao Paulo ( 1 )|Vanderbilt University Medical Center ( 1 )|Vascular Biogenics Ltd. operating as VBL Therapeutics ( 1 )|Xuzhou No.1 Peoples Hospital ( 1 )|Yale University ( 1 )",11.189,161,70
Drug,hydroxychloroquine,122,2020-05-04,12,3,35,56,16,"Rutgers, The State University of New Jersey ( 3 )|Shahid Beheshti University of Medical Sciences ( 3 )|Baqiyatallah Medical Sciences University ( 2 )|Barcelona Institute for Global Health ( 2 )|Burnasyan Federal Medical Biophysical Center ( 2 )|Centre Hospitalier Universitaire de Saint Etienne ( 2 )|Government of Punjab, Specialized Healthcare and Medical Education Department ( 2 )|Institute for Research and Development of Medicinal and Food Plants of Guinea ( 2 )|Intermountain Health Care, Inc. ( 2 )|National Institute of Respiratory Diseases, Mexico ( 2 )|NYU Langone Health ( 2 )|Postgraduate Institute of Medical Education and Research ( 2 )|ProgenaBiome ( 2 )|University Hospital Tuebingen ( 2 )|University of Minnesota ( 2 )|University of New Mexico ( 2 )|University of Oxford ( 2 )|University of Washington ( 2 )|Asan Medical Center ( 1 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Azienda Policlinico Umberto I ( 1 )|Baylor Research Institute ( 1 )|Benha University ( 1 )|Bryn Mawr Hospital ( 1 )|Cambridge University Hospitals NHS Foundation Trust ( 1 )|Cardresearch ( 1 )|Centenario Hospital Miguel Hidalgo ( 1 )|Centre Chirurgical Marie Lannelongue ( 1 )|Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva ( 1 )|Charles University, Czech Republic ( 1 )|Chronic Obstructive Pulmonary Disease Trial Network, Denmark ( 1 )|Columbia University ( 1 )|Duke University ( 1 )|Elaraby Hospital ( 1 )|Fasa University of Medical Sciences ( 1 )|FundaciÃ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau ( 1 )|Fundacion GenesisCare ( 1 )|General and Teaching Hospital Celje ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Gustave Roussy, Cancer Campus, Grand Paris ( 1 )|Hackensack Meridian Health ( 1 )|Hamad Medical Corporation ( 1 )|Health Institutes of Turkey ( 1 )|Henry Ford Health System ( 1 )|Hospital AlemÃ£o Oswaldo Cruz ( 1 )|Hospital do Coracao ( 1 )|Hospital Israelita Albert Einstein ( 1 )|Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )|Instituto Nacional de Rehabilitacion ( 1 )|Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori ( 1 )|King Abdullah International Medical Research Center ( 1 )|LCMC Health ( 1 )|Louisiana State University Health Sciences Center in New Orleans ( 1 )|Mahidol University ( 1 )|MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 )|Mansoura University ( 1 )|Massachusetts General Hospital ( 1 )|Materno-Perinatal Hospital of the State of Mexico ( 1 )|McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 )|Medical University of Vienna ( 1 )|Memorial Sloan Kettering Cancer Center ( 1 )|Ministry of Health, Turkey ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|National Institute of Integrative Medicine, Australia ( 1 )|National University Hospital, Singapore ( 1 )|Novartis ( 1 )|Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara ( 1 )|October 6 University ( 1 )|Oslo University Hospital ( 1 )|Perseverance Research Center, LLC ( 1 )|Plan Nacional sobre el Sida (PNS) ( 1 )|Queen's Medical Center ( 1 )|Royal College of Surgeons in Ireland - Medical University of Bahrain ( 1 )|Sanford Health ( 1 )|Sanofi ( 1 )|ScandiBio Therapeutics AB ( 1 )|Shaheed Zulfiqar Ali Bhutto Medical University ( 1 )|Shanghai Public Health Clinical Center ( 1 )|St. Francis Hospital, New York ( 1 )|Tanta University ( 1 )|Taoyuan General Hospital ( 1 )|The University of Hong Kong ( 1 )|UMC Utrecht ( 1 )|UNICEF ( 1 )|Universidad Peruana Cayetano Heredia ( 1 )|University Health Network, Toronto ( 1 )|University Hospital, Akershus ( 1 )|University Hospital, Angers ( 1 )|University Hospital, Montpellier ( 1 )|University Hospital, Strasbourg, France ( 1 )|University of Calgary ( 1 )|University of Chicago ( 1 )|University of Health Sciences Lahore ( 1 )|University of Pennsylvania ( 1 )|University of South Alabama ( 1 )|University of Southern California ( 1 )|University of the Philippines ( 1 )|University of Utah ( 1 )|Washington University School of Medicine ( 1 )|WellStar Health System ( 1 )|Yaounde Central Hospital ( 1 )|Zagazig University ( 1 )",11.122,102,83
Drug,saline,51,2020-05-01,3,9,22,13,4,"Bandim Health Project ( 2 )|Frederick Health ( 2 )|Johns Hopkins University ( 2 )|Stanford University ( 2 )|Tychan Pte Ltd. ( 2 )|Adagio Therapeutics, Inc. ( 1 )|Ampio Pharmaceuticals. Inc. ( 1 )|Apeiron Biologics ( 1 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Assiut University ( 1 )|Black Tie Medical, Inc. ( 1 )|Cellular Sciences, inc. ( 1 )|Centre hospitalier de l'UniversitÃ© de MontrÃ©al (CHUM) ( 1 )|Collegium Medicum w Bydgoszczy ( 1 )|Diffusion Pharmaceuticals Inc ( 1 )|EuBiologics Co.,Ltd ( 1 )|ExeVir Bio BV ( 1 )|Genexine, Inc. ( 1 )|Hampshire Hospitals NHS Foundation Trust ( 1 )|Hospital do Coracao ( 1 )|ImmunityBio, Inc. ( 1 )|Imperial College London ( 1 )|Murdoch Childrens Research Institute ( 1 )|NeuroRx, Inc. ( 1 )|NYU Langone Health ( 1 )|Pomeranian Medical University Szczecin ( 1 )|Renibus Therapeutics, Inc. ( 1 )|Resolve Therapeutics ( 1 )|Rigshospitalet, Denmark ( 1 )|SAb Biotherapeutics, Inc. ( 1 )|SBÃœ Dr. Sadi Konuk EÄŸitim ve AraÅŸtÄ±rma Hastanesi ( 1 )|Scandinavian Critical Care Trials Group ( 1 )|Singapore General Hospital ( 1 )|SK Chemicals Co., Ltd. ( 1 )|United Medical Specialties ( 1 )|University of Alabama at Birmingham ( 1 )|University of Edinburgh ( 1 )|University of North Carolina, Chapel Hill ( 1 )|University of Oklahoma ( 1 )|University of Oxford ( 1 )|University of Rzeszow ( 1 )|University of South Alabama ( 1 )|University of Southern Denmark ( 1 )|VA Office of Research and Development ( 1 )|Vanderbilt University Medical Center ( 1 )|Vaxine Pty Ltd ( 1 )",11.051,46,10
Drug,ivermectin,46,2020-05-01,7,2,16,17,4,"Ministry of Public Health, Argentina ( 3 )|Tanta University ( 2 )|Zagazig University ( 2 )|Afyonkarahisar Health Sciences University ( 1 )|Alkarkh Health Directorate-Baghdad ( 1 )|Bangkok Metropolitan Administration Medical College and Vajira Hospital ( 1 )|Benha University ( 1 )|Centenario Hospital Miguel Hidalgo ( 1 )|Centro de Estudios en InfectogÃ­a Pediatrica ( 1 )|CES University ( 1 )|Clinica Universidad de Navarra, Universidad de Navarra ( 1 )|Combined Military Hospital, Pakistan ( 1 )|CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )|Dhaka Medical College ( 1 )|Duke University ( 1 )|Elaraby Hospital ( 1 )|FMH College of Medicine and Dentistry ( 1 )|Instituto de CardiologÃ­a de Corrientes ( 1 )|Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado ( 1 )|Instituto do Cancer do Estado de SÃ£o Paulo ( 1 )|International Centre for Diarrhoeal Disease Research, Bangladesh ( 1 )|Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V. ( 1 )|IRCCS Sacro Cuore Don Calabria di Negrar ( 1 )|London School of Hygiene and Tropical Medicine ( 1 )|Max Health, Subsero Health ( 1 )|Max Healthcare Insititute Limited ( 1 )|MedinCell S.A ( 1 )|Ministry of Health and Population, Egypt ( 1 )|National University Hospital, Singapore ( 1 )|Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara ( 1 )|October 6 University ( 1 )|ProgenaBiome ( 1 )|Raincy Montfermeil Hospital Group ( 1 )|Sheba Medical Center ( 1 )|Sheikh Zayed Federal Postgraduate Medical Institute ( 1 )|Universidad Nacional de AsunciÃ³n ( 1 )|Universidad Peruana Cayetano Heredia ( 1 )|Universidade Federal de Sao Carlos ( 1 )|University of Baghdad ( 1 )|University of Kentucky ( 1 )|University of Minnesota ( 1 )|University of Oxford ( 1 )",11.046,42,13
Drug,remdesivir,45,2020-04-10,4,1,11,26,3,"National Institute of Allergy and Infectious Diseases (NIAID) ( 10 )|Gilead Sciences ( 5 )|M Abdur Rahim Medical College and Hospital ( 2 )|October 6 University ( 2 )|Ain Shams University ( 1 )|Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders ( 1 )|Beximco Pharmaceuticals Ltd. ( 1 )|Capital Medical University ( 1 )|Clinical Urology and Epidemiology Working Group ( 1 )|Duke University ( 1 )|Hoffmann-La Roche ( 1 )|Imperial College London ( 1 )|Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )|King Edward Medical University ( 1 )|Klinikum Bremen-Mitte, gGmbH ( 1 )|Lahore General Hospital ( 1 )|Medical University of Vienna ( 1 )|Nepal Health Research Council ( 1 )|Oslo University Hospital ( 1 )|PharmaMar ( 1 )|QuantumLeap Healthcare Collaborative ( 1 )|Sunnybrook Health Sciences Centre ( 1 )|Tanta University ( 1 )|The Camelot Foundation ( 1 )|The University of Hong Kong ( 1 )|UNICEF ( 1 )|University of Minnesota ( 1 )|University of Oxford ( 1 )|University of the Philippines ( 1 )|ViralClear Pharmaceuticals, Inc. ( 1 )",11.045,30,27
Drug,azithromycin,43,2020-05-04,5,1,16,19,2,"Institute for Research and Development of Medicinal and Food Plants of Guinea ( 2 )|Intermountain Health Care, Inc. ( 2 )|University of Oxford ( 2 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Azienda Policlinico Umberto I ( 1 )|BioXcellerator ( 1 )|Burnasyan Federal Medical Biophysical Center ( 1 )|Charles University, Czech Republic ( 1 )|Chronic Obstructive Pulmonary Disease Trial Network, Denmark ( 1 )|CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )|Corpometria Institute ( 1 )|Duke University ( 1 )|FundaciÃ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau ( 1 )|Fundacion GenesisCare ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Gustave Roussy, Cancer Campus, Grand Paris ( 1 )|Hamad Medical Corporation ( 1 )|HonorHealth Research Institute ( 1 )|Hospital do Coracao ( 1 )|Hospital Israelita Albert Einstein ( 1 )|Ina-Respond ( 1 )|Indonesia University ( 1 )|Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado ( 1 )|LCMC Health ( 1 )|Medical University of Vienna ( 1 )|Ministry of Health, Turkey ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|National Institute of Integrative Medicine, Australia ( 1 )|ProgenaBiome ( 1 )|Rutgers, The State University of New Jersey ( 1 )|South Valley University ( 1 )|St. Francis Hospital, New York ( 1 )|University Hospital, Montpellier ( 1 )|University Hospital, Strasbourg, France ( 1 )|University of California, San Francisco ( 1 )|University of Health Sciences Lahore ( 1 )|University of New Mexico ( 1 )|University of Washington ( 1 )|Washington University School of Medicine ( 1 )|Yaounde Central Hospital ( 1 )",11.043,40,35
Drug,tocilizumab,41,2020-05-04,7,1,18,12,3,"Assistance Publique - HÃ´pitaux de Paris ( 2 )|Hoffmann-La Roche ( 2 )|M Abdur Rahim Medical College and Hospital ( 2 )|University of Chicago ( 2 )|Azienda UnitÃ  Sanitaria Locale Reggio Emilia ( 1 )|BeneficÃªncia Portuguesa de SÃ£o Paulo ( 1 )|Beni-Suef University ( 1 )|FMH College of Medicine and Dentistry ( 1 )|FundaciÃ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau ( 1 )|Fundacion GenesisCare ( 1 )|Fundacion SEIMC-GESIDA ( 1 )|Genentech, Inc. ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Hadassah Medical Organization ( 1 )|Hellenic Institute for the Study of Sepsis ( 1 )|Hospital Universitario Ramon y Cajal ( 1 )|Instituto Nacional de Cancerologia de Mexico ( 1 )|Karolinska University Hospital ( 1 )|Lahore General Hospital ( 1 )|Massachusetts General Hospital ( 1 )|MedSIR ( 1 )|Memorial Sloan Kettering Cancer Center ( 1 )|National Cancer Institute (NCI) ( 1 )|National Cancer Institute, Naples ( 1 )|October 6 University ( 1 )|Peking University First Hospital ( 1 )|Queen's Medical Center ( 1 )|South Valley University ( 1 )|The Camelot Foundation ( 1 )|UNICEF ( 1 )|UniversitÃ  Politecnica delle Marche ( 1 )|University Hospital Inselspital, Berne ( 1 )|University Hospital of Patras ( 1 )|University Hospital, Ghent ( 1 )|University of Lahore ( 1 )|University of Oxford ( 1 )|University of Sao Paulo ( 1 )",11.041,37,24
Drug,ritonavir,33,2021-09-01,5,2,7,11,8,"Pfizer ( 5 )|Shahid Beheshti University of Medical Sciences ( 3 )|October 6 University ( 2 )|Tongji Hospital ( 2 )|Asan Medical Center ( 1 )|Baqiyatallah Medical Sciences University ( 1 )|Beijing 302 Hospital ( 1 )|BioXcellerator ( 1 )|Cardresearch ( 1 )|Centre Hospitalier Universitaire de Saint Etienne ( 1 )|Fasa University of Medical Sciences ( 1 )|Fundacion GenesisCare ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Guangzhou 8th People's Hospital ( 1 )|Huoshenshan Hospital ( 1 )|Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )|Medical University of Vienna ( 1 )|Obafemi Awolowo University ( 1 )|The Ninth Hospital of Nanchang ( 1 )|The University of Hong Kong ( 1 )|Unity Health Toronto ( 1 )|University College, London ( 1 )|University Hospital, Geneva ( 1 )|University of the Philippines ( 1 )|Vanderbilt University Medical Center ( 1 )",11.033,25,23
Dietary Supplement,vitamin d,25,2020-04-25,9,1,6,6,3,"ProgenaBiome ( 3 )|Ã–rebro University, Sweden ( 1 )|Applied Science Private University ( 1 )|Arizona State University ( 1 )|Ayub Teaching Hospital ( 1 )|Bioaraba Health Research Institute ( 1 )|Brigham and Women's Hospital ( 1 )|Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health ( 1 )|Hospital de la Soledad ( 1 )|Medical University of South Carolina ( 1 )|Mount Carmel Health System ( 1 )|National Institute of Integrative Medicine, Australia ( 1 )|Postgraduate Institute of Medical Education and Research ( 1 )|Queen Mary University of London ( 1 )|Royal Centre for Defence Medicine ( 1 )|Sanford Health ( 1 )|St. Justine's Hospital ( 1 )|University Hospitals Cleveland Medical Center ( 1 )|University of Alberta ( 1 )|University of Chicago ( 1 )|University of Guadalajara ( 1 )|University of Sao Paulo ( 1 )|Vitamin D Study Group ( 1 )",11.025,23,6
Device,oxygen,22,2020-05-04,14,1,3,2,2,"Cairo University ( 3 )|Laval University ( 2 )|Aalborg University Hospital ( 1 )|AsociaciÃ³n Argentina de Medicina HiperbÃ¡rica e InvestigaciÃ³n ( 1 )|Assaf-Harofeh Medical Center ( 1 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Fundacion GenesisCare ( 1 )|Fuzhou General Hospital ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Hospital Civil de Guadalajara ( 1 )|Karolinska Institutet ( 1 )|Karolinska University Hospital ( 1 )|Lund University ( 1 )|Maimonides Medical Center ( 1 )|Massachusetts General Hospital ( 1 )|Ottawa Hospital Research Institute ( 1 )|SchÃ¶n Klinik Berchtesgadener Land ( 1 )|Shanghai Asclepius Meditec Inc. ( 1 )|Steward St. Elizabeth's Medical Center of Boston, Inc. ( 1 )",11.022,19,10
Drug,control,20,2020-04-27,10,1,6,2,1,"Biosearch S.A. ( 1 )|Cairo University ( 1 )|Centre de Recherche de l'Institut Universitaire en santÃ© Mentale de MontrÃ©al ( 1 )|Columbia University ( 1 )|Fondation Ophtalmologique Adolphe de Rothschild ( 1 )|FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 1 )|Hospices Civils de Lyon ( 1 )|Hospital Reg. Lic. Adolfo Lopez Mateos ( 1 )|Icahn School of Medicine at Mount Sinai ( 1 )|International Islamic University Malaysia ( 1 )|Lawson Health Research Institute ( 1 )|PhaseBio Pharmaceuticals Inc. ( 1 )|Shenzhen Geno-Immune Medical Institute ( 1 )|South Valley University ( 1 )|Universidad de Sonora ( 1 )|UniversitÃ© de Sherbrooke ( 1 )|Universiti Tunku Abdul Rahman ( 1 )|University Hospital, Ghent ( 1 )|University Hospital, Strasbourg, France ( 1 )|Yale University ( 1 )",11.02,20,9
Biological,vaccine,10,2021-07-31,3,2,3,1,1,"Beijing 302 Hospital ( 2 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|City of Hope Medical Center ( 1 )|Health Institutes of Turkey ( 1 )|Kocak Farma ( 1 )|Maastricht University Medical Center ( 1 )|Ministry of Public Health, Argentina ( 1 )|Queen Mary University of London ( 1 )|University of Arizona ( 1 )",11.01,9,4
Drug,dexamethasone,28,2020-04-09,2,0,3,14,9,"Assistance Publique - HÃ´pitaux de Paris ( 2 )|ClinAmygate ( 2 )|Assiut University ( 1 )|Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders ( 1 )|Brno University Hospital ( 1 )|Cairo University ( 1 )|Centre Chirurgical Marie Lannelongue ( 1 )|Centre Hospitalier RenÃ© Dubos ( 1 )|Chattogram General Hospital ( 1 )|Chita State Regional Clinical Hospital Number 1 ( 1 )|Dr. Negrin University Hospital ( 1 )|Faron Pharmaceuticals Ltd ( 1 )|FundaciÃ³n Instituto de Estudios de Ciencias de la Salud de Castilla y LeÃ³n ( 1 )|General Practitioners Research Institute ( 1 )|Hospital Sirio-Libanes ( 1 )|Hospital Universitario Infanta Leonor ( 1 )|Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 )|Mateon Therapeutics ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|NeuroActiva, Inc. ( 1 )|PharmaMar ( 1 )|Scandinavian Critical Care Trials Group ( 1 )|South Valley University ( 1 )|Universidad Nacional Autonoma de Mexico ( 1 )|University of Oklahoma ( 1 )|University of Trieste ( 1 )",10.028,26,28
Drug,lopinavir,25,2020-05-04,5,0,6,8,6,"Shahid Beheshti University of Medical Sciences ( 3 )|October 6 University ( 2 )|University College, London ( 2 )|ANRS, Emerging Infectious Diseases ( 1 )|Asan Medical Center ( 1 )|Baqiyatallah Medical Sciences University ( 1 )|Beijing 302 Hospital ( 1 )|Cardresearch ( 1 )|Centre Hospitalier Universitaire de Saint Etienne ( 1 )|Fasa University of Medical Sciences ( 1 )|Fundacion GenesisCare ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Guangzhou 8th People's Hospital ( 1 )|Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )|Medical University of Vienna ( 1 )|The University of Hong Kong ( 1 )|Tongji Hospital ( 1 )|Unity Health Toronto ( 1 )|University Hospital, Geneva ( 1 )|University of the Philippines ( 1 )|Vanderbilt University Medical Center ( 1 )",10.025,21,22
Drug,colchicine,22,2020-04-29,1,0,9,11,1,"Ayub Teaching Hospital ( 1 )|Azienda Ospedaliero-Universitaria di Parma ( 1 )|ClinAmygate ( 1 )|Dhaka Medical College ( 1 )|Estudios ClÃ­nicos Latino AmÃ©rica ( 1 )|Fundacion Clinic per a la Recerca BiomÃ©dica ( 1 )|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia ( 1 )|Hawler Medical University ( 1 )|Instituto de InvestigaciÃ³n MarquÃ©s de Valdecilla ( 1 )|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 )|Kermanshah University of Medical Sciences ( 1 )|Maimonides Medical Center ( 1 )|Montreal Heart Institute ( 1 )|National and Kapodistrian University of Athens ( 1 )|Population Health Research Institute ( 1 )|Shahid Beheshti University of Medical Sciences ( 1 )|University Hospital Inselspital, Berne ( 1 )|University of California, Los Angeles ( 1 )|University of Oxford ( 1 )|University Of Perugia ( 1 )|University of Sao Paulo ( 1 )|Yale University ( 1 )",10.022,22,15
Drug,enoxaparin,21,2020-04-24,1,0,3,9,8,"ASST Fatebenefratelli Sacco ( 1 )|Brazilian Clinical Research Institute ( 1 )|Cedars-Sinai Medical Center ( 1 )|Central Hospital, Nancy, France ( 1 )|Clinica San Camilo, Argentina ( 1 )|Columbia University ( 1 )|Hospital Regional de Alta especialidad de Ixtapaluca ( 1 )|Icahn School of Medicine at Mount Sinai ( 1 )|IRCCS Azienda Ospedaliero-Universitaria di Bologna ( 1 )|Johns Hopkins All Children's Hospital ( 1 )|Niguarda Hospital ( 1 )|Northwell Health ( 1 )|Rajaie Cardiovascular Medical and Research Center ( 1 )|St. David's HealthCare ( 1 )|The TIMI Study Group ( 1 )|Thrombosis Research Institute ( 1 )|University Hospital, Geneva ( 1 )|University of Melbourne ( 1 )|University of Modena and Reggio Emilia ( 1 )|University of Zurich ( 1 )|Weill Medical College of Cornell University ( 1 )",10.021,21,7
Drug,lopinavir/ritonavir,21,2020-05-04,4,0,5,7,5,"Shahid Beheshti University of Medical Sciences ( 3 )|Asan Medical Center ( 1 )|Baqiyatallah Medical Sciences University ( 1 )|Cardresearch ( 1 )|Centre Hospitalier Universitaire de Saint Etienne ( 1 )|Fundacion GenesisCare ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Guangzhou 8th People's Hospital ( 1 )|Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )|Medical University of Vienna ( 1 )|October 6 University ( 1 )|The University of Hong Kong ( 1 )|Tongji Hospital ( 1 )|Unity Health Toronto ( 1 )|University College, London ( 1 )|University Hospital, Geneva ( 1 )|University of Oxford ( 1 )|University of the Philippines ( 1 )|Vanderbilt University Medical Center ( 1 )",10.021,19,25
Drug,methylprednisolone,21,2020-04-17,2,0,5,11,3,Ain Shams University ( 1 )|Assiut University ( 1 )|Auxilio Mutuo Cancer Center ( 1 )|Beijing Chao Yang Hospital ( 1 )|Cairo University ( 1 )|Chattogram General Hospital ( 1 )|Fatima Memorial Hospital ( 1 )|FundaÃ§Ã£o de Medicina Tropical Dr. Heitor Vieira Dourado ( 1 )|FundaciÃ³n Instituto de Estudios de Ciencias de la Salud de Castilla y LeÃ³n ( 1 )|FundaciÃ³n para el Fomento de la InvestigaciÃ³n Sanitaria y BiomÃ©dica de la Comunitat Valenciana ( 1 )|Fundacion Clinic per a la Recerca BiomÃ©dica ( 1 )|Fundacion Miguel Servet ( 1 )|Hospital Universitari de Bellvitge ( 1 )|Peking Union Medical College Hospital ( 1 )|Scandinavian Critical Care Trials Group ( 1 )|The Camelot Foundation ( 1 )|Tongji Hospital ( 1 )|Tulane University ( 1 )|University Children's Hospital Basel ( 1 )|University of Modena and Reggio Emilia ( 1 )|University of Trieste ( 1 ),10.021,21,8
Drug,nitazoxanide,21,2020-04-20,1,0,8,8,4,"Romark Laboratories L.C. ( 3 )|Materno-Perinatal Hospital of the State of Mexico ( 2 )|Universidade Federal do Rio de Janeiro ( 2 )|ANRS, Emerging Infectious Diseases ( 1 )|Assiut University ( 1 )|Azidus Brasil ( 1 )|CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )|Corpometria Institute ( 1 )|FundaciÃ³n HuÃ©sped ( 1 )|Laboratorios Roemmers S.A.I.C.F. ( 1 )|Obafemi Awolowo University ( 1 )|Rutgers, The State University of New Jersey ( 1 )|Shin Poong Pharmaceutical Co. Ltd. ( 1 )|Tanta University ( 1 )|University of Cape Town ( 1 )|University of Liverpool ( 1 )|University of Witwatersrand, South Africa ( 1 )",10.021,17,4
Drug,heparin,20,2020-05-04,3,0,5,5,7,"Frederick Health ( 2 )|University of Miami ( 2 )|University of Sao Paulo General Hospital ( 2 )|ARCA Biopharma, Inc. ( 1 )|Australian National University ( 1 )|Brazilian Clinical Research Institute ( 1 )|Clinica San Camilo, Argentina ( 1 )|Columbia University ( 1 )|Fundacion GenesisCare ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Rajaie Cardiovascular Medical and Research Center ( 1 )|University of Kentucky ( 1 )|University of Manitoba ( 1 )|University of Modena and Reggio Emilia ( 1 )|University of Pittsburgh ( 1 )|UPECLIN HC FM Botucatu Unesp ( 1 )|Weill Medical College of Cornell University ( 1 )",10.02,17,34
Drug,chloroquine,19,2020-04-20,1,0,6,8,4,"Tanta University ( 3 )|FundaÃ§Ã£o de Medicina Tropical Dr. Heitor Vieira Dourado ( 2 )|Government of Punjab, Specialized Healthcare and Medical Education Department ( 2 )|Beijing Chao Yang Hospital ( 1 )|Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva ( 1 )|Columbia University ( 1 )|Fundacion Clinica Valle del Lili ( 1 )|HaEmek Medical Center, Israel ( 1 )|Medical University of Vienna ( 1 )|Oxford University Clinical Research Unit, Vietnam ( 1 )|UMC Utrecht ( 1 )|Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. ( 1 )|University of Oxford ( 1 )|Washington University School of Medicine ( 1 )|Wroclaw Medical University ( 1 )",10.019,15,15
Drug,interferon,18,2020-05-06,1,0,9,5,3,"The University of Hong Kong ( 5 )|Shahid Beheshti University of Medical Sciences ( 2 )|Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|Novartis ( 1 )|Pontificia Universidad Catolica de Chile ( 1 )|Population Health Research Institute ( 1 )|Roswell Park Cancer Institute ( 1 )|Shanghai Jiao Tong University School of Medicine ( 1 )|Sunnybrook Health Sciences Centre ( 1 )|The Camelot Foundation ( 1 )|Tongji Hospital ( 1 )|University of the Philippines ( 1 )",10.018,13,11
Dietary Supplement,vitamin c,18,2020-04-16,5,0,7,5,1,"ProgenaBiome ( 3 )|University of Washington ( 2 )|Hunter Holmes Mcguire Veteran Affairs Medical Center ( 1 )|Lancaster General Hospital ( 1 )|Ministry of Health, Saudi Arabia ( 1 )|National Institute of Integrative Medicine, Australia ( 1 )|National University Hospital, Singapore ( 1 )|The Canadian College of Naturopathic Medicine ( 1 )|The Cleveland Clinic ( 1 )|Unidad Temporal COVID-19 en Centro Citibanamex ( 1 )|UniversitÃ© de Sherbrooke ( 1 )|University of Lahore ( 1 )|University of Palermo ( 1 )|Virginia Commonwealth University ( 1 )|Zhongnan Hospital ( 1 )",10.018,15,6
Drug,baricitinib,13,2020-04-17,1,0,3,8,1,"National Institute of Allergy and Infectious Diseases (NIAID) ( 2 )|Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders ( 1 )|Cambridge University Hospitals NHS Foundation Trust ( 1 )|Eli Lilly and Company ( 1 )|Hospital of Prato ( 1 )|Hospital Universitario de Fuenlabrada ( 1 )|Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 )|M Abdur Rahim Medical College and Hospital ( 1 )|Nova Scotia Health Authority ( 1 )|University Hospital of Patras ( 1 )|University of Oxford ( 1 )|University of Southern California ( 1 )",10.013,12,20
Drug,zinc,12,2020-04-26,2,0,4,4,2,"ProgenaBiome ( 3 )|Hospital Israelita Albert Einstein ( 1 )|Mansoura University ( 1 )|Ministry of Health, Saudi Arabia ( 1 )|National University Hospital, Singapore ( 1 )|Sheikh Zayed Federal Postgraduate Medical Institute ( 1 )|St. Francis Hospital, New York ( 1 )|Tanta University ( 1 )|The Canadian College of Naturopathic Medicine ( 1 )|The Cleveland Clinic ( 1 )",10.012,10,4
Drug,hydroxychloroquine / azithromycin,11,2020-04-08,1,0,3,6,1,"Institute for Research and Development of Medicinal and Food Plants of Guinea ( 2 )|Alkarkh Health Directorate-Baghdad ( 1 )|Hospital do Coracao ( 1 )|Hospital Israelita Albert Einstein ( 1 )|Ministry of Health, Turkey ( 1 )|Novartis ( 1 )|Rutgers, The State University of New Jersey ( 1 )|The Camelot Foundation ( 1 )|University Hospital, Montpellier ( 1 )|Yaounde Central Hospital ( 1 )",10.011,10,9
Drug,rivaroxaban,10,2020-04-10,1,0,3,4,2,"Bill & Melinda Gates Medical Research Institute ( 1 )|Brazilian Clinical Research Institute ( 1 )|Charite University, Berlin, Germany ( 1 )|Hospital AlemÃ£o Oswaldo Cruz ( 1 )|Imperial College London ( 1 )|Janssen Research & Development, LLC ( 1 )|Medical University of Vienna ( 1 )|Population Health Research Institute ( 1 )|Science Valley Research Institute ( 1 )|St. David's HealthCare ( 1 )",10.01,10,2
Drug,losartan,8,2020-04-11,0,1,3,3,1,University of Minnesota ( 2 )|Bassett Healthcare ( 1 )|Instituto do Cancer do Estado de SÃ£o Paulo ( 1 )|Sharp HealthCare ( 1 )|The Camelot Foundation ( 1 )|University of British Columbia ( 1 )|University of Kansas Medical Center ( 1 ),10.008,7,3
Procedure,therapeutic plasma exchange (tpe),7,2020-04-20,4,0,1,1,1,"UNICEF ( 2 )|Alexandria University ( 1 )|Emory University ( 1 )|Heidelberg University ( 1 )|Prisma Health-Upstate ( 1 )|University of Medicine and Pharmacy ""Victor Babes"" Timisoara ( 1 )",10.007,6,1
Drug,budesonide,6,2020-04-22,1,0,2,2,1,Fasa University of Medical Sciences ( 1 )|Fondation Ophtalmologique Adolphe de Rothschild ( 1 )|Fundacion Clinic per a la Recerca BiomÃ©dica ( 1 )|Mayo Clinic ( 1 )|University of Oxford ( 1 )|University of Pittsburgh ( 1 ),10.006,6,2
Drug,oseltamivir,6,2020-03-25,0,2,1,2,1,Tongji Hospital ( 2 )|Fuzhou General Hospital ( 1 )|Indonesia University ( 1 )|University Hospitals Coventry and Warwickshire NHS Trust ( 1 )|University of Health Sciences Lahore ( 1 ),10.006,5,1
Behavioral,NA,5,2020-04-07,2,0,1,1,1,"AgelessRx ( 1 )|Burnasyan Federal Medical Biophysical Center ( 1 )|Promundo, United States ( 1 )|The Ninth Hospital of Nanchang ( 1 )|University Hospital, Toulouse ( 1 )",10.005,5,243
Drug,pirfenidone,4,2020-02-10,1,0,1,1,1,Institut d'InvestigaciÃ³ BiomÃ¨dica de Bellvitge ( 1 )|Postgraduate Institute of Medical Education and Research ( 1 )|Soroka University Medical Center ( 1 )|Tongji Hospital ( 1 ),10.004,4,1
Biological,bnt162b2,13,2020-05-06,0,0,6,5,2,BioNTech SE ( 8 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 2 )|Canadian Immunization Research Network ( 1 )|Humanity & Health Medical Group Limited ( 1 )|The University of Hong Kong ( 1 ),9.013,5,9
Biological,bcg,13,2020-05-01,0,0,1,7,5,"Bandim Health Project ( 2 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Hellenic Institute for the Study of Sepsis ( 1 )|Hospital Universitario Dr. Jose E. Gonzalez ( 1 )|Murdoch Childrens Research Institute ( 1 )|Radboud University ( 1 )|Texas A&M University ( 1 )|Tuberculosis Research Centre, India ( 1 )|UMC Utrecht ( 1 )|Universidade Federal do Rio de Janeiro ( 1 )|University of Campinas, Brazil ( 1 )|University of Southern Denmark ( 1 )",9.013,12,4
Biological,coronavac,7,2021-06-24,0,0,2,3,2,Health Institutes of Turkey ( 4 )|Humanity & Health Medical Group Limited ( 1 )|The University of Hong Kong ( 1 )|University of Sao Paulo General Hospital ( 1 ),9.007,4,5
Biological,azd1222,6,2021-07-02,0,0,2,3,1,AstraZeneca ( 3 )|Humanity & Health Medical Group Limited ( 1 )|R-Pharm ( 1 )|Valneva Austria GmbH ( 1 ),9.006,4,3
Drug,sofosbuvir,6,2020-08-01,0,0,2,3,1,"Tanta University ( 2 )|Almaza Military Fever Hospital ( 1 )|Assiut University ( 1 )|Shin Poong Pharmaceutical Co. Ltd. ( 1 )|University of Witwatersrand, South Africa ( 1 )",9.006,5,NA
Drug,doxycycline,5,2020-04-26,0,0,1,1,3,"Dhaka Medical College ( 1 )|International Centre for Diarrhoeal Disease Research, Bangladesh ( 1 )|Max Health, Subsero Health ( 1 )|St. Francis Hospital, New York ( 1 )|Yaounde Central Hospital ( 1 )",9.005,5,1
Drug,sargramostim,5,2020-03-24,0,0,3,1,1,"Partner Therapeutics, Inc. ( 2 )|Nobelpharma ( 1 )|Singapore General Hospital ( 1 )|University Hospital, Ghent ( 1 )",9.005,4,2
Biological,bamlanivimab,5,2020-08-17,0,0,2,1,2,DHR Health Institute for Research and Development ( 1 )|Eli Lilly and Company ( 1 )|Fraser Health ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|UnitedHealth Group ( 1 ),9.005,5,NA
Drug,telmisartan,5,2020-04-21,0,0,2,2,1,"Hospital Regional de Alta Especialidad de Zumpango ( 1 )|Laboratorio Elea Phoenix S.A. ( 1 )|University Hospital, Bordeaux ( 1 )|University Hospital, Strasbourg, France ( 1 )|University of Hawaii ( 1 )",9.005,5,3
Biological,inactivated vaccine,4,2021-07-13,0,0,1,2,1,"Sinovac Biotech Co., Ltd ( 2 )|Pontificia Universidad Catolica de Chile ( 1 )|PT Bio Farma ( 1 )",9.004,3,1
Drug,kg,4,2021-05-31,0,0,1,1,2,"aTyr Pharma, Inc. ( 1 )|Clinical Research Centre, Malaysia ( 1 )|Corvus Pharmaceuticals, Inc. ( 1 )|The TIMI Study Group ( 1 )",9.004,4,NA
Drug,cholecalciferol,7,2020-04-09,2,0,0,3,2,"CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 2 )|FundaciÃ³n para la InvestigaciÃ³n Biosanitaria del Principado de Asturias ( 1 )|Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado ( 1 )|Kasr El Aini Hospital ( 1 )|University Hospital, Angers ( 1 )|University of Liege ( 1 )",8.007,6,1
Biological,convalescent plasma,110,2020-05-04,18,16,51,25,0,"Johns Hopkins University ( 3 )|Columbia University ( 2 )|Hackensack Meridian Health ( 2 )|Institute of Liver and Biliary Sciences, India ( 2 )|Karolinska University Hospital ( 2 )|University of Pennsylvania ( 2 )|Aga Khan University ( 1 )|Ain Shams University ( 1 )|Alkarkh Health Directorate-Baghdad ( 1 )|Andalusian Network for Design and Translation of Advanced Therapies ( 1 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Azienda Ospedaliero, Universitaria Pisana ( 1 )|Azienda Socio Sanitaria Territoriale di Mantova ( 1 )|Bagcilar Training and Research Hospital ( 1 )|Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh ( 1 )|Biofarma ( 1 )|Brigham and Women's Hospital ( 1 )|Cairo University ( 1 )|Cedars-Sinai Medical Center ( 1 )|Centenario Hospital Miguel Hidalgo ( 1 )|Centro de EducaciÃ³n Medica e Investigaciones ClÃ­nicas Norberto Quirno ( 1 )|Centro de HematologÃ­a y Medicina Interna ( 1 )|D'Or Institute for Research and Education ( 1 )|Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen ( 1 )|Emory University ( 1 )|Erasmus Medical Center ( 1 )|Federal Research Clinical Center of Federal Medical & Biological Agency, Russia ( 1 )|Fondazione Policlinico Universitario Agostino Gemelli IRCCS ( 1 )|Foundation IRCCS San Matteo Hospital ( 1 )|FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 1 )|Fundacion Arturo Lopez Perez ( 1 )|Fundacion Infant ( 1 )|Grifols Therapeutics LLC ( 1 )|Grupo Mexicano para el Estudio de la Medicina Intensiva ( 1 )|Heinrich-Heine University, Duesseldorf ( 1 )|Helsinki University Central Hospital ( 1 )|Henry Ford Health System ( 1 )|Hilton Pharma ( 1 )|Hospital de Clinicas de Porto Alegre ( 1 )|Hospital de Infecciosas Francisco Javier Muniz ( 1 )|Hospital Italiano de Buenos Aires ( 1 )|Hospital San Jose Tec de Monterrey ( 1 )|Hvidovre University Hospital ( 1 )|Indonesia University ( 1 )|Inova Health Care Services ( 1 )|Institute for Transfusion Medicine of RNM ( 1 )|Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado ( 1 )|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 )|IRCCS Policlinico S. Matteo ( 1 )|Istituto Superiore di SanitÃ  ( 1 )|King Fahad Specialist Hospital Dammam ( 1 )|Lahore General Hospital ( 1 )|Makerere University ( 1 )|Max Healthcare Insititute Limited ( 1 )|Mazandaran University of Medical Sciences ( 1 )|McMaster University ( 1 )|Medical College of Wisconsin ( 1 )|Ministry of Health and Population, Egypt ( 1 )|National and Kapodistrian University of Athens ( 1 )|Northside Hospital, Inc. ( 1 )|Norton Healthcare ( 1 )|NYU Langone Health ( 1 )|Orthosera Kft. ( 1 )|Pontificia Universidad Catolica de Chile ( 1 )|Rigshospitalet, Denmark ( 1 )|Royal College of Surgeons in Ireland - Medical University of Bahrain ( 1 )|Saint Francis Care ( 1 )|Science Valley Research Institute ( 1 )|Skane University Hospital ( 1 )|South African National Blood Service ( 1 )|South Valley University ( 1 )|Stanford University ( 1 )|Stony Brook University ( 1 )|The Camelot Foundation ( 1 )|The Christ Hospital ( 1 )|The Methodist Hospital Research Institute ( 1 )|Thomas Jefferson University ( 1 )|TriHealth Inc. ( 1 )|UNICEF ( 1 )|Universidad Nacional de AsunciÃ³n ( 1 )|Universidad Peruana Cayetano Heredia ( 1 )|Universitaire Ziekenhuizen Leuven ( 1 )|University Hospital, Basel, Switzerland ( 1 )|University Hospital, Geneva ( 1 )|University of California, San Francisco ( 1 )|University of Catanzaro ( 1 )|University of Chicago ( 1 )|University of Erlangen-NÃ¼rnberg Medical School ( 1 )|University of Illinois at Chicago ( 1 )|University of Liege ( 1 )|University of Mississippi Medical Center ( 1 )|University of New Mexico ( 1 )|University of North Carolina, Chapel Hill ( 1 )|University of Oxford ( 1 )|University of Sao Paulo General Hospital ( 1 )|University of the Philippines ( 1 )|University of Virginia ( 1 )|University of Zurich ( 1 )|VA Office of Research and Development ( 1 )|Vanderbilt University Medical Center ( 1 )|Vinmec Research Institute of Stem Cell and Gene Technology ( 1 )|West Virginia University ( 1 )|William Beaumont Hospitals ( 1 )",7.11,103,42
Drug,apixaban,6,2021-03-12,0,0,0,4,2,Brazilian Clinical Research Institute ( 1 )|Cambridge University Hospitals NHS Foundation Trust ( 1 )|Duke University ( 1 )|Icahn School of Medicine at Mount Sinai ( 1 )|Universidade do Vale do Sapucai ( 1 )|University of Pittsburgh ( 1 ),7.006,6,1
Drug,n-acetylcysteine,6,2020-05-01,1,2,2,1,0,Ain Shams University ( 1 )|Baylor College of Medicine ( 1 )|Cambridge Health Alliance ( 1 )|Memorial Sloan Kettering Cancer Center ( 1 )|Prisma Health-Upstate ( 1 )|Unidad Temporal COVID-19 en Centro Citibanamex ( 1 ),7.006,6,NA
Biological,inactivated covid-19 vaccine,6,2021-10-04,0,0,0,1,5,"China National Biotec Group Company Limited ( 4 )|Sinovac Biotech Co., Ltd ( 2 )",7.006,2,NA
Biological,biological,4,2020-09-04,1,1,1,1,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 1 )|BioNTech SE ( 1 )|Hospital Central Militar ( 1 )|Kanuni Sultan Suleyman Training and Research Hospital ( 1 )",7.004,4,NA
Drug,sodium,4,2021-03-09,1,0,2,0,1,IRCCS Azienda Ospedaliero-Universitaria di Bologna ( 1 )|Marinomed Biotech AG ( 1 )|Region Skane ( 1 )|The TIMI Study Group ( 1 ),7.004,4,NA
Biological,bacille calmette-guã©rin (bcg),4,2020-05-04,0,0,0,2,2,TASK Applied Science ( 2 )|UMC Utrecht ( 2 ),7.004,2,NA
Drug,cyclosporine,4,2020-07-20,0,1,2,0,1,Baylor College of Medicine ( 1 )|Instituto de InvestigaciÃ³n Sanitaria de la FundaciÃ³n JimÃ©nez DÃ­az ( 1 )|QuantumLeap Healthcare Collaborative ( 1 )|University of Pennsylvania ( 1 ),7.004,4,NA
Drug,clopidogrel,3,2020-04-23,1,0,1,0,1,Imperial College London ( 1 )|The TIMI Study Group ( 1 )|University of Milan ( 1 ),7.003,3,NA
Drug,distilled water,3,2021-01-19,1,0,1,0,1,"FundaciÃ³n para el Fomento de la InvestigaciÃ³n Sanitaria y BiomÃ©dica de la Comunitat Valenciana ( 1 )|King Abdulaziz University ( 1 )|University of California, San Francisco ( 1 )",7.003,3,7
Behavioral,experimental group,3,2021-03-17,1,0,1,0,1,"ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida ( 1 )|Sinovac Biotech Co., Ltd ( 1 )|University of Texas Southwestern Medical Center ( 1 )",7.003,3,NA
Biological,adsorbed covid-19 (inactivated) vaccine,3,2021-02-15,0,0,0,1,2,Butantan Institute ( 2 )|D'Or Institute for Research and Education ( 1 ),7.003,2,NA
Drug,ravulizumab,3,2020-04-28,0,0,0,2,1,Alexion Pharmaceuticals ( 1 )|Brigham and Women's Hospital ( 1 )|Cambridge University Hospitals NHS Foundation Trust ( 1 ),7.003,3,4
Drug,sevoflurane,3,2020-04-21,0,0,0,2,1,FundaciÃ³n para la InvestigaciÃ³n del Hospital ClÃ­nico de Valencia ( 1 )|Sunnybrook Health Sciences Centre ( 1 )|University of Zurich ( 1 ),7.003,3,NA
Biological,oral polio vaccine,2,2020-09-04,0,0,0,1,1,"Bandim Health Project ( 1 )|NeuroActiva, Inc. ( 1 )",7.002,2,NA
Dietary Supplement,d,2,2021-03-01,0,0,0,1,1,Brazilian Clinical Research Institute ( 1 )|The Canadian College of Naturopathic Medicine ( 1 ),7.002,2,2
Drug,ledipasvir,2,2020-08-26,0,0,0,1,1,Almaza Military Fever Hospital ( 1 )|Assiut University ( 1 ),7.002,2,NA
Biological,octagam,2,2020-05-21,0,0,0,1,1,Octapharma ( 1 )|Sharp HealthCare ( 1 ),7.002,2,NA
Drug,silymarin,2,2021-03-19,0,0,0,1,1,Cairo University ( 1 )|F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica ( 1 ),7.002,2,1
Drug,sofosbuvir/ledipasvir,2,2020-08-26,0,0,0,1,1,Almaza Military Fever Hospital ( 1 )|Assiut University ( 1 ),7.002,2,NA
Drug,thromboprophylaxis,2,2020-04-13,0,0,0,1,1,Medical University of Vienna ( 1 )|University of Iowa ( 1 ),7.002,2,1
Drug,favipiravir,34,2020-05-03,4,0,10,20,0,"Appili Therapeutics Inc. ( 2 )|King Abdullah International Medical Research Center ( 2 )|Peking University First Hospital ( 2 )|Ain Shams University ( 1 )|ASST Fatebenefratelli Sacco ( 1 )|Bangladesh Medical Research Council (BMRC) ( 1 )|Baqiyatallah Medical Sciences University ( 1 )|Bayside Health ( 1 )|Beijing Chao Yang Hospital ( 1 )|Chelsea and Westminster NHS Foundation Trust ( 1 )|Chromis LLC ( 1 )|CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )|Fujifilm Pharmaceuticals U.S.A., Inc. ( 1 )|Health Institutes of Turkey ( 1 )|Hospital General de MÃ©xico Dr. Eduardo Liceaga ( 1 )|Ina-Respond ( 1 )|Indonesia University ( 1 )|Ministry of Health, Turkey ( 1 )|Nepal Health Research Council ( 1 )|Penang Hospital, Malaysia ( 1 )|PharmaMar ( 1 )|Promomed, LLC ( 1 )|R-Pharm ( 1 )|Royal College of Surgeons in Ireland - Medical University of Bahrain ( 1 )|Shin Poong Pharmaceutical Co. Ltd. ( 1 )|Stanford University ( 1 )|Tanta University ( 1 )|University College, London ( 1 )|University of Oxford ( 1 )|University of Pecs ( 1 )|University of the Philippines ( 1 )",6.034,31,8
Biological,plasma,16,2020-05-01,3,0,11,2,0,"Johns Hopkins University ( 2 )|Universidad del Rosario ( 2 )|Ain Shams University ( 1 )|Azienda Ospedaliera CittÃ  della Salute e della Scienza di Torino ( 1 )|Brigham and Women's Hospital ( 1 )|Columbia University ( 1 )|Ente Ospedaliero Cantonale, Bellinzona ( 1 )|Federal Research Clinical Center of Federal Medical & Biological Agency, Russia ( 1 )|Fundacion Clinic per a la Recerca BiomÃ©dica ( 1 )|Hospital Universitario Dr. Jose E. Gonzalez ( 1 )|Institute of Liver and Biliary Sciences, India ( 1 )|Rigshospitalet, Denmark ( 1 )|Stony Brook University ( 1 )|Thomas Jefferson University ( 1 )",6.016,14,4
Drug,camostat mesilate,15,2020-05-01,0,1,12,2,0,"Stanford University ( 3 )|Academic and Community Cancer Research United ( 1 )|Cancer Research UK ( 1 )|Heinrich-Heine University, Duesseldorf ( 1 )|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 )|KU Leuven ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|Sagent Pharmaceuticals Inc. ( 1 )|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( 1 )|University Hospital, Ghent ( 1 )|University of Aarhus ( 1 )|University of Kentucky ( 1 )|Yale University ( 1 )",6.015,13,13
Drug,ruxolitinib,11,2020-05-04,1,0,7,3,0,"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ( 1 )|FundaciÃ³n de investigaciÃ³n HM ( 1 )|Grupo Cooperativo de HemopatÃ­as Malignas ( 1 )|Imperial College London ( 1 )|Incyte Corporation ( 1 )|Novartis ( 1 )|Philipps University Marburg Medical Center ( 1 )|Prisma Health-Upstate ( 1 )|University Health Network, Toronto ( 1 )|University of Jena ( 1 )|University of Sao Paulo General Hospital ( 1 )",6.011,11,4
Biological,ad26.cov2.s,11,2021-05-13,0,2,6,3,0,Janssen Vaccines & Prevention B.V. ( 8 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 2 )|Janssen Pharmaceutical K.K. ( 1 ),6.011,3,6
Biological,mrna-1273,11,2020-02-21,0,3,2,6,0,"ModernaTX, Inc. ( 6 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 3 )|GlaxoSmithKline ( 1 )|National Institutes of Health Clinical Center (CC) ( 1 )",6.011,4,10
Biological,inactivated sars-cov-2 vaccine,8,2020-04-14,0,1,4,3,0,"Chinese Academy of Medical Sciences ( 3 )|Beijing Minhai Biotechnology Co., Ltd ( 2 )|China National Biotec Group Company Limited ( 1 )|Laboratorio Elea Phoenix S.A. ( 1 )|Sinovac Biotech Co., Ltd ( 1 )",6.008,5,4
Drug,melatonin,6,2020-04-16,3,0,2,1,0,State University of New York at Buffalo ( 2 )|Baqiyatallah Medical Sciences University ( 1 )|Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 )|Lancaster General Hospital ( 1 )|Unidad Temporal COVID-19 en Centro Citibanamex ( 1 ),6.006,5,NA
Drug,niclosamide,6,2021-06-18,0,1,3,2,0,"AzurRx BioPharma, Inc. ( 1 )|Cambridge University Hospitals NHS Foundation Trust ( 1 )|CharitÃ© Research Organisation GmbH ( 1 )|NeuroBo Pharmaceuticals Inc. ( 1 )|Tufts Medical Center ( 1 )|UNION therapeutics ( 1 )",6.006,6,NA
Drug,povidone/iodine,6,2020-04-29,0,1,4,1,0,"Hampshire Hospitals NHS Foundation Trust ( 1 )|National University Hospital, Singapore ( 1 )|Poitiers University Hospital ( 1 )|Stanford University ( 1 )|Universiti Sains Islam Malaysia ( 1 )|University of Kentucky ( 1 )",6.006,6,1
Biological,adenovirus type 5 vector,6,2020-04-07,0,1,3,2,0,"CanSino Biologics Inc. ( 4 )|Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China ( 1 )|NPO Petrovax ( 1 )",6.006,3,2
Device,cellectraâ® 2000,6,2020-04-03,0,2,2,2,0,Inovio Pharmaceuticals ( 4 )|International Vaccine Institute ( 2 ),6.006,2,1
Drug,atorvastatin,5,2020-05-01,1,0,1,3,0,Cambridge University Hospitals NHS Foundation Trust ( 1 )|Imperial College London ( 1 )|Lebanese American University Medical Center ( 1 )|Mount Auburn Hospital ( 1 )|Rajaie Cardiovascular Medical and Research Center ( 1 ),6.005,5,2
Drug,quercetin,5,2020-05-01,2,2,0,0,1,"HÃ´pital Universitaire Sahloul ( 2 )|Azienda di Servizi alla Persona di Pavia ( 1 )|Kanuni Sultan Suleyman Training and Research Hospital ( 1 )|Ministry of Health, Saudi Arabia ( 1 )",6.005,4,NA
Drug,famotidine,5,2020-08-06,0,1,2,2,0,"Northwell Health ( 2 )|Chattogram General Hospital ( 1 )|Prisma Health-Upstate ( 1 )|Profact, Inc. ( 1 )",6.005,4,NA
Drug,ly3819253,5,2020-08-03,0,1,1,3,0,Eli Lilly and Company ( 4 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),6.005,2,6
Drug,regn10987,5,2021-04-19,0,1,3,1,0,Regeneron Pharmaceuticals ( 5 ),6.005,1,3
Drug,regn10933,5,2021-04-19,0,1,3,1,0,Regeneron Pharmaceuticals ( 5 ),6.005,1,3
Drug,bromhexine hydrochloride,4,2020-04-02,1,1,0,0,2,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health ( 1 )|General and Teaching Hospital Celje ( 1 )|Instituto Nacional de Rehabilitacion ( 1 )|Second Affiliated Hospital of Wenzhou Medical University ( 1 )",6.004,4,13
Biological,chadox1,4,2020-03-20,0,1,2,1,0,University of Oxford ( 4 ),6.004,1,11
Biological,inactive sars-cov-2 vaccine (vero cell),3,2021-09-13,0,0,1,0,2,Jiangsu Province Centers for Disease Control and Prevention ( 3 ),6.003,1,NA
Drug,ino-4800,3,2020-04-03,0,1,1,1,0,Inovio Pharmaceuticals ( 2 )|International Vaccine Institute ( 1 ),6.003,2,1
Drug,leflunomide,3,2020-04-22,0,1,1,1,0,Ashford and St. Peter's Hospitals NHS Trust ( 1 )|City of Hope Medical Center ( 1 )|University of Chicago ( 1 ),6.003,3,NA
Drug,regn10933 / regn10987,3,2021-04-19,0,1,1,1,0,Regeneron Pharmaceuticals ( 3 ),6.003,1,3
Drug,prednisone,3,2020-04-10,1,0,1,1,0,Hospices Civils de Lyon ( 1 )|South Valley University ( 1 )|University of Chile ( 1 ),6.003,3,1
Biological,bnt162b1,3,2020-05-06,0,1,1,1,0,BioNTech SE ( 3 ),6.003,1,6
Drug,ensovibep,3,2021-03-24,0,1,1,1,0,Molecular Partners AG ( 3 ),6.003,1,NA
Drug,gargle,2,2020-04-25,0,0,1,0,1,National Taiwan University Hospital ( 1 )|University of Kentucky ( 1 ),6.002,2,3
Drug,iota-carrageenan,2,2020-08-19,0,0,1,0,1,"Centro de EducaciÃ³n Medica e Investigaciones ClÃ­nicas Norberto Quirno ( 1 )|Ministry of Public Health, Argentina ( 1 )",6.002,2,1
Drug,fuzheng huayu,2,2020-02-15,0,0,1,0,1,ShuGuang Hospital ( 2 ),6.002,1,NA
Drug,ruconest,2,2021-01-07,0,0,1,0,1,IMMUNOe Research Centers ( 1 )|Pharming Technologies B.V. ( 1 ),6.002,2,NA
Other,telehealth,14,2020-04-20,13,0,0,0,1,Neuroganics LLC ( 2 )|BandÄ±rma Onyedi EylÃ¼l University ( 1 )|Chinese University of Hong Kong ( 1 )|Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory ( 1 )|Grigore T. Popa University of Medicine and Pharmacy ( 1 )|Hacettepe University ( 1 )|IRCCS Azienda Ospedaliero-Universitaria di Bologna ( 1 )|Istanbul University-Cerrahpasa ( 1 )|Istinye University ( 1 )|UKK Institute ( 1 )|Universidade Federal de Pernambuco ( 1 )|University of British Columbia ( 1 )|Wroclaw Medical University ( 1 ),5.014,13,1
Drug,anakinra,14,2020-04-27,0,0,6,8,0,"Hellenic Institute for the Study of Sepsis ( 3 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ( 1 )|Fundacion Miguel Servet ( 1 )|Hamad Medical Corporation ( 1 )|Karolinska University Hospital ( 1 )|Swedish Orphan Biovitrum ( 1 )|University Hospital, Ghent ( 1 )|University Hospital, Tours ( 1 )|University of Alabama at Birmingham ( 1 )|University of Manchester ( 1 )|University of Oxford ( 1 )",5.014,12,7
Other,best available therapy,10,2020-05-06,0,0,7,3,0,AO GENERIUM ( 2 )|MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 2 )|City of Hope Medical Center ( 1 )|Emory University ( 1 )|Hospital Universitario Dr. Jose E. Gonzalez ( 1 )|M.D. Anderson Cancer Center ( 1 )|Ohio State University Comprehensive Cancer Center ( 1 )|Roswell Park Cancer Institute ( 1 ),5.01,8,1
Drug,sarilumab,8,2020-04-20,0,0,5,3,0,"Assistance Publique - HÃ´pitaux de Paris ( 1 )|Clinica Universidad de Navarra, Universidad de Navarra ( 1 )|Frederiksberg University Hospital ( 1 )|FundaciÃ³n de InvestigaciÃ³n BiomÃ©dica - Hospital Universitario de La Princesa ( 1 )|MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 )|Regeneron Pharmaceuticals ( 1 )|Sanofi ( 1 )|VA Boston Healthcare System ( 1 )",5.008,8,4
Diagnostic Test,biological samples,8,2020-04-22,7,0,0,0,1,"Assistance Publique - HÃ´pitaux de Paris ( 1 )|Central Hospital, Nancy, France ( 1 )|Centre Hospitalier RÃ©gional d'OrlÃ©ans ( 1 )|Centre Hospitalier RenÃ© Dubos ( 1 )|Centre Hospitalier Universitaire de Besancon ( 1 )|Institut Pasteur ( 1 )|Poitiers University Hospital ( 1 )|Rennes University Hospital ( 1 )",5.008,8,4
Biological,gam-covid-vac,7,2020-11-17,0,0,4,3,0,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation ( 4 )|Ministerio de Salud de Ciudad AutÃ³noma de Buenos Aires ( 2 )|Dr. Reddy's Laboratories Limited ( 1 )",5.007,3,3
Drug,lenzilumab,6,2020-04-15,0,0,4,2,0,"CytoDyn, Inc. ( 3 )|Humanigen, Inc. ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|Peter MacCallum Cancer Centre, Australia ( 1 )",5.006,4,2
Drug,nafamostat mesilate,6,2020-04-03,0,0,3,3,0,Chong Kun Dang Pharmaceutical ( 2 )|Institut Pasteur de Dakar ( 1 )|University Hospital Padova ( 1 )|University of Edinburgh ( 1 )|University of Melbourne ( 1 ),5.006,5,3
Drug,peginterferon,6,2020-04-16,0,0,4,2,0,"University Health Network, Toronto ( 2 )|Cardresearch ( 1 )|Johns Hopkins University ( 1 )|Massachusetts General Hospital ( 1 )|Stanford University ( 1 )",5.006,5,3
Drug,pulmozyme,6,2020-04-15,0,0,5,1,0,"Acibadem University ( 1 )|Boston Children's Hospital ( 1 )|Fondation Ophtalmologique Adolphe de Rothschild ( 1 )|QuantumLeap Healthcare Collaborative ( 1 )|University College, London ( 1 )|University of South Alabama ( 1 )",5.006,6,1
Other,best supportive care,5,2020-04-28,0,0,3,2,0,AB Science ( 1 )|Alexion Pharmaceuticals ( 1 )|Biocon Limited ( 1 )|Hackensack Meridian Health ( 1 )|Hospital de Clinicas de Porto Alegre ( 1 ),5.005,5,3
Drug,ciclesonide,5,2020-05-07,0,0,2,3,0,"Covis Pharma S.Ã .r.l. ( 1 )|Korea University Guro Hospital ( 1 )|McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 )|St Goran's Hospital ( 1 )|University Hospital, Bordeaux ( 1 )",5.005,5,2
Drug,fluvoxamine,5,2020-04-08,0,0,2,3,0,Washington University School of Medicine ( 2 )|Duke University ( 1 )|SigmaDrugs Research Ltd. ( 1 )|University of Minnesota ( 1 ),5.005,4,1
Drug,arbidol,5,2020-02-14,1,0,0,0,4,Tongji Hospital ( 2 )|Guangzhou 8th People's Hospital ( 1 )|Ruijin Hospital ( 1 )|Second Affiliated Hospital of Wenzhou Medical University ( 1 ),5.005,4,1
Biological,vir-7831,5,2021-05-27,0,0,2,3,0,"Vir Biotechnology, Inc. ( 2 )|Eli Lilly and Company ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|University of Liverpool ( 1 )",5.005,4,3
Behavioral,information,4,2021-04-28,2,0,0,0,2,"Bandim Health Project ( 2 )|National Bureau of Economic Research, Inc. ( 1 )|University of the Balearic Islands ( 1 )",5.004,3,1
Biological,recombinant new coronavirus vaccine (cho cell) group,4,2021-10-11,1,1,0,2,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 4 )",5.004,1,NA
Drug,casirivimab,4,2021-04-05,0,0,2,2,0,Regeneron Pharmaceuticals ( 2 )|DHR Health Institute for Research and Development ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),5.004,3,2
Drug,daclatasvir,4,2020-08-01,0,0,2,2,0,"Tanta University ( 2 )|Shin Poong Pharmaceutical Co. Ltd. ( 1 )|University of Witwatersrand, South Africa ( 1 )",5.004,3,NA
Biological,imdevimab,4,2021-04-05,0,0,2,2,0,DHR Health Institute for Research and Development ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|Regeneron Pharmaceuticals ( 1 )|University of Pittsburgh ( 1 ),5.004,4,1
Drug,mavrilimumab,4,2020-07-28,0,0,3,1,0,"Kiniksa Pharmaceuticals, Ltd. ( 1 )|The Cleveland Clinic ( 1 )|University of Cincinnati ( 1 )|Virginia Commonwealth University ( 1 )",5.004,4,1
Drug,paracetamol,4,2020-03-20,0,0,1,3,0,"University of Oxford ( 2 )|ANRS, Emerging Infectious Diseases ( 1 )|CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )",5.004,3,4
Biological,sars-cov-2 rs,4,2020-04-24,0,0,2,2,0,Novavax ( 4 ),5.004,1,5
Drug,atazanavir,3,2020-07-03,0,0,1,2,0,"Hospital do Coracao ( 1 )|NeuroActiva, Inc. ( 1 )|Obafemi Awolowo University ( 1 )",5.003,3,1
Drug,canakinumab,3,2020-04-24,0,0,1,2,0,"Novartis ( 1 )|The Cleveland Clinic ( 1 )|University Hospital, Basel, Switzerland ( 1 )",5.003,3,2
Drug,cannabidiol,3,2021-01-28,0,0,1,2,0,University of Sao Paulo ( 2 )|Rabin Medical Center ( 1 ),5.003,2,2
Drug,fostamatinib,3,2020-11-13,0,0,2,1,0,Imperial College London ( 1 )|National Institutes of Health Clinical Center (CC) ( 1 )|Rigel Pharmaceuticals ( 1 ),5.003,3,2
Drug,infliximab,3,2020-09-23,0,0,2,1,0,Duke University ( 1 )|Jena University Hospital ( 1 )|Tufts Medical Center ( 1 ),5.003,3,NA
Drug,ly3832479,3,2020-11-17,0,0,1,2,0,Eli Lilly and Company ( 3 ),5.003,1,4
Drug,tofacitinib,3,2020-06-02,0,0,2,1,0,Hospital Israelita Albert Einstein ( 1 )|I.M. Sechenov First Moscow State Medical University ( 1 )|Yale University ( 1 ),5.003,3,1
Drug,anticoagulation,3,2020-06-22,0,0,1,2,0,Institute of Cell Therapy ( 1 )|Unity Health Toronto ( 1 )|University of Sao Paulo General Hospital ( 1 ),5.003,3,3
Biological,brii-196,3,2020-08-17,0,0,1,2,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 2 )|Brii Biosciences Limited ( 1 ),5.003,2,1
Biological,brii-196/brii-198,3,2020-08-17,0,0,1,2,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 2 )|Brii Biosciences Limited ( 1 ),5.003,2,1
Biological,brii-198,3,2020-08-17,0,0,1,2,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 2 )|Brii Biosciences Limited ( 1 ),5.003,2,1
Biological,epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),3,2021-08-19,0,0,1,2,0,"Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ""Vector"" ( 3 )",5.003,1,NA
Biological,moderna covid-19 vaccine,3,2021-03-19,0,0,1,2,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 2 )|McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 ),5.003,2,NA
placebo,placebo control,3,2021-05-26,0,0,2,1,0,"Universiti Sains Malaysia ( 1 )|University of Maryland, Baltimore ( 1 )|WestVac Biopharma Co., Ltd. ( 1 )",5.003,3,NA
Drug,sirolimus,3,2020-04-05,0,0,2,1,0,Alexandria University ( 1 )|University of Chicago ( 1 )|University of Cincinnati ( 1 ),5.003,3,NA
Drug,sng001,3,2020-08-17,0,0,1,2,0,Synairgen Research Ltd. ( 2 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),5.003,2,1
Biological,vla2001,3,2021-06-21,0,0,1,2,0,Valneva Austria GmbH ( 3 ),5.003,1,NA
Drug,arb,2,2020-05-18,1,0,0,0,1,"The George Institute ( 1 )|University Hospital, Gentofte, Copenhagen ( 1 )",5.002,2,4
Drug,sodium bicarbonate,2,2020-05-02,1,0,0,0,1,Mansoura University ( 1 )|West Virginia University ( 1 ),5.002,2,NA
Drug,imatinib,2,2020-04-07,0,0,1,1,0,"Hospital Universitario de Fuenlabrada ( 1 )|University of Maryland, Baltimore ( 1 )",5.002,2,1
Drug,imu-838,2,2020-05-01,0,0,1,1,0,Immunic AG ( 1 )|University Hospitals Coventry and Warwickshire NHS Trust ( 1 ),5.002,2,NA
Biological,mrna-1273.211,2,2021-05-13,0,0,1,1,0,"ModernaTX, Inc. ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )",5.002,2,1
Dietary Supplement,nigella sativa oil,2,2020-05-21,0,0,1,1,0,Beni-Suef University ( 1 )|King Abdulaziz University ( 1 ),5.002,2,2
Drug,omega-3,2,2020-07-30,0,0,1,1,0,Beni-Suef University ( 1 )|Icahn School of Medicine at Mount Sinai ( 1 ),5.002,2,1
Drug,opaganib,2,2020-07-09,0,0,1,1,0,RedHill Biopharma Limited ( 2 ),5.002,1,NA
Biological,pfizer-biontech covid-19 vaccine,2,2021-08-23,0,0,1,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|Sunnybrook Health Sciences Centre ( 1 ),5.002,2,NA
Biological,sars-cov-2 recombinant spike protein,2,2021-08-11,0,0,1,1,0,Cinnagen ( 2 ),5.002,1,NA
Biological,sars-cov-2 recombinant spike protein / advax-sm adjuvant,2,2021-08-11,0,0,1,1,0,Cinnagen ( 2 ),5.002,1,NA
Drug,xav-19,2,2021-05-27,0,0,1,1,0,Nantes University Hospital ( 1 )|Xenothera SAS ( 1 ),5.002,2,2
Biological,coronavirus vaccine,2,2021-08-20,1,0,0,0,1,Beijing 302 Hospital ( 2 ),5.002,1,NA
Drug,ibuprofen,2,2020-04-02,1,0,0,0,1,King's College London ( 1 )|QuÃ­mica Luar SRL ( 1 ),5.002,2,3
Biological,abatacept,2,2020-09-23,0,0,1,1,0,Bristol-Myers Squibb ( 1 )|Duke University ( 1 ),5.002,2,NA
Biological,advax-sm adjuvant,2,2021-08-11,0,0,1,1,0,Cinnagen ( 2 ),5.002,1,NA
Drug,ambrisentan,2,2021-02-24,0,0,1,1,0,Cambridge University Hospitals NHS Foundation Trust ( 1 )|Noorik Biopharmaceuticals AG ( 1 ),5.002,2,1
Drug,avigan,2,2021-01-15,0,0,1,1,0,Dr. Reddy's Laboratories Limited ( 1 )|Hayandra Peduli Foundation ( 1 ),5.002,2,NA
Drug,c21,2,2021-04-28,0,0,1,1,0,Vicore Pharma AB ( 2 ),5.002,1,NA
Drug,edp1815,2,2020-07-23,0,0,1,1,0,"Cambridge University Hospitals NHS Foundation Trust ( 1 )|Evelo Biosciences, Inc. ( 1 )",5.002,2,1
Combination Product,favipiravir / standard care,2,2020-04-16,0,0,1,1,0,"Fujifilm Pharmaceuticals U.S.A., Inc. ( 1 )|University of the Philippines ( 1 )",5.002,2,NA
Biological,kg),2,2020-08-17,0,0,1,1,0,"National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|Shanghai Junshi Bioscience Co., Ltd. ( 1 )",5.002,2,NA
Biological,lanadelumab,2,2020-10-14,0,0,1,1,0,Amgen ( 1 )|Radboud University ( 1 ),5.002,2,NA
Biological,menacwy,2,2020-03-20,0,0,1,1,0,University of Oxford ( 2 ),5.002,1,9
Drug,meplazumab,2,2020-02-06,0,0,1,1,0,Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd ( 1 )|Tang-Du Hospital ( 1 ),5.002,2,NA
Drug,selinexor,2,2020-04-14,0,0,1,1,0,"Karyopharm Therapeutics Inc ( 1 )|Peter MacCallum Cancer Centre, Australia ( 1 )",5.002,2,NA
Drug,siltuximab,2,2020-03-31,0,0,1,1,0,"Fundacion Clinic per a la Recerca BiomÃ©dica ( 1 )|University Hospital, Ghent ( 1 )",5.002,2,2
Drug,tacrolimus,2,2020-04-07,0,0,1,1,0,Hospital Universitari de Bellvitge ( 1 )|Leiden University Medical Center ( 1 ),5.002,2,2
Drug,txa127,2,2021-06-09,0,0,1,1,0,Columbia University ( 1 )|Vanderbilt University Medical Center ( 1 ),5.002,2,NA
Drug,veru-111,2,2020-05-13,0,0,1,1,0,Veru Inc. ( 2 ),5.002,1,NA
Biological,mesenchymal stem cells,33,2020-04-22,3,7,23,0,0,"Hope Biosciences ( 3 )|Beijing 302 Hospital ( 2 )|Ottawa Hospital Research Institute ( 2 )|Aljazeera Hospital ( 1 )|Andalusian Network for Design and Translation of Advanced Therapies ( 1 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Baylor College of Medicine ( 1 )|Fuzhou General Hospital ( 1 )|ImmunityBio, Inc. ( 1 )|Indonesia University ( 1 )|Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus ( 1 )|Instituto de Medicina Regenerativa ( 1 )|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 )|Jinnah Hospital ( 1 )|Kanuni Sultan Suleyman Training and Research Hospital ( 1 )|Masonic Cancer Center, University of Minnesota ( 1 )|National Institute of Blood and Marrow Transplant (NIBMT), Pakistan ( 1 )|Puerta de Hierro University Hospital ( 1 )|Puren Hospital Affiliated to Wuhan University of Science and Technology ( 1 )|Red de Terapia Celular ( 1 )|Renmin Hospital of Wuhan University ( 1 )|Restem, LLC. ( 1 )|Ruijin Hospital ( 1 )|SBÃœ Dr. Sadi Konuk EÄŸitim ve AraÅŸtÄ±rma Hastanesi ( 1 )|Stem Cells Arabia ( 1 )|UNICEF ( 1 )|University of Liege ( 1 )|University of Miami ( 1 )|Zhongnan Hospital ( 1 )",4.033,29,4
Drug,azd7442,6,2020-03-13,0,1,0,5,0,"AstraZeneca ( 4 )|Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )",4.006,3,6
Drug,pf-07321332,5,2021-09-01,0,2,0,3,0,Pfizer ( 5 ),4.005,1,NA
Drug,aspirin,5,2020-04-24,1,0,0,4,0,Imperial College London ( 1 )|Population Health Research Institute ( 1 )|University of Oxford ( 1 )|University of Pittsburgh ( 1 )|Xijing Hospital ( 1 ),4.005,5,5
Drug,acalabrutinib,4,2020-05-07,1,1,2,0,0,AstraZeneca ( 2 )|Acerta Pharma BV ( 1 )|University of the Philippines ( 1 ),4.004,3,NA
Drug,proxalutamide,4,2021-04-19,1,0,0,3,0,"Applied Biology, Inc. ( 4 )",4.004,1,1
Drug,corticosteroid,4,2020-05-04,2,0,0,2,0,Fundacion GenesisCare ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|University of Oxford ( 1 ),4.004,4,11
Drug,chloroquine/hydroxychloroquine,3,2020-04-15,1,0,0,2,0,Medical University of Vienna ( 1 )|Tanta University ( 1 )|University of Oxford ( 1 ),4.003,3,NA
Drug,suspension of heat killed (autoclaved) mycobacterium w,3,2020-04-21,1,0,0,2,0,Cadila Pharnmaceuticals ( 3 ),4.003,1,NA
Biological,cvncov vaccine,3,2020-06-18,0,1,0,2,0,CureVac AG ( 3 ),4.003,1,NA
Other,ace inhibitor,3,2020-10-06,2,0,0,1,0,D'Or Institute for Research and Education ( 1 )|Ottawa Heart Institute Research Corporation ( 1 )|University of Pennsylvania ( 1 ),4.003,3,6
Device,hyperbaric oxygen,3,2020-04-09,2,0,0,1,0,Direction Centrale du Service de SantÃ© des ArmÃ©es ( 1 )|Legacy Health System ( 1 )|NYU Langone Health ( 1 ),4.003,3,NA
Radiation,low,3,2020-06-12,2,0,0,1,0,"All India Institute of Medical Sciences, New Delhi ( 1 )|Emory University ( 1 )|Hospices Civils de Lyon ( 1 )",4.003,3,NA
Device,transcranial direct current stimulation,3,2021-05-17,2,0,0,1,0,El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez ( 1 )|University of Iowa ( 1 )|University of Sao Paulo ( 1 ),4.003,3,12
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",2,2020-01-28,1,0,0,1,0,"Beijing 302 Hospital ( 1 )|Staidson (Beijing) Biopharmaceuticals Co., Ltd ( 1 )",4.002,2,1
Combination Product,favipiravir/hydroxychloroquine,2,2020-05-23,1,0,0,1,0,"King Abdullah International Medical Research Center ( 1 )|Ministry of Health, Turkey ( 1 )",4.002,2,2
Diagnostic Test,ecg,2,2021-06-16,0,1,0,1,0,Code Pharma ( 1 )|MGC Pharmaceuticals d.o.o ( 1 ),4.002,2,1
Biological,grad-cov2,2,2021-02-22,0,1,0,1,0,ReiThera Srl ( 2 ),4.002,1,1
Biological,iiv4,2,2021-08-30,0,0,0,0,2,China National Biotec Group Company Limited ( 1 )|Duke University ( 1 ),4.002,2,NA
Biological,inactivated sars-cov-2 vaccine (vero cellï¼‰,2,2021-05-10,0,0,0,0,2,"Sinovac Biotech Co., Ltd ( 2 )",4.002,1,NA
Drug,interferon-î² 1a,2,2020-04-14,0,0,0,0,2,Shahid Beheshti University of Medical Sciences ( 2 ),4.002,1,1
Biological,intramuscular vaccine,2,2020-11-12,0,1,0,1,0,Medicago ( 2 ),4.002,1,1
Biological,mad0004j08,2,2021-07-01,0,1,0,1,0,Toscana Life Sciences Sviluppo s.r.l. ( 2 ),4.002,1,NA
Biological,moderna mrna-1273 covid-19 vaccine,2,2021-07-16,0,0,0,0,2,National Institute of Allergy and Infectious Diseases (NIAID) ( 2 ),4.002,1,NA
Drug,nintedanib,2,2020-11-05,0,0,0,0,2,Icahn School of Medicine at Mount Sinai ( 1 )|Postgraduate Institute of Medical Education and Research ( 1 ),4.002,2,NA
Drug,ofatumumab,2,2021-05-03,0,0,0,0,2,Novartis ( 2 ),4.002,1,NA
Drug,pf-07304814,2,2020-08-03,0,1,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|Pfizer ( 1 ),4.002,2,1
Drug,plitidepsin,2,2021-03-04,0,1,0,1,0,PharmaMar ( 2 ),4.002,1,NA
Dietary Supplement,vitamin d (cholecalciferol),2,2021-10-22,1,0,0,1,0,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia ( 1 )|Harvard School of Public Health ( 1 )",4.002,2,NA
Biological,2nd dose),2,2021-03-08,0,0,0,0,2,China National Biotec Group Company Limited ( 2 ),4.002,1,NA
Drug,bdb-001 injection,2,2021-08-22,0,1,0,1,0,"Staidson (Beijing) Biopharmaceuticals Co., Ltd ( 2 )",4.002,1,NA
Biological,covax,2,2021-03-08,0,0,0,0,2,China National Biotec Group Company Limited ( 2 ),4.002,1,NA
Biological,covax only (1st,2,2021-03-08,0,0,0,0,2,China National Biotec Group Company Limited ( 2 ),4.002,1,NA
Biological,covax only (1st/2nd dose),2,2021-03-08,0,0,0,0,2,China National Biotec Group Company Limited ( 2 ),4.002,1,NA
Biological,ct-p59,2,2020-10-05,0,1,0,1,0,Celltrion ( 2 ),4.002,1,1
Biological,dose),2,2021-08-09,0,1,0,1,0,"SK Bioscience Co., Ltd. ( 1 )|SK Chemicals Co., Ltd. ( 1 )",4.002,2,NA
Biological,recombinant sars-cov-2 ad5 vectored vaccine,2,2021-07-03,0,0,0,0,2,Jiangsu Province Centers for Disease Control and Prevention ( 2 ),4.002,1,NA
Biological,scta01,2,2020-11-22,0,1,0,1,0,Sinocelltech Ltd. ( 2 ),4.002,1,1
Biological,trv027,2,2021-06-09,0,1,0,1,0,Imperial College London ( 1 )|Vanderbilt University Medical Center ( 1 ),4.002,2,NA
Biological,ty027,2,2020-11-26,0,1,0,1,0,Tychan Pte Ltd. ( 2 ),4.002,1,NA
Drug,0.12% chlorhexidine gluconate mouth rinse,1,2020-10-21,0,0,0,0,1,Ohio State University ( 1 ),4.001,1,1
Drug,0.5% povidone iodine,1,2020-10-21,0,0,0,0,1,Ohio State University ( 1 ),4.001,1,1
Drug,1% povidone iodine (pvp-i),1,2021-01-19,0,0,0,0,1,King Abdulaziz University ( 1 ),4.001,1,7
Drug,1% pvp- mouthwash,1,2021-09-16,0,0,0,0,1,National Taiwan University Hospital ( 1 ),4.001,1,2
Drug,1.5% hydrogen peroxide (h2o2),1,2021-01-19,0,0,0,0,1,King Abdulaziz University ( 1 ),4.001,1,7
Biological,2 doses of vaccine,1,2021-04-27,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,"3-doses schedule 1 of covid-19 vaccine (vero cell), inactivated",1,2021-04-27,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Drug,amlodipine,1,2020-08-26,0,0,0,0,1,Queen Mary University of London ( 1 ),4.001,1,NA
Drug,anti-sars-cov-2 mab,1,2021-02-08,0,0,0,0,1,University of Calgary ( 1 ),4.001,1,NA
Drug,argatroban,1,2020-05-26,0,0,0,0,1,Weill Medical College of Cornell University ( 1 ),4.001,1,NA
Drug,baf312,1,2021-03-08,0,0,0,0,1,Novartis ( 1 ),4.001,1,NA
Drug,baseline disease modifying therapies (dmts),1,2021-03-08,0,0,0,0,1,Novartis ( 1 ),4.001,1,NA
Drug,berberine,1,2020-05-13,0,0,0,0,1,Chinese Medical Association ( 1 ),4.001,1,2
Drug,bno 1030,1,2021-03-08,0,0,0,0,1,Ivano-Frankivsk National Medical University ( 1 ),4.001,1,NA
Dietary Supplement,bromelain,1,2020-07-05,0,0,0,0,1,"Ministry of Health, Saudi Arabia ( 1 )",4.001,1,NA
Drug,combined art,1,2020-06-15,0,0,0,0,1,Mahidol University ( 1 ),4.001,1,NA
Behavioral,covid-19 individual awareness/education.,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Behavioral,covid-19 individual health education,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Behavioral,covid-19 individual health education/linkages to medical/supportive services.,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Biological,covid-19 vaccine astrazeneca suspension for injection,1,2021-02-08,0,0,0,0,1,"Rigshospitalet, Denmark ( 1 )",4.001,1,NA
Biological,covid-19 vaccine janssen (ad26.cov2-s),1,2021-09-06,0,0,0,0,1,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),4.001,1,NA
Biological,covid-19 vaccine moderna dispersion for injection - moderna biotech,1,2021-02-08,0,0,0,0,1,"Rigshospitalet, Denmark ( 1 )",4.001,1,NA
Drug,d followed by enoxaparin,1,2020-05-08,0,0,0,0,1,Brazilian Clinical Research Institute ( 1 ),4.001,1,2
Drug,danoprevir,1,2020-04-10,0,0,0,0,1,Huoshenshan Hospital ( 1 ),4.001,1,NA
Drug,danoprevir/ritonavir,1,2020-04-10,0,0,0,0,1,Huoshenshan Hospital ( 1 ),4.001,1,NA
Drug,day for 5 days,1,2021-05-31,0,0,0,0,1,"Clinical Research Centre, Malaysia ( 1 )",4.001,1,NA
Drug,diovan,1,2020-04-02,0,0,0,0,1,Radboud University ( 1 ),4.001,1,1
Drug,enoxaparin/lovenox,1,2020-04-27,0,0,0,0,1,Columbia University ( 1 ),4.001,1,NA
Drug,fluoxetine,1,2020-04-18,0,0,0,0,1,University of Toledo Health Science Campus ( 1 ),4.001,1,NA
Drug,fluvoxamine maleate 50 mg,1,2021-10-19,0,0,0,0,1,Chulalongkorn University ( 1 ),4.001,1,NA
Combination Product,"fluvoxamine, cyproheptadine",1,2021-10-19,0,0,0,0,1,Chulalongkorn University ( 1 ),4.001,1,NA
Drug,glatiramer acetate,1,2021-05-03,0,0,0,0,1,Novartis ( 1 ),4.001,1,NA
Drug,group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,1,2020-05-08,0,0,0,0,1,Brazilian Clinical Research Institute ( 1 ),4.001,1,2
Behavioral,health promotion.,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Diagnostic Test,immunogenicity after first,1,2021-04-14,0,0,0,0,1,Sciensano ( 1 ),4.001,1,NA
Drug,imunor,1,2021-01-13,0,0,0,0,1,University Hospital Ostrava ( 1 ),4.001,1,NA
Drug,ivermectin 0.4mg,1,2021-05-31,0,0,0,0,1,"Clinical Research Centre, Malaysia ( 1 )",4.001,1,NA
Drug,ivermectin pill,1,2020-06-15,0,0,0,0,1,Mahidol University ( 1 ),4.001,1,NA
Drug,lopinavir/ ritonavir/remdesivir combination,1,2021-01-31,0,0,0,0,1,October 6 University ( 1 ),4.001,1,NA
Drug,lovenox,1,2020-04-27,0,0,0,0,1,Columbia University ( 1 ),4.001,1,NA
Drug,methylprednisolone tablet,1,2021-07-22,0,0,0,0,1,Turkish Thoracic Society ( 1 ),4.001,1,NA
Dietary Supplement,micronized,1,2020-09-24,0,0,0,0,1,Epitech Group SpA ( 1 ),4.001,1,NA
placebo,normal saline placebo,1,2021-05-09,0,0,0,0,1,"University Health Network, Toronto ( 1 )",4.001,1,NA
Biological,one dose quadrivalent influenza vaccine on day 0,1,2021-03-15,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Biological,one dose quadrivalent influenza vaccine on day 14.,1,2021-03-15,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Drug,open label bss (pepto bismol),1,2021-03-20,0,0,0,0,1,University of Louisville ( 1 ),4.001,1,NA
Biological,oral polio vaccine / information,1,2020-06-22,0,0,0,0,1,Bandim Health Project ( 1 ),4.001,1,NA
Drug,p2y12,1,2020-08-06,0,0,0,0,1,University of Pittsburgh ( 1 ),4.001,1,NA
Drug,pioglitazone 45 mg,1,2020-10-26,0,0,0,0,1,Dasman Diabetes Institute ( 1 ),4.001,1,NA
Biological,pop-up community vaccination sites,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Biological,ppv23 for the 1st dose/iiv4 for the 2nd dose,1,2021-10-05,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,ppv23 for the 2nd dose,1,2021-03-08,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Drug,reduction in antimetabolite immunosuppression,1,2021-09-24,0,0,0,0,1,"University of California, Davis ( 1 )",4.001,1,NA
Drug,remdesivir combination,1,2021-01-31,0,0,0,0,1,October 6 University ( 1 ),4.001,1,NA
Drug,rivaroxaban 15mg tab,1,2020-10-02,0,0,0,0,1,Yaounde Central Hospital ( 1 ),4.001,1,NA
Biological,simultaneous administration of mrna covid-19,1,2021-08-30,0,0,0,0,1,Duke University ( 1 ),4.001,1,NA
Drug,standard treatment covid-19 / triazavirin,1,2021-07-03,0,0,0,0,1,Ain Shams University ( 1 ),4.001,1,NA
Behavioral,supportive services.,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Drug,tetrandrine,1,2020-03-04,0,0,0,0,1,Henan Provincial People's Hospital ( 1 ),4.001,1,NA
Biological,"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,2021-03-15,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Biological,"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28/one dose quadrivalent influenza vaccine on day 0/day 28.",1,2021-03-15,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Biological,"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28/one dose quadrivalent influenza vaccine on day 14.",1,2021-03-15,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Drug,-interferon nebulization,1,2020-02-27,0,0,0,0,1,The Ninth Hospital of Nanchang ( 1 ),4.001,1,NA
Drug,0.075% cetylpyridinium chloride (cpc),1,2021-01-19,0,0,0,0,1,King Abdulaziz University ( 1 ),4.001,1,7
Drug,0.1% sodium hypochlorite,1,2021-01-19,0,0,0,0,1,King Abdulaziz University ( 1 ),4.001,1,7
Drug,0.9% normal saline,1,2020-10-21,0,0,0,0,1,Ohio State University ( 1 ),4.001,1,1
Drug,1% hydrogen peroxide,1,2020-10-21,0,0,0,0,1,Ohio State University ( 1 ),4.001,1,1
Biological,23-valent pneumococcal polysaccharide vaccine,1,2021-07-05,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Biological,"3-doses schedule 2 of covid-19 vaccine (vero cell), inactivated",1,2021-04-27,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,"3-doses schedule 3 of covid-19 vaccine (vero cell), inactivated",1,2021-04-27,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Dietary Supplement,600mg) oral suspension,1,2020-09-24,0,0,0,0,1,Epitech Group SpA ( 1 ),4.001,1,NA
Drug,"ace inhibitor, angiotensin receptor blocker",1,2020-04-14,0,0,0,0,1,Medical University Innsbruck ( 1 ),4.001,1,1
Biological,adsorbed sars-cov-2 (inactivated) vaccine,1,2021-03-05,0,0,0,0,1,FundaÃ§Ã£o de Medicina Tropical Dr. Heitor Vieira Dourado ( 1 ),4.001,1,NA
Drug,arbidol hydrochloride/interferon atomization,1,2020-02-02,0,0,0,0,1,Tongji Hospital ( 1 ),4.001,1,NA
Dietary Supplement,artemisinin,1,2021-07-26,0,0,0,0,1,Mateon Therapeutics ( 1 ),4.001,1,NA
Drug,bivalirudin,1,2020-06-23,0,0,0,0,1,Hamad Medical Corporation ( 1 ),4.001,1,1
Drug,bromhexine oral tablet and/or hydroxychloroquine tablet,1,2020-04-15,0,0,0,0,1,General and Teaching Hospital Celje ( 1 ),4.001,1,NA
Drug,canrenoate potassium,1,2021-06-01,0,0,0,0,1,Pomeranian Medical University Szczecin ( 1 ),4.001,1,NA
Drug,carrageenan nasal spray,1,2021-09-16,0,0,0,0,1,National Taiwan University Hospital ( 1 ),4.001,1,2
Drug,carrageenan nasal spray/1% pvp- mouthwash/gargle,1,2021-09-16,0,0,0,0,1,National Taiwan University Hospital ( 1 ),4.001,1,2
Drug,cefditoren pivoxil 400mg,1,2021-01-12,0,0,0,0,1,Meiji Pharma Spain S.A. ( 1 ),4.001,1,NA
Drug,cerebrolysin,1,2020-12-24,0,0,0,0,1,Assiut University ( 1 ),4.001,1,1
Drug,cholecalciferol 6 lakh iu,1,2021-06-08,0,0,0,0,1,Postgraduate Institute of Medical Education and Research ( 1 ),4.001,1,NA
Combination Product,co-ultrapealut,1,2021-04-16,0,0,0,0,1,University Of Perugia ( 1 ),4.001,1,NA
Dietary Supplement,cod liver oil,1,2020-10-22,0,0,0,0,1,Oslo University Hospital ( 1 ),4.001,1,NA
Drug,combined art/hydroxychloroquine,1,2020-06-15,0,0,0,0,1,Mahidol University ( 1 ),4.001,1,NA
Biological,comirnaty - biontech manufacturing gmbh,1,2021-02-08,0,0,0,0,1,"Rigshospitalet, Denmark ( 1 )",4.001,1,NA
Biological,"comirnaty (covid-19, mrna vaccine)",1,2021-02-19,0,0,0,0,1,Karolinska University Hospital ( 1 ),4.001,1,NA
Biological,community-provided moderna mrna-1273 covid-19 vaccine,1,2021-06-28,0,0,0,0,1,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),4.001,1,NA
Biological,community-provided mrna-based covid-19 vaccine,1,2021-06-28,0,0,0,0,1,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),4.001,1,NA
placebo,corn oil (placebo),1,2020-10-22,0,0,0,0,1,Oslo University Hospital ( 1 ),4.001,1,NA
Biological,covax/iiv4; covax/ppv23,1,2021-03-08,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,covax/ppv23;covax/iiv4,1,2021-10-05,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Behavioral,covid-19 community outreach,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Behavioral,covid-19 community outreach/health promotion.,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Behavioral,covid-19 individual awareness,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Biological,day 28.,1,2021-03-15,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Drug,dexamethasone high dose,1,2021-01-23,0,0,0,0,1,Hospital Clinico Universitario de Santiago ( 1 ),4.001,1,NA
Drug,dexamethasone low dose,1,2021-01-23,0,0,0,0,1,Hospital Clinico Universitario de Santiago ( 1 ),4.001,1,NA
Behavioral,education.,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Drug,equinacea arkopharma,1,2021-07-26,0,0,0,0,1,University of Santiago de Compostela ( 1 ),4.001,1,NA
Combination Product,"fluvoxamine, bromhexine",1,2021-10-19,0,0,0,0,1,Chulalongkorn University ( 1 ),4.001,1,NA
Drug,fondapariniux,1,2020-05-26,0,0,0,0,1,Weill Medical College of Cornell University ( 1 ),4.001,1,NA
Drug,ganovo,1,2020-02-27,0,0,0,0,1,The Ninth Hospital of Nanchang ( 1 ),4.001,1,NA
Drug,ganovo/ritonavir//-interferon nebulization,1,2020-02-27,0,0,0,0,1,The Ninth Hospital of Nanchang ( 1 ),4.001,1,NA
Biological,iiv4 for the 1st dose,1,2021-03-08,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,iiv4 for the 1st dose/ppv23 for the 2nd dose,1,2021-03-08,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,iiv4 for the 2nd dose,1,2021-10-05,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,iiv4; covax,1,2021-03-08,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Diagnostic Test,immunogenicity after first/second dose,1,2021-04-14,0,0,0,0,1,Sciensano ( 1 ),4.001,1,NA
Biological,inactivated hepatitis a vaccine,1,2021-07-05,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Drug,interferon/glatiramer acetate,1,2021-05-03,0,0,0,0,1,Novartis ( 1 ),4.001,1,NA
Drug,ivermectin 0.4mg/kg/day for 5 days,1,2021-05-31,0,0,0,0,1,"Clinical Research Centre, Malaysia ( 1 )",4.001,1,NA
Drug,late dexamethazone,1,2020-08-24,0,0,0,0,1,ClinAmygate ( 1 ),4.001,1,NA
Behavioral,linkages to medical,1,2021-08-18,0,0,0,0,1,"University of California, San Diego ( 1 )",4.001,1,NA
Drug,low-molecular-weight heparin,1,2020-10-06,0,0,0,0,1,Ain Shams University ( 1 ),4.001,1,NA
Dietary Supplement,"micronized/ultra-micronized palmitoylethanolamide (mpea/umpea, 300mg / 600mg) oral suspension",1,2020-09-24,0,0,0,0,1,Epitech Group SpA ( 1 ),4.001,1,NA
Drug,montmorrillonite,1,2020-05-13,0,0,0,0,1,Chinese Medical Association ( 1 ),4.001,1,2
Biological,mrna-1273 vaccine,1,2021-05-09,0,0,0,0,1,"University Health Network, Toronto ( 1 )",4.001,1,NA
Biological,mrna covid-19 vaccine,1,2021-05-03,0,0,0,0,1,Novartis ( 1 ),4.001,1,NA
Drug,niagen,1,2021-03-19,0,0,0,0,1,Massachusetts General Hospital ( 1 ),4.001,1,NA
Drug,niclosamide pill,1,2021-10-19,0,0,0,0,1,Chulalongkorn University ( 1 ),4.001,1,NA
Combination Product,"niclosamide, bromhexine",1,2021-10-19,0,0,0,0,1,Chulalongkorn University ( 1 ),4.001,1,NA
Procedure,olfactory rehab,1,2021-04-16,0,0,0,0,1,University Of Perugia ( 1 ),4.001,1,NA
Biological,pfizer bnt162b2 covid-19 vaccine,1,2021-07-16,0,0,0,0,1,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),4.001,1,NA
Drug,pioglitazone,1,2020-06-22,0,0,0,0,1,Samaritan Health Services ( 1 ),4.001,1,NA
Drug,pioglitazone 30 mg,1,2020-08-27,0,0,0,0,1,Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal ( 1 ),4.001,1,NA
Biological,ppv23,1,2021-03-08,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,ppv23 for the 1st dose,1,2021-10-05,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Biological,ppv23;covax,1,2021-10-05,0,0,0,0,1,China National Biotec Group Company Limited ( 1 ),4.001,1,NA
Drug,propofol,1,2020-04-21,0,0,0,0,1,FundaciÃ³n para la InvestigaciÃ³n del Hospital ClÃ­nico de Valencia ( 1 ),4.001,1,NA
Biological,rbd-based protein subunit vaccine (zf2001) against covid-19,1,2021-04-03,0,0,0,0,1,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),4.001,1,NA
Biological,recombinant ad5 vectored covid-19 vaccine,1,2021-04-03,0,0,0,0,1,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),4.001,1,NA
Diagnostic Test,second dose,1,2021-04-14,0,0,0,0,1,Sciensano ( 1 ),4.001,1,NA
Biological,simultaneous administration of mrna covid-19/iiv4,1,2021-08-30,0,0,0,0,1,Duke University ( 1 ),4.001,1,NA
Drug,standard of care thromboprophylaxis,1,2020-04-13,0,0,0,0,1,University of Iowa ( 1 ),4.001,1,NA
Drug,standard treatment covid-19,1,2021-07-03,0,0,0,0,1,Ain Shams University ( 1 ),4.001,1,NA
Drug,sublingual micro-dose ketamine,1,2021-02-22,0,0,0,0,1,Limbic Medical ( 1 ),4.001,1,NA
Biological,the sars-cov-2 inactivated vaccine,1,2021-07-13,0,0,0,0,1,"Sinovac Biotech Co., Ltd ( 1 )",4.001,1,NA
Other,the standard protocol only,1,2021-02-13,0,0,0,0,1,ClinAmygate ( 1 ),4.001,1,NA
Drug,theraputic heparin,1,2020-08-06,0,0,0,0,1,University of Pittsburgh ( 1 ),4.001,1,NA
Drug,tnkase,1,2020-09-19,0,0,0,0,1,Cedars-Sinai Medical Center ( 1 ),4.001,1,NA
Drug,triazavirin,1,2021-07-03,0,0,0,0,1,Ain Shams University ( 1 ),4.001,1,NA
Biological,trivalent split influenza vaccine,1,2021-04-03,0,0,0,0,1,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),4.001,1,NA
Dietary Supplement,ultra-micronized palmitoylethanolamide (mpea,1,2020-09-24,0,0,0,0,1,Epitech Group SpA ( 1 ),4.001,1,NA
Drug,umifenovir,1,2020-04-14,0,0,0,0,1,Shahid Beheshti University of Medical Sciences ( 1 ),4.001,1,1
Dietary Supplement,"umpea, 300mg",1,2020-09-24,0,0,0,0,1,Epitech Group SpA ( 1 ),4.001,1,NA
Drug,unfractionated heparin iv,1,2020-05-28,0,0,0,0,1,The TIMI Study Group ( 1 ),4.001,1,NA
Drug,unfractionated heparin sc,1,2020-05-28,0,0,0,0,1,The TIMI Study Group ( 1 ),4.001,1,NA
Biological,vaccinated with polio vaccine (ipv),1,2020-11-16,0,0,0,0,1,E-MO Biology Inc ( 1 ),4.001,1,NA
Dietary Supplement,zinc sulfate 220 mg,1,2020-11-06,0,0,0,0,1,"St. Francis Hospital, New York ( 1 )",4.001,1,NA
Other,exercise,24,2020-05-07,23,0,1,0,0,"University of Sao Paulo ( 3 )|Biruni University ( 1 )|Cairo University ( 1 )|Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory ( 1 )|Gazi University ( 1 )|Government College University Faisalabad ( 1 )|Hacettepe University ( 1 )|Istinye University ( 1 )|Karolinska Institutet ( 1 )|KTO Karatay University ( 1 )|Medical University of Vienna ( 1 )|National Institutes of Health Clinical Center (CC) ( 1 )|Rigshospitalet, Denmark ( 1 )|Universidad de Murcia ( 1 )|Universidade Metodista de Piracicaba ( 1 )|University Hospital Southampton NHS Foundation Trust ( 1 )|University of Alberta ( 1 )|University of British Columbia ( 1 )|University of Erlangen-NÃ¼rnberg Medical School ( 1 )|University of Massachusetts, Amherst ( 1 )|University of Turin, Italy ( 1 )|Yeditepe University ( 1 )",3.024,22,7
Radiation,radiotherapy,11,2020-05-04,7,0,4,0,0,"Ohio State University Comprehensive Cancer Center ( 2 )|Fundacion GenesisCare ( 1 )|Grupo de InvestigaciÃ³n ClÃ­nica en OncologÃ­a Radioterapia ( 1 )|Hospital San Carlos, Madrid ( 1 )|Instituto Mexicano del Seguro Social ( 1 )|Lancashire Teaching Hospitals NHS Foundation Trust ( 1 )|Mahatma Gandhi Institute of Medical Sciences ( 1 )|Memorial Sloan Kettering Cancer Center ( 1 )|Shahid Beheshti University of Medical Sciences ( 1 )|University Hospital, Basel, Switzerland ( 1 )",3.011,10,8
Drug,nitric oxide,8,2020-04-05,0,1,7,0,0,"Massachusetts General Hospital ( 4 )|Sanotize Research and Development corp. ( 1 )|Tomsk National Research Medical Center of the Russian Academy of Sciences ( 1 )|Tufts Medical Center ( 1 )|University Health Network, Toronto ( 1 )",3.008,5,2
Other,supportive care,5,2020-04-14,2,0,3,0,0,"Aga Khan University ( 1 )|Baylor College of Medicine ( 1 )|BeiGene ( 1 )|Institute of Liver and Biliary Sciences, India ( 1 )|Mansoura University ( 1 )",3.005,5,NA
Biological,ampion,5,2021-05-06,0,3,2,0,0,Ampio Pharmaceuticals. Inc. ( 5 ),3.005,1,NA
Biological,nk cells,5,2020-04-22,0,2,3,0,0,"Celularity Incorporated ( 1 )|Chongqing Public Health Medical Center ( 1 )|Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 )|Masonic Cancer Center, University of Minnesota ( 1 )|Xinxiang medical university ( 1 )",3.005,5,2
Diagnostic Test,ct-scan,4,2020-04-22,3,0,1,0,0,"Hospital General de MÃ©xico Dr. Eduardo Liceaga ( 1 )|Jessa Hospital ( 1 )|Semmelweis University Heart and Vascular Center ( 1 )|State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia ( 1 )",3.004,4,2
Dietary Supplement,probiotic,4,2020-04-27,3,0,1,0,0,Bioithas SL ( 1 )|Biosearch S.A. ( 1 )|Brugmann University Hospital ( 1 )|Vanderbilt University Medical Center ( 1 ),3.004,4,NA
Other,blood,4,2020-05-01,2,0,2,0,0,"Centre Hospitalier Universitaire de Nice ( 1 )|Memorial Sloan Kettering Cancer Center ( 1 )|Puerta de Hierro University Hospital ( 1 )|University Hospital, Ghent ( 1 )",3.004,4,2
Drug,defibrotide,4,2020-03-31,0,1,3,0,0,Brigham and Women's Hospital ( 1 )|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia ( 1 )|IRCCS San Raffaele ( 1 )|University of Michigan ( 1 ),3.004,4,NA
Drug,emtricitabine,4,2020-04-15,0,0,0,4,0,"Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 )|Plan Nacional sobre el Sida (PNS) ( 1 )|Universidad Nacional de Colombia ( 1 )|University Hospital, Caen ( 1 )",3.004,4,9
Biological,mesenchymalÂ stem cells,4,2020-09-22,0,1,3,0,0,"Rohto Pharmaceutical Co., Ltd. ( 2 )|Institute of Cell Therapy ( 1 )|M.D. Anderson Cancer Center ( 1 )",3.004,3,NA
Drug,methylene blue,4,2020-05-01,0,1,3,0,0,Ain Shams University ( 1 )|Fondazione Epatocentro Ticino ( 1 )|I.M. Sechenov First Moscow State Medical University ( 1 )|Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences ( 1 ),3.004,4,NA
Combination Product,na-831,4,2020-09-04,0,0,0,4,0,"NeuroActiva, Inc. ( 4 )",3.004,1,NA
Drug,resveratrol,3,2021-03-10,1,0,2,0,0,Hong Kong Baptist University ( 1 )|Mount Carmel Health System ( 1 )|Swedish Medical Center ( 1 ),3.003,3,1
Drug,at-527,3,2021-05-04,0,1,2,0,0,"Atea Pharmaceuticals, Inc. ( 2 )|Hoffmann-La Roche ( 1 )",3.003,2,NA
Biological,comirnaty,3,2021-05-25,0,1,2,0,0,Medical University Innsbruck ( 1 )|Spanish Clinical Research Network - SCReN ( 1 )|UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),3.003,3,1
Drug,eidd-2801,3,2020-05-26,0,1,2,0,0,"Ridgeback Biotherapeutics, LP ( 3 )",3.003,1,3
Drug,honey,3,2020-04-11,0,0,0,3,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 2 )|Misr University for Science and Technology ( 1 ),3.003,2,1
Drug,immunoglobulin,3,2020-04-08,0,0,0,3,0,Centenario Hospital Miguel Hidalgo ( 1 )|Centre Hospitalier St Anne ( 1 )|University of Oxford ( 1 ),3.003,3,5
Drug,maraviroc,3,2020-06-18,0,1,2,0,0,Hospital General de MÃ©xico Dr. Eduardo Liceaga ( 1 )|Hospital Universitario Infanta Leonor ( 1 )|Rhode Island Hospital ( 1 ),3.003,3,NA
Drug,molnupiravir,3,2021-06-24,0,0,0,3,0,Merck Sharp & Dohme Corp. ( 3 ),3.003,1,NA
Biological,ub-612,3,2021-02-23,0,2,1,0,0,"United Biomedical Inc., Asia ( 3 )",3.003,1,NA
Dietary Supplement,vitamin super b-complex,3,2020-04-20,0,0,0,3,0,Romark Laboratories L.C. ( 3 ),3.003,1,NA
Dietary Supplement,asbrip,3,2021-01-04,1,0,2,0,0,Catalysis SL ( 3 ),3.003,1,NA
Drug,bevacizumab,3,2020-03-09,1,0,2,0,0,Qilu Hospital of Shandong University ( 2 )|MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 ),3.003,2,1
Other,education,3,2020-10-20,2,0,1,0,0,KTO Karatay University ( 1 )|National Institutes of Health Clinical Center (CC) ( 1 )|University of Malaga ( 1 ),3.003,3,NA
Dietary Supplement,viusid,3,2021-01-04,1,0,2,0,0,Catalysis SL ( 3 ),3.003,1,NA
Biological,allocetra-ots,3,2021-06-09,0,1,2,0,0,Hadassah Medical Organization ( 2 )|Enlivex Therapeutics Ltd. ( 1 ),3.003,2,NA
Biological,av-covid-19,3,2021-08-11,0,2,1,0,0,"Aivita Biomedical, Inc. ( 2 )|Indonesia-MoH ( 1 )",3.003,2,NA
Biological,vpm1002,3,2020-06-16,0,0,0,3,0,"Vakzine Projekt Management GmbH ( 2 )|University Health Network, Toronto ( 1 )",3.003,2,NA
Other,blood draw,2,2020-04-30,1,0,1,0,0,Assistance Publique Hopitaux De Marseille ( 1 )|Washington University School of Medicine ( 1 ),3.002,2,NA
Dietary Supplement,fotv,2,2021-06-30,1,0,1,0,0,"University of California, San Diego ( 2 )",3.002,1,NA
Device,rd-x19,2,2021-07-09,1,0,1,0,0,KNOWBio Inc. ( 2 ),3.002,1,NA
Drug,adg20,2,2021-03-17,0,0,0,2,0,"Adagio Therapeutics, Inc. ( 2 )",3.002,1,NA
Biological,aviptadil,2,2021-04-09,0,0,0,2,0,"National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )|NeuroRx, Inc. ( 1 )",3.002,2,NA
Drug,broncho-vaxomâ®,2,2020-07-26,0,0,0,2,0,The University of Queensland ( 2 ),3.002,1,NA
Drug,gx-19n,2,2021-06-03,0,1,1,0,0,"Genexine, Inc. ( 2 )",3.002,1,NA
Drug,interferon î²-1b,2,2020-04-11,0,0,0,2,0,"University Hospital, Bordeaux ( 2 )",3.002,1,1
Combination Product,mefloquine,2,2020-04-07,0,0,0,2,0,Burnasyan Federal Medical Biophysical Center ( 2 ),3.002,1,NA
Biological,"moderna covid-19 vaccine, mrna-1273 (100 î¼g)",2,2021-03-15,0,0,0,2,0,"University Hospital, Basel, Switzerland ( 2 )",3.002,1,1
Biological,mrna-1273.351,2,2021-03-04,0,1,1,0,0,"ModernaTX, Inc. ( 1 )|National Institute of Allergy and Infectious Diseases (NIAID) ( 1 )",3.002,2,1
Biological,mvc-cov1901,2,2020-07-22,0,1,1,0,0,Chang Gung Memorial Hospital ( 1 )|Medigen Vaccine Biologics Corp. ( 1 ),3.002,2,1
Drug,oral,2,2020-02-24,0,0,0,2,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 )|Rajavithi Hospital ( 1 ),3.002,2,NA
Biological,pfizer-biontech covid-19 vaccine bnt162b2 (30 âµg)( comirnatyâ®),2,2021-03-15,0,0,0,2,0,"University Hospital, Basel, Switzerland ( 2 )",3.002,1,1
Biological,qazcovid-inâ®-vaccine against covid-19,2,2020-12-21,0,0,0,2,0,Research Institute for Biological Safety Problems ( 2 ),3.002,1,NA
Biological,recombinant new coronavirus vaccine (cho cell) low-dose group,2,2020-07-08,0,1,1,0,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 2 )",3.002,1,1
Drug,reparixin,2,2021-04-30,0,0,0,2,0,DompÃ© Farmaceutici S.p.A ( 2 ),3.002,1,NA
Drug,"resp301, a nitric oxide generating solution",2,2021-04-12,0,0,0,2,0,Thirty Respiratory Limited ( 2 ),3.002,1,NA
Drug,rosuvastatin,2,2020-04-15,0,0,0,2,0,Universidad Nacional de Colombia ( 1 )|Yale University ( 1 ),3.002,2,9
Dietary Supplement,l-citrulline,2,2020-09-17,1,0,1,0,0,"Asklepion Pharmaceuticals, LLC ( 1 )|Rennes University Hospital ( 1 )",3.002,2,NA
Drug,vitamin e,2,2020-09-26,1,0,1,0,0,Unidad Temporal COVID-19 en Centro Citibanamex ( 1 )|Universiti Sains Malaysia ( 1 ),3.002,2,NA
Dietary Supplement,viusid/asbrip,2,2021-07-26,1,0,1,0,0,Catalysis SL ( 2 ),3.002,1,NA
Dietary Supplement,zinc acetate,2,2020-11-05,1,0,1,0,0,"Hospital de la Soledad ( 1 )|Profact, Inc. ( 1 )",3.002,2,NA
Drug,100 mg,2,2020-04-30,0,1,1,0,0,"Bausch Health Americas, Inc. ( 1 )|Vanderbilt University Medical Center ( 1 )",3.002,2,NA
Biological,202-cov low adjuvant dose,2,2021-08-02,0,1,1,0,0,"Shanghai Zerun Biotechnology Co.,Ltd ( 2 )",3.002,1,NA
Biological,202-cov low antigen dose,2,2021-08-02,0,1,1,0,0,"Shanghai Zerun Biotechnology Co.,Ltd ( 2 )",3.002,1,NA
Biological,202-cov standard dose,2,2021-08-02,0,1,1,0,0,"Shanghai Zerun Biotechnology Co.,Ltd ( 2 )",3.002,1,NA
Drug,amantadine,2,2021-06-28,0,0,0,2,0,"Copenhagen University Hospital, Hvidovre ( 1 )|Noblewell ( 1 )",3.002,2,NA
Drug,"anti-covid19 mrna-based vaccine (bnt162b2, comirnatyâ®, commercialized by pfizer)",2,2021-06-02,0,0,0,2,0,University of Liege ( 2 ),3.002,1,NA
Drug,artecomâ® (pyronaridine-artesunate),2,2021-01-06,0,0,0,2,0,Shin Poong Pharmaceutical Co. Ltd. ( 2 ),3.002,1,NA
Biological,chadox1-s not less than 2.5 ã— 10^8 infectious units,2,2021-08-09,0,0,0,2,0,"SK Bioscience Co., Ltd. ( 2 )",3.002,1,NA
Drug,dapagliflozin,2,2020-04-14,0,0,0,2,0,Cambridge University Hospitals NHS Foundation Trust ( 1 )|Saint Luke's Health System ( 1 ),3.002,2,2
Dietary Supplement,"ddropsâ® products, 50,000 iu, oral",2,2020-05-08,0,0,0,2,0,University of Alberta ( 2 ),3.002,1,NA
Drug,folic acid,2,2020-04-16,0,0,0,2,0,Lebanese American University Medical Center ( 1 )|University of Washington ( 1 ),3.002,2,1
Drug,gx-i7,2,2021-03-17,0,1,1,0,0,"Genexine, Inc. ( 1 )|PT Kalbe Genexine Biologics ( 1 )",3.002,2,NA
Drug,hormones,2,2020-03-25,0,1,1,0,0,Fuzhou General Hospital ( 1 )|Institute of Cell Therapy ( 1 ),3.002,2,NA
Biological,human amniotic fluid,2,2020-03-22,0,1,1,0,0,University of Utah ( 2 ),3.002,1,2
Biological,hyperimmune immunoglobulin to sars-cov-2 (hivig),2,2021-06-01,0,0,0,2,0,University of Minnesota ( 2 ),3.002,1,1
Drug,leronlimab,2,2021-05-24,0,0,0,2,0,Hospital Israelita Albert Einstein ( 2 ),3.002,1,NA
Biological,medium dosage inactivated sars-cov-2 vaccine,2,2021-02-09,0,1,1,0,0,"Beijing Minhai Biotechnology Co., Ltd ( 2 )",3.002,1,NA
Drug,povidone-iodine,2,2020-09-11,0,1,1,0,0,"Pi Research Consultancy Center, Bangladesh ( 1 )|University of Wisconsin, Madison ( 1 )",3.002,2,1
Biological,recombinant new coronavirus vaccine (cho cells) high-dose group,2,2020-07-08,0,1,1,0,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 2 )",3.002,1,1
Drug,standard covid-19 care,2,2020-12-11,0,0,0,2,0,Ayub Teaching Hospital ( 1 )|Liaquat University of Medical & Health Sciences ( 1 ),3.002,2,3
Drug,standard of care/placebo,2,2020-04-27,0,0,0,2,0,InflaRx GmbH ( 1 )|Northwell Health ( 1 ),3.002,2,1
Drug,td-0903,2,2020-04-14,0,1,1,0,0,Theravance Biopharma ( 2 ),3.002,1,NA
Drug,tenofovir disoproxil,2,2020-04-02,0,0,0,2,0,"Plan Nacional sobre el Sida (PNS) ( 1 )|University Hospital, Caen ( 1 )",3.002,2,1
Drug,tinzaparin,2,2021-01-14,0,0,0,2,0,Hospital Universitario Infanta Leonor ( 1 )|University of Melbourne ( 1 ),3.002,2,2
Drug,tricorâ® 145mg tablets,2,2020-12-09,0,0,0,2,0,Hebrew University of Jerusalem ( 2 ),3.002,1,NA
Drug,xc221,2,2021-06-23,0,0,0,2,0,RSV Therapeutics LLC ( 2 ),3.002,1,NA
Drug,zyesamiâ„¢ (aviptadil acetate),2,2020-04-21,0,0,0,2,0,"NeuroRx, Inc. ( 2 )",3.002,1,NA
Drug,0.6% pvp-i oral/nasal spray to moderately ill covid-19 positive patient,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,1200 mg),1,2020-05-23,0,0,0,1,0,"Ministry of Health, Turkey ( 1 )",3.001,1,NA
Drug,1600 mg),1,2020-05-23,0,0,0,1,0,"Ministry of Health, Turkey ( 1 )",3.001,1,NA
Biological,2.2x10^10vp (qpcr) boost,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Drug,almitrine,1,2020-04-20,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,alteplase,1,2020-11-20,0,0,0,1,0,Boehringer Ingelheim ( 1 ),3.001,1,NA
Drug,amiodarone,1,2020-04-14,0,0,0,1,0,Nicolaus Copernicus University ( 1 ),3.001,1,NA
Drug,anakinra/osoc,1,2020-04-17,0,0,0,1,0,"University Hospital, Tours ( 1 )",3.001,1,NA
Drug,andrographis paniculata,1,2021-08-21,0,0,0,1,0,Mahidol University ( 1 ),3.001,1,NA
Drug,anti-sars-cov-2,1,2021-06-01,0,0,0,1,0,Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran ( 1 ),3.001,1,NA
Biological,anti covid 19 intravenous immunoglobulin (c-ivig),1,2021-05-17,0,0,0,1,0,Dow University of Health Sciences ( 1 ),3.001,1,NA
Biological,anti sars-cov 2 convalescent plasma in severe covid-19 patients,1,2020-06-12,0,0,0,1,0,Centro Medico ABC ( 1 ),3.001,1,19
Drug,anticoagulation agents (edoxaban and,1,2020-09-06,0,0,0,1,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),3.001,1,NA
Drug,anticoagulation agents (edoxaban and/or high dose lmwh),1,2020-09-06,0,0,0,1,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),3.001,1,NA
Drug,antihypertensives,1,2020-04-10,0,0,0,1,0,Medical University of Vienna ( 1 ),3.001,1,1
Dietary Supplement,antioxidants,1,2020-03-23,0,0,0,1,0,King Saud University ( 1 ),3.001,1,NA
Drug,apremilast,1,2020-10-14,0,0,0,1,0,Amgen ( 1 ),3.001,1,NA
Biological,arct-154 self-amplifying rna sars-cov-2 vaccine,1,2021-08-13,0,0,0,1,0,Vinbiocare Biotechnology Joint Stock Company ( 1 ),3.001,1,NA
Drug,asc09,1,2020-02-04,0,0,0,1,0,Tongji Hospital ( 1 ),3.001,1,NA
Drug,aspirin 25mg orally,1,2020-05-28,0,0,0,1,0,"Rutgers, The State University of New Jersey ( 1 )",3.001,1,2
Drug,asunercept 25mg,1,2020-04-10,0,0,0,1,0,Medical University of Vienna ( 1 ),3.001,1,NA
Drug,asunercept 400mg,1,2020-04-10,0,0,0,1,0,Medical University of Vienna ( 1 ),3.001,1,NA
Drug,atorvastatin 20 mg oral tablet,1,2020-07-06,0,0,0,1,0,"ANRS, Emerging Infectious Diseases ( 1 )",3.001,1,NA
Drug,aviptadil/standard care,1,2020-03-14,0,0,0,1,0,"NeuroRx, Inc. ( 1 )",3.001,1,NA
Biological,azd7442 (iv),1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Drug,azoximer bromide,1,2020-05-07,0,0,0,1,0,NPO Petrovax ( 1 ),3.001,1,NA
Drug,azvudine,1,2020-12-04,0,0,0,1,0,HRH Pharmaceuticals Limited ( 1 ),3.001,1,NA
placebo,azvudine placebo,1,2020-12-04,0,0,0,1,0,HRH Pharmaceuticals Limited ( 1 ),3.001,1,NA
Drug,baricitinib / dexamethasone,1,2021-05-17,0,0,0,1,0,Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 ),3.001,1,NA
Biological,bbv152,1,2020-11-09,0,0,0,1,0,Bharat Biotech International Limited ( 1 ),3.001,1,1
Drug,bcg-10 vaccine,1,2020-10-18,0,0,0,1,0,University of Rzeszow ( 1 ),3.001,1,NA
Drug,best symptomatic treatment based on doctor recommendations),1,2020-06-03,0,0,0,1,0,Instituto de InvestigaciÃ³n MarquÃ©s de Valdecilla ( 1 ),3.001,1,1
Drug,bi 767551 inhaled,1,2021-03-29,0,0,0,1,0,Boehringer Ingelheim ( 1 ),3.001,1,NA
Drug,bi 767551 intravenous,1,2021-03-29,0,0,0,1,0,Boehringer Ingelheim ( 1 ),3.001,1,NA
Biological,biological/vaccine: bnt162b2 3mcg,1,2021-03-19,0,0,0,1,0,BioNTech SE ( 1 ),3.001,1,NA
Diagnostic Test,blood test for inflammatory markers,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Biological,bnt162b2 20mcg,1,2021-03-19,0,0,0,1,0,BioNTech SE ( 1 ),3.001,1,NA
Biological,bnt162b2 30mcg,1,2021-03-19,0,0,0,1,0,BioNTech SE ( 1 ),3.001,1,NA
Biological,bnt162b2.b.1.351,1,2021-01-15,0,0,0,1,0,BioNTech SE ( 1 ),3.001,1,NA
Biological,bnt162b2sa,1,2020-04-27,0,0,0,1,0,BioNTech SE ( 1 ),3.001,1,5
Drug,boesenbergia,1,2021-08-21,0,0,0,1,0,Mahidol University ( 1 ),3.001,1,NA
Biological,boost,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Drug,brazilian green propolis extract (epp-af),1,2020-07-12,0,0,0,1,0,D'Or Institute for Research and Education ( 1 ),3.001,1,6
Drug,brensocatib,1,2021-01-25,0,0,0,1,0,University of Dundee ( 1 ),3.001,1,NA
Drug,brexanolone,1,2020-09-01,0,0,0,1,0,Sage Therapeutics ( 1 ),3.001,1,NA
Dietary Supplement,broad-spectrum cbd oil,1,2020-10-03,0,0,0,1,0,University of Texas at Austin ( 1 ),3.001,1,NA
Dietary Supplement,cbd isolate,1,2020-10-03,0,0,0,1,0,University of Texas at Austin ( 1 ),3.001,1,NA
Drug,cd24fc,1,2020-03-19,0,0,0,1,0,"OncoImmune, Inc. ( 1 )",3.001,1,NA
Biological,cell therapy protocol 1,1,2020-04-20,0,0,0,1,0,Royan Institute ( 1 ),3.001,1,NA
Biological,cell therapy protocol 2,1,2020-04-20,0,0,0,1,0,Royan Institute ( 1 ),3.001,1,NA
Drug,cenicriviroc (closed to enrollment as of 3-sep-2021),1,2020-09-23,0,0,0,1,0,Duke University ( 1 ),3.001,1,NA
Biological,chadox1 ncov-19 two dose / paracetamol,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Drug,ciclã©sonide,1,2021-05-04,0,0,0,1,0,"ANRS, Emerging Infectious Diseases ( 1 )",3.001,1,NA
Drug,ckd-314/soc,1,2021-04-29,0,0,0,1,0,Chong Kun Dang Pharmaceutical ( 1 ),3.001,1,NA
Drug,colchcine,1,2021-08-03,0,0,0,1,0,Asociacion Instituto Biodonostia ( 1 ),3.001,1,NA
Drug,colchicine pill,1,2020-04-15,0,0,0,1,0,Universidad Nacional de Colombia ( 1 ),3.001,1,8
Drug,colchicine/symptomatic treatment (paracetamol),1,2020-06-03,0,0,0,1,0,Instituto de InvestigaciÃ³n MarquÃ©s de Valdecilla ( 1 ),3.001,1,1
Biological,covid-19 vaccine (vero cells),1,2021-08-30,0,0,0,1,0,"National Vaccine and Serum Institute, China ( 1 )",3.001,1,NA
Drug,covid-globulin,1,2021-04-12,0,0,0,1,0,Microgen ( 1 ),3.001,1,NA
Biological,cvncov,1,2020-12-01,0,0,0,1,0,CureVac AG ( 1 ),3.001,1,1
Drug,cyproheptadine,1,2021-07-23,0,0,0,1,0,Hospital de Clinicas de Porto Alegre ( 1 ),3.001,1,NA
Diagnostic Test,d-dimer test,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,d5w inj,1,2020-12-04,0,0,0,1,0,Guy's and St Thomas' NHS Foundation Trust ( 1 ),3.001,1,NA
Drug,daclastavir 60 mg,1,2020-07-03,0,0,0,1,0,Hospital do Coracao ( 1 ),3.001,1,NA
Drug,daclatasvir 200mg,1,2020-08-28,0,0,0,1,0,Mansoura University ( 1 ),3.001,1,NA
Drug,daclatasvir 60 mg,1,2020-07-03,0,0,0,1,0,Hospital do Coracao ( 1 ),3.001,1,NA
Drug,dalteparin,1,2020-07-22,0,0,0,1,0,University of Melbourne ( 1 ),3.001,1,1
Drug,darunavir,1,2020-01-29,0,0,0,1,0,Shanghai Public Health Clinical Center ( 1 ),3.001,1,1
Combination Product,device),1,2020-04-09,0,0,0,1,0,Direction Centrale du Service de SantÃ© des ArmÃ©es ( 1 ),3.001,1,NA
Drug,dexamethasone 2 mg,1,2020-10-21,0,0,0,1,0,Fatima Memorial Hospital ( 1 ),3.001,1,NA
Drug,dexamethasone 2 mg/ml,1,2020-10-21,0,0,0,1,0,Fatima Memorial Hospital ( 1 ),3.001,1,NA
Drug,dexamethasone/hydroxychloroquine,1,2020-04-09,0,0,0,1,0,Centre Chirurgical Marie Lannelongue ( 1 ),3.001,1,NA
Drug,dietary supplement containing resistant starch,1,2020-04-08,0,0,0,1,0,Yale University ( 1 ),3.001,1,NA
Drug,dimethyl fumarate,1,2020-05-07,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,4
Drug,dipyridamole er 200mg,1,2020-05-28,0,0,0,1,0,"Rutgers, The State University of New Jersey ( 1 )",3.001,1,2
Drug,dipyridamole er 200mg/ aspirin 25mg orally/enterally/standard of care,1,2020-05-28,0,0,0,1,0,"Rutgers, The State University of New Jersey ( 1 )",3.001,1,2
Drug,discontinuation of ras blocker,1,2020-03-28,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,dutasteride 0.5 mg,1,2021-01-25,0,0,0,1,0,Corpometria Institute ( 1 ),3.001,1,NA
Drug,dwj1248 with remdesivir,1,2021-01-14,0,0,0,1,0,Daewoong Pharmaceutical Co. LTD. ( 1 ),3.001,1,NA
Biological,emapalumab,1,2020-03-25,0,0,0,1,0,Swedish Orphan Biovitrum ( 1 ),3.001,1,NA
Drug,empagliflozin,1,2020-05-07,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,4
Drug,emtricitabine/tenofovir,1,2020-04-15,0,0,0,1,0,Universidad Nacional de Colombia ( 1 ),3.001,1,8
Drug,emtricitabine/tenofovir disoproxil,1,2020-04-02,0,0,0,1,0,Plan Nacional sobre el Sida (PNS) ( 1 ),3.001,1,NA
Drug,emtricitabine/tenofovir disoproxil fumarate 200 mg-245 mg oral tablet [truvada],1,2021-05-17,0,0,0,1,0,Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 ),3.001,1,NA
Drug,endothelial protocol,1,2021-03-22,0,0,0,1,0,Lebanese American University Medical Center ( 1 ),3.001,1,NA
Drug,enisamium iodide,1,2020-12-22,0,0,0,1,0,"Joint Stock Company ""Farmak"" ( 1 )",3.001,1,NA
Drug,enterally,1,2020-05-28,0,0,0,1,0,"Rutgers, The State University of New Jersey ( 1 )",3.001,1,2
Drug,escin,1,2020-03-23,0,0,0,1,0,University of Catanzaro ( 1 ),3.001,1,NA
Biological,etesevimab,1,2021-02-26,0,0,0,1,0,University of Pittsburgh ( 1 ),3.001,1,1
Drug,evolocumab,1,2021-06-21,0,0,0,1,0,Collegium Medicum w Bydgoszczy ( 1 ),3.001,1,NA
Drug,favipiravir / hydroxychloroquine,1,2021-07-26,0,0,0,1,0,Health Institutes of Turkey ( 1 ),3.001,1,NA
Biological,ffp,1,2020-10-12,0,0,0,1,0,Erasmus Medical Center ( 1 ),3.001,1,NA
Combination Product,flu d-qiv,1,2021-09-15,0,0,0,1,0,GlaxoSmithKline ( 1 ),3.001,1,NA
Drug,fluticasone propionate,1,2021-09-20,0,0,0,1,0,University of Medicine and Pharmacy at Ho Chi Minh City ( 1 ),3.001,1,NA
Drug,fluvoxamine maleate 100 mg [luvox],1,2021-01-25,0,0,0,1,0,Cardresearch ( 1 ),3.001,1,NA
Drug,fp-025 100 mg,1,2021-02-02,0,0,0,1,0,"Foresee Pharmaceuticals Co., Ltd. ( 1 )",3.001,1,NA
Dietary Supplement,full spectrum cbd oil,1,2020-10-03,0,0,0,1,0,University of Texas at Austin ( 1 ),3.001,1,NA
Combination Product,glutamine,1,2021-05-30,0,0,0,1,0,Assiut University ( 1 ),3.001,1,NA
placebo,group a (placebo),1,2020-11-26,0,0,0,1,0,"AnGes, Inc. ( 1 )",3.001,1,NA
Drug,group apixaban,1,2020-09-05,0,0,0,1,0,Universidade do Vale do Sapucai ( 1 ),3.001,1,NA
Biological,group b (ag0302-covid19),1,2020-11-26,0,0,0,1,0,"AnGes, Inc. ( 1 )",3.001,1,NA
placebo,group b (placebo),1,2020-11-26,0,0,0,1,0,"AnGes, Inc. ( 1 )",3.001,1,NA
Drug,group hydroxychloroquine,1,2020-09-05,0,0,0,1,0,Universidade do Vale do Sapucai ( 1 ),3.001,1,NA
Drug,group hydroxychloroquine/apixaban,1,2020-09-05,0,0,0,1,0,Universidade do Vale do Sapucai ( 1 ),3.001,1,NA
Drug,gt0918 tablets,1,2021-04-29,0,0,0,1,0,"Suzhou Kintor Pharmaceutical Inc, ( 1 )",3.001,1,NA
Biological,half dose of chadox1 ncov-19 (azd1222),1,2021-09-24,0,0,0,1,0,Federal University of Espirito Santo ( 1 ),3.001,1,NA
Diagnostic Test,hematology blood test,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,heparin - prophylactic dosage,1,2020-10-22,0,0,0,1,0,University of Sao Paulo ( 1 ),3.001,1,NA
Drug,heparin - therapeutic dosage,1,2020-10-22,0,0,0,1,0,University of Sao Paulo ( 1 ),3.001,1,NA
Drug,high-dose dexamethasone,1,2020-05-16,0,0,0,1,0,Centro de EducaciÃ³n Medica e Investigaciones ClÃ­nicas Norberto Quirno ( 1 ),3.001,1,1
Drug,high dose corticosteroid,1,2020-05-07,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,4
Drug,hydroxychloroquine with azithromycin,1,2021-06-25,0,0,0,1,0,"CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )",3.001,1,NA
Biological,hyperimmune globulin,1,2020-07-22,0,0,0,1,0,University of Melbourne ( 1 ),3.001,1,NA
Combination Product,immunofree tablets/reginmune capsule,1,2020-07-28,0,0,0,1,0,Nutrin GmbH ( 1 ),3.001,1,NA
Biological,inactivated sars cov 2 vaccine (vero cell) wuhan,1,2020-08-18,0,0,0,1,0,Universidad Peruana Cayetano Heredia ( 1 ),3.001,1,NA
Biological,inactivated sars cov 2 vaccine (vero cell) wuhan/beijing/placebo,1,2020-08-18,0,0,0,1,0,Universidad Peruana Cayetano Heredia ( 1 ),3.001,1,NA
Drug,inm005,1,2020-07-29,0,0,0,1,0,Inmunova S.A. ( 1 ),3.001,1,1
Combination Product,inopulse,1,2020-06-05,0,0,0,1,0,Bellerophon ( 1 ),3.001,1,NA
Drug,insulin,1,2020-09-03,0,0,0,1,0,Hospital Regional de Alta Especialidad del Bajio ( 1 ),3.001,1,NA
Drug,isavuconazonium injection [cresemba],1,2021-01-08,0,0,0,1,0,"University of California, San Diego ( 1 )",3.001,1,NA
Drug,iv tocillizumab (tcz),1,2020-09-03,0,0,0,1,0,Turku University Hospital ( 1 ),3.001,1,NA
Drug,ivermectin nasal spray,1,2021-06-30,0,0,0,1,0,South Valley University ( 1 ),3.001,1,NA
Drug,ivermectin powder,1,2020-12-16,0,0,0,1,0,Mansoura University ( 1 ),3.001,1,NA
Drug,"ivermectin,ribavirin ,nitazoxanide/zinc",1,2021-07-01,0,0,0,1,0,Mansoura University ( 1 ),3.001,1,NA
Drug,ivermectin/doxycycline,1,2020-08-19,0,0,0,1,0,Dhaka Medical College ( 1 ),3.001,1,1
Drug,ivig,1,2020-07-15,0,0,0,1,0,Biopharma Plasma LLC ( 1 ),3.001,1,NA
Drug,kan jang capsules,1,2021-04-13,0,0,0,1,0,Swedish Herbal Institute AB ( 1 ),3.001,1,NA
Drug,l,1,2020-12-04,0,0,0,1,0,Guy's and St Thomas' NHS Foundation Trust ( 1 ),3.001,1,NA
Drug,l-arginine,1,2020-10-28,0,0,0,1,0,Lebanese American University Medical Center ( 1 ),3.001,1,NA
Drug,lactose monohydrate,1,2021-05-12,0,0,0,1,0,"Copenhagen University Hospital, Hvidovre ( 1 )",3.001,1,NA
placebo,lanadelumab placebo,1,2020-10-14,0,0,0,1,0,Amgen ( 1 ),3.001,1,NA
Biological,licensed seasonal influenza vaccine,1,2020-10-09,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
Biological,lilly bamlanivimab,1,2021-02-26,0,0,0,1,0,University of Pittsburgh ( 1 ),3.001,1,1
Biological,lilly bamlanivimab / etesevimab,1,2021-02-26,0,0,0,1,0,University of Pittsburgh ( 1 ),3.001,1,1
Drug,linagliptin,1,2020-09-03,0,0,0,1,0,Hospital Regional de Alta Especialidad del Bajio ( 1 ),3.001,1,NA
Drug,linagliptin 5 mg,1,2020-04-30,0,0,0,1,0,Rabin Medical Center ( 1 ),3.001,1,NA
Drug,liposomal,1,2020-07-16,0,0,0,1,0,University of Rome Tor Vergata ( 1 ),3.001,1,NA
Drug,lopinavir/ritonavir / hydoxychloroquine,1,2020-03-30,0,0,0,1,0,Fasa University of Medical Sciences ( 1 ),3.001,1,NA
Drug,lopinavir/ritonavir 200 mg-50 mg oral tablet,1,2020-07-06,0,0,0,1,0,"ANRS, Emerging Infectious Diseases ( 1 )",3.001,1,NA
Drug,losmapimod,1,2020-08-08,0,0,0,1,0,Fulcrum Therapeutics ( 1 ),3.001,1,NA
Drug,low dose low molecular weight heparin,1,2020-09-06,0,0,0,1,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),3.001,1,NA
Drug,low dose low molecular weight heparin/placebo,1,2020-09-06,0,0,0,1,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),3.001,1,NA
Biological,matrix-m1 adjuvant (crossover vaccination period),1,2020-10-30,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
Biological,matrix-m1 adjuvant (initial vaccination period),1,2020-10-30,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
Biological,matrix m1-adjuvant,1,2020-10-09,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
Biological,menacwy prime,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Biological,menacwy prime/saline placebo boost / paracetamol,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Biological,menacwy single dose,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Biological,menacwy single dose / paracetamol,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Biological,menacwy vaccine,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Drug,metformin,1,2020-08-07,0,0,0,1,0,University of Minnesota ( 1 ),3.001,1,NA
Drug,methylprednisolone group,1,2021-08-09,0,0,0,1,0,Asociacion Instituto Biodonostia ( 1 ),3.001,1,NA
Drug,methylprednisolone injection,1,2020-10-21,0,0,0,1,0,Fatima Memorial Hospital ( 1 ),3.001,1,NA
Other,microcrystalline cellulose capsule,1,2021-03-01,0,0,0,1,0,The Canadian College of Naturopathic Medicine ( 1 ),3.001,1,NA
Drug,ml oral solution [calcidol],1,2021-04-20,0,0,0,1,0,University of Monastir ( 1 ),3.001,1,NA
Drug,ml prefilled syringe [kineret],1,2020-06-18,0,0,0,1,0,Fundacion Miguel Servet ( 1 ),3.001,1,NA
Biological,moderna sars-cov-2 vaccine,1,2021-08-23,0,0,0,1,0,Sunnybrook Health Sciences Centre ( 1 ),3.001,1,NA
Drug,molixan,1,2021-02-25,0,0,0,1,0,Pharma VAM ( 1 ),3.001,1,NA
Drug,mometasone furoate nasal spray,1,2020-07-22,0,0,0,1,0,Benha University ( 1 ),3.001,1,1
Biological,mrna-1273.617.2,1,2021-06-14,0,0,0,1,0,"ModernaTX, Inc. ( 1 )",3.001,1,NA
Drug,nangibotide,1,2020-05-29,0,0,0,1,0,Inotrem ( 1 ),3.001,1,NA
Biological,nanocovax,1,2021-06-08,0,0,0,1,0,Nanogen Pharmaceutical Biotechnology Joint Stock Company ( 1 ),3.001,1,NA
Drug,naproxen,1,2020-03-26,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Other,nasal spray by distilled water to control group,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,nasal spray to asymptomatic to mild covid-19 patient having multiple comorbidity,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,nasal spray to healthy volunteer,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,nebivolol,1,2020-10-28,0,0,0,1,0,Lebanese American University Medical Center ( 1 ),3.001,1,NA
Other,news score,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,nicorandil,1,2020-10-28,0,0,0,1,0,Lebanese American University Medical Center ( 1 ),3.001,1,NA
Drug,nicotine 7 mg,1,2020-10-23,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,nicotine patch,1,2020-09-28,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,normal saline intranasal/placebo inhaler,1,2020-06-16,0,0,0,1,0,McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 ),3.001,1,NA
Drug,olokizumab,1,2020-05-06,0,0,0,1,0,R-Pharm ( 1 ),3.001,1,NA
Drug,omega 3 fatty acid,1,2021-03-14,0,0,0,1,0,Hamad Medical Corporation ( 1 ),3.001,1,NA
Drug,omega 3/nigella sativa oil,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Drug,omega 3/nigella sativa oil/anise seed capsule,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Drug,omega 3/nigella sativa oil/deglycyrrhizinated licorice,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Drug,omega 3/nigella sativa oil/indian costus,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Drug,omega 3/nigella sativa oil/quinine pills,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Drug,or high dose lmwh),1,2020-09-06,0,0,0,1,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),3.001,1,NA
Other,oral/nasal spray by distilled water to control group,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,oseltamivir 75mg,1,2020-09-03,0,0,0,1,0,Indonesia University ( 1 ),3.001,1,NA
Drug,osoc,1,2020-04-17,0,0,0,1,0,"University Hospital, Tours ( 1 )",3.001,1,NA
Drug,p2et (caesalpinia spinosa extract),1,2020-05-27,0,0,0,1,0,Hospital Universitario San Ignacio ( 1 ),3.001,1,NA
Drug,pacritinib,1,2020-05-22,0,0,0,1,0,CTI BioPharma ( 1 ),3.001,1,NA
Other,part 1,1,2020-07-07,0,0,0,1,0,Daewoong Pharmaceutical Co. LTD. ( 1 ),3.001,1,NA
Other,part 2,1,2020-07-07,0,0,0,1,0,Daewoong Pharmaceutical Co. LTD. ( 1 ),3.001,1,NA
Drug,part a: upamostat 200 mg,1,2021-01-18,0,0,0,1,0,RedHill Biopharma Limited ( 1 ),3.001,1,NA
Drug,part a: upamostat 400 mg,1,2021-01-18,0,0,0,1,0,RedHill Biopharma Limited ( 1 ),3.001,1,NA
Drug,part b: upamostat 200/400 mg,1,2021-01-18,0,0,0,1,0,RedHill Biopharma Limited ( 1 ),3.001,1,NA
Biological,peginterferon beta-1a,1,2020-08-21,0,0,0,1,0,Pontificia Universidad Catolica de Chile ( 1 ),3.001,1,1
Drug,pentaglobin,1,2020-04-10,0,0,0,1,0,Medical University of Vienna ( 1 ),3.001,1,NA
Procedure,physical examination,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,physiological irrigating solution,1,2021-04-20,0,0,0,1,0,University of Monastir ( 1 ),3.001,1,NA
placebo,placebo (initial vaccination period),1,2020-10-30,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
placebo,placebo (iv),1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
placebo,placebo (normal saline),1,2021-08-13,0,0,0,1,0,Vinbiocare Biotechnology Joint Stock Company ( 1 ),3.001,1,NA
placebo,placebo (sc injections),1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
placebo,placebo for pf-07321332,1,2021-09-01,0,0,0,1,0,Pfizer ( 1 ),3.001,1,NA
placebo,placebo for ritonavir,1,2021-09-01,0,0,0,1,0,Pfizer ( 1 ),3.001,1,NA
placebo,placebo inhaler,1,2020-06-16,0,0,0,1,0,McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 ),3.001,1,NA
placebo,placebo of nicotine transdermal patch,1,2020-10-23,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
placebo,placebo sofusbuvir,1,2020-07-03,0,0,0,1,0,Hospital do Coracao ( 1 ),3.001,1,NA
Biological,placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1,2020-09-16,0,0,0,1,0,Laboratorio Elea Phoenix S.A. ( 1 ),3.001,1,NA
Combination Product,polio vaccine,1,2020-09-04,0,0,0,1,0,"NeuroActiva, Inc. ( 1 )",3.001,1,NA
Combination Product,polio vaccine/na-831,1,2020-09-04,0,0,0,1,0,"NeuroActiva, Inc. ( 1 )",3.001,1,NA
Drug,prednisolone,1,2021-02-18,0,0,0,1,0,Centre Hospitalier RenÃ© Dubos ( 1 ),3.001,1,NA
Drug,proxalutamide (gt0918),1,2021-04-27,0,0,0,1,0,"Suzhou Kintor Pharmaceutical Inc, ( 1 )",3.001,1,NA
Drug,ptc299,1,2020-06-17,0,0,0,1,0,PTC Therapeutics ( 1 ),3.001,1,NA
Drug,pyramax,1,2021-10-19,0,0,0,1,0,Shin Poong Pharmaceutical Co. Ltd. ( 1 ),3.001,1,NA
Drug,pyridostigmine bromide,1,2020-04-09,0,0,0,1,0,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 ),3.001,1,1
Drug,pyronaridine-artesunate (pa),1,2020-12-14,0,0,0,1,0,Liverpool School of Tropical Medicine ( 1 ),3.001,1,NA
Dietary Supplement,quercetin phytosome,1,2020-10-06,0,0,0,1,0,Liaquat University of Medical & Health Sciences ( 1 ),3.001,1,3
Drug,quinine,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Drug,r tablets,1,2020-03-25,0,0,0,1,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),3.001,1,NA
Biological,recombinant covid-19 vaccine (cho cell),1,2021-08-30,0,0,0,1,0,"National Vaccine and Serum Institute, China ( 1 )",3.001,1,NA
Biological,recombinant covid-19 vaccine (sf9 cells),1,2021-05-26,0,0,0,1,0,"WestVac Biopharma Co., Ltd. ( 1 )",3.001,1,NA
Biological,recombinant sars-cov-2 fusion protein vaccine (v-01),1,2021-10-21,0,0,0,1,0,Livzon Pharmaceutical Group Inc. ( 1 ),3.001,1,NA
Behavioral,refugee,1,2021-10-22,0,0,0,1,0,University of New Mexico ( 1 ),3.001,1,NA
Behavioral,refugee/immigrant well-being project (riwp),1,2021-10-22,0,0,0,1,0,University of New Mexico ( 1 ),3.001,1,NA
Biological,regeneron casirivimab,1,2021-02-26,0,0,0,1,0,University of Pittsburgh ( 1 ),3.001,1,1
Biological,regeneron casirivimab / imdevimab,1,2021-02-26,0,0,0,1,0,University of Pittsburgh ( 1 ),3.001,1,1
Combination Product,reginmune,1,2020-07-28,0,0,0,1,0,Nutrin GmbH ( 1 ),3.001,1,NA
Biological,remestemcel-l,1,2020-04-28,0,0,0,1,0,Icahn School of Medicine at Mount Sinai ( 1 ),3.001,1,NA
Drug,ritonavir 50 mg [kaletra],1,2020-04-16,0,0,0,1,0,University of Washington ( 1 ),3.001,1,1
Drug,rnapc2,1,2020-12-02,0,0,0,1,0,"ARCA Biopharma, Inc. ( 1 )",3.001,1,NA
Drug,ro7496998,1,2021-05-10,0,0,0,1,0,"Atea Pharmaceuticals, Inc. ( 1 )",3.001,1,NA
Biological,rph-104,1,2020-05-06,0,0,0,1,0,R-Pharm ( 1 ),3.001,1,NA
Biological,"sab-185 (10,240 units",1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Biological,"sab-185 (3,840 units",1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
placebo,saline placebo boost,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Drug,saline/standard care,1,2020-03-14,0,0,0,1,0,"NeuroRx, Inc. ( 1 )",3.001,1,NA
Biological,sars-cov-2 adjuvanted recombinant protein vaccine (bivalent),1,2021-05-26,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,sars-cov-2 adjuvanted recombinant protein vaccine (monovalent),1,2021-05-26,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614/b.1.351)-as03, dosage a",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (d614)-as03, dosage b",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,sars-cov-2 neutralizing antibody titer,1,2021-02-13,0,0,0,1,0,Zagazig University ( 1 ),3.001,1,NA
Biological,sars-cov-2 recombinant protein vaccine phase 2 formulation 1,1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,sars-cov-2 recombinant protein vaccine phase 2 formulation 2,1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,sars-cov-2 recombinant protein vaccine phase 2 formulation 3,1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,sars-cov-2 rs/matrix-m1 adjuvant (initial vaccination period),1,2020-10-30,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
Biological,sars-cov-2 rs/matrix m1-adjuvant,1,2020-10-09,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
Drug,sildenafil citrate,1,2020-02-14,0,0,0,1,0,Tongji Hospital ( 1 ),3.001,1,1
Drug,soc therapy,1,2020-07-16,0,0,0,1,0,University of Rome Tor Vergata ( 1 ),3.001,1,NA
Drug,sofosbuvir 400 mg,1,2020-08-28,0,0,0,1,0,Mansoura University ( 1 ),3.001,1,NA
Drug,sofosbuvir 400 mg/daclatasvir 200mg,1,2020-08-28,0,0,0,1,0,Mansoura University ( 1 ),3.001,1,NA
Drug,sofosbuvir ledipsavir,1,2020-07-04,0,0,0,1,0,Tanta University ( 1 ),3.001,1,NA
Drug,sofusbuvir,1,2020-07-03,0,0,0,1,0,Hospital do Coracao ( 1 ),3.001,1,NA
Procedure,sphenopalatine ganglion block with local anesthetic,1,2020-11-18,0,0,0,1,0,University Hospital Bispebjerg and Frederiksberg ( 1 ),3.001,1,NA
placebo,sphenopalatine ganglion block with placebo (isotone nacl),1,2020-11-18,0,0,0,1,0,University Hospital Bispebjerg and Frederiksberg ( 1 ),3.001,1,NA
Drug,spironolactone,1,2021-03-28,0,0,0,1,0,Chita State Regional Clinical Hospital Number 1 ( 1 ),3.001,1,NA
Drug,spironolactone / dexamethasone,1,2021-03-28,0,0,0,1,0,Chita State Regional Clinical Hospital Number 1 ( 1 ),3.001,1,NA
Drug,standard-of-care sars-cov-2 treatment,1,2021-03-28,0,0,0,1,0,Chita State Regional Clinical Hospital Number 1 ( 1 ),3.001,1,NA
Biological,standard care/placebo,1,2020-08-12,0,0,0,1,0,South African National Blood Service ( 1 ),3.001,1,1
Biological,standard dose of chadox1 ncov-19 (azd1222),1,2021-09-24,0,0,0,1,0,Federal University of Espirito Santo ( 1 ),3.001,1,NA
Dietary Supplement,standard enteral nutrition,1,2021-05-30,0,0,0,1,0,Assiut University ( 1 ),3.001,1,NA
Drug,standard of care_1,1,2021-03-01,0,0,0,1,0,Ain Shams University ( 1 ),3.001,1,NA
Drug,standard prophylactic dose enoxaparin,1,2020-07-22,0,0,0,1,0,Rajaie Cardiovascular Medical and Research Center ( 1 ),3.001,1,2
Procedure,standard therapy recommended by the ministry of health of the russian federation/leitragin inhalation,1,2020-04-08,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
Procedure,standard therapy recommended by the ministry of health of the russian federation/leitragin intramuscular injection,1,2020-04-08,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
Procedure,standard therapy recommended by the ministry of health of the russian federation/leitragin intramuscular injection/with leitragin inhalation,1,2020-04-08,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
Drug,standardized brazilian green propolis extract,1,2021-03-12,0,0,0,1,0,D'Or Institute for Research and Education ( 1 ),3.001,1,NA
Drug,sterile normal saline (0.9%),1,2020-10-12,0,0,0,1,0,Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd ( 1 ),3.001,1,NA
Drug,sulodexide,1,2020-07-22,0,0,0,1,0,Clinedem ( 1 ),3.001,1,NA
Drug,tenofovir,1,2020-04-15,0,0,0,1,0,Universidad Nacional de Colombia ( 1 ),3.001,1,8
Drug,tenofovir disoproxil/emtricitabine,1,2020-11-16,0,0,0,1,0,"University Hospital, Caen ( 1 )",3.001,1,1
Drug,thymosin,1,2020-03-21,0,0,0,1,0,Shanghai Jiao Tong University School of Medicine ( 1 ),3.001,1,NA
Biological,tigeraseâ®,1,2020-07-03,0,0,0,1,0,AO GENERIUM ( 1 ),3.001,1,NA
Drug,tj003234,1,2020-04-04,0,0,0,1,0,I-Mab Biopharma Co. Ltd. ( 1 ),3.001,1,NA
Biological,to monitor the effectiveness of the single dose ad26.cov2.s covid-19 vaccine,1,2021-02-17,0,0,0,1,0,Wits Health Consortium (Pty) Ltd ( 1 ),3.001,1,NA
Drug,tradipitant,1,2020-03-26,0,0,0,1,0,Vanda Pharmaceuticals ( 1 ),3.001,1,1
Biological,turcovac,1,2021-06-24,0,0,0,1,0,Health Institutes of Turkey ( 1 ),3.001,1,NA
Biological,two dose chadox1 ncov-19,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Biological,two dose chadox1 ncov-19/covishield 0.25ml/0.5ml,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Biological,two dose chadox1 ncov-19/covishield 0.5ml,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Biological,two dose menacwy vaccine min. 4 weeks apart,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Biological,"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",1,2020-11-04,0,0,0,1,0,"Sinovac Biotech Co., Ltd ( 1 )",3.001,1,NA
Biological,"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",1,2020-11-04,0,0,0,1,0,"Sinovac Biotech Co., Ltd ( 1 )",3.001,1,NA
Diagnostic Test,urine pregnancy test for women of childbearing potential,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,usual practice / symbicort rapihaler,1,2020-03-29,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Biological,vaccine: bnt162b2 3mcg,1,2021-03-19,0,0,0,1,0,BioNTech SE ( 1 ),3.001,1,NA
Drug,vit-d 0.2 mg,1,2021-04-20,0,0,0,1,0,University of Monastir ( 1 ),3.001,1,NA
Drug,vit-d 0.2 mg/ml oral solution [calcidol],1,2021-04-20,0,0,0,1,0,University of Monastir ( 1 ),3.001,1,NA
Procedure,vital signs,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Dietary Supplement,vitamin c/zinc,1,2021-03-01,0,0,0,1,0,The Canadian College of Naturopathic Medicine ( 1 ),3.001,1,NA
Dietary Supplement,vitamin k2,1,2021-03-01,0,0,0,1,0,The Canadian College of Naturopathic Medicine ( 1 ),3.001,1,NA
Dietary Supplement,vitamins,1,2020-04-11,0,0,0,1,0,"University Hospital, Bordeaux ( 1 )",3.001,1,1
Biological,vla2101,1,2021-06-21,0,0,0,1,0,Valneva Austria GmbH ( 1 ),3.001,1,NA
Other,weekly assessment,1,2020-04-07,0,0,0,1,0,Henry Ford Health System ( 1 ),3.001,1,NA
Combination Product,- tocilizumab,1,2020-04-07,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
placebo,"""sham""-block with placebo (isotone nacl)",1,2020-11-18,0,0,0,1,0,University Hospital Bispebjerg and Frederiksberg ( 1 ),3.001,1,NA
Drug,0.4ml inj syringe 0.4ml,1,2020-05-15,0,0,0,1,0,University of Zurich ( 1 ),3.001,1,1
Biological,0.5ml,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Drug,0.6% pvp-i oral,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,0.6% pvp-i oral/nasal spray to asymptomatic to mild covid-19 patient having multiple comorbidity,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,0.6% pvp-i oral/nasal spray to healthy volunteer,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,0.9% sodium chloride,1,2021-04-14,0,0,0,1,0,Grifols Therapeutics LLC ( 1 ),3.001,1,NA
Drug,24h transdermal patch - 24 hour,1,2020-10-23,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,400 mg,1,2021-01-18,0,0,0,1,0,RedHill Biopharma Limited ( 1 ),3.001,1,NA
Behavioral,a faithful response to covid-19,1,2021-07-19,0,0,0,1,0,"University of Missouri, Kansas City ( 1 )",3.001,1,NA
Drug,abx464,1,2020-05-18,0,0,0,1,0,Abivax S.A. ( 1 ),3.001,1,NA
Drug,active comparator,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Dietary Supplement,adapt-232 oral solution,1,2021-03-08,0,0,0,1,0,Swedish Herbal Institute AB ( 1 ),3.001,1,NA
Biological,aldesleukin,1,2020-10-05,0,0,0,1,0,University of Sao Paulo ( 1 ),3.001,1,NA
Biological,aluminum adjuvant of inactivated sars-cov-2 vaccine,1,2020-09-16,0,0,0,1,0,Laboratorio Elea Phoenix S.A. ( 1 ),3.001,1,NA
Drug,amantadine hydrochloride,1,2021-04-17,0,0,0,1,0,Independent Public Clinical Hospital No. 4 in Lublin ( 1 ),3.001,1,NA
Drug,angiotensin ii receptor blockers,1,2020-10-06,0,0,0,1,0,Ottawa Heart Institute Research Corporation ( 1 ),3.001,1,NA
Drug,anise,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Biological,anti sars-cov-2 equine hyperimmune serum,1,2021-03-23,0,0,0,1,0,Caja Costarricense de Seguro Social ( 1 ),3.001,1,NA
Biological,anti sars-cov 2 convalescent plasma in critical covid-19 patients,1,2020-06-12,0,0,0,1,0,Centro Medico ABC ( 1 ),3.001,1,19
Drug,apixaban 5mg,1,2020-08-03,0,0,0,1,0,University of Pittsburgh ( 1 ),3.001,1,1
placebo,apremilast placebo,1,2020-10-14,0,0,0,1,0,Amgen ( 1 ),3.001,1,NA
Drug,artemether-lumefantrine (al),1,2020-12-14,0,0,0,1,0,Liverpool School of Tropical Medicine ( 1 ),3.001,1,NA
Drug,asc09f/oseltamivir,1,2020-02-04,0,0,0,1,0,Tongji Hospital ( 1 ),3.001,1,NA
Drug,asp,1,2021-01-06,0,0,0,1,0,London School of Hygiene and Tropical Medicine ( 1 ),3.001,1,NA
Biological,astrazeneca,1,2021-05-08,0,0,0,1,0,Ain Shams University ( 1 ),3.001,1,NA
Biological,astrazeneca/oxford vaccine,1,2021-05-08,0,0,0,1,0,Ain Shams University ( 1 ),3.001,1,NA
Biological,astrazenica vaccine,1,2021-08-23,0,0,0,1,0,Theodor Bilharz Research Institute ( 1 ),3.001,1,NA
Drug,asunercept 100mg,1,2020-04-10,0,0,0,1,0,Medical University of Vienna ( 1 ),3.001,1,NA
Combination Product,atazanavir/dexamethasone,1,2020-06-26,0,0,0,1,0,"NeuroActiva, Inc. ( 1 )",3.001,1,NA
Drug,atorvastatin / l-arginine / folic acid / nicorandil / nebivolol,1,2020-10-28,0,0,0,1,0,Lebanese American University Medical Center ( 1 ),3.001,1,NA
Drug,atorvastatin 40 mg oral tablet,1,2021-07-01,0,0,0,1,0,Mansoura University ( 1 ),3.001,1,NA
placebo,aviptadil placebo,1,2021-04-09,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Biological,azd2816,1,2021-07-02,0,0,0,1,0,AstraZeneca ( 1 ),3.001,1,NA
Biological,azd7442 (im),1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Drug,azithromycin / ivermectin / ribaroxaban / paracetamol,1,2020-12-16,0,0,0,1,0,"CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )",3.001,1,NA
Drug,azithromycin / ribaroxaban / paracetamol,1,2020-12-16,0,0,0,1,0,"CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )",3.001,1,NA
Biological,"b.1.351)-as03, dosage a",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"b.1.351)-as03, dosage b",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
placebo,b: placebo,1,2021-01-18,0,0,0,1,0,RedHill Biopharma Limited ( 1 ),3.001,1,NA
Biological,bactek-r,1,2020-04-19,0,0,0,1,0,Inmunotek S.L. ( 1 ),3.001,1,NA
Biological,beijing,1,2020-08-18,0,0,0,1,0,Universidad Peruana Cayetano Heredia ( 1 ),3.001,1,NA
Drug,bemiparin sodium,1,2020-10-23,0,0,0,1,0,"Clinica Universidad de Navarra, Universidad de Navarra ( 1 )",3.001,1,NA
Drug,bio101,1,2020-07-06,0,0,0,1,0,Biophytis ( 1 ),3.001,1,1
Diagnostic Test,biochemistry blood test,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Biological,biological/vaccine: bnt162b2 10mcg,1,2021-03-19,0,0,0,1,0,BioNTech SE ( 1 ),3.001,1,NA
Other,blank preparation of recombinant sars-cov-2 fusion protein vaccine (v-01),1,2021-10-21,0,0,0,1,0,Livzon Pharmaceutical Group Inc. ( 1 ),3.001,1,NA
Biological,bms-986413,1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Biological,bms-986414,1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Biological,bms-986414 / bms-986413,1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Drug,bucillamine,1,2020-08-04,0,0,0,1,0,"Revive Therapeutics, Ltd. ( 1 )",3.001,1,NA
Biological,c19-ig 20%,1,2021-04-14,0,0,0,1,0,Grifols Therapeutics LLC ( 1 ),3.001,1,NA
Drug,camostat mesylate,1,2020-10-28,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,candesartan,1,2020-04-10,0,0,0,1,0,Medical University of Vienna ( 1 ),3.001,1,NA
Drug,"cannabidiol, pharmaceutically produced with < 5 ppm thc",1,2020-11-02,0,0,0,1,0,Cardiol Therapeutics Inc. ( 1 ),3.001,1,NA
Drug,carrimycin,1,2020-12-16,0,0,0,1,0,"Shenyang Tonglian Group CO., Ltd ( 1 )",3.001,1,NA
Drug,casirivimab / imdevimab,1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Drug,casirivimab/imdevimab combination therapy,1,2020-06-08,0,0,0,1,0,Regeneron Pharmaceuticals ( 1 ),3.001,1,2
Biological,chadox1 ncov-19 single dose,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Biological,chadox1 ncov-19 single dose / paracetamol,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Biological,chadox1 ncov-19 two dose,1,2020-09-01,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,NA
Drug,ciclesonide nasal,1,2020-06-16,0,0,0,1,0,McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 ),3.001,1,NA
Drug,cimetra-1,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,cimetra-2,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,ckd-314,1,2021-04-29,0,0,0,1,0,Chong Kun Dang Pharmaceutical ( 1 ),3.001,1,NA
placebo,ckd-314 placebo,1,2021-04-29,0,0,0,1,0,Chong Kun Dang Pharmaceutical ( 1 ),3.001,1,NA
Drug,ckd-314 placebo/soc,1,2021-04-29,0,0,0,1,0,Chong Kun Dang Pharmaceutical ( 1 ),3.001,1,NA
Drug,cobicistat,1,2020-01-29,0,0,0,1,0,Shanghai Public Health Clinical Center ( 1 ),3.001,1,1
Diagnostic Test,confirm sars-cov-2 infection,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,continuation of ras blocker,1,2020-03-28,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,control group (standard hospital treatment),1,2020-09-05,0,0,0,1,0,Universidade do Vale do Sapucai ( 1 ),3.001,1,NA
Biological,controlled vaccine,1,2021-08-03,0,0,0,1,0,"Sinovac Biotech Co., Ltd ( 1 )",3.001,1,NA
Biological,convalescent plasma treatment,1,2021-04-26,0,0,0,1,0,"National Institute of Health Research and Development, Ministry of Health Republic of Indonesia ( 1 )",3.001,1,NA
Biological,convalescent plasma/standard care,1,2020-08-12,0,0,0,1,0,South African National Blood Service ( 1 ),3.001,1,1
Biological,convp,1,2020-10-12,0,0,0,1,0,Erasmus Medical Center ( 1 ),3.001,1,NA
Biological,covaxin,1,2021-05-18,0,0,0,1,0,Bharat Biotech International Limited ( 1 ),3.001,1,NA
Other,covid-19-impact on quality of life questionnaire,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Biological,covishield 0.25ml,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Biological,covishield 0.5ml,1,2020-05-12,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,5
Drug,cpi-006 1 mg,1,2021-01-29,0,0,0,1,0,"Corvus Pharmaceuticals, Inc. ( 1 )",3.001,1,NA
Drug,cpi-006 1 mg/kg / soc,1,2021-01-29,0,0,0,1,0,"Corvus Pharmaceuticals, Inc. ( 1 )",3.001,1,NA
Drug,cpi-006 2 mg,1,2021-01-29,0,0,0,1,0,"Corvus Pharmaceuticals, Inc. ( 1 )",3.001,1,NA
Drug,cpi-006 2 mg/kg / soc,1,2021-01-29,0,0,0,1,0,"Corvus Pharmaceuticals, Inc. ( 1 )",3.001,1,NA
Dietary Supplement,cretan iama,1,2021-01-06,0,0,0,1,0,University of Crete ( 1 ),3.001,1,1
Biological,ct-p59/placebo,1,2020-10-18,0,0,0,1,0,Celltrion ( 1 ),3.001,1,NA
Drug,cumin,1,2020-04-11,0,0,0,1,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),3.001,1,NA
Drug,darunavir/cobicistat,1,2020-01-29,0,0,0,1,0,Shanghai Public Health Clinical Center ( 1 ),3.001,1,1
Drug,deglycyrrhizinated licorice,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Drug,dociparstat sodium,1,2020-05-13,0,0,0,1,0,Chimerix ( 1 ),3.001,1,1
Drug,dornase alfa,1,2020-05-20,0,0,0,1,0,University of Missouri-Columbia ( 1 ),3.001,1,NA
Drug,doxazosin 2 mg oral tablet,1,2021-01-25,0,0,0,1,0,Cardresearch ( 1 ),3.001,1,NA
Drug,doxycyclin,1,2020-10-06,0,0,0,1,0,"General Administration of Military Health, Tunisia ( 1 )",3.001,1,NA
Drug,edoxaban tablets,1,2020-08-05,0,0,0,1,0,"University Hospital Inselspital, Berne ( 1 )",3.001,1,4
Drug,ergoferon,1,2021-10-04,0,0,0,1,0,Materia Medica Holding ( 1 ),3.001,1,NA
Drug,extract psidii guava,1,2021-03-16,0,0,0,1,0,Faculty of Medicine Baiturrahmah University ( 1 ),3.001,1,NA
Drug,favipiravir/azithromycin,1,2020-05-23,0,0,0,1,0,"Ministry of Health, Turkey ( 1 )",3.001,1,NA
Drug,favipiravir/chloroquine,1,2020-03-20,0,0,0,1,0,Beijing Chao Yang Hospital ( 1 ),3.001,1,NA
Drug,fluoxetine tablets,1,2021-03-02,0,0,0,1,0,El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez ( 1 ),3.001,1,12
Drug,fluticasone,1,2021-04-30,0,0,0,1,0,Duke University ( 1 ),3.001,1,NA
Drug,formoterol,1,2020-03-30,0,0,0,1,0,Fasa University of Medical Sciences ( 1 ),3.001,1,NA
Drug,foy-305,1,2020-11-09,0,0,0,1,0,Ono Pharmaceutical Co. Ltd ( 1 ),3.001,1,NA
Drug,fp-025 300 mg,1,2021-02-02,0,0,0,1,0,"Foresee Pharmaceuticals Co., Ltd. ( 1 )",3.001,1,NA
Biological,gam-covid-vac m,1,2021-07-05,0,0,0,1,0,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation ( 1 )",3.001,1,NA
Biological,gbp510 adjuvanted with as03 (receptor-binding domain(rbd) 25ug,1,2021-08-09,0,0,0,1,0,"SK Bioscience Co., Ltd. ( 1 )",3.001,1,NA
Biological,gbp510 adjuvanted with as03 (receptor-binding domain(rbd) 25ug/dose),1,2021-08-09,0,0,0,1,0,"SK Bioscience Co., Ltd. ( 1 )",3.001,1,NA
Biological,group a (ag0302-covid19),1,2020-11-26,0,0,0,1,0,"AnGes, Inc. ( 1 )",3.001,1,NA
Drug,gt0918 tablets/placebo,1,2021-04-29,0,0,0,1,0,"Suzhou Kintor Pharmaceutical Inc, ( 1 )",3.001,1,NA
Behavioral,hospital: dd-ca,1,2020-10-05,0,0,0,1,0,Scripps Whittier Diabetes Institute ( 1 ),3.001,1,NA
Behavioral,hospital: usual care (uc),1,2020-10-05,0,0,0,1,0,Scripps Whittier Diabetes Institute ( 1 ),3.001,1,NA
Biological,human normal immunoglobulin (ivig),1,2021-03-31,0,0,0,1,0,University Children's Hospital Basel ( 1 ),3.001,1,NA
Drug,hydrocortisone,1,2020-04-11,0,0,0,1,0,Scandinavian Critical Care Trials Group ( 1 ),3.001,1,1
Drug,hydroxychloroquine / metabolic cofactor supplementation,1,2020-09-30,0,0,0,1,0,ScandiBio Therapeutics AB ( 1 ),3.001,1,NA
Drug,hydroxychloroquine / sorbitol,1,2020-09-30,0,0,0,1,0,ScandiBio Therapeutics AB ( 1 ),3.001,1,NA
Combination Product,hydroxychloroquine/azithromycin/ tocilizumab,1,2020-04-07,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
Drug,hydroxychloroquine/clindamycin,1,2020-04-11,0,0,0,1,0,The Camelot Foundation ( 1 ),3.001,1,NA
Drug,hydroxychloroquine/clindamycin/primaquine,1,2020-04-11,0,0,0,1,0,The Camelot Foundation ( 1 ),3.001,1,NA
Drug,hydroxychloroquine/doxycycline,1,2020-04-11,0,0,0,1,0,The Camelot Foundation ( 1 ),3.001,1,NA
Drug,hydroxychloroquine/lopinavir/ritonavir,1,2020-05-23,0,0,0,1,0,Cardresearch ( 1 ),3.001,1,1
Drug,hydroxychloroquine/placebo,1,2020-04-05,0,0,0,1,0,"University Hospital, Montpellier ( 1 )",3.001,1,NA
Drug,hydroxyvitamin,1,2020-05-11,0,0,0,1,0,Tehran University of Medical Sciences ( 1 ),3.001,1,NA
Biological,hz,1,2021-09-15,0,0,0,1,0,GlaxoSmithKline ( 1 ),3.001,1,NA
Biological,hz/su,1,2021-09-15,0,0,0,1,0,GlaxoSmithKline ( 1 ),3.001,1,NA
Drug,icosapent ethyl (ipe),1,2020-07-02,0,0,0,1,0,Estudios ClÃ­nicos Latino AmÃ©rica ( 1 ),3.001,1,NA
Drug,ifx-1,1,2020-04-01,0,0,0,1,0,InflaRx GmbH ( 1 ),3.001,1,1
Drug,imdevimab combination therapy,1,2020-06-08,0,0,0,1,0,Regeneron Pharmaceuticals ( 1 ),3.001,1,2
Biological,imm-101,1,2020-06-19,0,0,0,1,0,Canadian Cancer Trials Group ( 1 ),3.001,1,NA
Behavioral,immigrant well-being project (riwp),1,2021-10-22,0,0,0,1,0,University of New Mexico ( 1 ),3.001,1,NA
Combination Product,immunofree tablets,1,2020-07-28,0,0,0,1,0,Nutrin GmbH ( 1 ),3.001,1,NA
Drug,inb03,1,2020-04-29,0,0,0,1,0,"Inmune Bio, Inc. ( 1 )",3.001,1,NA
Drug,indian costus,1,2020-09-15,0,0,0,1,0,Beni-Suef University ( 1 ),3.001,1,NA
Drug,inhaled low molecular weight heparin,1,2021-07-29,0,0,0,1,0,Istanbul University ( 1 ),3.001,1,NA
Drug,interferon alfa,1,2020-08-30,0,0,0,1,0,"Peter MacCallum Cancer Centre, Australia ( 1 )",3.001,1,NA
Drug,intermediate dose enoxaparin/ unfractionated heparin,1,2020-07-22,0,0,0,1,0,Rajaie Cardiovascular Medical and Research Center ( 1 ),3.001,1,2
Behavioral,intervention app,1,2020-05-18,0,0,0,1,0,FundaciÃ³ d'investigaciÃ³ SanitÃ ria de les Illes Balears ( 1 ),3.001,1,2
Drug,intramuscular injection,1,2020-11-12,0,0,0,1,0,Medicago ( 1 ),3.001,1,NA
Drug,intranasal ivermectin spray,1,2021-01-19,0,0,0,1,0,South Valley University ( 1 ),3.001,1,1
Drug,intravenous drug,1,2020-03-26,0,0,0,1,0,University of Zurich ( 1 ),3.001,1,NA
Drug,isoflurane inhalant product,1,2020-06-02,0,0,0,1,0,Sunnybrook Health Sciences Centre ( 1 ),3.001,1,NA
Drug,ivermectin 06 mg oral tablet,1,2021-01-25,0,0,0,1,0,Cardresearch ( 1 ),3.001,1,NA
Drug,"ivermectin,ribavirin ,nitazoxanide",1,2021-07-01,0,0,0,1,0,Mansoura University ( 1 ),3.001,1,NA
Biological,ixekizumab,1,2020-10-05,0,0,0,1,0,University of Sao Paulo ( 1 ),3.001,1,NA
Procedure,leitragin inhalation,1,2020-04-08,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
Procedure,leitragin intramuscular injection,1,2020-04-08,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
Drug,leukotriene receptor antagonist,1,2021-05-01,0,0,0,1,0,King Abdullah International Medical Research Center ( 1 ),3.001,1,NA
Drug,levamisole,1,2020-03-30,0,0,0,1,0,Fasa University of Medical Sciences ( 1 ),3.001,1,NA
Drug,levamisole / budesonide/formoterol,1,2020-03-30,0,0,0,1,0,Fasa University of Medical Sciences ( 1 ),3.001,1,NA
Drug,levilimab,1,2020-05-19,0,0,0,1,0,Biocad ( 1 ),3.001,1,1
Drug,lidocaine 2%,1,2020-10-23,0,0,0,1,0,"University Hospital, Strasbourg, France ( 1 )",3.001,1,1
Drug,lopinavir 200 mg,1,2020-04-16,0,0,0,1,0,University of Washington ( 1 ),3.001,1,1
Drug,lopinavir 200 mg / ritonavir 50 mg [kaletra],1,2020-04-16,0,0,0,1,0,University of Washington ( 1 ),3.001,1,1
Drug,m-m-r ii â® vaccine,1,2020-03-31,0,0,0,1,0,Washington University School of Medicine ( 1 ),3.001,1,NA
placebo,masked saline placebo,1,2020-08-27,0,0,0,1,0,VA Office of Research and Development ( 1 ),3.001,1,NA
Other,medium chain triglyceride oil,1,2021-03-01,0,0,0,1,0,The Canadian College of Naturopathic Medicine ( 1 ),3.001,1,NA
Drug,mefloquine as a prophylaxis against sars-cov-2 infection in household contacts of covid 19 confirmed cases,1,2021-04-14,0,0,0,1,0,Helwan University ( 1 ),3.001,1,NA
Combination Product,mefloquine/azithromycin/ tocilizumab,1,2020-04-07,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
Drug,metabolic cofactor supplementation,1,2020-09-30,0,0,0,1,0,ScandiBio Therapeutics AB ( 1 ),3.001,1,NA
Drug,metenkefalin,1,2020-04-30,0,0,0,1,0,Bosnalijek D.D ( 1 ),3.001,1,NA
Drug,metenkefalin / tridecactide,1,2020-04-30,0,0,0,1,0,Bosnalijek D.D ( 1 ),3.001,1,NA
Diagnostic Test,monitoring visit,1,2020-04-07,0,0,0,1,0,Henry Ford Health System ( 1 ),3.001,1,NA
Drug,mp0420,1,2020-08-03,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,1
Drug,mr,1,2020-03-31,0,0,0,1,0,Washington University School of Medicine ( 1 ),3.001,1,NA
Drug,mr/m-m-r ii â® vaccine,1,2020-03-31,0,0,0,1,0,Washington University School of Medicine ( 1 ),3.001,1,NA
Biological,multistem,1,2020-04-27,0,0,0,1,0,"Athersys, Inc ( 1 )",3.001,1,NA
Combination Product,na-831/atazanavir,1,2020-06-26,0,0,0,1,0,"NeuroActiva, Inc. ( 1 )",3.001,1,NA
Combination Product,na-831/dexamethasone,1,2020-06-26,0,0,0,1,0,"NeuroActiva, Inc. ( 1 )",3.001,1,NA
Drug,nasal spray to moderately ill covid-19 positive patient,1,2021-04-26,0,0,0,1,0,Bangladesh Reference Institute of Chemical Measurements (BRICM) ( 1 ),3.001,1,NA
Drug,nebulised unfractionated heparin (ufh),1,2020-09-05,0,0,0,1,0,Australian National University ( 1 ),3.001,1,NA
Device,nebulized administration of zyesamiâ„¢,1,2020-04-21,0,0,0,1,0,"NeuroRx, Inc. ( 1 )",3.001,1,NA
Device,nebulized administration of zyesamiâ„¢/placebo,1,2020-04-21,0,0,0,1,0,"NeuroRx, Inc. ( 1 )",3.001,1,NA
Drug,nebulized furosemide,1,2020-10-14,0,0,0,1,0,Queen's University ( 1 ),3.001,1,NA
Drug,nebulized saline,1,2020-10-14,0,0,0,1,0,Queen's University ( 1 ),3.001,1,NA
Drug,niclosamide suspension,1,2020-09-18,0,0,0,1,0,Imuneks Farma ilac San. Tic. A.S. ( 1 ),3.001,1,NA
Drug,nicotine 7 mg/ 24h transdermal patch - 24 hour,1,2020-10-23,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,nigella sativa,1,2020-04-11,0,0,0,1,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),3.001,1,NA
Drug,nigella sativa / black cumin,1,2020-04-11,0,0,0,1,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),3.001,1,NA
Drug,nigella sativa seed,1,2021-02-20,0,0,0,1,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),3.001,1,1
Drug,nintedanib 150 mg [ofev],1,2020-08-17,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,nitazoxanide/ciclã©sonide,1,2021-05-04,0,0,0,1,0,"ANRS, Emerging Infectious Diseases ( 1 )",3.001,1,NA
Drug,nk-1r antagonist,1,2020-07-07,0,0,0,1,0,University of Health Sciences Lahore ( 1 ),3.001,1,NA
Drug,normal saline intranasal,1,2020-06-16,0,0,0,1,0,McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 ),3.001,1,NA
Biological,novaferon,1,2020-12-14,0,0,0,1,0,Genova Inc. ( 1 ),3.001,1,NA
Drug,np-120 (ifenprodil),1,2020-05-08,0,0,0,1,0,Algernon Pharmaceuticals ( 1 ),3.001,1,NA
Other,observation,1,2020-06-19,0,0,0,1,0,Canadian Cancer Trials Group ( 1 ),3.001,1,1
Biological,oxford vaccine,1,2021-05-08,0,0,0,1,0,Ain Shams University ( 1 ),3.001,1,NA
Drug,part a,1,2021-01-18,0,0,0,1,0,RedHill Biopharma Limited ( 1 ),3.001,1,NA
Drug,part a/b: placebo,1,2021-01-18,0,0,0,1,0,RedHill Biopharma Limited ( 1 ),3.001,1,NA
Drug,part b: upamostat 200,1,2021-01-18,0,0,0,1,0,RedHill Biopharma Limited ( 1 ),3.001,1,NA
Drug,"patch, nicotine",1,2020-10-15,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
placebo,"patch, placebo",1,2020-10-15,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,peginterferon beta-1a prefilled syringe,1,2021-01-25,0,0,0,1,0,Cardresearch ( 1 ),3.001,1,NA
Diagnostic Test,pk test,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
placebo,placebo-simulation of transcranial direct current stimulation,1,2021-03-02,0,0,0,1,0,El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez ( 1 ),3.001,1,12
placebo,placebo (crossover vaccination period),1,2020-10-30,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
placebo,placebo (im),1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
placebo,placebo (inhaled solution),1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
placebo,placebo (oral tablet),1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
placebo,"placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",1,2021-02-25,0,0,0,1,0,"Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ""Vector"" ( 1 )",3.001,1,NA
Drug,placebo / soc,1,2021-01-29,0,0,0,1,0,"Corvus Pharmaceuticals, Inc. ( 1 )",3.001,1,NA
placebo,placebo atazanavir,1,2020-07-03,0,0,0,1,0,Hospital do Coracao ( 1 ),3.001,1,NA
placebo,placebo daclatasvir 60 mg,1,2020-07-03,0,0,0,1,0,Hospital do Coracao ( 1 ),3.001,1,NA
placebo,placebo inhaled,1,2021-03-29,0,0,0,1,0,Boehringer Ingelheim ( 1 ),3.001,1,NA
placebo,placebo oil,1,2020-10-03,0,0,0,1,0,University of Texas at Austin ( 1 ),3.001,1,NA
placebo,placebo oral solution,1,2021-03-08,0,0,0,1,0,Swedish Herbal Institute AB ( 1 ),3.001,1,NA
placebo,placebo patch,1,2020-09-28,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,placebo sofusbuvir / daclatasvir 60 mg,1,2020-07-03,0,0,0,1,0,Hospital do Coracao ( 1 ),3.001,1,NA
placebo,placebo with remdesivir,1,2021-01-14,0,0,0,1,0,Daewoong Pharmaceutical Co. LTD. ( 1 ),3.001,1,NA
Drug,prednisone tablet,1,2020-07-28,0,0,0,1,0,Fundacion Clinic per a la Recerca BiomÃ©dica ( 1 ),3.001,1,NA
Drug,prophylactic,1,2020-05-20,0,0,0,1,0,Northwell Health ( 1 ),3.001,1,2
Drug,prophylaxis,1,2020-03-05,0,0,0,1,0,"FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 1 )",3.001,1,1
Drug,prospekta,1,2021-10-05,0,0,0,1,0,Materia Medica Holding ( 1 ),3.001,1,NA
Drug,rdv,1,2020-08-05,0,0,0,1,0,Gilead Sciences ( 1 ),3.001,1,NA
placebo,rdv placebo,1,2021-02-08,0,0,0,1,0,Gilead Sciences ( 1 ),3.001,1,NA
Drug,remdesivir-hu,1,2020-10-11,0,0,0,1,0,University of Pecs ( 1 ),3.001,1,5
Drug,renin-angiotensin system inhibitors,1,2020-07-29,0,0,0,1,0,University of Sao Paulo ( 1 ),3.001,1,NA
Drug,ribaroxaban,1,2020-12-16,0,0,0,1,0,"CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )",3.001,1,NA
Drug,ritonavir 200 mg-50 mg oral tablet,1,2020-07-06,0,0,0,1,0,"ANRS, Emerging Infectious Diseases ( 1 )",3.001,1,NA
Drug,ritonavir/oseltamivir,1,2020-02-04,0,0,0,1,0,Tongji Hospital ( 1 ),3.001,1,NA
Biological,"sab-185 (10,240 units/kg)",1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Biological,"sab-185 (3,840 units/kg)",1,2020-08-17,0,0,0,1,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, bivalent (d614/b.1.351)-as03, dosage b",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 1",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 2",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 3",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03 alternative exploratory formulation 4",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03, dosage a",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (b.1.351)-as03, dosage b",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,"sars-cov-2 adjuvanted recombinant protein vaccine, monovalent (d614)-as03, dosage a",1,2021-02-18,0,0,0,1,0,Sanofi ( 1 ),3.001,1,NA
Biological,sars-cov-2 rs/matrix-m1 adjuvant (crossover vaccination period),1,2020-10-30,0,0,0,1,0,Novavax ( 1 ),3.001,1,NA
Other,serum,1,2020-04-22,0,0,0,1,0,Fondation Ophtalmologique Adolphe de Rothschild ( 1 ),3.001,1,1
Drug,shen cao gan jiang tang (gan cao gan jiang tang with ginseng),1,2021-09-21,0,0,0,1,0,University of Medicine and Pharmacy at Ho Chi Minh City ( 1 ),3.001,1,NA
Biological,sinopharm vaccine,1,2021-05-08,0,0,0,1,0,Ain Shams University ( 1 ),3.001,1,NA
Drug,smoflipid,1,2021-07-06,0,0,0,1,0,Assiut University ( 1 ),3.001,1,NA
Drug,soc / ifx-1,1,2020-04-01,0,0,0,1,0,InflaRx GmbH ( 1 ),3.001,1,1
Drug,soc / intravenous famotidine,1,2020-04-27,0,0,0,1,0,Northwell Health ( 1 ),3.001,1,NA
Drug,sodium bicarbonate 150meq,1,2020-12-04,0,0,0,1,0,Guy's and St Thomas' NHS Foundation Trust ( 1 ),3.001,1,NA
Drug,sodium bicarbonate 150meq/l/d5w inj,1,2020-12-04,0,0,0,1,0,Guy's and St Thomas' NHS Foundation Trust ( 1 ),3.001,1,NA
Drug,sodium pyruvate,1,2021-03-26,0,0,0,1,0,"Cellular Sciences, inc. ( 1 )",3.001,1,NA
Drug,sodium pyruvate nasal spray,1,2021-04-27,0,0,0,1,0,"Cellular Sciences, inc. ( 1 )",3.001,1,NA
Drug,sofusbuvir / daclastavir 60 mg,1,2020-07-03,0,0,0,1,0,Hospital do Coracao ( 1 ),3.001,1,NA
Drug,sorbitol,1,2020-09-30,0,0,0,1,0,ScandiBio Therapeutics AB ( 1 ),3.001,1,NA
Biological,sotrovimab,1,2021-02-26,0,0,0,1,0,University of Pittsburgh ( 1 ),3.001,1,1
Drug,standard of care (soc)/colchicine/rosuvastatin,1,2020-07-14,0,0,0,1,0,Yale University ( 1 ),3.001,1,1
Drug,standard of care_2,1,2021-03-01,0,0,0,1,0,Ain Shams University ( 1 ),3.001,1,NA
Drug,standard prophylactic dose enoxaparin/ unfractionated heparin,1,2020-07-22,0,0,0,1,0,Rajaie Cardiovascular Medical and Research Center ( 1 ),3.001,1,2
Other,standard supportive treatment,1,2021-08-21,0,0,0,1,0,Mahidol University ( 1 ),3.001,1,NA
Combination Product,standard therapy for covid-19 patient,1,2021-03-16,0,0,0,1,0,Faculty of Medicine Baiturrahmah University ( 1 ),3.001,1,NA
Biological,su,1,2021-09-15,0,0,0,1,0,GlaxoSmithKline ( 1 ),3.001,1,NA
Drug,sulfur hexafluoride lipid-type a microspheres,1,2020-11-19,0,0,0,1,0,Children's Hospital of Philadelphia ( 1 ),3.001,1,NA
Drug,symbicort,1,2020-03-29,0,0,0,1,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),3.001,1,NA
Drug,symptomatic treatment (paracetamol,1,2020-06-03,0,0,0,1,0,Instituto de InvestigaciÃ³n MarquÃ©s de Valdecilla ( 1 ),3.001,1,1
Drug,symptomatic treatment (paracetamol),1,2020-06-03,0,0,0,1,0,Instituto de InvestigaciÃ³n MarquÃ©s de Valdecilla ( 1 ),3.001,1,1
Drug,symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),1,2020-06-03,0,0,0,1,0,Instituto de InvestigaciÃ³n MarquÃ©s de Valdecilla ( 1 ),3.001,1,1
Drug,synthetic neutralising antibodies,1,2020-05-07,0,0,0,1,0,University of Oxford ( 1 ),3.001,1,4
Drug,telmisartan 20mg oral tablet,1,2021-05-04,0,0,0,1,0,"ANRS, Emerging Infectious Diseases ( 1 )",3.001,1,NA
Drug,telmisartan 40mg oral tablet,1,2020-07-06,0,0,0,1,0,"ANRS, Emerging Infectious Diseases ( 1 )",3.001,1,NA
Drug,tempol,1,2021-01-25,0,0,0,1,0,Adamis Pharmaceuticals Corporation ( 1 ),3.001,1,NA
Drug,tenofovir disoproxil fumarate 200 mg-245 mg oral tablet [truvada],1,2021-05-17,0,0,0,1,0,Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 ),3.001,1,NA
Biological,tigeraseâ®/best available care,1,2020-07-03,0,0,0,1,0,AO GENERIUM ( 1 ),3.001,1,NA
Drug,to be given as a treatment,1,2021-08-17,0,0,0,1,0,Salmaniya Medical Complex ( 1 ),3.001,1,NA
Drug,tociliziumab group,1,2021-08-09,0,0,0,1,0,Asociacion Instituto Biodonostia ( 1 ),3.001,1,NA
Drug,transfusion of sars-cov-2 convalescent plasma.,1,2020-04-24,0,0,0,1,0,Direction Centrale du Service de SantÃ© des ArmÃ©es ( 1 ),3.001,1,NA
Drug,transfusion of standard plasma.,1,2020-04-24,0,0,0,1,0,Direction Centrale du Service de SantÃ© des ArmÃ©es ( 1 ),3.001,1,NA
Drug,treatment,1,2020-03-05,0,0,0,1,0,"FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 1 )",3.001,1,1
Drug,treatment/prophylaxis,1,2020-03-05,0,0,0,1,0,"FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 1 )",3.001,1,1
Drug,triazavirin (riamilovir),1,2020-09-16,0,0,0,1,0,Wits Health Consortium (Pty) Ltd ( 1 ),3.001,1,NA
Drug,tridecactide,1,2020-04-30,0,0,0,1,0,Bosnalijek D.D ( 1 ),3.001,1,NA
Biological,turkovac,1,2021-10-13,0,0,0,1,0,Health Institutes of Turkey ( 1 ),3.001,1,NA
Biological,"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",1,2020-11-04,0,0,0,1,0,"Sinovac Biotech Co., Ltd ( 1 )",3.001,1,NA
Biological,vaccine: bnt162b2 10mcg,1,2021-03-19,0,0,0,1,0,BioNTech SE ( 1 ),3.001,1,NA
Other,vas scale,1,2021-03-10,0,0,0,1,0,MGC Pharmaceuticals d.o.o ( 1 ),3.001,1,NA
Drug,verapamil,1,2020-04-14,0,0,0,1,0,Nicolaus Copernicus University ( 1 ),3.001,1,NA
Dietary Supplement,vitamin d3 (cholecalciferol),1,2020-11-19,0,0,0,1,0,Harvard School of Public Health ( 1 ),3.001,1,NA
Drug,"vitamin d3 50,000 iu",1,2021-03-01,0,0,0,1,0,The Canadian College of Naturopathic Medicine ( 1 ),3.001,1,NA
Dietary Supplement,vitamin k2/d,1,2021-03-01,0,0,0,1,0,The Canadian College of Naturopathic Medicine ( 1 ),3.001,1,NA
Procedure,with leitragin inhalation,1,2020-04-08,0,0,0,1,0,Burnasyan Federal Medical Biophysical Center ( 1 ),3.001,1,NA
Drug,zavegepant (bhv-3500),1,2020-04-09,0,0,0,1,0,"Biohaven Pharmaceuticals, Inc. ( 1 )",3.001,1,NA
Drug,zidovudine,1,2020-04-08,0,0,0,1,0,Novartis ( 1 ),3.001,1,NA
Drug,zilucoplan,1,2020-10-14,0,0,0,1,0,Amgen ( 1 ),3.001,1,NA
placebo,zilucoplan placebo,1,2020-10-14,0,0,0,1,0,Amgen ( 1 ),3.001,1,NA
Dietary Supplement,zinc (zinc gluconate),1,2020-11-19,0,0,0,1,0,Harvard School of Public Health ( 1 ),3.001,1,NA
Dietary Supplement,zinc (zinc gluconate)/vitamin d (cholecalciferol),1,2020-11-19,0,0,0,1,0,Harvard School of Public Health ( 1 ),3.001,1,NA
Other,questionnaire,17,2020-05-01,16,1,0,0,0,"M.D. Anderson Cancer Center ( 3 )|Centre Hospitalier Universitaire, Amiens ( 2 )|The Royal Wolverhampton Hospitals NHS Trust ( 2 )|Tourcoing Hospital ( 2 )|University Hospital, Bordeaux ( 2 )|Acibadem University ( 1 )|Central Hospital, Nancy, France ( 1 )|Centre Hospitalier le Mans ( 1 )|Centre Hospitalier Universitaire de Saint Etienne ( 1 )|Guangzhou Blood Center ( 1 )|National Institutes of Health Clinical Center (CC) ( 1 )",2.017,11,16
Drug,clazakizumab,6,2020-05-06,0,0,6,0,0,Cedars-Sinai Medical Center ( 1 )|Columbia University ( 1 )|Johns Hopkins University ( 1 )|Mayo Clinic ( 1 )|NYU Langone Health ( 1 )|The Methodist Hospital Research Institute ( 1 ),2.006,6,4
Biological,mvc-cov1901(s protein with adjuvant),4,2021-09-03,0,0,4,0,0,Medigen Vaccine Biologics Corp. ( 4 ),2.004,1,1
Drug,fisetin,3,2021-02-24,0,0,3,0,0,Mayo Clinic ( 3 ),2.003,1,NA
Drug,hzvsf-v13,3,2020-12-21,0,0,3,0,0,"ImmuneMed, Inc. ( 3 )",2.003,1,NA
Drug,interleukin,3,2020-05-05,0,0,3,0,0,Revimmune ( 3 ),2.003,1,3
Drug,naltrexone,3,2020-04-26,0,0,3,0,0,AgelessRx ( 1 )|HealthPartners Institute ( 1 )|William Beaumont Hospitals ( 1 ),2.003,3,NA
Drug,ribavirin,3,2020-02-11,0,0,3,0,0,"The University of Hong Kong ( 2 )|Rutgers, The State University of New Jersey ( 1 )",2.003,2,1
Other,water,3,2020-02-04,0,0,3,0,0,"Universiti Sains Islam Malaysia ( 1 )|University of North Carolina, Chapel Hill ( 1 )|Zhongnan Hospital ( 1 )",2.003,3,1
Dietary Supplement,glycine,2,2021-01-06,1,1,0,0,0,Baylor College of Medicine ( 1 )|Instituto Nacional de Enfermedades Respiratorias ( 1 ),2.002,2,NA
Drug,photodynamic therapy,2,2021-06-15,1,1,0,0,0,Cairo University ( 1 )|I.M. Sechenov First Moscow State Medical University ( 1 ),2.002,2,NA
Drug,acetylsalicylic acid,2,2020-04-23,0,0,2,0,0,University of Milan ( 1 )|University of Sao Paulo General Hospital ( 1 ),2.002,2,19
Drug,aviptadil 67î¼g,2,2020-08-21,0,0,2,0,0,"Cantonal Hosptal, Baselland ( 2 )",2.002,1,NA
Drug,clevudine,2,2020-04-14,0,0,2,0,0,Bukwang Pharmaceutical ( 2 ),2.002,1,NA
Biological,cvncov 12 î¼g,2,2020-08-13,0,0,2,0,0,CureVac AG ( 2 ),2.002,1,NA
Biological,dose)- stage 2,2,2021-02-10,0,0,2,0,0,"SK Bioscience Co., Ltd. ( 2 )",2.002,1,1
Drug,ec-18,2,2020-09-28,0,0,2,0,0,Enzychem Lifesciences Corporation ( 2 ),2.002,1,NA
Drug,essential oils,2,2020-05-27,0,0,2,0,0,"Universiti Sains Islam Malaysia ( 1 )|University of North Carolina, Chapel Hill ( 1 )",2.002,2,NA
Drug,ibrutinib,2,2020-05-04,0,0,2,0,0,AbbVie ( 1 )|Ohio State University Comprehensive Cancer Center ( 1 ),2.002,2,NA
Drug,iloprost,2,2020-06-09,0,0,2,0,0,"Hamad Medical Corporation ( 1 )|Rigshospitalet, Denmark ( 1 )",2.002,2,2
Biological,mvc-cov1901(saline),2,2021-06-30,0,0,2,0,0,Medigen Vaccine Biologics Corp. ( 2 ),2.002,1,1
Biological,ndv-hxp-s 10î¼g (stage a),2,2021-08-03,0,0,2,0,0,Butantan Institute ( 2 ),2.002,1,NA
Other,normal saline (0.9% sodium chloride solution)- stage 2,2,2021-02-10,0,0,2,0,0,"SK Bioscience Co., Ltd. ( 2 )",2.002,1,1
Other,normal saline (0.9% sodium chloride solution) - stage 1,2,2021-02-10,0,0,2,0,0,"SK Bioscience Co., Ltd. ( 2 )",2.002,1,1
Drug,nusepinâ® 0.2 mg,2,2020-09-23,0,0,2,0,0,Shaperon ( 2 ),2.002,1,NA
Drug,pegylated interferon-î±2b,2,2020-07-20,0,0,2,0,0,Cadila Healthcare Limited ( 2 ),2.002,1,NA
Drug,pentarlandirâ„¢ uppta,2,2021-06-01,0,0,2,0,0,SyneuRx International (Taiwan) Corp ( 2 ),2.002,1,NA
Drug,pf-06650833,2,2020-08-05,0,0,2,0,0,Bronx-Lebanon Hospital Center Health Care System ( 1 )|Yale University ( 1 ),2.002,2,NA
placebo,placebo injection,2,2021-09-07,0,0,2,0,0,Biocad ( 1 )|Tulane University ( 1 ),2.002,2,NA
Biological,plx-pad,2,2020-11-02,0,0,2,0,0,Pluristem Ltd. ( 2 ),2.002,1,NA
Drug,prothioneâ„¢ (6g),2,2021-02-03,0,0,2,0,0,"Prothione, LLC ( 2 )",2.002,1,NA
Drug,pul-042,2,2020-03-16,0,0,2,0,0,"Pulmotect, Inc. ( 2 )",2.002,1,NA
Drug,pyronaridine-artesunate,2,2020-08-26,0,0,2,0,0,Shin Poong Pharmaceutical Co. Ltd. ( 2 ),2.002,1,NA
Biological,qazcovid-inâ® - covid-19 inactivated vaccine,2,2020-08-26,0,0,2,0,0,Research Institute for Biological Safety Problems ( 2 ),2.002,1,1
Biological,recombinant covid-19 vaccine (cho cellï¼œnvsi-06-08),2,2021-10-03,0,0,2,0,0,"National Vaccine and Serum Institute, China ( 2 )",2.002,1,NA
Biological,saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,2,2020-02-24,0,0,2,0,0,Beijing 302 Hospital ( 2 ),2.002,1,1
Other,quality-of-life assessment,2,2021-02-09,1,1,0,0,0,M.D. Anderson Cancer Center ( 2 ),2.002,1,1
Biological,sars-cov-2 virus,2,2021-04-01,1,1,0,0,0,Imperial College London ( 1 )|University of Oxford ( 1 ),2.002,2,NA
Other,teleorientation,2,2021-07-09,1,1,0,0,0,University of Sao Paulo ( 2 ),2.002,1,NA
Other,yoga,2,2020-07-21,1,1,0,0,0,"M.D. Anderson Cancer Center ( 1 )|Rutgers, The State University of New Jersey ( 1 )",2.002,2,1
Biological,28-day schedule,2,2020-07-13,0,0,2,0,0,Chinese Academy of Medical Sciences ( 2 ),2.002,1,2
Biological,3 doses recombinant covid-19 vaccine (cho cellï¼œnvsi-06-08),2,2021-10-03,0,0,2,0,0,"National Vaccine and Serum Institute, China ( 2 )",2.002,1,NA
Drug,99mtc-pertechnetate aerosol,2,2020-12-29,0,0,2,0,0,National Medical Research Radiological Centre of the Ministry of Health of Russia ( 2 ),2.002,1,NA
Dietary Supplement,aã§aã­ palm berry extract - natural product,2,2020-05-24,0,0,2,0,0,"University Health Network, Toronto ( 2 )",2.002,1,NA
Drug,acebilustat,2,2020-12-08,0,0,2,0,0,Stanford University ( 2 ),2.002,1,NA
Biological,adjuvant,2,2020-04-24,0,0,2,0,0,Novavax ( 2 ),2.002,1,5
Drug,artesunate,2,2020-05-01,0,0,2,0,0,Shin Poong Pharmaceutical Co. Ltd. ( 1 )|University of Kentucky ( 1 ),2.002,2,NA
Biological,avdoralimab,2,2020-04-29,0,0,2,0,0,Assistance Publique Hopitaux De Marseille ( 1 )|Centre Leon Berard ( 1 ),2.002,2,NA
Drug,bat,2,2020-04-25,0,0,2,0,0,MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 2 ),2.002,1,NA
Drug,brequinar,2,2020-10-01,0,0,2,0,0,"Clear Creek Bio, Inc. ( 2 )",2.002,1,NA
Device,cellectraâ„¢ 2000,2,2020-10-06,0,0,2,0,0,Inovio Pharmaceuticals ( 2 ),2.002,1,NA
Biological,covi-amg,2,2021-02-23,0,0,2,0,0,"Sorrento Therapeutics, Inc. ( 2 )",2.002,1,NA
Drug,curosurfâ® (poractant alfa),2,2020-08-03,0,0,2,0,0,Chiesi Farmaceutici S.p.A. ( 2 ),2.002,1,NA
Biological,cvncov 12î¼g,2,2020-08-13,0,0,2,0,0,CureVac AG ( 2 ),2.002,1,NA
Biological,cvncov 6 î¼g,2,2020-08-13,0,0,2,0,0,CureVac AG ( 2 ),2.002,1,NA
Drug,cyt107,2,2020-06-19,0,0,2,0,0,Revimmune ( 2 ),2.002,1,2
Drug,dipyridamole,2,2020-05-29,0,0,2,0,0,UConn Health ( 1 )|University of Michigan ( 1 ),2.002,2,NA
Drug,disulfiram,2,2020-10-18,0,0,2,0,0,"ETICA ( 1 )|University of California, San Francisco ( 1 )",2.002,2,3
Biological,dose) - stage 1,2,2021-02-10,0,0,2,0,0,"SK Bioscience Co., Ltd. ( 2 )",2.002,1,1
Biological,dose) - stage 2,2,2021-02-10,0,0,2,0,0,"SK Bioscience Co., Ltd. ( 2 )",2.002,1,1
Drug,duvelisib,2,2020-04-30,0,0,2,0,0,Emory University ( 1 )|Washington University School of Medicine ( 1 ),2.002,2,NA
Biological,dzif-10c,2,2020-11-10,0,0,2,0,0,University of Cologne ( 2 ),2.002,1,NA
Device,ðžxygen therapy,2,2020-07-01,0,0,2,0,0,Institute of Cell Therapy ( 2 ),2.002,1,NA
Drug,ebselen,2,2020-07-13,0,0,2,0,0,"Sound Pharmaceuticals, Incorporated ( 2 )",2.002,1,NA
Drug,exo 1,2,2020-10-21,0,0,2,0,0,"State-Financed Health Facility ""Samara Regional Medical Center Dinasty"" ( 2 )",2.002,1,NA
Drug,exo 2,2,2020-10-21,0,0,2,0,0,"State-Financed Health Facility ""Samara Regional Medical Center Dinasty"" ( 2 )",2.002,1,NA
Drug,gam-covid-vac / gam-covid-vac,2,2021-07-28,0,0,2,0,0,Ministerio de Salud de Ciudad AutÃ³noma de Buenos Aires ( 2 ),2.002,1,NA
Drug,interferon-ãÿ-1a,2,2020-06-23,0,0,2,0,0,IRCCS San Raffaele ( 2 ),2.002,1,1
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-,2,2020-07-13,0,0,2,0,0,Chinese Academy of Medical Sciences ( 2 ),2.002,1,2
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,2,2020-07-13,0,0,2,0,0,Chinese Academy of Medical Sciences ( 2 ),2.002,1,2
Biological,ndv-hxp-s 1î¼g (stage a),2,2021-08-03,0,0,2,0,0,Butantan Institute ( 2 ),2.002,1,NA
Biological,ndv-hxp-s 3î¼g (stage a),2,2021-08-03,0,0,2,0,0,Butantan Institute ( 2 ),2.002,1,NA
Dietary Supplement,nicotinamide riboside,2,2021-03-24,0,0,2,0,0,The University of Texas Health Science Center at San Antonio ( 1 )|University of Copenhagen ( 1 ),2.002,2,NA
Drug,nusepinâ® 0.1 mg,2,2020-09-23,0,0,2,0,0,Shaperon ( 2 ),2.002,1,NA
Drug,omegavenâ®,2,2020-06-12,0,0,2,0,0,Karolinska University Hospital ( 2 ),2.002,1,1
Drug,regn10933/regn10987 combination therapy,2,2020-12-10,0,0,2,0,0,Regeneron Pharmaceuticals ( 2 ),2.002,1,NA
Drug,rtb101,2,2020-10-08,0,0,2,0,0,Restorbio Inc. ( 2 ),2.002,1,NA
Biological,rutiâ® vaccine,2,2021-05-21,0,0,2,0,0,RUTI Immunotherapeutics S.L. ( 2 ),2.002,1,NA
Biological,sars-cov-2 rs/matrix-m1 adjuvant,2,2020-04-24,0,0,2,0,0,Novavax ( 2 ),2.002,1,5
Drug,silmitasertib,2,2020-12-02,0,0,2,0,0,"Senhwa Biosciences, Inc. ( 1 )|University of Arizona ( 1 )",2.002,2,NA
Drug,sofosbuvir/daclatasvir,2,2020-09-21,0,0,2,0,0,"Shin Poong Pharmaceutical Co. Ltd. ( 1 )|University of Witwatersrand, South Africa ( 1 )",2.002,2,NA
Drug,thymalfasin,2,2020-07-22,0,0,2,0,0,Inova Health System ( 1 )|Rhode Island Hospital ( 1 ),2.002,2,NA
Biological,"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",2,2020-09-15,0,0,2,0,0,"Sinovac Biotech Co., Ltd ( 2 )",2.002,1,2
Biological,"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",2,2020-09-15,0,0,2,0,0,"Sinovac Biotech Co., Ltd ( 2 )",2.002,1,2
Drug,zilucoplanâ®,2,2020-05-07,0,0,2,0,0,"University Hospital, Ghent ( 2 )",2.002,1,1
Drug,0.075% cetylpyridinium chloride,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,0.5% w,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,0.67ml inj syringe,1,2020-06-12,0,0,1,0,0,University of Manchester ( 1 ),2.001,1,NA
Drug,1.5% w,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Biological,14-day schedule,1,2020-05-21,0,0,1,0,0,Chinese Academy of Medical Sciences ( 1 ),2.001,1,2
Biological,15mg,1,2020-05-21,0,0,1,0,0,Edesa Biotech Inc. ( 1 ),2.001,1,NA
Drug,27% ethanol/essential oils,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Biological,3 consecutive lots (group c1a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,3 consecutive lots (group c2a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Combination Product,4plants/azythromycin,1,2020-08-03,0,0,1,0,0,Institute for Research and Development of Medicinal and Food Plants of Guinea ( 1 ),2.001,1,7
Biological,"a high-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",1,2021-03-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
placebo,"a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56",1,2021-03-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,"a middle-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",1,2021-03-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,"a middle-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",1,2021-03-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Drug,"a single ""booster"" dose of the moderna mrna covid-19 vaccine",1,2021-08-23,0,0,1,0,0,Barbara Ann Karmanos Cancer Institute ( 1 ),2.001,1,NA
Biological,abncov2,1,2021-10-11,0,0,1,0,0,Bavarian Nordic ( 1 ),2.001,1,NA
Biological,active vaccine control (group b1b),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control (group b1c),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control (group c2a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,adcld-cov19,1,2020-12-10,0,0,1,0,0,"Cellid Co., Ltd. ( 1 )",2.001,1,NA
Device,akl-t01,1,2021-04-10,0,0,1,0,0,Weill Medical College of Cornell University ( 1 ),2.001,1,NA
Biological,aks-452,1,2020-12-22,0,0,1,0,0,University Medical Center Groningen ( 1 ),2.001,1,NA
Biological,allogeneic wharton's jelly-mscs (wj-msc),1,2021-04-29,0,0,1,0,0,McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 ),2.001,1,NA
Biological,alpha variant,1,2021-07-12,0,0,1,0,0,The Scientific and Technological Research Council of Turkey ( 1 ),2.001,1,NA
Drug,amor 18 powder,1,2021-05-19,0,0,1,0,0,Amorphical Ltd. ( 1 ),2.001,1,NA
Drug,amor 18 powder/inhalation,1,2021-05-19,0,0,1,0,0,Amorphical Ltd. ( 1 ),2.001,1,NA
Drug,anakinra/ruxolitinib,1,2020-04-27,0,0,1,0,0,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ( 1 ),2.001,1,NA
Drug,antibiotics,1,2020-07-01,0,0,1,0,0,Institute of Cell Therapy ( 1 ),2.001,1,NA
Drug,anticov-220,1,2021-09-08,0,0,1,0,0,"Trieu, Nguyen Thi, M.D. ( 1 )",2.001,1,5
Drug,antithrombin,1,2021-02-08,0,0,1,0,0,MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 ),2.001,1,NA
Biological,arct-021,1,2021-08-30,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 dose 1,1,2020-07-17,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 dose 2,1,2020-07-17,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 dose 3,1,2020-07-17,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 dose 4,1,2020-07-17,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 single dose priming,1,2020-11-25,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 two higher dose priming,1,2020-11-25,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 two lower dose priming,1,2020-11-25,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-154,1,2021-08-30,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,artemic,1,2020-05-07,0,0,1,0,0,MGC Pharmaceuticals d.o.o ( 1 ),2.001,1,NA
Drug,at-001,1,2020-04-25,0,0,1,0,0,NYU Langone Health ( 1 ),2.001,1,NA
Drug,atr-002,1,2021-02-26,0,0,1,0,0,Atriva Therapeutics GmbH ( 1 ),2.001,1,NA
Drug,bardoxolone methyl,1,2020-07-29,0,0,1,0,0,NYU Langone Health ( 1 ),2.001,1,NA
Drug,bat / calcifediol,1,2020-04-25,0,0,1,0,0,MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 ),2.001,1,NA
Biological,bbv152a - phase i,1,2020-07-11,0,0,1,0,0,Bharat Biotech International Limited ( 1 ),2.001,1,3
Biological,bbv152a - phase ii,1,2020-07-11,0,0,1,0,0,Bharat Biotech International Limited ( 1 ),2.001,1,3
Biological,bbv152b - phase i,1,2020-07-11,0,0,1,0,0,Bharat Biotech International Limited ( 1 ),2.001,1,3
Biological,bbv152b - phase ii,1,2020-07-11,0,0,1,0,0,Bharat Biotech International Limited ( 1 ),2.001,1,3
Biological,bbv152c - phase i,1,2020-07-11,0,0,1,0,0,Bharat Biotech International Limited ( 1 ),2.001,1,3
Drug,bgb-dxp593,1,2020-09-10,0,0,1,0,0,BeiGene ( 1 ),2.001,1,NA
Drug,bge-175,1,2021-01-04,0,0,1,0,0,"BioAge Labs, Inc. ( 1 )",2.001,1,NA
Drug,bi 764198,1,2020-10-26,0,0,1,0,0,Boehringer Ingelheim ( 1 ),2.001,1,NA
Drug,bio 300 oral suspension,1,2020-07-17,0,0,1,0,0,Humanetics Corporation ( 1 ),2.001,1,NA
Drug,bld-2660,1,2020-04-02,0,0,1,0,0,Blade Therapeutics ( 1 ),2.001,1,NA
Biological,bnt162a1,1,2020-05-06,0,0,1,0,0,BioNTech SE ( 1 ),2.001,1,1
Biological,bnt162b3,1,2020-09-02,0,0,1,0,0,BioNTech SE ( 1 ),2.001,1,NA
Biological,bnt162c2,1,2020-05-06,0,0,1,0,0,BioNTech SE ( 1 ),2.001,1,1
Drug,brilacidin,1,2021-03-03,0,0,1,0,0,"Innovation Pharmaceuticals, Inc. ( 1 )",2.001,1,NA
Drug,calcifediol,1,2020-04-25,0,0,1,0,0,MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 ),2.001,1,NA
Biological,ccp,1,2020-06-17,0,0,1,0,0,Metro Infectious Disease Consultants ( 1 ),2.001,1,NA
Drug,cenicriviroc,1,2020-08-04,0,0,1,0,0,"Charite University, Berlin, Germany ( 1 )",2.001,1,NA
Drug,cerc-002,1,2020-05-29,0,0,1,0,0,Cerecor Inc ( 1 ),2.001,1,1
Device,cliniporatorâ®,1,2021-03-01,0,0,1,0,0,Takis ( 1 ),2.001,1,NA
Device,cliniporatorâ®/epsgun,1,2021-03-01,0,0,1,0,0,Takis ( 1 ),2.001,1,NA
Drug,clofazimine,1,2020-07-09,0,0,1,0,0,The University of Hong Kong ( 1 ),2.001,1,NA
Drug,cm4620-ie (injectable emulsion),1,2020-12-04,0,0,1,0,0,"CalciMedica, Inc. ( 1 )",2.001,1,NA
Drug,coenzyme q10,1,2021-06-11,0,0,1,0,0,University of Aarhus ( 1 ),2.001,1,NA
Drug,colchicine 0.6 mg,1,2021-01-28,0,0,1,0,0,HealthPartners Institute ( 1 ),2.001,1,NA
Other,colgate total zero,1,2021-02-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,collagen-polyvinylpyrrolidone,1,2020-08-14,0,0,1,0,0,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 ),2.001,1,7
Other,covid-19 convalescent plasma (cp),1,2020-06-07,0,0,1,0,0,Azienda Ospedaliera CittÃ  della Salute e della Scienza di Torino ( 1 ),2.001,1,NA
Biological,covid-19 mrna vaccine (nucleoside modified),1,2021-07-16,0,0,1,0,0,Sanofi ( 1 ),2.001,1,NA
Biological,covid-19 vaccine hipra 10,1,2021-08-12,0,0,1,0,0,"Laboratorios Hipra, S.A. ( 1 )",2.001,1,NA
Biological,covid-19 vaccine hipra 20,1,2021-08-12,0,0,1,0,0,"Laboratorios Hipra, S.A. ( 1 )",2.001,1,NA
Biological,covid-19 vaccine hipra 40,1,2021-08-12,0,0,1,0,0,"Laboratorios Hipra, S.A. ( 1 )",2.001,1,NA
Biological,covid-evax,1,2021-03-01,0,0,1,0,0,Takis ( 1 ),2.001,1,NA
Drug,cst-2: eidd-2801,1,2020-10-13,0,0,1,0,0,University of Liverpool ( 1 ),2.001,1,1
Other,current care per ucla treating physicians,1,2020-04-14,0,0,1,0,0,"University of California, Los Angeles ( 1 )",2.001,1,NA
Biological,cyp-001,1,2020-08-25,0,0,1,0,0,Cynata Therapeutics Limited ( 1 ),2.001,1,NA
Drug,danicopan,1,2021-07-29,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Drug,dapansutrile capsules,1,2020-08-13,0,0,1,0,0,Olatec Therapeutics LLC ( 1 ),2.001,1,NA
Biological,db-001,1,2020-07-29,0,0,1,0,0,"Direct Biologics, LLC ( 1 )",2.001,1,NA
Drug,decitabine,1,2020-07-21,0,0,1,0,0,Johns Hopkins University ( 1 ),2.001,1,NA
Drug,defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,1,2020-04-08,0,0,1,0,0,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia ( 1 ),2.001,1,NA
Other,derivatives.,1,2020-04-02,0,0,1,0,0,Puerta de Hierro University Hospital ( 1 ),2.001,1,2
Drug,desidustat,1,2020-07-07,0,0,1,0,0,Cadila Healthcare Limited ( 1 ),2.001,1,NA
Drug,dfv890,1,2020-05-08,0,0,1,0,0,Novartis ( 1 ),2.001,1,NA
Device,doctella telehealth monitoring,1,2020-07-24,0,0,1,0,0,University Hospitals Cleveland Medical Center ( 1 ),2.001,1,NA
Drug,drug covid19-0001-usr,1,2020-10-15,0,0,1,0,0,United Medical Specialties ( 1 ),2.001,1,NA
Biological,ds-5670a,1,2021-03-25,0,0,1,0,0,"Daiichi Sankyo, Inc. ( 1 )",2.001,1,NA
Drug,duact,1,2020-09-21,0,0,1,0,0,"University of Witwatersrand, South Africa ( 1 )",2.001,1,NA
Biological,dupilumab,1,2021-06-08,0,0,1,0,0,University of Virginia ( 1 ),2.001,1,NA
Drug,dur-928,1,2020-06-23,0,0,1,0,0,Durect ( 1 ),2.001,1,NA
Device,electronic portable aromatic rehabilitation (epar) diffuser,1,2021-05-17,0,0,1,0,0,The University of Hong Kong ( 1 ),2.001,1,NA
Drug,eltrombopag,1,2020-08-16,0,0,1,0,0,Peking University People's Hospital ( 1 ),2.001,1,NA
Drug,ensifentrine,1,2020-08-06,0,0,1,0,0,Verona Pharma plc ( 1 ),2.001,1,NA
Drug,enzalutamide,1,2020-06-08,0,0,1,0,0,VÃ¤sterbotten County Council ( 1 ),2.001,1,1
Biological,equine covid-19 antiserum,1,2021-03-23,0,0,1,0,0,Bharat Serums and Vaccines Limited ( 1 ),2.001,1,NA
Biological,erucov-vac 3 âµg,1,2021-03-25,0,0,1,0,0,Health Institutes of Turkey ( 1 ),2.001,1,NA
Biological,erucov-vac 3 âµg/0.5 ml vaccine,1,2021-03-25,0,0,1,0,0,Health Institutes of Turkey ( 1 ),2.001,1,NA
Biological,erucov-vac 6 âµg,1,2021-03-25,0,0,1,0,0,Health Institutes of Turkey ( 1 ),2.001,1,NA
Biological,erucov-vac 6 âµg/0.5 ml vaccine,1,2021-03-25,0,0,1,0,0,Health Institutes of Turkey ( 1 ),2.001,1,NA
Drug,estetrol monohydrate 15 mg,1,2021-03-12,0,0,1,0,0,NEURALIS s.a. ( 1 ),2.001,1,NA
Drug,estradiol cypionate 5 mg,1,2021-04-21,0,0,1,0,0,Tulane University ( 1 ),2.001,1,NA
Drug,etoposide,1,2020-04-17,0,0,1,0,0,Boston Medical Center ( 1 ),2.001,1,NA
Biological,eucorvac-19,1,2021-03-03,0,0,1,0,0,"EuBiologics Co.,Ltd ( 1 )",2.001,1,NA
Biological,exg-5003,1,2021-04-15,0,0,1,0,0,Fujita Health University ( 1 ),2.001,1,NA
Drug,exosomes overexpressing cd24,1,2021-07-18,0,0,1,0,0,Tel-Aviv Sourasky Medical Center ( 1 ),2.001,1,NA
Drug,favipiravir/nitazoxanide,1,2020-08-26,0,0,1,0,0,Shin Poong Pharmaceutical Co. Ltd. ( 1 ),2.001,1,NA
Other,fenofibrate,1,2020-08-17,0,0,1,0,0,University of Pennsylvania ( 1 ),2.001,1,NA
Other,fenofibrate/fenofibric acid,1,2020-08-17,0,0,1,0,0,University of Pennsylvania ( 1 ),2.001,1,NA
Drug,firazyr,1,2021-06-30,0,0,1,0,0,Hospital Universitari de Bellvitge ( 1 ),2.001,1,NA
Drug,fsd201,1,2020-11-05,0,0,1,0,0,"FSD Pharma, Inc. ( 1 )",2.001,1,NA
Combination Product,furfat,1,2021-03-31,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Drug,fx06,1,2020-10-23,0,0,1,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),2.001,1,NA
Drug,gam-covid-vac (rad26),1,2021-08-18,0,0,1,0,0,Ministerio de Salud de Ciudad AutÃ³noma de Buenos Aires ( 1 ),2.001,1,NA
Biological,gbp510 (rbd 10î¼g/dose) - stage 1,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 (rbd 25î¼g,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 (rbd 25î¼g/dose)- stage 2,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 1,1,2021-02-04,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,1
Biological,gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 2,1,2021-02-04,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,1
Biological,gbp510 adjuvanted with alum (rbd 25î¼g,1,2021-02-04,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,1
Biological,gbp510 adjuvanted with alum (rbd 25î¼g/dose) - stage 1,1,2021-02-04,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,1
Biological,gbp510 adjuvanted with as03 (rbd 10î¼g,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 1,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 2,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 adjuvanted with as03 (rbd 25î¼g/dose)- stage 2,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 adjuvanted with as03 (rbd 25î¼g/dose) - stage 1,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Drug,gimsilumab,1,2020-04-15,0,0,1,0,0,Kinevant Sciences GmbH ( 1 ),2.001,1,NA
Drug,glenzocimab,1,2020-11-30,0,0,1,0,0,Acticor Biotech ( 1 ),2.001,1,NA
Drug,gls-1027,1,2020-10-13,0,0,1,0,0,"GeneOne Life Science, Inc. ( 1 )",2.001,1,NA
Drug,gls-1200,1,2020-05-22,0,0,1,0,0,"GeneOne Life Science, Inc. ( 1 )",2.001,1,NA
Biological,gls-5310,1,2020-12-11,0,0,1,0,0,"GeneOne Life Science, Inc. ( 1 )",2.001,1,NA
Drug,group 1 hcq,1,2020-04-09,0,0,1,0,0,UnitedHealth Group ( 1 ),2.001,1,NA
placebo,group 2 placebo,1,2020-04-09,0,0,1,0,0,UnitedHealth Group ( 1 ),2.001,1,NA
Biological,hepatitis a vaccine,1,2020-08-13,0,0,1,0,0,CureVac AG ( 1 ),2.001,1,NA
Drug,herbal phenolic monoterpene,1,2020-05-15,0,0,1,0,0,Kermanshah University of Medical Sciences ( 1 ),2.001,1,NA
Drug,hesperidin,1,2021-01-15,0,0,1,0,0,Montreal Heart Institute ( 1 ),2.001,1,NA
Biological,heterologous prime-boost schedule with azd1222/mvc-cov1901,1,2021-09-13,0,0,1,0,0,Chang Gung Memorial Hospital ( 1 ),2.001,1,NA
placebo,high-dose placebo (18-59 years),1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose placebo (18-59 years)/three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
placebo,high-dose placebo (60-85 years),1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose placebo (60-85 years)/three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose placebo (60-85 years)/two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high dose of kbp-covid-19,1,2020-07-14,0,0,1,0,0,"Kentucky BioProcessing, Inc. ( 1 )",2.001,1,NA
Drug,"hydroxychloroquine, lopinavir",1,2020-05-12,0,0,1,0,0,BioXcellerator ( 1 ),2.001,1,NA
Drug,ic14,1,2020-07-14,0,0,1,0,0,QuantumLeap Healthcare Collaborative ( 1 ),2.001,1,NA
Drug,icosapent ethyl,1,2020-05-29,0,0,1,0,0,Canadian Medical and Surgical Knowledge Translation Research Group ( 1 ),2.001,1,1
Biological,iibr-100 medium-dose (prime-boost),1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
Biological,iibr-100 top-dose (prime-boost),1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
Biological,"iibr-100, low dose (prime)",1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
Biological,inactivated vaccine booster,1,2021-08-02,0,0,1,0,0,Universidad del Desarrollo ( 1 ),2.001,1,NA
Drug,indomethacin,1,2020-04-08,0,0,1,0,0,"Perseverance Research Center, LLC ( 1 )",2.001,1,NA
Drug,inhaled aviptadil,1,2021-03-25,0,0,1,0,0,Centurion Pharma ( 1 ),2.001,1,NA
placebo,injectable placebo,1,2020-07-14,0,0,1,0,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),2.001,1,1
Biological,injection,1,2020-02-17,0,0,1,0,0,Shenzhen Geno-Immune Medical Institute ( 1 ),2.001,1,NA
Biological,injection of secretome-mscs,1,2021-02-11,0,0,1,0,0,Stem Cell and Cancer Research Indonesia ( 1 ),2.001,1,2
Drug,ino-4700,1,2020-10-06,0,0,1,0,0,Inovio Pharmaceuticals ( 1 ),2.001,1,NA
Behavioral,instrumental activities of daily living shaping,1,2020-11-23,0,0,1,0,0,University of Alabama at Birmingham ( 1 ),2.001,1,NA
Combination Product,insulin film,1,2020-12-02,0,0,1,0,0,Deraya University ( 1 ),2.001,1,NA
Other,intravenous saline injection,1,2021-07-03,0,0,1,0,0,Avicenna Research Institute ( 1 ),2.001,1,NA
Drug,iodine,1,2020-07-14,0,0,1,0,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),2.001,1,1
Biological,is (b cell depletion therapy),1,2021-08-06,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Drug,is (mmf,1,2021-08-06,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Drug,is (mtx),1,2021-08-06,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Drug,isis 721744,1,2020-09-09,0,0,1,0,0,Hospital do Coracao ( 1 ),2.001,1,NA
Drug,itolizumab,1,2020-07-16,0,0,1,0,0,Biocon Limited ( 1 ),2.001,1,NA
Drug,ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,1,2020-05-05,0,0,1,0,0,Laboratorio Elea Phoenix S.A. ( 1 ),2.001,1,1
Drug,ivermectin / doxycycline / placebo,1,2020-05-17,0,0,1,0,0,"International Centre for Diarrhoeal Disease Research, Bangladesh ( 1 )",2.001,1,NA
Drug,ivermectin / iota-carrageenan,1,2021-01-07,0,0,1,0,0,"Ministry of Public Health, Argentina ( 1 )",2.001,1,NA
Drug,ivermectin / placebo,1,2020-05-17,0,0,1,0,0,"International Centre for Diarrhoeal Disease Research, Bangladesh ( 1 )",2.001,1,NA
Drug,ivermectin/doxycyline,1,2020-10-15,0,0,1,0,0,Alkarkh Health Directorate-Baghdad ( 1 ),2.001,1,NA
Combination Product,"jinhua qinggan (jhqg) granules, traditional chinese medicine",1,2021-01-22,0,0,1,0,0,University of Karachi ( 1 ),2.001,1,NA
Drug,js016,1,2021-06-13,0,0,1,0,0,Peking Union Medical College Hospital ( 1 ),2.001,1,1
Drug,ketamine,1,2020-04-26,0,0,1,0,0,William Beaumont Hospitals ( 1 ),2.001,1,NA
Drug,kg 24 hours continuous infusion for 15 days,1,2020-04-08,0,0,1,0,0,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia ( 1 ),2.001,1,NA
Biological,kg eb05 iv,1,2020-05-21,0,0,1,0,0,Edesa Biotech Inc. ( 1 ),2.001,1,NA
Drug,kg once daily,1,2020-05-05,0,0,1,0,0,Laboratorio Elea Phoenix S.A. ( 1 ),2.001,1,1
Biological,kg;100mg,1,2020-09-23,0,0,1,0,0,"Shanghai Junshi Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,kg;50mg,1,2020-09-23,0,0,1,0,0,"Shanghai Junshi Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Dietary Supplement,kovir (td0068) oral capsule,1,2021-10-15,0,0,1,0,0,Sunstar Joint Stock Company ( 1 ),2.001,1,NA
Dietary Supplement,"lactoferrin, green tea extract",1,2020-11-05,0,0,1,0,0,"Profact, Inc. ( 1 )",2.001,1,NA
Drug,larazotide acetate,1,2021-08-09,0,0,1,0,0,Massachusetts General Hospital ( 1 ),2.001,1,NA
Biological,licensed covid-19 vaccine,1,2021-04-24,0,0,1,0,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),2.001,1,NA
Biological,liquid alpha1-proteinase inhibitor (human),1,2020-09-10,0,0,1,0,0,Grifols Therapeutics LLC ( 1 ),2.001,1,NA
Drug,losartan 50 mg,1,2020-11-24,0,0,1,0,0,Assistance Publique Hopitaux De Marseille ( 1 ),2.001,1,NA
placebo,low-dose placebo (18-59 years),1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose placebo (18-59 years)/three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose placebo (60-85 years)/two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low dose of kbp-covid-19,1,2020-07-14,0,0,1,0,0,"Kentucky BioProcessing, Inc. ( 1 )",2.001,1,NA
Biological,low dose/high dose bcd-250 injection,1,2021-09-07,0,0,1,0,0,Biocad ( 1 ),2.001,1,NA
Drug,magnesium citrate,1,2021-06-24,0,0,1,0,0,Vanderbilt University Medical Center ( 1 ),2.001,1,NA
Drug,magnesium citrate/probiotic,1,2021-06-24,0,0,1,0,0,Vanderbilt University Medical Center ( 1 ),2.001,1,NA
Drug,masitinib,1,2020-11-09,0,0,1,0,0,AB Science ( 1 ),2.001,1,NA
Biological,matrix-m adjuvant - phase 2,1,2020-04-24,0,0,1,0,0,Novavax ( 1 ),2.001,1,4
Drug,melatonin intravenous,1,2020-09-28,0,0,1,0,0,Pharmamel S.L. ( 1 ),2.001,1,NA
Drug,melphalan,1,2020-05-06,0,0,1,0,0,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute ( 1 )",2.001,1,NA
Drug,merimepodib,1,2020-04-28,0,0,1,0,0,"ViralClear Pharmaceuticals, Inc. ( 1 )",2.001,1,NA
Biological,mesenchymalÂ stem cells/heparin,1,2020-04-13,0,0,1,0,0,University of Miami ( 1 ),2.001,1,NA
Drug,metformin glycinate,1,2020-10-23,0,0,1,0,0,Laboratorios Silanes S.A. de C.V. ( 1 ),2.001,1,NA
Drug,methotrexate-lde phase 1,1,2020-10-24,0,0,1,0,0,University of Sao Paulo General Hospital ( 1 ),2.001,1,3
Drug,methotrexate-lde phase 2,1,2020-10-24,0,0,1,0,0,University of Sao Paulo General Hospital ( 1 ),2.001,1,3
Drug,ml intravenous solution [actemra]_#1,1,2020-06-11,0,0,1,0,0,Hospital Universitario Ramon y Cajal ( 1 ),2.001,1,NA
Device,mls laser,1,2020-05-04,0,0,1,0,0,Lowell General Hospital ( 1 ),2.001,1,NA
Biological,moderna mrna-1273,1,2021-08-06,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Biological,moderna mrna-1273 vaccine,1,2021-04-19,0,0,1,0,0,Regeneron Pharmaceuticals ( 1 ),2.001,1,NA
Drug,molgramostim nebuliser solution,1,2020-09-25,0,0,1,0,0,University of Giessen ( 1 ),2.001,1,NA
Drug,monoclonal antibodies,1,2021-09-07,0,0,1,0,0,University of Oxford ( 1 ),2.001,1,NA
Biological,mrna-1273 vaccine (pfizer,1,2021-07-16,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Biological,mrna-1273 vaccine (pfizer/biontech),1,2021-07-16,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Biological,mt-2766 low dose,1,2021-10-01,0,0,1,0,0,Medicago ( 1 ),2.001,1,NA
Dietary Supplement,nad,1,2020-10-26,0,0,1,0,0,AgelessRx ( 1 ),2.001,1,NA
Drug,narsoplimab,1,2020-07-14,0,0,1,0,0,QuantumLeap Healthcare Collaborative ( 1 ),2.001,1,NA
Drug,nbt-nm108,1,2020-09-03,0,0,1,0,0,Notitia Biotechnologies Company ( 1 ),2.001,1,NA
Biological,ndv-hxp-s b.1351 vaccine (group b1e),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s p.1 vaccine (group b1e),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s p.1 vaccine (group b2a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s p.1.351 vaccine (group b2a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s parental vaccine (group b1b),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s parental vaccine (group b1c),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Drug,nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 1,1,2020-04-14,0,0,1,0,0,"University College, London ( 1 )",2.001,1,NA
Drug,nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 imv,1,2020-04-14,0,0,1,0,0,"University College, London ( 1 )",2.001,1,NA
Drug,nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 niv,1,2020-04-14,0,0,1,0,0,"University College, London ( 1 )",2.001,1,NA
Biological,ngm621,1,2020-10-07,0,0,1,0,0,"NGM Biopharmaceuticals, Inc ( 1 )",2.001,1,NA
Drug,nitazoxanide/atazanavir/ritonavir,1,2020-07-03,0,0,1,0,0,Obafemi Awolowo University ( 1 ),2.001,1,1
Drug,octaplas,1,2020-06-11,0,0,1,0,0,"University College, London ( 1 )",2.001,1,NA
Biological,one dose of bnt162b2 vaccine,1,2021-03-07,0,0,1,0,0,"ANRS, Emerging Infectious Diseases ( 1 )",2.001,1,NA
Drug,op-101,1,2020-06-29,0,0,1,0,0,"Orpheris, Inc. ( 1 )",2.001,1,NA
Drug,oral-b mouth sore mouthwash,1,2020-05-28,0,0,1,0,0,"University of California, San Francisco ( 1 )",2.001,1,NA
Drug,oral ivermectin,1,2020-07-14,0,0,1,0,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),2.001,1,1
Biological,otilimab,1,2020-05-04,0,0,1,0,0,GlaxoSmithKline ( 1 ),2.001,1,NA
Other,oxygen-ozone,1,2020-04-22,0,0,1,0,0,Azienda Policlinico Umberto I ( 1 ),2.001,1,3
Drug,ozone plasma,1,2021-10-14,0,0,1,0,0,"Centro Universitario de Ciencias de la Salud, Mexico ( 1 )",2.001,1,NA
Drug,pamrevlumab,1,2020-06-12,0,0,1,0,0,FibroGen ( 1 ),2.001,1,NA
Drug,pdno,1,2021-02-15,0,0,1,0,0,Attgeno AB ( 1 ),2.001,1,NA
Drug,periogard,1,2021-02-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Biological,pfizer-biontech covid-19 vaccine (comirnaty),1,2021-07-24,0,0,1,0,0,National Institutes of Health Clinical Center (CC) ( 1 ),2.001,1,NA
Biological,phosphate-buffered saline,1,2021-03-12,0,0,1,0,0,"Institute of Vaccines and Medical Biologicals, Vietnam ( 1 )",2.001,1,NA
Drug,piclidenoson,1,2020-04-01,0,0,1,0,0,Can-Fite BioPharma ( 1 ),2.001,1,NA
Drug,pjs-539 dose 1,1,2021-08-16,0,0,1,0,0,Hospital do Coracao ( 1 ),2.001,1,NA
Drug,pjs-539 dose 2,1,2021-08-16,0,0,1,0,0,Hospital do Coracao ( 1 ),2.001,1,NA
placebo,placebo-lde phase 2,1,2020-10-24,0,0,1,0,0,University of Sao Paulo General Hospital ( 1 ),2.001,1,3
placebo,placebo (methylcellulose) capsule,1,2020-05-15,0,0,1,0,0,State University of New York at Buffalo ( 1 ),2.001,1,NA
placebo,placebo booster,1,2020-11-25,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
placebo,placebo for inhalation,1,2021-04-08,0,0,1,0,0,CanSino Biologics Inc. ( 1 ),2.001,1,NA
placebo,placebo gel,1,2021-04-21,0,0,1,0,0,Pharma Holdings AS ( 1 ),2.001,1,NA
placebo,placebo hydroxychloroquine,1,2020-10-26,0,0,1,0,0,"Rutgers, The State University of New Jersey ( 1 )",2.001,1,NA
placebo,placebo nitazoxanide,1,2020-10-26,0,0,1,0,0,"Rutgers, The State University of New Jersey ( 1 )",2.001,1,NA
placebo,placebo of fx06,1,2020-10-23,0,0,1,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),2.001,1,NA
placebo,placebo ribavirin,1,2020-10-26,0,0,1,0,0,"Rutgers, The State University of New Jersey ( 1 )",2.001,1,NA
placebo,placebo tablets,1,2021-09-16,0,0,1,0,0,Vaxart ( 1 ),2.001,1,NA
Biological,pneumococcal vaccine,1,2020-08-13,0,0,1,0,0,CureVac AG ( 1 ),2.001,1,NA
Combination Product,purapo,1,2021-03-31,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Combination Product,purclo,1,2021-03-31,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Combination Product,purinf,1,2021-03-31,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Combination Product,purwet,1,2021-03-31,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Combination Product,quinquina-stevia,1,2020-08-03,0,0,1,0,0,Institute for Research and Development of Medicinal and Food Plants of Guinea ( 1 ),2.001,1,7
Combination Product,quinquina-stevia/azythromycin,1,2020-08-03,0,0,1,0,0,Institute for Research and Development of Medicinal and Food Plants of Guinea ( 1 ),2.001,1,7
Biological,rad26-s,1,2020-12-23,0,0,1,0,0,R-Pharm ( 1 ),2.001,1,NA
Drug,ramipril,1,2020-04-24,0,0,1,0,0,"University of California, San Diego ( 1 )",2.001,1,1
Biological,randomized booster,1,2020-11-25,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,rbt-9 (90 mg),1,2020-04-20,0,0,1,0,0,"Renibus Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,recombinant human annexin a5,1,2021-02-02,0,0,1,0,0,Lawson Health Research Institute ( 1 ),2.001,1,NA
Biological,recombinant human anti-sars-cov-2 monoclonal antibody(25mg,1,2020-09-23,0,0,1,0,0,"Shanghai Junshi Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,recombinant human anti-sars-cov-2 monoclonal antibody(25mg/kg;50mg/kg;100mg/kg),1,2020-09-23,0,0,1,0,0,"Shanghai Junshi Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Drug,recombinant human plasma gelsolin (rhu-pgsn),1,2020-04-16,0,0,1,0,0,BioAegis Therapeutics Inc. ( 1 ),2.001,1,NA
placebo,recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,1,2020-09-22,0,0,1,0,0,CanSino Biologics Inc. ( 1 ),2.001,1,NA
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector) (ad5-ncov),1,2021-06-07,0,0,1,0,0,FundaciÃ³n HuÃ©sped ( 1 ),2.001,1,NA
Drug,regadenoson,1,2020-10-26,0,0,1,0,0,"University of Maryland, Baltimore ( 1 )",2.001,1,NA
Other,regular care,1,2020-06-03,0,0,1,0,0,Radboud University ( 1 ),2.001,1,NA
Drug,rejuveinix (rjx) active comparator,1,2021-01-04,0,0,1,0,0,"Reven Pharmaceuticals, Inc. ( 1 )",2.001,1,NA
Drug,remimazolam,1,2020-10-07,0,0,1,0,0,Nantes University Hospital ( 1 ),2.001,1,NA
Drug,rp7214,1,2021-08-09,0,0,1,0,0,Rhizen Pharmaceuticals SA ( 1 ),2.001,1,NA
Drug,rp7214 / standard of care (soc),1,2021-08-09,0,0,1,0,0,Rhizen Pharmaceuticals SA ( 1 ),2.001,1,NA
Drug,rslv-132,1,2021-06-25,0,0,1,0,0,Resolve Therapeutics ( 1 ),2.001,1,NA
Drug,sacubitril,1,2021-05-06,0,0,1,0,0,Duke University ( 1 ),2.001,1,NA
Drug,sacubitril / valsartan oral tablet [entresto],1,2021-05-06,0,0,1,0,0,Duke University ( 1 ),2.001,1,NA
Dietary Supplement,saisei maf capsules,1,2020-11-17,0,0,1,0,0,Ospedale del Mare ( 1 ),2.001,1,NA
Other,saline-sodium citrate (ssc) buffer,1,2020-06-16,0,0,1,0,0,International Vaccine Institute ( 1 ),2.001,1,NA
placebo,saline placebo (double),1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
placebo,saline placebo (single),1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
Biological,sars-cov-2 antibody based ivig therapy,1,2020-05-07,0,0,1,0,0,Dow University of Health Sciences ( 1 ),2.001,1,3
Biological,sars-cov-2 mrna vaccine formulation 1,1,2021-03-11,0,0,1,0,0,Sanofi ( 1 ),2.001,1,NA
Biological,sars-cov-2 mrna vaccine formulation 2,1,2021-03-11,0,0,1,0,0,Sanofi ( 1 ),2.001,1,NA
Biological,sars-cov-2 mrna vaccine formulation 3,1,2021-03-11,0,0,1,0,0,Sanofi ( 1 ),2.001,1,NA
Biological,sars-cov-2 rs nanoparticle vaccine in-clinic mixed with matrix-m1 adjuvant,1,2021-07-09,0,0,1,0,0,Novavax ( 1 ),2.001,1,NA
Biological,sars-cov-2 rs/matrix-m adjuvant - phase 2,1,2020-04-24,0,0,1,0,0,Novavax ( 1 ),2.001,1,4
Biological,sars-cov-2 specific t cells,1,2020-07-02,0,0,1,0,0,KK Women's and Children's Hospital ( 1 ),2.001,1,NA
Biological,sars-cov-2 vaccine formulation 1 with adjuvant 1,1,2020-09-02,0,0,1,0,0,Sanofi ( 1 ),2.001,1,1
Biological,sars-cov-2 vaccine formulation 1 with adjuvant 2,1,2020-09-02,0,0,1,0,0,Sanofi ( 1 ),2.001,1,1
Biological,sars-cov-2 vaccine formulation 2 without adjuvant,1,2020-09-02,0,0,1,0,0,Sanofi ( 1 ),2.001,1,1
Biological,sars-cov-2 vlp vaccine-wuhan,1,2021-07-12,0,0,1,0,0,The Scientific and Technological Research Council of Turkey ( 1 ),2.001,1,NA
Biological,sars-cov-2 vlp vaccine-wuhan/alpha variant,1,2021-07-12,0,0,1,0,0,The Scientific and Technological Research Council of Turkey ( 1 ),2.001,1,NA
Drug,sildenafil,1,2020-07-25,0,0,1,0,0,Universidad Nacional Andres Bello ( 1 ),2.001,1,NA
Device,soterix tavns model 0125-lte stimulator - active-active group,1,2020-11-18,0,0,1,0,0,Medical University of South Carolina ( 1 ),2.001,1,NA
Biological,sotrovimab (gen1),1,2021-03-01,0,0,1,0,0,"Vir Biotechnology, Inc. ( 1 )",2.001,1,NA
Biological,sotrovimab (gen2),1,2021-03-01,0,0,1,0,0,"Vir Biotechnology, Inc. ( 1 )",2.001,1,NA
Drug,spironolactone 25 mg pillules oral use,1,2020-11-24,0,0,1,0,0,Assistance Publique Hopitaux De Marseille ( 1 ),2.001,1,NA
Biological,sputnik light,1,2021-01-13,0,0,1,0,0,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation ( 1 )",2.001,1,NA
Drug,standard therapy protocol (stp),1,2020-06-07,0,0,1,0,0,Azienda Ospedaliera CittÃ  della Salute e della Scienza di Torino ( 1 ),2.001,1,NA
Drug,sti-5656,1,2020-08-20,0,0,1,0,0,"Sorrento Therapeutics, Inc. ( 1 )",2.001,1,NA
Other,stp / covid-19 convalescent plasma (cp),1,2020-06-07,0,0,1,0,0,Azienda Ospedaliera CittÃ  della Salute e della Scienza di Torino ( 1 ),2.001,1,NA
Drug,tenecteplase,1,2020-08-06,0,0,1,0,0,Icahn School of Medicine at Mount Sinai ( 1 ),2.001,1,NA
Drug,theophylline powder,1,2021-03-08,0,0,1,0,0,Washington University School of Medicine ( 1 ),2.001,1,NA
Biological,three doses of high dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1,2020-04-14,0,0,1,0,0,"Sinovac Biotech Co., Ltd ( 1 )",2.001,1,1
Biological,three doses of high dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1,2020-04-14,0,0,1,0,0,"Sinovac Biotech Co., Ltd ( 1 )",2.001,1,1
Biological,three doses of medium dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1,2020-04-14,0,0,1,0,0,"Sinovac Biotech Co., Ltd ( 1 )",2.001,1,1
Biological,three doses of medium dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1,2020-04-14,0,0,1,0,0,"Sinovac Biotech Co., Ltd ( 1 )",2.001,1,1
placebo,three doses of placebo at the emergency vaccination schedule,1,2020-04-14,0,0,1,0,0,"Sinovac Biotech Co., Ltd ( 1 )",2.001,1,1
placebo,three doses of placebo at the routine vaccination schedule,1,2020-04-14,0,0,1,0,0,"Sinovac Biotech Co., Ltd ( 1 )",2.001,1,1
Biological,thymic peptides,1,2021-02-24,0,0,1,0,0,Universidad CatÃ³lica de Honduras ( 1 ),2.001,1,NA
Drug,"tinzaparin, high dose prophylactic anticoagulation",1,2021-03-08,0,0,1,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),2.001,1,NA
Drug,"tinzaparin,therapeutic anticoagulation",1,2021-03-08,0,0,1,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),2.001,1,NA
Drug,tirofiban,1,2020-04-23,0,0,1,0,0,University of Milan ( 1 ),2.001,1,NA
Drug,tm5614,1,2020-11-17,0,0,1,0,0,Northwestern University ( 1 ),2.001,1,NA
Drug,tq formula/tab,1,2021-06-02,0,0,1,0,0,Novatek Pharmaceuticals ( 1 ),2.001,1,NA
Drug,tranexamic acid,1,2020-04-06,0,0,1,0,0,University of Alabama at Birmingham ( 1 ),2.001,1,NA
Biological,two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,2020-05-09,0,0,1,0,0,"Sinovac Biotech Co., Ltd ( 1 )",2.001,1,1
Drug,usb002,1,2021-02-26,0,0,1,0,0,"US Biotest, Inc. ( 1 )",2.001,1,NA
Drug,usual care treatment,1,2021-04-25,0,0,1,0,0,Hawler Medical University ( 1 ),2.001,1,NA
Biological,utooth btc),1,2020-03-28,0,0,1,0,0,Renmin Hospital of Wuhan University ( 1 ),2.001,1,1
Drug,uttr1147a,1,2020-05-11,0,0,1,0,0,"Genentech, Inc. ( 1 )",2.001,1,NA
Biological,v-sars,1,2020-04-29,0,0,1,0,0,Immunitor LLC ( 1 ),2.001,1,NA
Drug,v hydrogen peroxide,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,v povidone-iodide,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,v) saline,1,2020-08-21,0,0,1,0,0,AstraZeneca ( 1 ),2.001,1,1
Drug,vadadustat,1,2020-07-15,0,0,1,0,0,"The University of Texas Health Science Center, Houston ( 1 )",2.001,1,NA
Biological,vb10.2210,1,2021-10-04,0,0,1,0,0,Vaccibody AS ( 1 ),2.001,1,NA
Other,vehicle / heparin along with best supportive care,1,2020-04-13,0,0,1,0,0,University of Miami ( 1 ),2.001,1,NA
Other,vehicle control,1,2020-05-22,0,0,1,0,0,"Apellis Pharmaceuticals, Inc. ( 1 )",2.001,1,NA
Drug,ventaprost (inhaled epoprostenol delivered via a dedicated delivery system),1,2020-06-29,0,0,1,0,0,Aerogen Pharma Limited ( 1 ),2.001,1,NA
Drug,vir-7832,1,2020-10-13,0,0,1,0,0,University of Liverpool ( 1 ),2.001,1,1
Drug,viral vector vaccine booster,1,2021-08-02,0,0,1,0,0,Universidad del Desarrollo ( 1 ),2.001,1,NA
Drug,vitamin a,1,2021-05-17,0,0,1,0,0,The University of Hong Kong ( 1 ),2.001,1,NA
Dietary Supplement,vitamin b,1,2020-05-18,0,0,1,0,0,"National Institute of Integrative Medicine, Australia ( 1 )",2.001,1,NA
Drug,vitamin d3/placebo,1,2020-07-24,0,0,1,0,0,University Hospitals Cleveland Medical Center ( 1 ),2.001,1,NA
Dietary Supplement,vitamin k2 in the form of menaquinone-7 (mk-7),1,2021-02-24,0,0,1,0,0,Canisius-Wilhelmina Hospital ( 1 ),2.001,1,NA
Drug,voclosporin,1,2020-10-27,0,0,1,0,0,Leiden University Medical Center ( 1 ),2.001,1,NA
Drug,wfi water nebulization,1,2020-07-13,0,0,1,0,0,"Centre Hospitalier Universitaire, Amiens ( 1 )",2.001,1,NA
Drug,wharton's jelly derived mesenchymal stem cells.,1,2020-05-12,0,0,1,0,0,BioXcellerator ( 1 ),2.001,1,NA
Drug,xuanfei baidu granules,1,2021-03-17,0,0,1,0,0,University of Southern California ( 1 ),2.001,1,NA
Drug,zithromax,1,2020-04-08,0,0,1,0,0,"Perseverance Research Center, LLC ( 1 )",2.001,1,NA
Other,"0, 112 day schedule",1,2021-05-18,0,0,1,0,0,Canadian Immunization Research Network ( 1 ),2.001,1,NA
Other,"0, 28 day schedule",1,2021-05-18,0,0,1,0,0,Canadian Immunization Research Network ( 1 ),2.001,1,NA
Drug,0.12% chlorhexidine gluconate,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,0.5% w/v povidone-iodide,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,0.9% (w,1,2020-08-21,0,0,1,0,0,AstraZeneca ( 1 ),2.001,1,1
Drug,0.9% (w/v) saline,1,2020-08-21,0,0,1,0,0,AstraZeneca ( 1 ),2.001,1,1
Drug,1.5% w/v hydrogen peroxide,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,27% ethanol,1,2020-10-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,3),1,2020-04-27,0,0,1,0,0,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ( 1 ),2.001,1,NA
Combination Product,4plants,1,2020-08-03,0,0,1,0,0,Institute for Research and Development of Medicinal and Food Plants of Guinea ( 1 ),2.001,1,7
placebo,"a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56",1,2021-03-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
placebo,"a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",1,2021-03-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,"a high-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",1,2021-03-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
placebo,"a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56",1,2021-03-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Drug,abivertinib,1,2020-06-17,0,0,1,0,0,"Sorrento Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,activase,1,2020-04-18,0,0,1,0,0,Denver Health and Hospital Authority ( 1 ),2.001,1,2
Biological,active vaccine control (group b1a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control (group b1d),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control (group c2b),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control (group c2c),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control simple dose (group b1d),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control simple dose (group c2d),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control simple dose (group c2d) - 60 years old,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,active vaccine control simple dose (group c2d) - 60 years old/more,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,administration of equine immunoglobulin anti sars-cov-2,1,2020-09-15,0,0,1,0,0,Caja Costarricense de Seguro Social ( 1 ),2.001,1,NA
Drug,adx-629,1,2021-04-13,0,0,1,0,0,"Aldeyra Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,aerosolized dnase,1,2020-06-05,0,0,1,0,0,Region Skane ( 1 ),2.001,1,NA
Biological,ag0301-covid19,1,2020-07-08,0,0,1,0,0,"AnGes, Inc. ( 1 )",2.001,1,NA
Biological,ag0302-covid19,1,2020-08-24,0,0,1,0,0,"AnGes, Inc. ( 1 )",2.001,1,NA
Biological,ag0302-covid19 for intradermal injection,1,2021-07-30,0,0,1,0,0,"AnGes, Inc. ( 1 )",2.001,1,NA
Biological,ag0302-covid19 for intramuscular injection,1,2021-07-30,0,0,1,0,0,"AnGes, Inc. ( 1 )",2.001,1,NA
Other,albumine,1,2020-05-26,0,0,1,0,0,Grupo Mexicano para el Estudio de la Medicina Intensiva ( 1 ),2.001,1,NA
Drug,allogeneic,1,2020-04-22,0,0,1,0,0,Andalusian Network for Design and Translation of Advanced Therapies ( 1 ),2.001,1,NA
Biological,allogeneic human menstrual blood stem cells secretome,1,2021-07-03,0,0,1,0,0,Avicenna Research Institute ( 1 ),2.001,1,NA
Drug,alvelestat,1,2020-09-03,0,0,1,0,0,University of Alabama at Birmingham ( 1 ),2.001,1,NA
Drug,ang-3777,1,2020-07-03,0,0,1,0,0,Angion Biomedica Corp ( 1 ),2.001,1,NA
Drug,angiotensin,1,2020-10-27,0,0,1,0,0,Rambam Health Care Campus ( 1 ),2.001,1,NA
Drug,angiotensin-(1-7),1,2020-11-06,0,0,1,0,0,Erasme University Hospital ( 1 ),2.001,1,NA
Biological,anti-cd14,1,2020-05-14,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Drug,antithrombin / best available treatment,1,2021-02-08,0,0,1,0,0,MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 ),2.001,1,NA
Drug,antithrombin iii,1,2021-05-20,0,0,1,0,0,University of Miami ( 1 ),2.001,1,NA
Drug,antroquinonol,1,2020-08-19,0,0,1,0,0,Golden Biotechnology Corporation ( 1 ),2.001,1,NA
Drug,apilimod dimesylate,1,2020-06-23,0,0,1,0,0,"AI Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,apl-9,1,2020-05-22,0,0,1,0,0,"Apellis Pharmaceuticals, Inc. ( 1 )",2.001,1,NA
Drug,aprepitant injectable emulsion,1,2020-07-13,0,0,1,0,0,Heron Therapeutics ( 1 ),2.001,1,NA
Drug,apx-115,1,2021-04-29,0,0,1,0,0,"Aptabio Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 dose regimen 1,1,2020-07-17,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-021 dose regimen 2,1,2020-07-17,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Biological,arct-165,1,2021-08-30,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Dietary Supplement,artemesia annua,1,2020-05-01,0,0,1,0,0,University of Kentucky ( 1 ),2.001,1,NA
Drug,artemisia annua leaf,1,2020-08-26,0,0,1,0,0,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 ),2.001,1,10
Biological,asunercept,1,2020-08-31,0,0,1,0,0,Apogenix AG ( 1 ),2.001,1,NA
Drug,ati-450,1,2020-07-15,0,0,1,0,0,University of Kansas Medical Center ( 1 ),2.001,1,NA
Drug,atovaquone,1,2020-04-07,0,0,1,0,0,HonorHealth Research Institute ( 1 ),2.001,1,NA
Drug,atovaquone/azithromycin,1,2020-04-07,0,0,1,0,0,HonorHealth Research Institute ( 1 ),2.001,1,NA
Drug,atyr1923,1,2020-06-01,0,0,1,0,0,"aTyr Pharma, Inc. ( 1 )",2.001,1,NA
Combination Product,autologous activated platelet-rich plasma,1,2021-01-15,0,0,1,0,0,Hayandra Peduli Foundation ( 1 ),2.001,1,NA
Biological,autologous non-hematopoietic peripheral blood stem cells (nhpbsc),1,2020-07-14,0,0,1,0,0,Abu Dhabi Stem Cells Center ( 1 ),2.001,1,NA
Drug,autophagy inhibitor (gns651),1,2020-04-01,0,0,1,0,0,Centre Leon Berard ( 1 ),2.001,1,NA
Drug,auxora,1,2020-04-07,0,0,1,0,0,"CalciMedica, Inc. ( 1 )",2.001,1,1
Drug,aviptadil acetate,1,2020-07-14,0,0,1,0,0,QuantumLeap Healthcare Collaborative ( 1 ),2.001,1,NA
Drug,azd1656,1,2020-08-14,0,0,1,0,0,St George Street Capital ( 1 ),2.001,1,NA
Drug,azithromycin pill,1,2021-07-06,0,0,1,0,0,MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 ),2.001,1,NA
Drug,bemcentinib,1,2021-05-17,0,0,1,0,0,BerGenBio ASA ( 1 ),2.001,1,NA
Drug,bemiparin,1,2020-06-05,0,0,1,0,0,FundaciÃ³n de investigaciÃ³n HM ( 1 ),2.001,1,NA
Biological,biological: mrna-1273,1,2020-05-13,0,0,1,0,0,"ModernaTX, Inc. ( 1 )",2.001,1,1
Biological,biontech),1,2021-07-16,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Other,blood/derivatives,1,2020-04-02,0,0,1,0,0,Puerta de Hierro University Hospital ( 1 ),2.001,1,2
Drug,bms-986253,1,2020-04-02,0,0,1,0,0,Columbia University ( 1 ),2.001,1,NA
Drug,btl-tml-covid,1,2020-08-18,0,0,1,0,0,"Beech Tree Labs, Inc. ( 1 )",2.001,1,NA
Drug,c1 inhibitor human,1,2021-08-16,0,0,1,0,0,GCS Ramsay SantÃ© pour l'Enseignement et la Recherche ( 1 ),2.001,1,NA
Biological,cap-1002,1,2020-10-07,0,0,1,0,0,Capricor Inc. ( 1 ),2.001,1,NA
Drug,casirivimab/imdevimab,1,2021-08-03,0,0,1,0,0,Regeneron Pharmaceuticals ( 1 ),2.001,1,NA
Biological,castem,1,2020-02-06,0,0,1,0,0,Chinese Academy of Sciences ( 1 ),2.001,1,NA
Drug,celecoxib famotidine,1,2020-07-14,0,0,1,0,0,QuantumLeap Healthcare Collaborative ( 1 ),2.001,1,NA
Biological,chadox1-s [recombinant],1,2021-05-18,0,0,1,0,0,Canadian Immunization Research Network ( 1 ),2.001,1,NA
Biological,chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine (lv),1,2020-03-20,0,0,1,0,0,University of Oxford ( 1 ),2.001,1,4
Biological,chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine two (lvt),1,2020-03-20,0,0,1,0,0,University of Oxford ( 1 ),2.001,1,4
Other,chlorine dioxide,1,2020-11-05,0,0,1,0,0,"Profact, Inc. ( 1 )",2.001,1,NA
Drug,clarithromycin,1,2020-05-17,0,0,1,0,0,Hellenic Institute for the Study of Sepsis ( 1 ),2.001,1,1
Drug,closys ultra sensitive rinse mouthwash,1,2020-05-28,0,0,1,0,0,"University of California, San Francisco ( 1 )",2.001,1,NA
Drug,colchicine/herbal phenolic monoterpene fractions,1,2020-05-15,0,0,1,0,0,Kermanshah University of Medical Sciences ( 1 ),2.001,1,NA
Biological,commercial covid-19 vaccine,1,2021-08-12,0,0,1,0,0,"Laboratorios Hipra, S.A. ( 1 )",2.001,1,NA
Drug,conestat alfa,1,2020-05-19,0,0,1,0,0,"University Hospital, Basel, Switzerland ( 1 )",2.001,1,1
Drug,control test,1,2020-09-28,0,0,1,0,0,Fondazione Epatocentro Ticino ( 1 ),2.001,1,NA
Biological,convalescent plasma infusion,1,2020-11-18,0,0,1,0,0,The University of The West Indies ( 1 ),2.001,1,NA
Drug,cor-101,1,2020-12-17,0,0,1,0,0,Corat Therapeutics Gmbh ( 1 ),2.001,1,NA
Combination Product,cospherunate,1,2020-08-04,0,0,1,0,0,Institute for Research and Development of Medicinal and Food Plants of Guinea ( 1 ),2.001,1,NA
Combination Product,cospherunate/azythromycine,1,2020-08-04,0,0,1,0,0,Institute for Research and Development of Medicinal and Food Plants of Guinea ( 1 ),2.001,1,NA
Combination Product,cospherunate/phytomedicine/azythromycien,1,2020-08-04,0,0,1,0,0,Institute for Research and Development of Medicinal and Food Plants of Guinea ( 1 ),2.001,1,NA
Biological,covac-1,1,2021-07-05,0,0,1,0,0,University Hospital Tuebingen ( 1 ),2.001,1,NA
Drug,covend24,1,2021-05-21,0,0,1,0,0,Athens Medical Society ( 1 ),2.001,1,NA
Biological,covi-drops,1,2021-05-20,0,0,1,0,0,"Sorrento Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,covid-19 standard of care,1,2021-04-14,0,0,1,0,0,"Qurient Co., Ltd. ( 1 )",2.001,1,NA
Biological,covigenix vax-001,1,2020-09-23,0,0,1,0,0,Entos Pharmaceuticals Inc. ( 1 ),2.001,1,NA
placebo,covigenix vax-001 placebo,1,2020-09-23,0,0,1,0,0,Entos Pharmaceuticals Inc. ( 1 ),2.001,1,NA
Biological,covivac,1,2021-03-12,0,0,1,0,0,"Institute of Vaccines and Medical Biologicals, Vietnam ( 1 )",2.001,1,NA
Drug,crest pro-health multi-protection mouthwash,1,2020-05-28,0,0,1,0,0,"University of California, San Francisco ( 1 )",2.001,1,NA
Drug,crizanlizumab,1,2020-06-16,0,0,1,0,0,Johns Hopkins University ( 1 ),2.001,1,1
placebo,cst-2: placebo,1,2020-10-13,0,0,1,0,0,University of Liverpool ( 1 ),2.001,1,1
placebo,cst-5: placebo,1,2020-10-13,0,0,1,0,0,University of Liverpool ( 1 ),2.001,1,1
Procedure,curently used therapy for covid-19 non-critical patients,1,2020-07-15,0,0,1,0,0,Hospital General de MÃ©xico Dr. Eduardo Liceaga ( 1 ),2.001,1,NA
Drug,currently used therapy,1,2020-07-15,0,0,1,0,0,Hospital General de MÃ©xico Dr. Eduardo Liceaga ( 1 ),2.001,1,NA
Drug,dalcetrapib,1,2020-12-17,0,0,1,0,0,DalCor Pharmaceuticals ( 1 ),2.001,1,NA
Drug,deferoxamine,1,2020-04-01,0,0,1,0,0,Kermanshah University of Medical Sciences ( 1 ),2.001,1,1
Drug,degarelix,1,2020-05-14,0,0,1,0,0,VA Office of Research and Development ( 1 ),2.001,1,1
Other,diagnostic laboratory biomarker analysis,1,2021-06-11,0,0,1,0,0,City of Hope Medical Center ( 1 ),2.001,1,NA
Drug,doxycycline hcl,1,2020-07-21,0,0,1,0,0,ProgenaBiome ( 1 ),2.001,1,NA
Drug,doxycyline,1,2020-10-15,0,0,1,0,0,Alkarkh Health Directorate-Baghdad ( 1 ),2.001,1,NA
Drug,eculizumab,1,2020-04-06,0,0,1,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),2.001,1,NA
Device,epsgun,1,2021-03-01,0,0,1,0,0,Takis ( 1 ),2.001,1,NA
Drug,estradiol,1,2020-04-21,0,0,1,0,0,Stony Brook University ( 1 ),2.001,1,NA
Drug,estradiol cypionate 5 mg/ml,1,2021-04-21,0,0,1,0,0,Tulane University ( 1 ),2.001,1,NA
Biological,f-652,1,2020-07-31,0,0,1,0,0,Generon (Shanghai) Corporation Ltd. ( 1 ),2.001,1,NA
Device,fast dissolving film,1,2020-12-02,0,0,1,0,0,Deraya University ( 1 ),2.001,1,NA
Drug,favipiravir / currently used therapy,1,2020-07-15,0,0,1,0,0,Hospital General de MÃ©xico Dr. Eduardo Liceaga ( 1 ),2.001,1,NA
Other,fenofibric acid,1,2020-08-17,0,0,1,0,0,University of Pennsylvania ( 1 ),2.001,1,NA
Drug,fondaparinux,1,2020-04-23,0,0,1,0,0,University of Milan ( 1 ),2.001,1,1
Drug,gam-covid-vac (rad26) / gam-covid-vac (rad5),1,2021-08-18,0,0,1,0,0,Ministerio de Salud de Ciudad AutÃ³noma de Buenos Aires ( 1 ),2.001,1,NA
Drug,gam-covid-vac (rad5),1,2021-08-18,0,0,1,0,0,Ministerio de Salud de Ciudad AutÃ³noma de Buenos Aires ( 1 ),2.001,1,NA
Biological,gam-covid-vac lyo,1,2020-06-16,0,0,1,0,0,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation ( 1 )",2.001,1,NA
Biological,gamunex-c,1,2020-07-20,0,0,1,0,0,Grifols Therapeutics LLC ( 1 ),2.001,1,NA
Biological,"garadacimab, factor xiia antagonist monoclonal antibody",1,2020-05-28,0,0,1,0,0,CSL Behring ( 1 ),2.001,1,NA
Biological,gbp510 (rbd 10î¼g,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 (rbd 25î¼g/dose) - stage 1,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Biological,gbp510 adjuvanted with alum (rbd 10î¼g,1,2021-02-04,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,1
Biological,gbp510 adjuvanted with alum (rbd 25î¼g/dose)- stage 2,1,2021-02-04,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,1
Biological,gbp510 adjuvanted with as03 (rbd 25î¼g,1,2021-02-10,0,0,1,0,0,"SK Bioscience Co., Ltd. ( 1 )",2.001,1,NA
Drug,gc4419,1,2020-09-16,0,0,1,0,0,"Galera Therapeutics, Inc. ( 1 )",2.001,1,1
Biological,gc5131,1,2020-09-16,0,0,1,0,0,Green Cross Corporation ( 1 ),2.001,1,NA
Drug,gns561,1,2020-11-17,0,0,1,0,0,Genoscience Pharma ( 1 ),2.001,1,NA
Drug,gx-03,1,2021-06-30,0,0,1,0,0,Turn Therapeutics ( 1 ),2.001,1,NA
Drug,gx-19,1,2020-06-19,0,0,1,0,0,"Genexine, Inc. ( 1 )",2.001,1,NA
Biological,heterologous prime-boost schedule with azd1222,1,2021-09-13,0,0,1,0,0,Chang Gung Memorial Hospital ( 1 ),2.001,1,NA
Biological,high-dose placebo (18-59 years)/two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high-dose recombinant sars-cov-2 vaccine (cho cell),1,2021-04-24,0,0,1,0,0,"National Vaccine and Serum Institute, China ( 1 )",2.001,1,NA
Biological,high dose aerosolized ad5-ncov,1,2021-09-13,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,high dose bcd-250 injection,1,2021-09-07,0,0,1,0,0,Biocad ( 1 ),2.001,1,NA
Radiation,high dose radiation 100 cgy,1,2020-06-20,0,0,1,0,0,Ohio State University Comprehensive Cancer Center ( 1 ),2.001,1,1
Biological,hmsc,1,2021-03-01,0,0,1,0,0,"Stemedica Cell Technologies, Inc. ( 1 )",2.001,1,NA
Drug,hmw-ha,1,2021-03-31,0,0,1,0,0,Campus Bio-Medico University ( 1 ),2.001,1,NA
Biological,homologous prime-boost schedule with two doses of azd1222,1,2021-09-13,0,0,1,0,0,Chang Gung Memorial Hospital ( 1 ),2.001,1,NA
Biological,human cord tissue mesenchymal stromal cells (hct-msc) manufactured by duke university.,1,2020-05-21,0,0,1,0,0,Duke University ( 1 ),2.001,1,NA
Drug,human recombinant interleukin 2,1,2020-04-10,0,0,1,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),2.001,1,NA
Drug,hydroxychloroquine pill / azithromycin pill,1,2021-07-06,0,0,1,0,0,MaimÃ³nides Biomedical Research Institute of CÃ³rdoba ( 1 ),2.001,1,NA
Drug,hydroxychloroquine tablets,1,2021-04-23,0,0,1,0,0,Makerere University ( 1 ),2.001,1,NA
Drug,"hydroxychloroquine, lopinavir/ritonavir/azithromycin/placebo (standard therapy)",1,2020-05-12,0,0,1,0,0,BioXcellerator ( 1 ),2.001,1,NA
Drug,hyperpolarized 129xenon gas,1,2021-03-11,0,0,1,0,0,Duke University ( 1 ),2.001,1,NA
Drug,ibudilast,1,2020-06-09,0,0,1,0,0,MediciNova ( 1 ),2.001,1,NA
Drug,icatibant injection,1,2021-08-16,0,0,1,0,0,GCS Ramsay SantÃ© pour l'Enseignement et la Recherche ( 1 ),2.001,1,NA
Biological,icc vaccine,1,2021-07-09,0,0,1,0,0,Novavax ( 1 ),2.001,1,NA
Drug,idoine complex,1,2020-07-14,0,0,1,0,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),2.001,1,1
Drug,ifn beta-1a,1,2021-04-22,0,0,1,0,0,Faron Pharmaceuticals Ltd ( 1 ),2.001,1,NA
Drug,igiv,1,2020-05-18,0,0,1,0,0,Versailles Hospital ( 1 ),2.001,1,NA
Biological,iibr-100 high-dose (prime-boost),1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
Biological,iibr-100 high-dose (prime),1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
Biological,iibr-100 low-dose (prime-boost),1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
Biological,iibr-100 medium dose (prime),1,2020-10-26,0,0,1,0,0,Israel Institute for Biological Research (IIBR) ( 1 ),2.001,1,NA
Drug,imatinib mesylate,1,2021-06-29,0,0,1,0,0,Exvastat Ltd. ( 1 ),2.001,1,NA
Drug,imatinib mesylate intravenous solution,1,2021-02-26,0,0,1,0,0,VU University Medical Center ( 1 ),2.001,1,NA
Biological,immune globulin,1,2020-06-12,0,0,1,0,0,Grifols Therapeutics LLC ( 1 ),2.001,1,NA
Biological,immune plasma,1,2020-11-04,0,0,1,0,0,Azienda USL Toscana Nord Ovest ( 1 ),2.001,1,NA
Biological,inactivated covid-19 vaccine (vero cells),1,2021-10-03,0,0,1,0,0,"National Vaccine and Serum Institute, China ( 1 )",2.001,1,NA
Dietary Supplement,inflammation (i),1,2021-02-23,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Dietary Supplement,inflammation (ii),1,2021-02-23,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Dietary Supplement,inflammation (iii),1,2021-02-23,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Drug,inhalation,1,2021-05-19,0,0,1,0,0,Amorphical Ltd. ( 1 ),2.001,1,NA
Drug,inhaled type i interferon,1,2020-07-13,0,0,1,0,0,"Centre Hospitalier Universitaire, Amiens ( 1 )",2.001,1,NA
Other,intravenous normal saline,1,2020-07-29,0,0,1,0,0,"Direct Biologics, LLC ( 1 )",2.001,1,NA
Drug,is (mmf/mpa),1,2021-08-06,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Drug,isoquercetin,1,2020-11-09,0,0,1,0,0,AB Science ( 1 ),2.001,1,NA
Drug,ivermectin (iver pâ®) arm will receive ivm 600 âµg,1,2020-05-05,0,0,1,0,0,Laboratorio Elea Phoenix S.A. ( 1 ),2.001,1,1
Drug,ivermectin 3 mg,1,2020-12-01,0,0,1,0,0,Kitasato University ( 1 ),2.001,1,NA
Biological,kamada anti-sars-cov-2,1,2020-09-10,0,0,1,0,0,"Kamada, Ltd. ( 1 )",2.001,1,NA
Drug,lambda 180 mcg s.c,1,2020-04-20,0,0,1,0,0,Soroka University Medical Center ( 1 ),2.001,1,NA
Drug,lau-7b,1,2020-05-28,0,0,1,0,0,Laurent Pharmaceuticals Inc. ( 1 ),2.001,1,NA
Drug,leaf-4l6715,1,2020-05-05,0,0,1,0,0,Institut de cancÃ©rologie Strasbourg Europe ( 1 ),2.001,1,NA
Drug,listerine zero mouthwash product,1,2020-05-28,0,0,1,0,0,"University of California, San Francisco ( 1 )",2.001,1,NA
Drug,losartan 50 mg/spironolactone 25 mg pillules oral use,1,2020-11-24,0,0,1,0,0,Assistance Publique Hopitaux De Marseille ( 1 ),2.001,1,NA
Biological,low-dose placebo (18-59 years)/two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
placebo,low-dose placebo (60-85 years),1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose placebo (60-85 years)/three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low-dose recombinant sars-cov-2 vaccine (cho cell),1,2021-04-24,0,0,1,0,0,"National Vaccine and Serum Institute, China ( 1 )",2.001,1,NA
Biological,low dose,1,2021-09-07,0,0,1,0,0,Biocad ( 1 ),2.001,1,NA
Biological,low dose aerosolized ad5-ncov,1,2021-09-13,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Biological,low dose bcd-250 injection,1,2021-09-07,0,0,1,0,0,Biocad ( 1 ),2.001,1,NA
Drug,lsalt peptide,1,2020-05-12,0,0,1,0,0,Arch Biopartners Inc. ( 1 ),2.001,1,NA
Drug,"ltx-109 gel, 3%",1,2021-04-21,0,0,1,0,0,Pharma Holdings AS ( 1 ),2.001,1,NA
Drug,lucinactant,1,2020-05-13,0,0,1,0,0,Windtree Therapeutics ( 1 ),2.001,1,NA
Biological,lv-smenp-dc vaccine,1,2020-02-17,0,0,1,0,0,Shenzhen Geno-Immune Medical Institute ( 1 ),2.001,1,NA
Biological,lv-smenp-dc vaccine/antigen-specific ctls,1,2020-02-17,0,0,1,0,0,Shenzhen Geno-Immune Medical Institute ( 1 ),2.001,1,NA
Drug,ly3127804,1,2020-04-10,0,0,1,0,0,Eli Lilly and Company ( 1 ),2.001,1,NA
Drug,ly3853113,1,2020-11-17,0,0,1,0,0,Eli Lilly and Company ( 1 ),2.001,1,NA
Drug,lyt-100,1,2020-12-02,0,0,1,0,0,PureTech ( 1 ),2.001,1,NA
Drug,m5049,1,2020-06-25,0,0,1,0,0,EMD Serono ( 1 ),2.001,1,NA
Drug,maraviroc / currently used therapy,1,2020-07-15,0,0,1,0,0,Hospital General de MÃ©xico Dr. Eduardo Liceaga ( 1 ),2.001,1,NA
Drug,maraviroc experimental group,1,2021-01-05,0,0,1,0,0,FundaciÃ³n PÃºblica Andaluza para la gestiÃ³n de la InvestigaciÃ³n en Sevilla ( 1 ),2.001,1,NA
Drug,maraviroc/favipiravir/ct,1,2020-07-15,0,0,1,0,0,Hospital General de MÃ©xico Dr. Eduardo Liceaga ( 1 ),2.001,1,NA
Drug,mas825,1,2020-05-08,0,0,1,0,0,Novartis ( 1 ),2.001,1,NA
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,1,2020-05-21,0,0,1,0,0,Chinese Academy of Medical Sciences ( 1 ),2.001,1,2
Biological,mesencure,1,2021-01-17,0,0,1,0,0,BonusBio Group Ltd ( 1 ),2.001,1,NA
Drug,ml intravenous solution [actemra]_#1 (2 doses),1,2020-06-11,0,0,1,0,0,Hospital Universitario Ramon y Cajal ( 1 ),2.001,1,NA
Biological,mon002,1,2021-03-03,0,0,1,0,0,Guy's and St Thomas' NHS Foundation Trust ( 1 ),2.001,1,NA
Drug,monalizumab,1,2020-04-01,0,0,1,0,0,Centre Leon Berard ( 1 ),2.001,1,NA
Biological,more,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Drug,mpa),1,2021-08-06,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Drug,mrg-001,1,2020-11-24,0,0,1,0,0,MedRegen LLC ( 1 ),2.001,1,NA
Biological,mrna-1273 sars-cov-2 vaccine,1,2021-05-18,0,0,1,0,0,Canadian Immunization Research Network ( 1 ),2.001,1,NA
Biological,mrna-1273 vaccine (moderna),1,2021-07-16,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Biological,mrna vaccine booster,1,2021-08-02,0,0,1,0,0,Universidad del Desarrollo ( 1 ),2.001,1,NA
Drug,mstt1041a,1,2020-05-11,0,0,1,0,0,"Genentech, Inc. ( 1 )",2.001,1,NA
Biological,mt-2766 high dose,1,2021-10-01,0,0,1,0,0,Medicago ( 1 ),2.001,1,NA
Biological,mva-sars-2-st,1,2021-04-24,0,0,1,0,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),2.001,1,NA
Biological,mvc-cov1901 (high-dose),1,2021-03-25,0,0,1,0,0,Medigen Vaccine Biologics Corp. ( 1 ),2.001,1,NA
Biological,mvc-cov1901(mid-dose),1,2021-03-25,0,0,1,0,0,Medigen Vaccine Biologics Corp. ( 1 ),2.001,1,NA
Combination Product,mw33 injection,1,2020-11-12,0,0,1,0,0,"Mabwell (Shanghai) Bioscience Co., Ltd. ( 1 )",2.001,1,1
placebo,mw33 injection placebo,1,2020-11-12,0,0,1,0,0,"Mabwell (Shanghai) Bioscience Co., Ltd. ( 1 )",2.001,1,1
Dietary Supplement,nad/,1,2020-10-26,0,0,1,0,0,AgelessRx ( 1 ),2.001,1,NA
Biological,nasovax,1,2020-06-17,0,0,1,0,0,"Altimmune, Inc. ( 1 )",2.001,1,NA
Biological,ndv-hxp-s parental vaccine in 3 consecutive lots (group b1a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s parental vaccine simple dose (group b1d),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s parental vaccine simple dose (group b1d) - 60 years old,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s parental vaccine simple dose (group b1d) - 60 years old/more,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s parental vaccine simple dose (group c2d),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s parental vaccine simple dose (group c2d) - 60 years old,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s parental vaccine simple dose (group c2d) - 60 years old/more,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant (group c1b),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant (group c1c),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant (group c1c) - 60 years old,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant (group c1c) - 60 years old/more,1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant (group c2b),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant (group c2c),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant / 3 consecutive lots (group c1a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Biological,ndv-hxp-s vaccine based in variant / 3 consecutive lots (group c2a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
Drug,nebulised heparin,1,2020-08-10,0,0,1,0,0,University College Hospital Galway ( 1 ),2.001,1,NA
Drug,niclosamide oral tablet,1,2021-02-10,0,0,1,0,0,University of Baghdad ( 1 ),2.001,1,NA
placebo,nitazoxanide placebo,1,2021-06-04,0,0,1,0,0,"CoordinaciÃ³n de InvestigaciÃ³n en Salud, Mexico ( 1 )",2.001,1,NA
Drug,"nitric oxide lozenges, 30 mg",1,2020-10-21,0,0,1,0,0,Nitric Oxide Innovations LLC ( 1 ),2.001,1,NA
Other,no treatment,1,2021-09-07,0,0,1,0,0,University of Oxford ( 1 ),2.001,1,NA
Drug,ozanimod,1,2020-05-26,0,0,1,0,0,"Institut universitaire de cardiologie et de pneumologie de QuÃ©bec, University Laval ( 1 )",2.001,1,NA
Biological,pembrolizumab,1,2020-03-31,0,0,1,0,0,MedSIR ( 1 ),2.001,1,NA
Drug,pemziviptadil (pb1046),1,2020-05-28,0,0,1,0,0,PhaseBio Pharmaceuticals Inc. ( 1 ),2.001,1,NA
Other,peroxyl,1,2021-02-09,0,0,1,0,0,"University of North Carolina, Chapel Hill ( 1 )",2.001,1,NA
Drug,petrolatum ointment,1,2021-06-30,0,0,1,0,0,Turn Therapeutics ( 1 ),2.001,1,NA
Combination Product,phytomedicine,1,2020-08-04,0,0,1,0,0,Institute for Research and Development of Medicinal and Food Plants of Guinea ( 1 ),2.001,1,NA
placebo,placebo - phase i,1,2020-07-11,0,0,1,0,0,Bharat Biotech International Limited ( 1 ),2.001,1,3
placebo,placebo (stage a),1,2021-08-03,0,0,1,0,0,Butantan Institute ( 1 ),2.001,1,NA
placebo,placebo (standard therapy),1,2020-05-12,0,0,1,0,0,BioXcellerator ( 1 ),2.001,1,NA
placebo,"placebo (two doses), priming",1,2020-11-25,0,0,1,0,0,"Arcturus Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,placebo / standard of care (soc),1,2021-08-09,0,0,1,0,0,Rhizen Pharmaceuticals SA ( 1 ),2.001,1,NA
placebo,placebo 0.9% nacl solution,1,2020-08-21,0,0,1,0,0,"Cantonal Hosptal, Baselland ( 1 )",2.001,1,NA
placebo,placebo 1,1,2020-05-04,0,0,1,0,0,GlaxoSmithKline ( 1 ),2.001,1,NA
placebo,placebo 2,1,2020-05-04,0,0,1,0,0,GlaxoSmithKline ( 1 ),2.001,1,NA
placebo,placebo comparator (without active ingredient) for intramuscular injection,1,2021-08-26,0,0,1,0,0,Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products ( 1 ),2.001,1,NA
placebo,placebo empty capsule,1,2020-07-14,0,0,1,0,0,Sheikh Zayed Federal Postgraduate Medical Institute ( 1 ),2.001,1,1
placebo,placebo for camostat mesilate,1,2020-12-17,0,0,1,0,0,"Heinrich-Heine University, Duesseldorf ( 1 )",2.001,1,1
Other,placebo injection/placebo pill,1,2021-04-21,0,0,1,0,0,Tulane University ( 1 ),2.001,1,NA
placebo,placebo iv,1,2020-05-21,0,0,1,0,0,Edesa Biotech Inc. ( 1 ),2.001,1,NA
placebo,placebo pill,1,2021-04-21,0,0,1,0,0,Tulane University ( 1 ),2.001,1,NA
Drug,placebo/control,1,2020-07-30,0,0,1,0,0,Icahn School of Medicine at Mount Sinai ( 1 ),2.001,1,1
Drug,pln-74809,1,2020-09-15,0,0,1,0,0,"Pliant Therapeutics, Inc. ( 1 )",2.001,1,NA
Drug,poractant alfa,1,2020-05-07,0,0,1,0,0,Versailles Hospital ( 1 ),2.001,1,NA
Drug,prazosin,1,2020-04-24,0,0,1,0,0,Johns Hopkins University ( 1 ),2.001,1,NA
Drug,progesterone 200 mg oral capsule,1,2021-04-21,0,0,1,0,0,Tulane University ( 1 ),2.001,1,NA
Biological,prolastin,1,2020-07-28,0,0,1,0,0,Grifols Therapeutics LLC ( 1 ),2.001,1,NA
Drug,pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),1,2020-06-22,0,0,1,0,0,University of South Alabama ( 1 ),2.001,1,NA
Combination Product,purphl,1,2021-03-31,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Biological,qazcovac-p -covid-19 subunit vaccine,1,2021-02-22,0,0,1,0,0,Research Institute for Biological Safety Problems ( 1 ),2.001,1,NA
Biological,qniv nanoparticle vaccine2 in-clinic mixed with matrix-m1 adjuvant,1,2021-07-09,0,0,1,0,0,Novavax ( 1 ),2.001,1,NA
Biological,quadrivalent inactivated influenza high dose,1,2021-07-16,0,0,1,0,0,Sanofi ( 1 ),2.001,1,NA
Biological,rapa-501-allo off-the-shelf therapy of covid-19,1,2020-07-20,0,0,1,0,0,Rapa Therapeutics LLC ( 1 ),2.001,1,NA
Drug,rayaldee 30mcg extended-release (er) capsule,1,2020-09-15,0,0,1,0,0,"OPKO Health, Inc. ( 1 )",2.001,1,NA
Drug,razuprotafib subcutaneous solution,1,2020-08-07,0,0,1,0,0,Aerpio Therapeutics ( 1 ),2.001,1,NA
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector) for inhalation,1,2021-04-08,0,0,1,0,0,CanSino Biologics Inc. ( 1 ),2.001,1,NA
Drug,resp301,1,2021-04-19,0,0,1,0,0,Thirty Respiratory Limited ( 1 ),2.001,1,NA
Other,respiratory function rehabilitation training,1,2020-02-15,0,0,1,0,0,ShuGuang Hospital ( 1 ),2.001,1,NA
Drug,rh-dnase,1,2020-06-22,0,0,1,0,0,University of South Alabama ( 1 ),2.001,1,NA
Drug,rhace2,1,2020-04-01,0,0,1,0,0,Apeiron Biologics ( 1 ),2.001,1,NA
Drug,rhtpo,1,2020-08-16,0,0,1,0,0,Peking University People's Hospital ( 1 ),2.001,1,NA
Drug,rintatolimod,1,2020-05-06,0,0,1,0,0,Roswell Park Cancer Institute ( 1 ),2.001,1,NA
Biological,risankizumab,1,2020-10-09,0,0,1,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),2.001,1,NA
Drug,roactemra,1,2020-03-24,0,0,1,0,0,Frederiksberg University Hospital ( 1 ),2.001,1,NA
Drug,saline nasal spray,1,2021-08-11,0,0,1,0,0,Irkutsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences ( 1 ),2.001,1,NA
Biological,sars-cov-2 vaccine formulation 2 with adjuvant 1,1,2020-09-02,0,0,1,0,0,Sanofi ( 1 ),2.001,1,1
Biological,sars-cov-2 vaccine formulation 2 with adjuvant 2,1,2020-09-02,0,0,1,0,0,Sanofi ( 1 ),2.001,1,1
Biological,sars-cov-2 vlp vaccine-alpha (british) variant,1,2021-07-12,0,0,1,0,0,The Scientific and Technological Research Council of Turkey ( 1 ),2.001,1,NA
Biological,sbi-101,1,2020-06-22,0,0,1,0,0,"Sentien Biotechnologies, Inc. ( 1 )",2.001,1,NA
Drug,senicapoc,1,2020-10-07,0,0,1,0,0,University of Aarhus ( 1 ),2.001,1,NA
Drug,sessions,1,2020-07-16,0,0,1,0,0,Tomsk National Research Medical Center of the Russian Academy of Sciences ( 1 ),2.001,1,NA
Device,sham transcranial direct-current stimulation,1,2021-03-16,0,0,1,0,0,D'Or Institute for Research and Education ( 1 ),2.001,1,NA
Procedure,sham treatment,1,2021-04-09,0,0,1,0,0,Karolinska University Hospital ( 1 ),2.001,1,NA
Drug,simvastatin,1,2020-04-13,0,0,1,0,0,FundaciÃ³n de investigaciÃ³n HM ( 1 ),2.001,1,NA
Drug,sirukumab,1,2020-05-07,0,0,1,0,0,"Janssen Pharmaceutica N.V., Belgium ( 1 )",2.001,1,NA
Dietary Supplement,sivomixx,1,2020-04-22,0,0,1,0,0,Azienda Policlinico Umberto I ( 1 ),2.001,1,4
Other,smell retraining,1,2021-07-15,0,0,1,0,0,University of Pittsburgh ( 1 ),2.001,1,NA
Combination Product,smoliv,1,2021-03-31,0,0,1,0,0,"All Natural Medicine Clinic, LLC ( 1 )",2.001,1,NA
Biological,soc/15mg/kg eb05 iv,1,2020-05-21,0,0,1,0,0,Edesa Biotech Inc. ( 1 ),2.001,1,NA
Other,soc/placebo iv,1,2020-05-21,0,0,1,0,0,Edesa Biotech Inc. ( 1 ),2.001,1,NA
Drug,sodium chloride,1,2020-06-12,0,0,1,0,0,Karolinska University Hospital ( 1 ),2.001,1,1
Device,soterix tavns model 0125-lte stimulator - sham-active group,1,2020-11-18,0,0,1,0,0,Medical University of South Carolina ( 1 ),2.001,1,NA
Behavioral,speed of processing training,1,2020-11-23,0,0,1,0,0,University of Alabama at Birmingham ( 1 ),2.001,1,NA
Drug,standard treatment of covid-19,1,2021-02-11,0,0,1,0,0,Stem Cell and Cancer Research Indonesia ( 1 ),2.001,1,2
Drug,stc3141,1,2021-04-25,0,0,1,0,0,Grand Medical Pty Ltd. ( 1 ),2.001,1,NA
Other,stp,1,2020-06-07,0,0,1,0,0,Azienda Ospedaliera CittÃ  della Salute e della Scienza di Torino ( 1 ),2.001,1,NA
Other,stp / standard plasma (sp),1,2020-06-07,0,0,1,0,0,Azienda Ospedaliera CittÃ  della Salute e della Scienza di Torino ( 1 ),2.001,1,NA
Other,supportive tratment,1,2020-04-07,0,0,1,0,0,Hospital Universitario de Fuenlabrada ( 1 ),2.001,1,NA
Biological,synthetic mva-based sars-cov-2 vaccine coh04s1,1,2021-06-11,0,0,1,0,0,City of Hope Medical Center ( 1 ),2.001,1,NA
Biological,t memory cells,1,2020-10-01,0,0,1,0,0,Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 ),2.001,1,2
Biological,t memory cells/nk cells,1,2020-10-01,0,0,1,0,0,Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 ),2.001,1,2
Drug,t3 solution,1,2020-04-09,0,0,1,0,0,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. ( 1 ),2.001,1,2
Drug,tab,1,2021-06-02,0,0,1,0,0,Novatek Pharmaceuticals ( 1 ),2.001,1,NA
Drug,tafenoquine oral tablet,1,2020-08-28,0,0,1,0,0,60 Degrees Pharmaceuticals LLC ( 1 ),2.001,1,4
Biological,tak-019,1,2021-01-14,0,0,1,0,0,Takeda ( 1 ),2.001,1,NA
Biological,tak-919,1,2020-12-18,0,0,1,0,0,Takeda ( 1 ),2.001,1,NA
Drug,td139,1,2020-07-09,0,0,1,0,0,University of Edinburgh ( 1 ),2.001,1,NA
Drug,telacebec,1,2021-04-14,0,0,1,0,0,"Qurient Co., Ltd. ( 1 )",2.001,1,NA
Other,tele-exergaming tablet,1,2021-01-12,0,0,1,0,0,VA Office of Research and Development ( 1 ),2.001,1,NA
Other,telehealth monitoring,1,2020-05-19,0,0,1,0,0,Tufts Medical Center ( 1 ),2.001,1,NA
Drug,telmisartan oral product,1,2021-01-14,0,0,1,0,0,University of Hawaii ( 1 ),2.001,1,NA
Biological,three dose regimen,1,2020-11-19,0,0,1,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),2.001,1,NA
Drug,"tinzaparin, low dose prophylactic anticoagulation",1,2021-03-08,0,0,1,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),2.001,1,NA
Drug,tociliuzumab,1,2020-04-21,0,0,1,0,0,Hoffmann-La Roche ( 1 ),2.001,1,NA
Drug,tocilizumab 20 mg/ml intravenous solution [actemra]_#1,1,2020-06-11,0,0,1,0,0,Hospital Universitario Ramon y Cajal ( 1 ),2.001,1,NA
Drug,tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),1,2020-06-11,0,0,1,0,0,Hospital Universitario Ramon y Cajal ( 1 ),2.001,1,NA
Drug,tocotrienols,1,2021-01-07,0,0,1,0,0,Universiti Sains Malaysia ( 1 ),2.001,1,NA
Drug,tocotrienols / vitamin e,1,2021-01-07,0,0,1,0,0,Universiti Sains Malaysia ( 1 ),2.001,1,NA
Biological,tozinameran,1,2021-03-01,0,0,1,0,0,The University of Hong Kong ( 1 ),2.001,1,NA
Drug,tq formula,1,2021-06-02,0,0,1,0,0,Novatek Pharmaceuticals ( 1 ),2.001,1,NA
Drug,trans sodium crocetinate,1,2020-09-29,0,0,1,0,0,Diffusion Pharmaceuticals Inc ( 1 ),2.001,1,NA
Device,transcranial direct-current stimulation,1,2021-03-16,0,0,1,0,0,D'Or Institute for Research and Education ( 1 ),2.001,1,NA
Behavioral,transfer package from ci therapy,1,2020-11-23,0,0,1,0,0,University of Alabama at Birmingham ( 1 ),2.001,1,NA
Other,travelan otc,1,2020-11-24,0,0,1,0,0,Hadassah Medical Organization ( 1 ),2.001,1,NA
Drug,treamid,1,2020-08-24,0,0,1,0,0,PHARMENTERPRISES LLC ( 1 ),2.001,1,NA
Drug,trimetazidine,1,2021-02-17,0,0,1,0,0,"Ministry of Health, Brazil ( 1 )",2.001,1,NA
Drug,trimodulin,1,2020-09-24,0,0,1,0,0,Biotest ( 1 ),2.001,1,NA
Drug,trimoxazole,1,2020-07-11,0,0,1,0,0,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh ( 1 )",2.001,1,NA
Biological,two doses of bnt162b2 vaccine,1,2021-03-07,0,0,1,0,0,"ANRS, Emerging Infectious Diseases ( 1 )",2.001,1,NA
Other,usual care only,1,2020-09-03,0,0,1,0,0,Notitia Biotechnologies Company ( 1 ),2.001,1,NA
Biological,v591,1,2020-08-03,0,0,1,0,0,Merck Sharp & Dohme Corp. ( 1 ),2.001,1,NA
Biological,vaccine for intramuscular injection,1,2021-08-26,0,0,1,0,0,Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products ( 1 ),2.001,1,NA
Drug,valsartan oral tablet [entresto],1,2021-05-06,0,0,1,0,0,Duke University ( 1 ),2.001,1,NA
Drug,varespladib,1,2021-07-08,0,0,1,0,0,"Ophirex, Inc. ( 1 )",2.001,1,NA
Biological,vaxzevria,1,2021-05-25,0,0,1,0,0,Medical University Innsbruck ( 1 ),2.001,1,NA
Drug,vb-201,1,2021-01-27,0,0,1,0,0,Vascular Biogenics Ltd. operating as VBL Therapeutics ( 1 ),2.001,1,NA
Drug,vb-201 / standard of care,1,2021-01-27,0,0,1,0,0,Vascular Biogenics Ltd. operating as VBL Therapeutics ( 1 ),2.001,1,NA
Biological,vb10.2129,1,2021-10-04,0,0,1,0,0,Vaccibody AS ( 1 ),2.001,1,NA
Other,vehicle,1,2020-04-13,0,0,1,0,0,University of Miami ( 1 ),2.001,1,NA
Drug,virgin coconut oil,1,2021-03-19,0,0,1,0,0,University of the Philippines ( 1 ),2.001,1,NA
Drug,virgin coconut oil (vco),1,2020-10-05,0,0,1,0,0,Gadjah Mada University ( 1 ),2.001,1,NA
Drug,vitamin c tablets,1,2020-02-15,0,0,1,0,0,ShuGuang Hospital ( 1 ),2.001,1,NA
Drug,vortioxetine,1,2021-09-12,0,0,1,0,0,Brain and Cognition Discovery Foundation ( 1 ),2.001,1,NA
Drug,vxa-cov2-1.1-s,1,2021-09-16,0,0,1,0,0,Vaxart ( 1 ),2.001,1,NA
Combination Product,xagrotin,1,2021-04-04,0,0,1,0,0,Biomad AS ( 1 ),2.001,1,NA
Drug,xcel-umc-beta,1,2020-05-07,0,0,1,0,0,Banc de Sang i Teixits ( 1 ),2.001,1,NA
Drug,xvr011,1,2021-05-06,0,0,1,0,0,ExeVir Bio BV ( 1 ),2.001,1,NA
Drug,zanubrutinib,1,2020-05-07,0,0,1,0,0,BeiGene ( 1 ),2.001,1,NA
Dietary Supplement,zinc citrate,1,2020-05-18,0,0,1,0,0,"National Institute of Integrative Medicine, Australia ( 1 )",2.001,1,NA
Dietary Supplement,zinc picolinate,1,2020-09-08,0,0,1,0,0,Swedish Medical Center ( 1 ),2.001,1,NA
Biological,zofin,1,2020-05-09,0,0,1,0,0,Organicell Regenerative Medicine ( 1 ),2.001,1,NA
Other,blood sample,29,2020-04-28,29,0,0,0,0,"Assistance Publique - HÃ´pitaux de Paris ( 4 )|Assistance Publique Hopitaux De Marseille ( 4 )|Centre Hospitalier Universitaire de Nice ( 4 )|University Hospital, Bordeaux ( 3 )|Hospices Civils de Lyon ( 2 )|Centre Hospitalier de PAU ( 1 )|Centre Hospitalier Universitaire, Amiens ( 1 )|CHU de Reims ( 1 )|CRG UZ Brussel ( 1 )|Institut Curie ( 1 )|Institut Pasteur ( 1 )|Rennes University Hospital ( 1 )|University Hospital, Antwerp ( 1 )|University Hospital, Ghent ( 1 )|University Hospital, Rouen ( 1 )|University Hospital, Strasbourg, France ( 1 )|University Hospital, Toulouse ( 1 )",1.029,17,9
Other,prone positioning,21,2020-04-26,21,0,0,0,0,"Assistance Publique - HÃ´pitaux de Paris ( 1 )|Boston University ( 1 )|Cambridge University Hospitals NHS Foundation Trust ( 1 )|Centre Hospitalier Intercommunal Aix-Pertuis ( 1 )|Centre Hospitalier RÃ©gional d'OrlÃ©ans ( 1 )|HÃ´pital de Verdun ( 1 )|Hamad Medical Corporation ( 1 )|Hospital Civil de Guadalajara ( 1 )|Hospital St. Joseph, Marseille, France ( 1 )|Hospital Universitari Vall d'Hebron Research Institute ( 1 )|Johns Hopkins University ( 1 )|Poudre Valley Health System ( 1 )|Rush University Medical Center ( 1 )|Southeast University, China ( 1 )|St. Joseph's Healthcare Hamilton ( 1 )|Unity Health Toronto ( 1 )|University College Hospital Galway ( 1 )|University Hospital, Tours ( 1 )|University of Calgary ( 1 )|University of Milano Bicocca ( 1 )|Vanderbilt University Medical Center ( 1 )",1.021,21,14
Diagnostic Test,serology test,15,2020-04-24,15,0,0,0,0,"Assistance Publique - HÃ´pitaux de Paris ( 3 )|Universitair Ziekenhuis Brussel ( 3 )|Brugmann University Hospital ( 1 )|Centre Antoine Lacassagne ( 1 )|Centre Georges Francois Leclerc ( 1 )|Centre Hospitalier de Cornouaille ( 1 )|Hospices Civils de Lyon ( 1 )|Northwell Health ( 1 )|Sciensano ( 1 )|UniversitÃ© de Reims Champagne-Ardenne ( 1 )|University Hospital, Clermont-Ferrand ( 1 )",1.015,11,13
Diagnostic Test,saliva,9,2020-04-22,9,0,0,0,0,"Assistance Publique - HÃ´pitaux de Paris ( 4 )|Centre Hospitalier Universitaire de Saint Etienne ( 1 )|LumiraDx UK Limited ( 1 )|Paradigm Laboratories LLC ( 1 )|Rennes University Hospital ( 1 )|University Hospital, Rouen ( 1 )",1.009,6,4
Behavioral,mindfulness,7,2020-10-20,7,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 3 )|Instituto de InvestigaciÃ³n Hospital Universitario La Paz ( 1 )|Monash University Malaysia ( 1 )|National Institutes of Health Clinical Center (CC) ( 1 )|University of the Balearic Islands ( 1 ),1.007,5,2
Diagnostic Test,rapid test,7,2021-05-19,7,0,0,0,0,"University of Wisconsin, Madison ( 3 )|Assistance Publique - HÃ´pitaux de Paris ( 1 )|Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland ( 1 )|CMC Ambroise ParÃ© ( 1 )|Neuroganics LLC ( 1 )",1.007,5,1
Biological,blood test,6,2020-04-24,6,0,0,0,0,"Assistance Publique - HÃ´pitaux de Paris ( 1 )|Centre Hospitalier Universitaire de Saint Etienne ( 1 )|Centre Hospitalier Universitaire, Amiens ( 1 )|Rennes University Hospital ( 1 )|State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia ( 1 )|The University of Hong Kong ( 1 )",1.006,6,2
Diagnostic Test,nasopharyngeal swab,5,2020-04-17,5,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 3 )|LumiraDx UK Limited ( 1 )|Medical University Innsbruck ( 1 ),1.005,3,4
Diagnostic Test,pcr,5,2020-04-22,5,0,0,0,0,"Assistance Publique - HÃ´pitaux de Paris ( 1 )|Northwell Health ( 1 )|Poitiers University Hospital ( 1 )|University Hospital, Toulouse ( 1 )|Versailles Hospital ( 1 )",1.005,5,17
Device,cpap,4,2020-04-09,4,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 )|Germans Trias i Pujol Hospital ( 1 )|Lund University ( 1 )|Mario Negri Institute for Pharmacological Research ( 1 ),1.004,4,1
Device,high flow nasal cannula,4,2020-03-26,4,0,0,0,0,Fundacion Clinica Valle del Lili ( 1 )|Lahore General Hospital ( 1 )|Rush University Medical Center ( 1 )|Sultan Qaboos University ( 1 ),1.004,4,3
Other,phone call,4,2020-04-28,4,0,0,0,0,"Assistance Publique - HÃ´pitaux de Paris ( 1 )|Hospices Civils de Lyon ( 1 )|University Hospital, Toulouse ( 1 )|University of Pennsylvania ( 1 )",1.004,4,NA
Other,pulmonary rehabilitation,4,2021-07-08,4,0,0,0,0,"Centro UniversitÃ¡rio de Anapolis ( 1 )|Sisli Hamidiye Etfal Training and Research Hospital ( 1 )|University Hospital, Geneva ( 1 )|University of Rzeszow ( 1 )",1.004,4,NA
Other,survey,4,2020-07-25,4,0,0,0,0,Eskisehir Osmangazi University ( 2 )|Institut Paoli-Calmettes ( 1 )|Universitair Ziekenhuis Brussel ( 1 ),1.004,3,NA
Other,ayurveda,3,2020-04-14,3,0,0,0,0,Aarogyam UK ( 3 ),1.003,1,NA
Behavioral,blood donation sms,3,2020-04-28,3,0,0,0,0,Guangzhou Blood Center ( 3 ),1.003,1,NA
Behavioral,meditation,3,2020-05-01,3,0,0,0,0,"University of Arizona ( 2 )|Research Foundation for Mental Hygiene, Inc. ( 1 )",1.003,2,4
Other,physiotherapy,3,2021-09-01,3,0,0,0,0,Centro UniversitÃ¡rio Augusto Motta ( 1 )|Hospital Universitario Getafe ( 1 )|Istanbul Medipol University Hospital ( 1 ),1.003,3,1
Biological,had5-s-fusion,3,2021-01-27,0,3,0,0,0,"ImmunityBio, Inc. ( 3 )",1.003,1,NA
Other,acupressure,3,2021-06-05,3,0,0,0,0,Mersin University ( 3 ),1.003,1,NA
Behavioral,data collection,3,2020-11-30,3,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 2 )|Centre Hospitalier Intercommunal Creteil ( 1 ),1.003,2,6
Diagnostic Test,igg,3,2021-01-16,3,0,0,0,0,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida ( 1 )|ProofPilot ( 1 )|Washington University School of Medicine ( 1 ),1.003,3,2
Procedure,physical therapy,3,2020-04-24,3,0,0,0,0,Cairo University ( 2 )|University of Kentucky ( 1 ),1.003,2,1
Behavioral,simple cognitive task intervention,3,2021-09-30,3,0,0,0,0,Uppsala University ( 2 )|Karolinska Institutet ( 1 ),1.003,2,NA
Device,splenic ultrasound,3,2021-04-20,3,0,0,0,0,"University of Minnesota ( 2 )|University of California, San Diego ( 1 )",1.003,2,NA
Other,surgical mask,3,2021-06-30,3,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 1 )|Fraunhofer-Institute of Toxicology and Experimental Medicine ( 1 )|Fundacion Clinica Valle del Lili ( 1 ),1.003,3,NA
placebo,active placebo,2,2021-06-21,2,0,0,0,0,Chinese University of Hong Kong ( 2 ),1.002,1,NA
Other,aerobic exercises,2,2021-07-28,2,0,0,0,0,Cairo University ( 1 )|Sivas Cumhuriyet University ( 1 ),1.002,2,NA
Behavioral,behavior,2,2020-04-12,2,0,0,0,0,Beijing Normal University ( 1 )|University Hospital Southampton NHS Foundation Trust ( 1 ),1.002,2,1
Other,canine odor detection of volatile organic compounds,2,2021-03-15,2,0,0,0,0,Hopital Foch ( 2 ),1.002,1,NA
Other,caring contacts,2,2020-06-30,2,0,0,0,0,"St. Luke's Health System, Boise, Idaho ( 1 )|Sunnybrook Health Sciences Centre ( 1 )",1.002,2,NA
Other,colgate peroxylâ® mouthwash,2,2020-07-14,2,0,0,0,0,Hospital Israelita Albert Einstein ( 2 ),1.002,1,NA
Device,cytosorb,2,2020-04-09,2,0,0,0,0,Brugmann University Hospital ( 1 )|UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),1.002,2,NA
Diagnostic Test,drã¤ger antigen test sars-cov-2,2,2021-01-05,2,0,0,0,0,DrÃ¤gerwerk AG & Co. KGaA ( 2 ),1.002,1,NA
Behavioral,entrã©e: behavioral skills,2,2020-11-12,2,0,0,0,0,Ohio State University ( 2 ),1.002,1,NA
Behavioral,entrã©e: cognitive skills,2,2020-11-12,2,0,0,0,0,Ohio State University ( 2 ),1.002,1,NA
Behavioral,entrã©e: interpersonal skills,2,2020-11-12,2,0,0,0,0,Ohio State University ( 2 ),1.002,1,NA
Other,escola l'horitzã³,2,2021-04-28,2,0,0,0,0,"FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 2 )",1.002,1,NA
Device,face mask,2,2020-11-13,2,0,0,0,0,University of Toronto ( 1 )|Yale University ( 1 ),1.002,2,NA
Device,fit test,2,2021-02-04,2,0,0,0,0,Bangkok Metropolitan Administration Medical College and Vajira Hospital ( 2 ),1.002,1,1
Diagnostic Test,id nowâ„¢ covid-19 screening test,2,2021-03-01,2,0,0,0,0,Groupe Hospitalier Paris Saint Joseph ( 2 ),1.002,1,NA
Device,igm antibodytest,2,2020-08-12,2,0,0,0,0,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida ( 1 )|ProofPilot ( 1 ),1.002,2,NA
Device,igm/igg rapid test,2,2020-08-12,2,0,0,0,0,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida ( 1 )|ProofPilot ( 1 ),1.002,2,4
Device,lung ultrasound,2,2020-04-04,2,0,0,0,0,Hasselt University ( 1 )|Kanuni Sultan Suleyman Training and Research Hospital ( 1 ),1.002,2,27
Device,"magpro x100 stimulator, b70 fluid-cooled coil",2,2020-06-10,2,0,0,0,0,Centre for Addiction and Mental Health ( 2 ),1.002,1,NA
Behavioral,mechanical ventilation,2,2020-04-09,2,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 )|Gaziosmanpasa Research and Education Hospital ( 1 ),1.002,2,NA
Other,meditation (1 x 20-minute guided audio training),2,2020-10-19,2,0,0,0,0,The University of Queensland ( 2 ),1.002,1,NA
Device,metanebâ® system,2,2020-10-06,2,0,0,0,0,Hill-Rom ( 2 ),1.002,1,NA
Device,nasal rinse,2,2020-12-21,2,0,0,0,0,Kerecis Ltd. ( 1 )|Marinomed Biotech AG ( 1 ),1.002,2,NA
Device,nitric oxide delivered via lungfitâ„¢ system,2,2020-05-19,2,0,0,0,0,Beyond Air Inc. ( 2 ),1.002,1,NA
Other,nutrition,2,2020-06-03,2,0,0,0,0,University Hospital Southampton NHS Foundation Trust ( 1 )|University of Alberta ( 1 ),1.002,2,1
Dietary Supplement,probiotics,2,2021-04-07,2,0,0,0,0,"AB Biotics, SA ( 1 )|I.M. Sechenov First Moscow State Medical University ( 1 )",1.002,2,5
Drug,recombinant human interferon î±2b spray,2,2020-02-14,2,0,0,0,0,Second Affiliated Hospital of Wenzhou Medical University ( 2 ),1.002,1,NA
Dietary Supplement,rosmalipâ®,2,2020-10-16,2,0,0,0,0,FundaciÃ³n InvestigaciÃ³n E InnovaciÃ³n BiomÃ©dica Hospital Universitario Infanta Sofia-Henares ( 2 ),1.002,1,1
Other,self supportive care (ssc),2,2020-07-23,2,0,0,0,0,Kaleido Biosciences ( 2 ),1.002,1,1
Biological,serum test,2,2020-04-24,2,0,0,0,0,Assistance Publique Hopitaux De Marseille ( 1 )|Centre Hospitalier de Cornouaille ( 1 ),1.002,2,1
Biological,stool collection,2,2020-04-28,2,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 )|Hospices Civils de Lyon ( 1 ),1.002,2,1
Diagnostic Test,take home saliva kits,2,2021-09-20,2,0,0,0,0,The Hospital for Sick Children ( 2 ),1.002,1,NA
Other,tele-yoga,2,2020-07-09,2,0,0,0,0,Aarogyam UK ( 2 ),1.002,1,NA
Behavioral,test,2,2021-04-14,2,0,0,0,0,University of Pennsylvania ( 2 ),1.002,1,NA
Biological,n-etsd vaccine,2,2021-01-13,0,2,0,0,0,"ImmunityBio, Inc. ( 2 )",1.002,1,NA
Biological,protransâ®,2,2021-05-18,0,2,0,0,0,NextCell Pharma Ab ( 2 ),1.002,1,NA
Device,aeonose,2,2020-07-15,2,0,0,0,0,Maastricht University Medical Center ( 2 ),1.002,1,NA
Behavioral,behavioral,2,2020-08-10,2,0,0,0,0,Universidad Nacional Autonoma de Honduras ( 1 )|Uppsala University ( 1 ),1.002,2,NA
Dietary Supplement,bioargininaâ®,2,2020-11-18,2,0,0,0,0,"University of Campania ""Luigi Vanvitelli"" ( 2 )",1.002,1,1
Diagnostic Test,chest ct,2,2020-04-30,2,0,0,0,0,Centre Chirurgical Marie Lannelongue ( 1 )|Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department ( 1 ),1.002,2,1
Drug,clorhexidine dental phbâ©,2,2021-01-07,2,0,0,0,0,FundaciÃ³n para el Fomento de la InvestigaciÃ³n Sanitaria y BiomÃ©dica de la Comunitat Valenciana ( 2 ),1.002,1,NA
Other,colgate periogardâ® mouthwash,2,2020-07-14,2,0,0,0,0,Hospital Israelita Albert Einstein ( 2 ),1.002,1,NA
Drug,colgate peroxylâ® -1.5% hydrogen peroxide,2,2021-01-05,2,0,0,0,0,Queen Mary University of London ( 2 ),1.002,1,NA
Other,colgate totalâ® mouthwash,2,2020-07-14,2,0,0,0,0,Hospital Israelita Albert Einstein ( 2 ),1.002,1,NA
Diagnostic Test,conjunctival swab,2,2020-04-22,2,0,0,0,0,Fondazione Policlinico Universitario Agostino Gemelli IRCCS ( 1 )|Medical University Innsbruck ( 1 ),1.002,2,NA
Device,conventional oxygen therapy,2,2020-12-03,2,0,0,0,0,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo ( 1 )|Fundacion Clinica Valle del Lili ( 1 ),1.002,2,NA
Drug,corsodylâ® alcohol free -0.2 % chlorhexidine digluconate,2,2021-01-05,2,0,0,0,0,Queen Mary University of London ( 2 ),1.002,1,NA
Device,coviage,2,2020-06-08,2,0,0,0,0,Dascena ( 2 ),1.002,1,NA
Other,covid-19 patients,2,2020-08-03,2,0,0,0,0,Centre Hospitalier Universitaire de Nice ( 2 ),1.002,1,1
Diagnostic Test,covid-viroâ® test,2,2020-10-28,2,0,0,0,0,Centre Hospitalier RÃ©gional d'OrlÃ©ans ( 2 ),1.002,1,NA
Device,cytokine adsorption,2,2020-04-21,2,0,0,0,0,Hospital Clinic of Barcelona ( 1 )|University Hospital Freiburg ( 1 ),1.002,2,1
Device,extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,2,2020-07-14,2,0,0,0,0,Zan Mitrev Clinic ( 2 ),1.002,1,NA
Drug,fultiumâ® -d3 800,2,2021-04-12,2,0,0,0,0,Tilman S.A. ( 2 ),1.002,1,NA
Device,gammacoreâ® (vagus nerve stimulation),2,2020-04-20,2,0,0,0,0,Hospital ClÃ­nico Universitario de Valencia ( 2 ),1.002,1,1
Device,gammacoreâ® sapphire (non-invasive vagus nerve stimulator),2,2020-04-14,2,0,0,0,0,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) ( 2 ),1.002,1,NA
Other,health supplements,2,2020-08-25,2,0,0,0,0,Chinese University of Hong Kong ( 2 ),1.002,1,NA
Dietary Supplement,î²-hydroxy î²-methyl butyrate (hmb) enriched amino acid,2,2021-04-21,2,0,0,0,0,The Cleveland Clinic ( 2 ),1.002,1,NA
Device,inspiratory muscle training,2,2021-06-30,2,0,0,0,0,Istinye University ( 1 )|Universidade Federal do Rio Grande do Norte ( 1 ),1.002,2,NA
Other,kb109,2,2020-07-23,2,0,0,0,0,Kaleido Biosciences ( 2 ),1.002,1,1
Other,kb109 / self supportive care (ssc),2,2020-07-23,2,0,0,0,0,Kaleido Biosciences ( 2 ),1.002,1,1
Device,life2000â® ventilator,2,2020-08-19,2,0,0,0,0,Hill-Rom ( 2 ),1.002,1,NA
Device,lucira covid-19 all-in-one test kit,2,2021-01-15,2,0,0,0,0,Lucira Health Inc ( 2 ),1.002,1,NA
Device,marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),2,2020-04-20,2,0,0,0,0,Marker Therapeutics AG ( 2 ),1.002,1,NA
Device,mask,2,2020-04-08,2,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 2 ),1.002,1,NA
Dietary Supplement,microbiome immunity formula,2,2021-06-21,2,0,0,0,0,Chinese University of Hong Kong ( 2 ),1.002,1,NA
Other,musä±c therapy,2,2021-09-05,2,0,0,0,0,Kutahya Health Sciences University ( 2 ),1.002,1,NA
Drug,nasafytolâ®,2,2021-04-12,2,0,0,0,0,Tilman S.A. ( 2 ),1.002,1,NA
Biological,nasopharyngeal swabs,2,2020-04-27,2,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 )|Institut Curie ( 1 ),1.002,2,NA
Device,neuromuscular electrical stimulation,2,2020-05-08,2,0,0,0,0,"Escola Superior de Ciencias da Saude ( 1 )|University of Turin, Italy ( 1 )",1.002,2,NA
Dietary Supplement,nicotinamide,2,2021-05-24,2,0,0,0,0,Shenyang Northern Hospital ( 1 )|University Hospital Schleswig-Holstein ( 1 ),1.002,2,NA
Device,nioâ® (intraosseous access),2,2020-04-23,2,0,0,0,0,Lazarski University ( 2 ),1.002,1,NA
Device,nowdx covid-19 test,2,2021-03-14,2,0,0,0,0,"NOWDiagnostics, Inc. ( 2 )",1.002,1,NA
Dietary Supplement,omega3-fatty acid,2,2020-12-05,2,0,0,0,0,Applied Science Private University ( 2 ),1.002,1,NA
Behavioral,online support group,2,2020-05-05,2,0,0,0,0,Centre de Recherche de l'Institut Universitaire en santÃ© Mentale de MontrÃ©al ( 1 )|Columbia University ( 1 ),1.002,2,1
Procedure,ophthalmologic exam,2,2020-05-12,2,0,0,0,0,Fondation Ophtalmologique Adolphe de Rothschild ( 2 ),1.002,1,NA
Drug,oximenâ® 3%,2,2021-01-07,2,0,0,0,0,FundaciÃ³n para el Fomento de la InvestigaciÃ³n Sanitaria y BiomÃ©dica de la Comunitat Valenciana ( 2 ),1.002,1,NA
Behavioral,patient navigation (pn),2,2021-04-07,2,0,0,0,0,University of Utah ( 2 ),1.002,1,NA
Procedure,photobiomodulation,2,2021-10-23,2,0,0,0,0,Cairo University ( 2 ),1.002,1,NA
Behavioral,prayer,2,2020-04-16,2,0,0,0,0,Hospital do Coracao ( 1 )|Kansas City Heart Rhythm Institute ( 1 ),1.002,2,NA
Behavioral,preventive information,2,2020-07-14,2,0,0,0,0,Bandim Health Project ( 2 ),1.002,1,NA
Behavioral,psychoeducational intervention,2,2020-04-11,2,0,0,0,0,"Copenhagen University Hospital, Hvidovre ( 1 )|Emory University ( 1 )",1.002,2,NA
Behavioral,psychological,2,2020-04-20,2,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 )|University Hospital Southampton NHS Foundation Trust ( 1 ),1.002,2,1
Dietary Supplement,rhea health toneâ®,2,2020-11-10,2,0,0,0,0,Universitas Padjadjaran ( 2 ),1.002,1,3
Behavioral,self-benefit,2,2021-03-15,2,0,0,0,0,"University of California, Los Angeles ( 1 )|University of Pennsylvania ( 1 )",1.002,2,NA
Other,self supportive care (ssc) alone,2,2020-07-23,2,0,0,0,0,Kaleido Biosciences ( 2 ),1.002,1,1
Behavioral,self test,2,2021-04-14,2,0,0,0,0,University of Pennsylvania ( 2 ),1.002,1,NA
Behavioral,smell training,2,2021-09-02,2,0,0,0,0,UniversitÃ© de MontrÃ©al ( 1 )|Washington University School of Medicine ( 1 ),1.002,2,NA
Behavioral,soap,2,2021-02-11,2,0,0,0,0,BRAC University ( 1 )|University of Toronto ( 1 ),1.002,2,NA
Dietary Supplement,targeted wellness formula câ„¢ sublingual drops - 1200mg - 30 ml (formula c),2,2021-03-10,2,0,0,0,0,"Endourage, LLC ( 2 )",1.002,1,1
Other,"telerehabilitation ä°ntervention, motor learning",2,2021-05-14,2,0,0,0,0,Inonu University ( 2 ),1.002,1,NA
Behavioral,text-messaging (tm),2,2021-04-07,2,0,0,0,0,University of Utah ( 2 ),1.002,1,NA
Diagnostic Test,the binaxnowâ„¢ antibody tests measure igg antibodies against sars-cov-2.,2,2021-07-01,2,0,0,0,0,Abbott Rapid Diagnostics Jena GmbH ( 2 ),1.002,1,NA
Other,therapeutic exercise,2,2021-02-09,2,0,0,0,0,Universitat Internacional de Catalunya ( 1 )|University of Malaga ( 1 ),1.002,2,NA
Device,uvc irradiation,2,2021-02-04,2,0,0,0,0,Bangkok Metropolitan Administration Medical College and Vajira Hospital ( 2 ),1.002,1,NA
Drug,vitis xtra forteâ©,2,2021-01-07,2,0,0,0,0,FundaciÃ³n para el Fomento de la InvestigaciÃ³n Sanitaria y BiomÃ©dica de la Comunitat Valenciana ( 2 ),1.002,1,NA
Device,volatile organic compounds analysis,2,2020-04-28,2,0,0,0,0,Hopital Foch ( 2 ),1.002,1,NA
Behavioral,writing,2,2020-10-12,2,0,0,0,0,Duke University ( 2 ),1.002,1,1
Drug,[18f]f-arag (2'-deoxy-2'-fluoro-9-î²-d-arabinofuranosylguanine),2,2021-03-23,0,2,0,0,0,"CellSight Technologies, Inc. ( 2 )",1.002,1,NA
Biological,1 âµg cov2 sam (lnp),2,2021-02-08,0,2,0,0,0,GlaxoSmithKline ( 2 ),1.002,1,NA
Drug,18f-î±vî²6-bp,2,2020-05-03,0,2,0,0,0,"University of California, Davis ( 2 )",1.002,1,NA
Biological,covidity administered via needle-free injection (pharmajet stratisâ®; intramuscular injection).,2,2021-08-27,0,2,0,0,0,Scancell Ltd ( 2 ),1.002,1,NA
Biological,covidity administered via needle-free injection (pharmajet tropisâ®; intradermal injection).,2,2021-08-27,0,2,0,0,0,Scancell Ltd ( 2 ),1.002,1,NA
Drug,dwrx2003,2,2021-01-20,0,2,0,0,0,Daewoong Pharmaceutical Co. LTD. ( 2 ),1.002,1,NA
Biological,had5-s-fusion/n-etsd vaccine,2,2021-01-13,0,2,0,0,0,"ImmunityBio, Inc. ( 2 )",1.002,1,NA
Biological,scb-2019,2,2021-04-13,0,2,0,0,0,Clover Biopharmaceuticals AUS Pty Ltd ( 2 ),1.002,1,1
placebo,"three doses of placebo at the schedule of day 0, 14, 28ï¼ˆhigh-dose groupï¼‰",2,2020-08-27,0,2,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 2 ),1.002,1,NA
placebo,"two doses of placebo at the schedule of day 0, 28ï¼ˆhigh-dose groupï¼‰",2,2020-08-27,0,2,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 2 ),1.002,1,NA
placebo,"two doses of placebo at the schedule of day 0, 28ï¼ˆmiddle-dose groupï¼‰",2,2020-08-27,0,2,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 2 ),1.002,1,NA
Behavioral,2-way sms delivery of information,1,2021-06-07,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Dietary Supplement,5-ala-phosphate,1,2020-08-16,1,0,0,0,0,Royal College of Surgeons in Ireland - Medical University of Bahrain ( 1 ),1.001,1,NA
Dietary Supplement,5-ala-phosphate / sfc (5-ala / sfc),1,2020-08-16,1,0,0,0,0,Royal College of Surgeons in Ireland - Medical University of Bahrain ( 1 ),1.001,1,NA
Other,6-min-walk fpp2,1,2021-03-04,1,0,0,0,0,Universitat Internacional de Catalunya ( 1 ),1.001,1,NA
Device,a 940-nm diode laser,1,2021-03-29,1,0,0,0,0,Fayoum University ( 1 ),1.001,1,NA
Other,a short video intervention,1,2020-07-21,1,0,0,0,0,"Research Foundation for Mental Hygiene, Inc. ( 1 )",1.001,1,1
Other,a vignette intervention,1,2020-07-21,1,0,0,0,0,"Research Foundation for Mental Hygiene, Inc. ( 1 )",1.001,1,1
Diagnostic Test,aaz covid-19 rapid test,1,2020-08-21,1,0,0,0,0,Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux ( 1 ),1.001,1,NA
Behavioral,"acp educator led, video assisted discussion",1,2021-04-20,1,0,0,0,0,Boston Medical Center ( 1 ),1.001,1,NA
Behavioral,act,1,2021-03-26,1,0,0,0,0,University of Basel ( 1 ),1.001,1,NA
Behavioral,active control:healthy living,1,2020-06-03,1,0,0,0,0,Northwestern University ( 1 ),1.001,1,NA
Combination Product,acupuncture,1,2021-04-12,1,0,0,0,0,Indonesia University ( 1 ),1.001,1,NA
Device,acupuncture therapy,1,2021-07-02,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Combination Product,acupuncture/standard care,1,2021-04-12,1,0,0,0,0,Indonesia University ( 1 ),1.001,1,NA
Other,aerobic training,1,2020-10-30,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
Behavioral,african american sender acknowledgement,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Behavioral,african american sender in informational videos.,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Other,after-each-case room disinfection,1,2020-05-19,1,0,0,0,0,The First Affiliated Hospital of Zhejiang Chinese Medical University ( 1 ),1.001,1,1
Procedure,after covid-19 vaccination,1,2021-07-05,1,0,0,0,0,"University Hospital, Ghent ( 1 )",1.001,1,NA
Other,ai algorithm,1,2020-05-04,1,0,0,0,0,The Christie NHS Foundation Trust ( 1 ),1.001,1,NA
Device,airflo2,1,2020-10-14,1,0,0,0,0,Duke University ( 1 ),1.001,1,NA
Drug,"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/5% glucose",1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Drug,"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/high-dose vitamin c treatment",1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Behavioral,also no soap (pure control),1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Radiation,angiography scanner,1,2020-07-06,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Biological,angiotensin peptide (1-7) derived plasma,1,2020-05-01,1,0,0,0,0,Kanuni Sultan Suleyman Training and Research Hospital ( 1 ),1.001,1,NA
Other,anxiety,1,2020-05-22,1,0,0,0,0,Institut Paoli-Calmettes ( 1 ),1.001,1,NA
Other,ardsnet,1,2020-07-31,1,0,0,0,0,University of Sao Paulo General Hospital ( 1 ),1.001,1,NA
Other,ardsnet table,1,2020-12-18,1,0,0,0,0,University of Pernambuco ( 1 ),1.001,1,NA
Dietary Supplement,ascorbic acid/zinc gluconate,1,2020-04-08,1,0,0,0,0,The Cleveland Clinic ( 1 ),1.001,1,2
Other,ashmolean website,1,2020-11-27,1,0,0,0,0,University of Oxford ( 1 ),1.001,1,1
Behavioral,assigned strategies: active choice,1,2020-07-22,1,0,0,0,0,"Western University, Canada ( 1 )",1.001,1,NA
Behavioral,assigned strategies: enhanced active choice,1,2020-07-22,1,0,0,0,0,"Western University, Canada ( 1 )",1.001,1,NA
Other,asynchronous telerehabilitation programme,1,2021-03-01,1,0,0,0,0,Universidad San Jorge ( 1 ),1.001,1,NA
Drug,atorvastatin-ezetimibe,1,2021-05-09,1,0,0,0,0,Penza State University ( 1 ),1.001,1,NA
Behavioral,attention bias modification (abm),1,2020-04-24,1,0,0,0,0,Tel Aviv University ( 1 ),1.001,1,NA
Behavioral,audio for relaxation techniques,1,2020-10-08,1,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 1 ),1.001,1,NA
Procedure,auricular neuromodulation,1,2020-04-07,1,0,0,0,0,Fondation Ophtalmologique Adolphe de Rothschild ( 1 ),1.001,1,1
Device,auricular percutaneous neurostimulation,1,2020-07-08,1,0,0,0,0,Olive View-UCLA Education & Research Institute ( 1 ),1.001,1,NA
Device,auristim,1,2021-09-25,1,0,0,0,0,Vienna Hospital Association ( 1 ),1.001,1,NA
Dietary Supplement,balanced amino acid,1,2021-04-21,1,0,0,0,0,The Cleveland Clinic ( 1 ),1.001,1,NA
Other,baseline message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Behavioral,basic feedback,1,2020-07-20,1,0,0,0,0,University of South Carolina ( 1 ),1.001,1,NA
Other,beck anxiety inventory,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Other,beck depression inventory,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Behavioral,behavioral activation ssi,1,2020-11-11,1,0,0,0,0,Stony Brook University ( 1 ),1.001,1,NA
Behavioral,best message / augmented message/implementation strategy,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Device,bidirectional oxygenation mouthpiece,1,2020-03-25,1,0,0,0,0,TMC HealthCare ( 1 ),1.001,1,NA
Diagnostic Test,binaxnow ag card,1,2021-10-18,1,0,0,0,0,"University of Wisconsin, Madison ( 1 )",1.001,1,NA
Behavioral,biobehavioral tele-rehabilitation sessions,1,2020-12-08,1,0,0,0,0,"University of Colorado, Denver ( 1 )",1.001,1,NA
Procedure,biospecimen collection,1,2020-06-05,1,0,0,0,0,M.D. Anderson Cancer Center ( 1 ),1.001,1,NA
Device,biovitals,1,2020-02-20,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Diagnostic Test,biozek covid-19 antigen rapid test,1,2021-03-17,1,0,0,0,0,Mach-E B.V. ( 1 ),1.001,1,NA
Procedure,bipap,1,2021-04-22,1,0,0,0,0,Germans Trias i Pujol Hospital ( 1 ),1.001,1,NA
Behavioral,blended gaming covid-19 training system (bgcts),1,2021-02-25,1,0,0,0,0,The Hong Kong Polytechnic University ( 1 ),1.001,1,NA
Procedure,blink,1,2020-05-08,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Procedure,blink/masseter inhibitory reflex,1,2020-05-08,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Dietary Supplement,blis k12,1,2021-09-11,1,0,0,0,0,King Edward Medical University ( 1 ),1.001,1,NA
Other,blood samples for the study of the humoral response to sars-cov-2 variants,1,2021-04-02,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,blood samples for the study of the humoral response to sars-cov-2 variants/of the cellular response after vaccination against covid-19,1,2021-04-02,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,body position change,1,2020-07-14,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Drug,brain parenchyma biopsies,1,2020-05-26,1,0,0,0,0,Fondation Ophtalmologique Adolphe de Rothschild ( 1 ),1.001,1,NA
Diagnostic Test,breath biopsy,1,2020-10-21,1,0,0,0,0,Scentech Medical Technologies Ltd ( 1 ),1.001,1,NA
Diagnostic Test,breath biopsy analysis,1,2020-10-21,1,0,0,0,0,Scentech Medical Technologies Ltd ( 1 ),1.001,1,NA
Behavioral,breathing,1,2021-09-29,1,0,0,0,0,National Cardiovascular Center Harapan Kita Hospital Indonesia ( 1 ),1.001,1,NA
Other,"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation",1,2020-09-18,1,0,0,0,0,Istanbul Medipol University Hospital ( 1 ),1.001,1,NA
Drug,bridge therapy,1,2020-05-25,1,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 1 ),1.001,1,NA
Behavioral,brief counseling,1,2021-02-15,1,0,0,0,0,University of Illinois at Urbana-Champaign ( 1 ),1.001,1,NA
Behavioral,brief interpersonal telepsychotherapy,1,2020-11-05,1,0,0,0,0,Hospital de Clinicas de Porto Alegre ( 1 ),1.001,1,NA
Behavioral,buddy,1,2021-04-28,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,NA
Device,canswab,1,2020-11-27,1,0,0,0,0,Orthopaedic Innovation Centre ( 1 ),1.001,1,NA
Diagnostic Test,capillary collection,1,2020-10-19,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Diagnostic Test,cardiac echocardiography,1,2021-06-02,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Diagnostic Test,cardiac pet/mri,1,2021-06-29,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Diagnostic Test,cardiac rhythm monitoring,1,2021-06-02,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Behavioral,caregiver,1,2021-07-05,1,0,0,0,0,Seoul National University Hospital ( 1 ),1.001,1,NA
Other,caring contacts without an introductory phone call (cc),1,2021-01-05,1,0,0,0,0,"St. Luke's Health System, Boise, Idaho ( 1 )",1.001,1,NA
Other,cash transfer,1,2020-04-16,1,0,0,0,0,Unity Health Toronto ( 1 ),1.001,1,NA
Biological,cellular response to vaccination bnt162b2 in the elderly,1,2021-06-04,1,0,0,0,0,GÃ©rond'if ( 1 ),1.001,1,NA
Drug,"cerebrospinal fluid sampling, meningeal",1,2020-05-26,1,0,0,0,0,Fondation Ophtalmologique Adolphe de Rothschild ( 1 ),1.001,1,NA
Other,certified cloth face mask/preventive information,1,2020-07-14,1,0,0,0,0,Bandim Health Project ( 1 ),1.001,1,NA
Biological,chadox1-ncov-19 (astra-zeneca),1,2021-08-24,1,0,0,0,0,National Taiwan University Hospital ( 1 ),1.001,1,NA
Behavioral,chat-based instant messaging support,1,2020-05-26,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Behavioral,chat-based support,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Device,chatbot on covid-19 vaccine hesitancy,1,2021-05-10,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,chiropractic care (more than one visit),1,2020-09-29,1,0,0,0,0,Real Centro Universitario Maria Cristina ( 1 ),1.001,1,NA
Other,chiropractic care (one visit),1,2020-09-29,1,0,0,0,0,Real Centro Universitario Maria Cristina ( 1 ),1.001,1,NA
Other,cig tilted,1,2020-07-14,1,0,0,0,0,October University for Modern Sciences and Arts ( 1 ),1.001,1,NA
Device,clinical decision support system based on non-invasive multimodal monitoring,1,2021-03-16,1,0,0,0,0,Increase-Tech ( 1 ),1.001,1,NA
Procedure,clinical examination,1,2020-04-14,1,0,0,0,0,"Central Hospital, Nancy, France ( 1 )",1.001,1,NA
Behavioral,clinician endorsement,1,2021-04-06,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Other,closed face shield with surgical face mask use,1,2020-11-24,1,0,0,0,0,"University of Los Andes, Columbia ( 1 )",1.001,1,NA
Behavioral,cognitive,1,2020-04-12,1,0,0,0,0,Beijing Normal University ( 1 ),1.001,1,NA
Other,cognitive behavioural group therapy for perinatal anxiety,1,2020-07-30,1,0,0,0,0,St. Joseph's Healthcare Hamilton ( 1 ),1.001,1,NA
Behavioral,cognitive training,1,2021-06-07,1,0,0,0,0,Yale-NUS College ( 1 ),1.001,1,NA
Other,"collection of blood, salivary",1,2020-11-16,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Dietary Supplement,"combination of curcumin, quercetin",1,2021-08-11,1,0,0,0,0,Ayub Teaching Hospital ( 1 ),1.001,1,NA
Other,communication type,1,2020-05-29,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,"community-based, mobile van testing",1,2020-12-16,1,0,0,0,0,Johns Hopkins University ( 1 ),1.001,1,NA
Other,community health worker support,1,2020-06-03,1,0,0,0,0,University Ghent ( 1 ),1.001,1,NA
Other,community health workers.,1,2020-08-05,1,0,0,0,0,Surgical Systems Research Group ( 1 ),1.001,1,NA
Other,community interest message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Other,community popular opinion leader (pol) based intervention,1,2020-11-25,1,0,0,0,0,Drexel University ( 1 ),1.001,1,NA
Behavioral,comparator,1,2020-10-20,1,0,0,0,0,Makerere University ( 1 ),1.001,1,1
Behavioral,comparison group,1,2021-03-17,1,0,0,0,0,"ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida ( 1 )",1.001,1,NA
Behavioral,compass,1,2020-08-12,1,0,0,0,0,King's College London ( 1 ),1.001,1,1
Other,continuation of acei,1,2020-04-14,1,0,0,0,0,"University Hospital, Gentofte, Copenhagen ( 1 )",1.001,1,NA
Other,continuation of arb,1,2020-04-01,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,1
Other,continued self-enhancement (enhance) for covid-19,1,2020-10-23,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,NA
Device,continuous blind glucose measurement device (free style pro),1,2021-01-19,1,0,0,0,0,"University Hospital, Strasbourg, France ( 1 )",1.001,1,NA
Device,continuous glucose monitor (cgm),1,2021-02-12,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Device,"continuous glucose monitoring (cgm, dexcom g6)",1,2021-04-29,1,0,0,0,0,Federico II University ( 1 ),1.001,1,NA
Device,continuous positive airway pressure,1,2020-05-12,1,0,0,0,0,Icahn School of Medicine at Mount Sinai ( 1 ),1.001,1,NA
Device,contrast-enhanced cmr,1,2020-11-18,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Other,control group - waiting list,1,2021-03-08,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Other,convalescent plasma with antibody against sars-cov-2.,1,2021-03-09,1,0,0,0,0,Hospital Son Llatzer ( 1 ),1.001,1,NA
Other,conventional exercises,1,2021-07-28,1,0,0,0,0,Sivas Cumhuriyet University ( 1 ),1.001,1,NA
Behavioral,covid-19 related health warning leaflet,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Diagnostic Test,covid-19 vaccinated people,1,2021-09-28,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Other,covid-19 vaccine education campaign,1,2021-05-13,1,0,0,0,0,University of Rochester ( 1 ),1.001,1,NA
Other,covid 19 self-questionnaire,1,2020-07-21,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Other,covid watch,1,2020-10-07,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Device,covsurf drug delivery system,1,2020-04-20,1,0,0,0,0,University Hospital Southampton NHS Foundation Trust ( 1 ),1.001,1,4
Procedure,cuff application with inflation,1,2021-01-06,1,0,0,0,0,University College London Hospitals ( 1 ),1.001,1,1
Behavioral,culturally adapted cognitive behavioral intervention (ca-cbi),1,2021-04-22,1,0,0,0,0,KoÃ§ University ( 1 ),1.001,1,NA
Diagnostic Test,cytokines,1,2020-04-13,1,0,0,0,0,Brugmann University Hospital ( 1 ),1.001,1,NA
Dietary Supplement,"d-beta-hydroxybutyrate-(r)-1,3 butanediol monoester",1,2020-10-01,1,0,0,0,0,Steno Diabetes Center Copenhagen ( 1 ),1.001,1,NA
Behavioral,daily coping toolkit,1,2020-05-20,1,0,0,0,0,Kent State University ( 1 ),1.001,1,NA
Behavioral,daily monitoring,1,2020-07-06,1,0,0,0,0,"Rutgers, The State University of New Jersey ( 1 )",1.001,1,NA
Other,daily room disinfection,1,2020-05-19,1,0,0,0,0,The First Affiliated Hospital of Zhejiang Chinese Medical University ( 1 ),1.001,1,1
Diagnostic Test,ddpcr,1,2020-08-11,1,0,0,0,0,Centre Leon Berard ( 1 ),1.001,1,NA
Biological,decidual stromal cells (dsc),1,2020-06-26,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Other,decision science-based design,1,2021-02-12,1,0,0,0,0,Carnegie Mellon University ( 1 ),1.001,1,NA
Other,decision tool for clinicians,1,2021-02-03,1,0,0,0,0,Erasmus Medical Center ( 1 ),1.001,1,NA
Other,dect,1,2020-12-17,1,0,0,0,0,University of Ulm ( 1 ),1.001,1,NA
Other,deep breathing training,1,2020-05-05,1,0,0,0,0,University of Parma ( 1 ),1.001,1,NA
Behavioral,desmond,1,2021-02-28,1,0,0,0,0,"Korle-Bu Teaching Hospital, Accra, Ghana ( 1 )",1.001,1,NA
Device,device: butterfly iq,1,2021-07-07,1,0,0,0,0,Rocket Doctor Inc. ( 1 ),1.001,1,NA
Device,dexcom,1,2020-05-26,1,0,0,0,0,Nordsjaellands Hospital ( 1 ),1.001,1,1
Diagnostic Test,diagnostic,1,2020-07-02,1,0,0,0,0,GCS Ramsay SantÃ© pour l'Enseignement et la Recherche ( 1 ),1.001,1,NA
Other,dig axial,1,2020-07-14,1,0,0,0,0,October University for Modern Sciences and Arts ( 1 ),1.001,1,NA
Behavioral,digital brochure,1,2021-02-15,1,0,0,0,0,University of Illinois at Urbana-Champaign ( 1 ),1.001,1,NA
Device,digital dance for pd,1,2021-06-23,1,0,0,0,0,UmeÃ¥ University ( 1 ),1.001,1,NA
Behavioral,digital health online platform,1,2020-05-21,1,0,0,0,0,University of Victoria ( 1 ),1.001,1,NA
Other,discontinuation of acei/arb,1,2020-04-14,1,0,0,0,0,"University Hospital, Gentofte, Copenhagen ( 1 )",1.001,1,NA
Behavioral,discussion board for social support,1,2020-07-20,1,0,0,0,0,University of South Carolina ( 1 ),1.001,1,NA
Behavioral,discussion board for social support /basic feedback,1,2020-07-20,1,0,0,0,0,University of South Carolina ( 1 ),1.001,1,NA
Behavioral,discussion board for social support/personalized feedback,1,2020-07-20,1,0,0,0,0,University of South Carolina ( 1 ),1.001,1,NA
Other,distance learning,1,2020-04-27,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
Other,distilled water with the same colorant as the experimental product,1,2021-02-16,1,0,0,0,0,Dentaid SL ( 1 ),1.001,1,NA
Diagnostic Test,dried blood spot,1,2021-05-05,1,0,0,0,0,University Ghent ( 1 ),1.001,1,NA
Other,educational moral injury video,1,2021-07-28,1,0,0,0,0,Unity Health Toronto ( 1 ),1.001,1,NA
Other,educational program (cartoon),1,2021-01-10,1,0,0,0,0,Medical University of Vienna ( 1 ),1.001,1,NA
Behavioral,educational video,1,2020-04-30,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,2
Behavioral,educational vocal health modules,1,2021-03-22,1,0,0,0,0,University of Cincinnati ( 1 ),1.001,1,NA
Biological,elispot test,1,2021-06-18,1,0,0,0,0,Centre Georges Francois Leclerc ( 1 ),1.001,1,NA
Device,elmo project at covid-19: proof of concept/usability,1,2020-06-10,1,0,0,0,0,Escola de SaÃºde PÃºblica do CearÃ¡ ( 1 ),1.001,1,NA
Other,elmo project at covid-19: study in humans,1,2020-06-10,1,0,0,0,0,Escola de SaÃºde PÃºblica do CearÃ¡ ( 1 ),1.001,1,NA
Other,embarrassment message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Behavioral,emdr,1,2020-09-28,1,0,0,0,0,"University Hospital, Tours ( 1 )",1.001,1,NA
Behavioral,emotional freedom techniques (eft),1,2021-05-27,1,0,0,0,0,Marmara University ( 1 ),1.001,1,NA
Behavioral,emotional support plan,1,2020-07-06,1,0,0,0,0,"Rutgers, The State University of New Jersey ( 1 )",1.001,1,NA
Device,endoscopy,1,2020-05-09,1,0,0,0,0,Changhai Hospital ( 1 ),1.001,1,NA
Behavioral,enriched survey feedback,1,2020-04-30,1,0,0,0,0,"Mount Sinai Hospital, Canada ( 1 )",1.001,1,NA
Diagnostic Test,ent exam,1,2020-08-03,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Diagnostic Test,ep,1,2020-05-26,1,0,0,0,0,"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia ( 1 )",1.001,1,NA
Dietary Supplement,epa,1,2021-03-12,1,0,0,0,0,Hospital de la Soledad ( 1 ),1.001,1,NA
Other,epi-net intervention,1,2021-03-30,1,0,0,0,0,"Ponce Medical School Foundation, Inc. ( 1 )",1.001,1,NA
Other,ergonomic training,1,2021-06-14,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Device,esophageal catheter,1,2021-05-11,1,0,0,0,0,San Luigi Gonzaga Hospital ( 1 ),1.001,1,5
Behavioral,ethnic frame,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Other,exercise booklet,1,2020-09-18,1,0,0,0,0,Istanbul Medipol University Hospital ( 1 ),1.001,1,NA
Diagnostic Test,exercise test ecg,1,2020-11-18,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Behavioral,experimental,1,2021-04-12,1,0,0,0,0,Saglik Bilimleri Universitesi ( 1 ),1.001,1,NA
Other,experimental: questionnaire without precaution information,1,2020-03-08,1,0,0,0,0,Guangzhou Blood Center ( 1 ),1.001,1,NA
Other,expiratory muscle training group,1,2020-12-31,1,0,0,0,0,Universidad Complutense de Madrid ( 1 ),1.001,1,NA
Device,face-mask niv,1,2021-01-09,1,0,0,0,0,Sultan Qaboos University ( 1 ),1.001,1,NA
Other,face-to-face rehabilitation,1,2020-12-21,1,0,0,0,0,Universidade Federal de Pernambuco ( 1 ),1.001,1,NA
Behavioral,facebook ads on the importance of staying safe during the thanksgiving / christmas holiday,1,2020-11-13,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Diagnostic Test,faeces samples,1,2020-11-30,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,family risk messaging,1,2021-03-29,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Other,farmalarm,1,2020-06-06,1,0,0,0,0,Hospital Universitari Vall d'Hebron Research Institute ( 1 ),1.001,1,NA
Device,ffp2,1,2020-04-17,1,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 1 ),1.001,1,NA
Other,ffp2 respirator,1,2021-01-26,1,0,0,0,0,Fraunhofer-Institute of Toxicology and Experimental Medicine ( 1 ),1.001,1,NA
Other,ffp3 respirator,1,2021-01-26,1,0,0,0,0,Fraunhofer-Institute of Toxicology and Experimental Medicine ( 1 ),1.001,1,NA
Device,filtration test,1,2020-06-26,1,0,0,0,0,Bangkok Metropolitan Administration Medical College and Vajira Hospital ( 1 ),1.001,1,1
Diagnostic Test,fingerstick,1,2020-09-17,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,1
Behavioral,fixed site standard of care testing,1,2020-12-16,1,0,0,0,0,Johns Hopkins University ( 1 ),1.001,1,NA
Other,follow-up visit,1,2020-10-10,1,0,0,0,0,Tourcoing Hospital ( 1 ),1.001,1,NA
Other,food diary,1,2020-04-24,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Device,freestyle libre 14 day cgm system,1,2020-06-01,1,0,0,0,0,Northwell Health ( 1 ),1.001,1,NA
Other,gastroscopy in transnasal techique,1,2021-01-13,1,0,0,0,0,Johannes Gutenberg University Mainz ( 1 ),1.001,1,NA
Behavioral,gender concordant,1,2021-04-27,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Behavioral,general messages,1,2021-03-23,1,0,0,0,0,University of Glasgow ( 1 ),1.001,1,1
Behavioral,general practitioner tandem,1,2020-04-18,1,0,0,0,0,"University Hospital, Tours ( 1 )",1.001,1,NA
Genetic,genetic blood collection,1,2020-11-30,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Dietary Supplement,glycophosphopeptical am3,1,2021-07-29,1,0,0,0,0,University of Valladolid ( 1 ),1.001,1,NA
Other,guilt message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Behavioral,habit,1,2021-03-25,1,0,0,0,0,University of Bern ( 1 ),1.001,1,NA
Behavioral,health literacy,1,2020-06-29,1,0,0,0,0,Jacobs University Bremen gGmbH ( 1 ),1.001,1,4
Diagnostic Test,health staff,1,2020-05-18,1,0,0,0,0,Institut Cancerologie de l'Ouest ( 1 ),1.001,1,NA
Other,healthy lifestyle advise,1,2020-09-19,1,0,0,0,0,Universidad Politecnica de Madrid ( 1 ),1.001,1,NA
Behavioral,healthy minds program foundations training,1,2020-06-09,1,0,0,0,0,"University of Wisconsin, Madison ( 1 )",1.001,1,NA
Behavioral,heat therapy,1,2020-10-23,1,0,0,0,0,"University of Massachusetts, Amherst ( 1 )",1.001,1,NA
Device,helmet niv,1,2021-01-09,1,0,0,0,0,Sultan Qaboos University ( 1 ),1.001,1,NA
Device,helmet non-invasive ventilation,1,2020-07-09,1,0,0,0,0,King Abdullah International Medical Research Center ( 1 ),1.001,1,1
Procedure,hemodialysis by protein-leaking dialyzer for covid19 maintenance hemodialysis patients,1,2020-12-22,1,0,0,0,0,Universita degli Studi di Genova ( 1 ),1.001,1,NA
Behavioral,hiking challenge,1,2020-12-07,1,0,0,0,0,State University of New York at Buffalo ( 1 ),1.001,1,NA
Other,home-cov rule implementation,1,2020-04-05,1,0,0,0,0,"University Hospital, Angers ( 1 )",1.001,1,2
Other,home care monitoring,1,2020-04-14,1,0,0,0,0,Mario Negri Institute for Pharmacological Research ( 1 ),1.001,1,NA
Other,home sample collection of concerning mole with physician supervision,1,2020-06-03,1,0,0,0,0,Northwestern University ( 1 ),1.001,1,NA
Device,hospital telemedicine management system,1,2021-01-21,1,0,0,0,0,Xuzhou No.1 Peoples Hospital ( 1 ),1.001,1,NA
Other,"human coach first, then virtual assistant",1,2020-06-09,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Device,hydrogen oxygen generator with nebulizer,1,2020-04-29,1,0,0,0,0,Guangzhou Institute of Respiratory Disease ( 1 ),1.001,1,NA
Device,hydrogen peroxide,1,2021-05-04,1,0,0,0,0,EPISTATA ( 1 ),1.001,1,NA
Other,hydrogen peroxide (b) mouth rinse with the solution provided,1,2020-10-21,1,0,0,0,0,Augusta University ( 1 ),1.001,1,NA
Other,hypoxia : 14.3,1,2020-04-20,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,"hypoxia : 14.3/12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",1,2020-04-20,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,implementation strategy,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Behavioral,in-person postoperative visit,1,2020-12-02,1,0,0,0,0,Cedars-Sinai Medical Center ( 1 ),1.001,1,NA
Behavioral,increasing willingness,1,2020-09-03,1,0,0,0,0,Charles Drew University of Medicine and Science ( 1 ),1.001,1,NA
Device,innova lateral flow device,1,2020-11-04,1,0,0,0,0,Alder Hey Children's NHS Foundation Trust ( 1 ),1.001,1,NA
Device,inspiratory muscle traiing,1,2020-10-19,1,0,0,0,0,Escola Superior de Ciencias da Saude ( 1 ),1.001,1,1
Device,inspiratory muscle trainer,1,2021-06-07,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
placebo,inspiratory muscle training placebo group,1,2020-12-31,1,0,0,0,0,Universidad Complutense de Madrid ( 1 ),1.001,1,NA
Behavioral,insurance navigation,1,2020-10-29,1,0,0,0,0,Harvard Pilgrim Health Care ( 1 ),1.001,1,NA
Behavioral,interactive,1,2021-06-07,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Behavioral,interactive/2-way sms delivery of information,1,2021-06-07,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Drug,interferon gamma human recombinant (ifn-g),1,2021-09-21,1,0,0,0,0,SPP Pharmaclon Ltd. ( 1 ),1.001,1,NA
Behavioral,internet cognitive behavioral therapy,1,2020-10-19,1,0,0,0,0,Cambridge Health Alliance ( 1 ),1.001,1,NA
Behavioral,internet cognitive behavioral therapy/chamindwell,1,2020-10-19,1,0,0,0,0,Cambridge Health Alliance ( 1 ),1.001,1,NA
Device,intervention,1,2021-10-05,1,0,0,0,0,University of Edinburgh ( 1 ),1.001,1,NA
Behavioral,intervention 1: according to dgp,1,2021-07-25,1,0,0,0,0,Helios Research Center ( 1 ),1.001,1,NA
Behavioral,"intervention 2: according to cacioppo ""e.a.s.e.""",1,2021-07-25,1,0,0,0,0,Helios Research Center ( 1 ),1.001,1,NA
Behavioral,intervention for tecc model,1,2020-07-30,1,0,0,0,0,Centre for Addiction and Mental Health ( 1 ),1.001,1,NA
Other,interview by psychologists,1,2020-05-19,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Device,intraosseous,1,2020-04-23,1,0,0,0,0,Lazarski University ( 1 ),1.001,1,NA
Device,intravenous,1,2020-04-23,1,0,0,0,0,Lazarski University ( 1 ),1.001,1,NA
Drug,intravenous antibiotics with low dose steroid.,1,2021-06-20,1,0,0,0,0,UR Anoop Research Group ( 1 ),1.001,1,NA
Other,introductory phone call (cc,1,2021-01-05,1,0,0,0,0,"St. Luke's Health System, Boise, Idaho ( 1 )",1.001,1,NA
Dietary Supplement,investigational product - viracide,1,2020-10-19,1,0,0,0,0,"The Herb, Inc ( 1 )",1.001,1,NA
Other,ivermectin impregnated mask,1,2021-01-20,1,0,0,0,0,South Valley University ( 1 ),1.001,1,NA
Drug,jing-si-herbal-tea,1,2021-07-13,1,0,0,0,0,"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation ( 1 )",1.001,1,NA
Behavioral,kundalini yoga,1,2020-05-11,1,0,0,0,0,"Research Foundation for Mental Hygiene, Inc. ( 1 )",1.001,1,NA
Behavioral,kundalini yoga/anxiety reduction training,1,2020-05-11,1,0,0,0,0,"Research Foundation for Mental Hygiene, Inc. ( 1 )",1.001,1,NA
Other,lab session,1,2021-07-17,1,0,0,0,0,Beni-Suef University ( 1 ),1.001,1,NA
Dietary Supplement,lactobacillus,1,2021-01-21,1,0,0,0,0,Biosearch S.A. ( 1 ),1.001,1,NA
Dietary Supplement,lactoferrin,1,2021-04-21,1,0,0,0,0,Zagazig University ( 1 ),1.001,1,NA
Device,laryngoscope,1,2020-06-01,1,0,0,0,0,Singapore General Hospital ( 1 ),1.001,1,6
Behavioral,lifestyle (exercise),1,2021-01-08,1,0,0,0,0,4YouandMe ( 1 ),1.001,1,NA
Behavioral,lifestyle (meditation),1,2021-01-08,1,0,0,0,0,4YouandMe ( 1 ),1.001,1,NA
Behavioral,lifestyle change promotion program,1,2020-06-09,1,0,0,0,0,University of the Balearic Islands ( 1 ),1.001,1,1
Behavioral,lifestyle modification webinars focused on hypertension control,1,2021-09-02,1,0,0,0,0,Weill Medical College of Cornell University ( 1 ),1.001,1,NA
Behavioral,lift,1,2020-10-04,1,0,0,0,0,Duke University ( 1 ),1.001,1,NA
Biological,ligilactobacillus salivarius mp101,1,2021-06-09,1,0,0,0,0,Universidad Complutense de Madrid ( 1 ),1.001,1,NA
Biological,longitudinally,1,2020-05-05,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,1
Behavioral,loss protection,1,2021-03-29,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Behavioral,lottery incentive,1,2021-03-29,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Diagnostic Test,low-field magnetic resonance imaging,1,2021-07-22,1,0,0,0,0,University of Erlangen-NÃ¼rnberg Medical School ( 1 ),1.001,1,NA
Device,low-field thoracic magnetic stimulation (lf-thms),1,2021-05-15,1,0,0,0,0,Hospital Univeristario Benemerita Universidad Autonoma de Puebla ( 1 ),1.001,1,1
Other,low-intensity aerobic training,1,2021-03-10,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
Drug,low dose prednisolone,1,2020-12-05,1,0,0,0,0,Postgraduate Institute of Medical Education and Research ( 1 ),1.001,1,NA
Behavioral,low dose rmt,1,2021-06-30,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Other,low tailored message,1,2021-05-25,1,0,0,0,0,"Children's Hospital Medical Center, Cincinnati ( 1 )",1.001,1,NA
Other,low tailored message/covid-19 vaccine message,1,2021-05-25,1,0,0,0,0,"Children's Hospital Medical Center, Cincinnati ( 1 )",1.001,1,NA
Biological,low/upper respiratory tract sample,1,2020-04-28,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Diagnostic Test,lung impedance,1,2020-05-23,1,0,0,0,0,Hillel Yaffe Medical Center ( 1 ),1.001,1,NA
Other,lung mechanics at different peep,1,2020-04-13,1,0,0,0,0,"Southeast University, China ( 1 )",1.001,1,1
Device,lung ultrasonography,1,2021-01-20,1,0,0,0,0,Bursa YÃ¼ksek Ä°htisas Education and Research Hospital ( 1 ),1.001,1,1
Device,lus fourteen area,1,2021-03-15,1,0,0,0,0,Bursa YÃ¼ksek Ä°htisas Education and Research Hospital ( 1 ),1.001,1,NA
Procedure,manual acupuncture,1,2021-04-23,1,0,0,0,0,Indonesia University ( 1 ),1.001,1,NA
Procedure,masseter inhibitory reflex,1,2020-05-08,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Behavioral,me,1,2021-08-24,1,0,0,0,0,University of Utah ( 1 ),1.001,1,NA
Behavioral,me/my wishes,1,2021-08-24,1,0,0,0,0,University of Utah ( 1 ),1.001,1,NA
Device,medical mask,1,2020-03-03,1,0,0,0,0,McMaster University ( 1 ),1.001,1,NA
Other,medical record review - inpatient treatment,1,2020-07-23,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,NA
Behavioral,medication review,1,2020-07-31,1,0,0,0,0,McMaster University ( 1 ),1.001,1,NA
Behavioral,meditation app usage,1,2020-04-24,1,0,0,0,0,Lake Erie College of Osteopathic Medicine ( 1 ),1.001,1,1
Behavioral,meditation/anxiety reduction training,1,2020-05-11,1,0,0,0,0,"Research Foundation for Mental Hygiene, Inc. ( 1 )",1.001,1,NA
Drug,medium dose prednisolone,1,2020-12-05,1,0,0,0,0,Postgraduate Institute of Medical Education and Research ( 1 ),1.001,1,NA
Device,mejoracare,1,2020-12-07,1,0,0,0,0,Universidad AutÃ³noma de EncarnaciÃ³n ( 1 ),1.001,1,NA
Diagnostic Test,memory b-cell function,1,2020-07-13,1,0,0,0,0,"Institute of Tropical Medicine, Belgium ( 1 )",1.001,1,NA
Behavioral,mencare,1,2020-06-19,1,0,0,0,0,"Promundo, United States ( 1 )",1.001,1,NA
Behavioral,mencare//bandebereho fathers'/couples' group education,1,2020-06-19,1,0,0,0,0,"Promundo, United States ( 1 )",1.001,1,NA
Behavioral,mental imagery,1,2020-10-02,1,0,0,0,0,University of East London ( 1 ),1.001,1,NA
Behavioral,mental well-being,1,2020-04-07,1,0,0,0,0,Federal University of Rio Grande do Sul ( 1 ),1.001,1,NA
Other,methylene-blue photodisinfection,1,2020-11-02,1,0,0,0,0,Sunnybrook Health Sciences Centre ( 1 ),1.001,1,NA
Drug,methylprednisolone injectable product,1,2020-09-15,1,0,0,0,0,Lahore General Hospital ( 1 ),1.001,1,NA
Device,mfs,1,2020-04-17,1,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 1 ),1.001,1,NA
Other,mhealth assessments,1,2020-05-20,1,0,0,0,0,University of Oklahoma ( 1 ),1.001,1,NA
Behavioral,mhealth platform,1,2021-02-01,1,0,0,0,0,University of Minnesota ( 1 ),1.001,1,NA
Behavioral,mind body syndrome therapy for long covid,1,2021-04-20,1,0,0,0,0,Beth Israel Deaconess Medical Center ( 1 ),1.001,1,NA
Behavioral,mindfullness training,1,2020-05-04,1,0,0,0,0,University of Miami ( 1 ),1.001,1,NA
Other,mindfulness rounds,1,2020-06-12,1,0,0,0,0,Icahn School of Medicine at Mount Sinai ( 1 ),1.001,1,NA
Behavioral,mindfulness session(s),1,2020-03-20,1,0,0,0,0,Wake Forest University Health Sciences ( 1 ),1.001,1,NA
Behavioral,minimal attention control intervention,1,2020-08-10,1,0,0,0,0,Uppsala University ( 1 ),1.001,1,NA
Behavioral,mobile mental health app - 3,1,2020-08-22,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Other,moderate intensity aerobic exercises,1,2020-10-04,1,0,0,0,0,Istanbul Gelisim University ( 1 ),1.001,1,NA
Other,modified bai he gu jin tang,1,2020-09-27,1,0,0,0,0,Hong Kong Baptist University ( 1 ),1.001,1,1
Device,modified ipac-uhn ppe,1,2020-04-30,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Dietary Supplement,molecular hydrogen,1,2021-01-13,1,0,0,0,0,AGIR Ã  Dom ( 1 ),1.001,1,NA
Other,monitoring,1,2020-12-03,1,0,0,0,0,Icahn School of Medicine at Mount Sinai ( 1 ),1.001,1,NA
Biological,monitoring of the immune response,1,2021-05-18,1,0,0,0,0,"University Hospital, Clermont-Ferrand ( 1 )",1.001,1,NA
Behavioral,motivation,1,2021-03-25,1,0,0,0,0,University of Bern ( 1 ),1.001,1,NA
Behavioral,motivational interviewing,1,2021-01-29,1,0,0,0,0,Johns Hopkins Bloomberg School of Public Health ( 1 ),1.001,1,NA
Behavioral,motivational interviewing/covid-19 symptom monitoring system,1,2021-01-29,1,0,0,0,0,Johns Hopkins Bloomberg School of Public Health ( 1 ),1.001,1,NA
Other,motivational messages,1,2021-02-08,1,0,0,0,0,Saglik Bilimleri Universitesi ( 1 ),1.001,1,NA
Procedure,mout-to-mouth ventilation,1,2021-04-26,1,0,0,0,0,Brno University Hospital ( 1 ),1.001,1,NA
Procedure,mout-to-mouth ventilation with quantitative analysis,1,2021-04-26,1,0,0,0,0,Brno University Hospital ( 1 ),1.001,1,NA
Device,"mouthpiece b1(mouthpiece mpc-st gmdn:62534 generic name: endoscopic bite block, basic, reusable",1,2021-04-27,1,0,0,0,0,Universitaire Ziekenhuizen Leuven ( 1 ),1.001,1,NA
Device,mouthrinse with bãªta-cyclodextrin,1,2020-04-15,1,0,0,0,0,Claude Bernard University ( 1 ),1.001,1,2
Device,mouthrinse with bãªta-cyclodextrin/citrox,1,2020-04-15,1,0,0,0,0,Claude Bernard University ( 1 ),1.001,1,2
Device,mouthrinse without bãªta-cyclodextrin,1,2020-04-15,1,0,0,0,0,Claude Bernard University ( 1 ),1.001,1,2
Device,mouthrinse without bãªta-cyclodextrin/citrox,1,2020-04-15,1,0,0,0,0,Claude Bernard University ( 1 ),1.001,1,2
Device,mouthwash,1,2021-05-16,1,0,0,0,0,"Cluster de Bioeconomia de Baja California, A.C ( 1 )",1.001,1,NA
Device,mouthwash/nose rinse with the agnps solution,1,2021-05-16,1,0,0,0,0,"Cluster de Bioeconomia de Baja California, A.C ( 1 )",1.001,1,NA
Other,moxibustion,1,2020-04-20,1,0,0,0,0,Guang'anmen Hospital of China Academy of Chinese Medical Sciences ( 1 ),1.001,1,NA
Other,moxibustion/cupping,1,2020-04-20,1,0,0,0,0,Guang'anmen Hospital of China Academy of Chinese Medical Sciences ( 1 ),1.001,1,NA
Biological,mrna-1273 sars-cov-2 vaccine from moderna,1,2021-01-11,1,0,0,0,0,University Medical Center Groningen ( 1 ),1.001,1,NA
Diagnostic Test,nasal,1,2020-09-17,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,2
Other,nasopharyngeal samples.,1,2020-11-16,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Diagnostic Test,nasopharyngeal/throat/oropharyngeal swabs analyses by rt-pcr/ddpcr,1,2020-08-11,1,0,0,0,0,Centre Leon Berard ( 1 ),1.001,1,NA
Other,nasopharynx,1,2020-04-20,1,0,0,0,0,Jessa Hospital ( 1 ),1.001,1,NA
Behavioral,nature,1,2021-04-14,1,0,0,0,0,National Institutes of Health Clinical Center (CC) ( 1 ),1.001,1,NA
Behavioral,nature only,1,2021-04-14,1,0,0,0,0,National Institutes of Health Clinical Center (CC) ( 1 ),1.001,1,NA
Other,neuro /,1,2021-06-09,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Behavioral,neurocognitive assessment,1,2020-10-12,1,0,0,0,0,Ziekenhuis Oost-Limburg ( 1 ),1.001,1,NA
Diagnostic Test,neurology test,1,2021-02-01,1,0,0,0,0,Somogy Megyei Kaposi MÃ³r Teaching Hospital ( 1 ),1.001,1,NA
Device,neuromuscular,1,2020-04-24,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Other,neutral writing control,1,2020-05-12,1,0,0,0,0,"University College, London ( 1 )",1.001,1,NA
Other,new ppe,1,2021-01-11,1,0,0,0,0,University of Oxford ( 1 ),1.001,1,NA
Behavioral,news,1,2020-05-04,1,0,0,0,0,The University of Queensland ( 1 ),1.001,1,NA
Diagnostic Test,ng test,1,2020-05-27,1,0,0,0,0,Rennes University Hospital ( 1 ),1.001,1,NA
Dietary Supplement,nigella sativa capsule twice daily,1,2021-07-09,1,0,0,0,0,Ain Shams University ( 1 ),1.001,1,NA
Other,nirs (near-infrared spectroscopy),1,2021-06-15,1,0,0,0,0,University of Athens ( 1 ),1.001,1,NA
Drug,nitroglycerin,1,2020-12-24,1,0,0,0,0,University of Lahore ( 1 ),1.001,1,NA
Behavioral,no activities of the hbcc project,1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Behavioral,no activities of the hbcc project/also no soap (pure control),1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Behavioral,no instruction regarding positioning,1,2020-04-26,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,no intervention,1,2020-07-05,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,28
Other,no message,1,2021-05-25,1,0,0,0,0,"Children's Hospital Medical Center, Cincinnati ( 1 )",1.001,1,NA
Behavioral,no messaging,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Behavioral,no racial inequality highlighting,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Other,no research related technology based social interactions,1,2020-07-19,1,0,0,0,0,Boston University ( 1 ),1.001,1,NA
Other,no rinsing,1,2021-01-05,1,0,0,0,0,Queen Mary University of London ( 1 ),1.001,1,NA
Behavioral,no social norm,1,2021-10-12,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Device,non-contact mce system,1,2020-03-21,1,0,0,0,0,Changhai Hospital ( 1 ),1.001,1,NA
placebo,non-deceptive placebo,1,2021-08-12,1,0,0,0,0,Michigan State University ( 1 ),1.001,1,NA
Other,"non invasive cardiovascular monitoring with cnap device of arterial pressure, ecg",1,2021-10-07,1,0,0,0,0,IRCCS Policlinico S. Donato ( 1 ),1.001,1,NA
Other,"non invasive cardiovascular monitoring with cnap device of arterial pressure, ecg/respiratory activity",1,2021-10-07,1,0,0,0,0,IRCCS Policlinico S. Donato ( 1 ),1.001,1,NA
Device,nose rinse with the agnps solution,1,2021-05-16,1,0,0,0,0,"Cluster de Bioeconomia de Baja California, A.C ( 1 )",1.001,1,NA
Dietary Supplement,nutritional support system (nss),1,2020-08-06,1,0,0,0,0,Anahuac University ( 1 ),1.001,1,7
Other,obvio-19 app,1,2020-06-17,1,0,0,0,0,Groupe Hospitalier Paris Saint Joseph ( 1 ),1.001,1,1
Behavioral,ocat,1,2020-04-20,1,0,0,0,0,University Ghent ( 1 ),1.001,1,NA
Other,of the cellular response after vaccination against covid-19,1,2021-04-02,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Dietary Supplement,"ol-1, standard dose",1,2021-04-13,1,0,0,0,0,"Rutgers, The State University of New Jersey ( 1 )",1.001,1,NA
Other,olfactory training,1,2021-07-02,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Dietary Supplement,omnibiotic aad,1,2020-06-04,1,0,0,0,0,Medical University of Graz ( 1 ),1.001,1,NA
Other,on-ice testing while wearing a face mask,1,2021-04-23,1,0,0,0,0,University of Saskatchewan ( 1 ),1.001,1,1
Other,on-ice testing while wearing a sham face mask,1,2021-04-23,1,0,0,0,0,University of Saskatchewan ( 1 ),1.001,1,1
Diagnostic Test,on-site testing (lumiradx),1,2021-02-17,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Behavioral,online bibliotherapy programme,1,2020-04-21,1,0,0,0,0,"University Hospital, Strasbourg, France ( 1 )",1.001,1,1
Behavioral,online cognitive behavioral therapy (cbt),1,2020-04-21,1,0,0,0,0,"University Hospital, Strasbourg, France ( 1 )",1.001,1,1
Other,online questionnaires,1,2020-07-23,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,NA
Device,online self-help intervention,1,2021-02-15,1,0,0,0,0,Penn State University ( 1 ),1.001,1,NA
Behavioral,online social network,1,2021-02-21,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,online social network/collective intelligence intervention,1,2021-02-21,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Device,onsite pcr testing,1,2021-05-19,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Behavioral,onsite point-of-care,1,2021-04-30,1,0,0,0,0,Montefiore Medical Center ( 1 ),1.001,1,NA
Procedure,operative management,1,2021-02-05,1,0,0,0,0,The Cleveland Clinic ( 1 ),1.001,1,NA
Diagnostic Test,optical coherence tomography (oct),1,2020-05-21,1,0,0,0,0,IRCCS San Raffaele ( 1 ),1.001,1,NA
Other,"or psychotherapy, n=10)",1,2020-06-22,1,0,0,0,0,Centre de Recherche de l'Institut Universitaire en santÃ© Mentale de MontrÃ©al ( 1 ),1.001,1,1
Drug,oral anti-coagulant,1,2021-06-20,1,0,0,0,0,UR Anoop Research Group ( 1 ),1.001,1,NA
Drug,"oral antibiotic, antihistamine, anti-inflammatory, multivitamins",1,2021-06-20,1,0,0,0,0,UR Anoop Research Group ( 1 ),1.001,1,NA
Other,oral intervention with cetylpyridinium chloride,1,2021-03-23,1,0,0,0,0,Instituto de InvestigaciÃ³n Sanitaria AragÃ³n ( 1 ),1.001,1,NA
Drug,oral low dose steroid,1,2021-06-20,1,0,0,0,0,UR Anoop Research Group ( 1 ),1.001,1,NA
Diagnostic Test,oropharyngeal swabs analyses by rt-pcr,1,2020-08-11,1,0,0,0,0,Centre Leon Berard ( 1 ),1.001,1,NA
Other,osteopathic manipulative treatment (omt),1,2021-06-11,1,0,0,0,0,Western University of Health Sciences ( 1 ),1.001,1,NA
Other,osteopathic manipulative treatment in addition to physiotherapy,1,2021-08-16,1,0,0,0,0,Centro UniversitÃ¡rio Augusto Motta ( 1 ),1.001,1,NA
Behavioral,other benefit,1,2021-10-12,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,other benefit/no social norm,1,2021-10-12,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,other benefit/social norm,1,2021-10-12,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,overcoming anxiety in pregnancy,1,2021-04-05,1,0,0,0,0,University of Manitoba ( 1 ),1.001,1,NA
Behavioral,overcoming anxiety in pregnancy/postpartum online self-directed program,1,2021-04-05,1,0,0,0,0,University of Manitoba ( 1 ),1.001,1,NA
Dietary Supplement,oxaloacetate medical food,1,2020-10-15,1,0,0,0,0,Terra Biological LLC ( 1 ),1.001,1,NA
Other,oxygen mask,1,2021-03-10,1,0,0,0,0,Region Skane ( 1 ),1.001,1,NA
Procedure,oxygen therapy/physical therapy,1,2021-06-28,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
Device,oxyhydrogen,1,2020-03-25,1,0,0,0,0,Shanghai Asclepius Meditec Inc. ( 1 ),1.001,1,NA
Procedure,ozone,1,2020-05-11,1,0,0,0,0,Azienda Sanitaria-Universitaria Integrata di Udine ( 1 ),1.001,1,NA
Dietary Supplement,palmitoylethanolamide,1,2020-10-15,1,0,0,0,0,Arizona State University ( 1 ),1.001,1,NA
Other,parent,1,2021-08-04,1,0,0,0,0,"University Hospital, Ghent ( 1 )",1.001,1,NA
Behavioral,parentchat for parents of children ages 2-17,1,2021-03-15,1,0,0,0,0,University of Oxford ( 1 ),1.001,1,NA
Other,parents during induction,1,2020-09-24,1,0,0,0,0,"Children's Hospital Medical Center, Cincinnati ( 1 )",1.001,1,NA
Behavioral,participate in a massive musical event,1,2020-12-09,1,0,0,0,0,"FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 1 )",1.001,1,1
Other,particle measurement,1,2020-12-03,1,0,0,0,0,Universitaire Ziekenhuizen Leuven ( 1 ),1.001,1,NA
Diagnostic Test,passive microwave radiometry,1,2020-09-23,1,0,0,0,0,Kyrgyz State Medical Academy ( 1 ),1.001,1,1
Behavioral,patient educational video,1,2021-02-06,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Behavioral,patient mychart scheduling link,1,2021-02-06,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Other,patients covid 19,1,2020-05-18,1,0,0,0,0,Centre Hospitalier Universitaire de Nice ( 1 ),1.001,1,NA
Device,pbmt,1,2020-05-08,1,0,0,0,0,University of Nove de Julho ( 1 ),1.001,1,1
Device,pbmt/smf,1,2020-05-08,1,0,0,0,0,University of Nove de Julho ( 1 ),1.001,1,1
Diagnostic Test,pcr/serology,1,2020-05-15,1,0,0,0,0,Northwell Health ( 1 ),1.001,1,11
Other,peer presence,1,2021-08-04,1,0,0,0,0,"University Hospital, Ghent ( 1 )",1.001,1,NA
Behavioral,peer resilience champion,1,2020-04-30,1,0,0,0,0,"Mount Sinai Hospital, Canada ( 1 )",1.001,1,NA
Drug,pentoxifylline,1,2020-09-26,1,0,0,0,0,Unidad Temporal COVID-19 en Centro Citibanamex ( 1 ),1.001,1,NA
Device,pep flute,1,2020-08-25,1,0,0,0,0,Bispebjerg Hospital ( 1 ),1.001,1,1
Diagnostic Test,performance evaluation (sensitivity,1,2021-01-08,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Diagnostic Test,performance evaluation (sensitivity/specificity) for covid-19 diagnosis of the vocus ptr-tof process,1,2021-01-08,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Diagnostic Test,performance of the test antigenic/test rt-pcr,1,2020-10-01,1,0,0,0,0,Centre Hospitalier Intercommunal Creteil ( 1 ),1.001,1,NA
Device,peripheral sealing device for surgical mask,1,2021-09-08,1,0,0,0,0,University of the Balearic Islands ( 1 ),1.001,1,NA
Diagnostic Test,peripheral venous ultrasound,1,2020-11-02,1,0,0,0,0,Centre Antoine Lacassagne ( 1 ),1.001,1,NA
Device,personal protective equipment (ppe),1,2020-09-02,1,0,0,0,0,Institute of Mountain Emergency Medicine ( 1 ),1.001,1,NA
Behavioral,personalized feedback,1,2020-07-20,1,0,0,0,0,University of South Carolina ( 1 ),1.001,1,NA
Behavioral,personalized health education,1,2020-03-20,1,0,0,0,0,University of Pecs ( 1 ),1.001,1,1
Behavioral,personalized text message delivery of information,1,2021-06-07,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Biological,pfizer,1,2021-05-21,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Diagnostic Test,phase-1: breath holding test,1,2021-07-06,1,0,0,0,0,University of Chicago ( 1 ),1.001,1,NA
Radiation,phase 1,1,2020-05-15,1,0,0,0,0,Brigham and Women's Hospital ( 1 ),1.001,1,NA
Radiation,phase 2,1,2020-05-15,1,0,0,0,0,Brigham and Women's Hospital ( 1 ),1.001,1,NA
Diagnostic Test,phase 2: 6-minute walk test (6mwt),1,2021-07-06,1,0,0,0,0,University of Chicago ( 1 ),1.001,1,NA
Behavioral,philly vax sweepstakes,1,2021-06-16,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,phone-call screening,1,2020-04-18,1,0,0,0,0,"University Hospital, Tours ( 1 )",1.001,1,NA
Procedure,photobiomodulation/photodynamic therapy,1,2020-05-24,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
Behavioral,physical activity counseling,1,2021-04-18,1,0,0,0,0,Gazi University ( 1 ),1.001,1,NA
Other,physical exercise/computerized cognitive training,1,2021-04-10,1,0,0,0,0,Yeditepe University ( 1 ),1.001,1,NA
Behavioral,physical therapy that include a standardized cycling training with functional electrical stimulation,1,2021-04-09,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Behavioral,physical therapy that include a standardized cycling training with no additional functional electrical stimulation,1,2021-04-09,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
placebo,placebo fluorescent light,1,2021-01-26,1,0,0,0,0,Nova Scotia Health Authority ( 1 ),1.001,1,NA
placebo,placebo intervention by photobiomodulation device,1,2021-10-23,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
placebo,placebo magnesium,1,2021-01-13,1,0,0,0,0,AGIR Ã  Dom ( 1 ),1.001,1,NA
placebo,placebo without radiofrequency.,1,2021-05-26,1,0,0,0,0,Clinica Gema Leon ( 1 ),1.001,1,NA
Dietary Supplement,plant stanol mini drinks,1,2021-04-13,1,0,0,0,0,Maastricht University Medical Center ( 1 ),1.001,1,NA
Other,plasebo acupressure,1,2021-03-11,1,0,0,0,0,Mersin University ( 1 ),1.001,1,NA
Procedure,plasma exchange/convalescent plasma,1,2020-11-14,1,0,0,0,0,"Rigshospitalet, Denmark ( 1 )",1.001,1,NA
Behavioral,positive psychotherapy,1,2020-12-22,1,0,0,0,0,FundaÃ§Ã£o Bahiana de Infectologia ( 1 ),1.001,1,4
Behavioral,postpartum online self-directed program,1,2021-04-05,1,0,0,0,0,University of Manitoba ( 1 ),1.001,1,NA
Other,postural positioning,1,2020-04-10,1,0,0,0,0,Johns Hopkins University ( 1 ),1.001,1,NA
Device,power breathe,1,2020-10-25,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Device,ppg,1,2021-09-13,1,0,0,0,0,Technische UniversitÃ¤t MÃ¼nchen ( 1 ),1.001,1,NA
Other,prediction market,1,2020-05-27,1,0,0,0,0,"National University, Singapore ( 1 )",1.001,1,NA
Dietary Supplement,preservision areds formulation soft gels,1,2020-09-09,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Dietary Supplement,preservision areds formulation soft gels/tablets,1,2020-09-09,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Procedure,press needles,1,2021-05-02,1,0,0,0,0,Indonesia University ( 1 ),1.001,1,NA
Other,primary care,1,2020-07-09,1,0,0,0,0,Aarogyam UK ( 1 ),1.001,1,NA
Dietary Supplement,probiotics (2 strains 10x10^9 ufc),1,2020-11-05,1,0,0,0,0,Centre de recherche du Centre hospitalier universitaire de Sherbrooke ( 1 ),1.001,1,NA
Other,produce prescription program,1,2020-11-30,1,0,0,0,0,Boston Medical Center ( 1 ),1.001,1,NA
Behavioral,progressive muscle relaxation,1,2020-12-04,1,0,0,0,0,Imam Abdulrahman Bin Faisal University ( 1 ),1.001,1,NA
Device,prom,1,2021-09-13,1,0,0,0,0,Technische UniversitÃ¤t MÃ¼nchen ( 1 ),1.001,1,NA
Behavioral,promotores de salud,1,2021-02-25,1,0,0,0,0,University of Oregon ( 1 ),1.001,1,NA
Procedure,prone position (pp),1,2020-12-11,1,0,0,0,0,IRCCS Azienda Ospedaliero-Universitaria di Bologna ( 1 ),1.001,1,NA
Dietary Supplement,propolis,1,2021-05-26,1,0,0,0,0,Trabzon Kanuni Education and Research Hospital ( 1 ),1.001,1,NA
Behavioral,prosocial-benefit,1,2021-03-15,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Behavioral,protect your elders campaign,1,2021-07-13,1,0,0,0,0,North Carolina Central University ( 1 ),1.001,1,NA
Device,"ps membrane versus pmma membrane,",1,2021-08-01,1,0,0,0,0,FundaciÃ³n para la InvestigaciÃ³n del Hospital ClÃ­nico de Valencia ( 1 ),1.001,1,NA
Other,psycho-education video,1,2020-04-20,1,0,0,0,0,University Ghent ( 1 ),1.001,1,NA
Other,psychoeducation,1,2020-08-20,1,0,0,0,0,"Limbix Health, Inc. ( 1 )",1.001,1,NA
Other,psychological rehabilitation,1,2020-11-30,1,0,0,0,0,Universidad Peruana Cayetano Heredia ( 1 ),1.001,1,NA
Other,psychological support,1,2021-02-08,1,0,0,0,0,Centre Francois Baclesse ( 1 ),1.001,1,NA
Behavioral,psychological triaging intervention,1,2021-03-26,1,0,0,0,0,Alexandria University ( 1 ),1.001,1,NA
Behavioral,psychological/behaviour change support,1,2020-06-03,1,0,0,0,0,University Hospital Southampton NHS Foundation Trust ( 1 ),1.001,1,1
Other,pulmonary tele-rehabilitation,1,2020-12-02,1,0,0,0,0,"Institut universitaire de cardiologie et de pneumologie de QuÃ©bec, University Laval ( 1 )",1.001,1,NA
Diagnostic Test,qrt-pcr,1,2020-08-18,1,0,0,0,0,Sciensano ( 1 ),1.001,1,NA
Diagnostic Test,qrt-pcr/serology,1,2020-08-18,1,0,0,0,0,Sciensano ( 1 ),1.001,1,NA
Dietary Supplement,quadramune(tm),1,2020-06-04,1,0,0,0,0,Therapeutic Solutions International ( 1 ),1.001,1,NA
Diagnostic Test,qualitative/quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,1,2021-02-01,1,0,0,0,0,Johann Wolfgang Goethe University Hospital ( 1 ),1.001,1,NA
Other,quality of life promotion,1,2020-08-07,1,0,0,0,0,Hospital de Clinicas de Porto Alegre ( 1 ),1.001,1,1
Radiation,radiological,1,2020-05-04,1,0,0,0,0,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia ( 1 ),1.001,1,NA
Device,radius ppg tetherless pulse oximetry (masimo),1,2021-03-25,1,0,0,0,0,Assistance Publique Hopitaux De Marseille ( 1 ),1.001,1,NA
Other,radx chcs testing intervention strategy,1,2021-03-12,1,0,0,0,0,Massachusetts General Hospital ( 1 ),1.001,1,NA
Diagnostic Test,rapid antigen test,1,2020-12-08,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,NA
Device,rapid antigen testing/offsite pcr testing,1,2021-05-19,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Diagnostic Test,rapid salivary test,1,2020-04-15,1,0,0,0,0,UniversitÃ  degli Studi dell'Insubria ( 1 ),1.001,1,NA
Biological,rectal swab,1,2020-04-17,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,referral card,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Device,rehabilitation of cognitive function after remission of the symptoms of covid-19,1,2020-11-14,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Other,rehabilitation programme,1,2021-03-01,1,0,0,0,0,Universidad San Jorge ( 1 ),1.001,1,NA
Other,rehabilitation protocol through a digital platform,1,2020-12-29,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Behavioral,relationship improvement intervention.,1,2020-04-12,1,0,0,0,0,Beijing Normal University ( 1 ),1.001,1,NA
Behavioral,residence-based testing participation pilot (sars-cov-2 testing with relaxed social distancing restrictions),1,2021-09-06,1,0,0,0,0,University of Nottingham ( 1 ),1.001,1,NA
Behavioral,resilience program,1,2020-08-26,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Other,resistance exercise,1,2021-05-10,1,0,0,0,0,NHS Greater Glasgow and Clyde ( 1 ),1.001,1,NA
Other,respiratory rehabilitation program (rr).,1,2020-11-17,1,0,0,0,0,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ( 1 ),1.001,1,NA
Other,respiratory tele-rehabilitation program (trr).,1,2020-11-17,1,0,0,0,0,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer ( 1 ),1.001,1,NA
Biological,respiratory tract sample,1,2020-04-28,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Other,respiratory training,1,2020-10-30,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
Diagnostic Test,resting 12 lead ecg,1,2020-11-18,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Diagnostic Test,resting electrocardiogram,1,2021-06-02,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Diagnostic Test,rt-qpcr test,1,2020-10-28,1,0,0,0,0,Centre Hospitalier RÃ©gional d'OrlÃ©ans ( 1 ),1.001,1,NA
Device,saline nasal,1,2020-05-28,1,0,0,0,0,Swansea University ( 1 ),1.001,1,NA
Other,saline with baby shampoo nasal irrigation,1,2020-04-11,1,0,0,0,0,Vanderbilt University Medical Center ( 1 ),1.001,1,NA
Biological,salivary sample,1,2021-03-10,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Biological,sample,1,2020-10-12,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Diagnostic Test,sample collection/performance evaluation (a),1,2020-04-30,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Diagnostic Test,sample collection/performance evaluation (b),1,2020-04-30,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Behavioral,sampler skills,1,2020-11-12,1,0,0,0,0,Ohio State University ( 1 ),1.001,1,NA
Other,sampling by venipuncture (and eventually by nasopharyngeal swab),1,2021-02-09,1,0,0,0,0,Centre Hospitalier RÃ©gional d'OrlÃ©ans ( 1 ),1.001,1,NA
Other,sampling of oropharynx/nasopharynx,1,2020-04-20,1,0,0,0,0,Jessa Hospital ( 1 ),1.001,1,NA
Diagnostic Test,sampling of sars-cov-2 rna from nasopharyngeal swab specimen,1,2020-10-22,1,0,0,0,0,Boehringer Ingelheim ( 1 ),1.001,1,NA
Diagnostic Test,sampling of sars-cov-2 rna from nasopharyngeal swab specimen/saliva collected via salivette cortisol,1,2020-10-22,1,0,0,0,0,Boehringer Ingelheim ( 1 ),1.001,1,NA
Diagnostic Test,sars-cov-2 ig g levels,1,2021-01-17,1,0,0,0,0,I.M. Sechenov First Moscow State Medical University ( 1 ),1.001,1,NA
Other,sars-cov-2 infection,1,2020-04-03,1,0,0,0,0,University Hospital of Ferrara ( 1 ),1.001,1,3
Biological,sars-cov-2 messenger rna-1273 (moderna) vaccine,1,2021-08-24,1,0,0,0,0,National Taiwan University Hospital ( 1 ),1.001,1,NA
Diagnostic Test,"sars-cov-2 research in nasopharyngeal swab, sperm",1,2020-07-21,1,0,0,0,0,"University Hospital, Clermont-Ferrand ( 1 )",1.001,1,NA
Diagnostic Test,"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",1,2020-07-21,1,0,0,0,0,"University Hospital, Clermont-Ferrand ( 1 )",1.001,1,NA
Diagnostic Test,sars-cov-2 rt-pcr assay for detection of covid-19 infection,1,2021-02-12,1,0,0,0,0,Temple University ( 1 ),1.001,1,NA
Diagnostic Test,sars-cov-2 screening by molecular biology,1,2021-01-08,1,0,0,0,0,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )",1.001,1,NA
Diagnostic Test,sars-cov-2 testing on the eppendorf thermal cycler pcr system using self-collected saliva as the specimen,1,2020-10-23,1,0,0,0,0,David Grant U.S. Air Force Medical Center ( 1 ),1.001,1,NA
Genetic,sars-cov-2 viral composition,1,2020-04-22,1,0,0,0,0,University Hospital Tuebingen ( 1 ),1.001,1,NA
Behavioral,scarcity,1,2021-04-06,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,scarcity message,1,2021-01-26,1,0,0,0,0,Geisinger Clinic ( 1 ),1.001,1,NA
Device,scd,1,2020-05-17,1,0,0,0,0,SeaStar Medical ( 1 ),1.001,1,NA
Behavioral,self-benefit/no social norm,1,2021-10-12,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,self-benefit/social norm,1,2021-10-12,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,self-care tools,1,2020-10-19,1,0,0,0,0,"St. Mary's Research Center, Canada ( 1 )",1.001,1,NA
Behavioral,"self-collected, home-based testing",1,2020-12-16,1,0,0,0,0,Johns Hopkins University ( 1 ),1.001,1,NA
Behavioral,self-focused acts,1,2020-08-14,1,0,0,0,0,University of Toronto ( 1 ),1.001,1,NA
Behavioral,self-help booklet,1,2020-05-26,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Other,self-help mindfulness,1,2021-01-12,1,0,0,0,0,Radboud University ( 1 ),1.001,1,NA
Other,self-help mindfulness/compassion exercises,1,2021-01-12,1,0,0,0,0,Radboud University ( 1 ),1.001,1,NA
Other,self-interest message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Other,self measurement with pulse oximeter,1,2020-11-27,1,0,0,0,0,Ostfold Hospital Trust ( 1 ),1.001,1,NA
Diagnostic Test,serological tests for sars cov-2,1,2021-01-21,1,0,0,0,0,Grand HÃ´pital de Charleroi ( 1 ),1.001,1,NA
Other,serology test follow-up,1,2020-07-20,1,0,0,0,0,Groupe Hospitalier Paris Saint Joseph ( 1 ),1.001,1,4
Diagnostic Test,serology to determine sars-cov-2 infection,1,2021-03-21,1,0,0,0,0,Grand HÃ´pital de Charleroi ( 1 ),1.001,1,NA
Biological,serology/elispot test,1,2021-06-18,1,0,0,0,0,Centre Georges Francois Leclerc ( 1 ),1.001,1,NA
Other,severity of lung involvement with covid-19.,1,2020-09-29,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Other,sf-12,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Other,sham inflation,1,2021-01-06,1,0,0,0,0,University College London Hospitals ( 1 ),1.001,1,1
Behavioral,shared decision making,1,2020-09-09,1,0,0,0,0,Massachusetts General Hospital ( 1 ),1.001,1,NA
Behavioral,simple cognitive task,1,2020-07-13,1,0,0,0,0,University of Oxford ( 1 ),1.001,1,NA
Behavioral,simulation intervention,1,2020-11-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Drug,single high dose vitamin d,1,2020-08-17,1,0,0,0,0,"Cantonal Hosptal, Baselland ( 1 )",1.001,1,NA
Other,singstrong: strong lungs through song,1,2021-03-19,1,0,0,0,0,University of Limerick ( 1 ),1.001,1,NA
Other,sit-to-stand test,1,2020-12-29,1,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 1 ),1.001,1,NA
Behavioral,sm-ema,1,2021-01-06,1,0,0,0,0,Johns Hopkins University ( 1 ),1.001,1,NA
Device,smf,1,2020-05-08,1,0,0,0,0,University of Nove de Julho ( 1 ),1.001,1,1
Behavioral,sms-based support,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Behavioral,sms delivery of information,1,2021-06-07,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Behavioral,sms message support,1,2020-05-26,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Behavioral,soap distributed but no activities of the hbcc project,1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Behavioral,social,1,2021-03-25,1,0,0,0,0,University of Bern ( 1 ),1.001,1,NA
Behavioral,socialization,1,2020-07-31,1,0,0,0,0,McMaster University ( 1 ),1.001,1,NA
Drug,sodium bicarbonate solution,1,2021-09-02,1,0,0,0,0,Mansoura University ( 1 ),1.001,1,NA
Other,solution-focused support program,1,2020-10-26,1,0,0,0,0,Adiyaman University Research Hospital ( 1 ),1.001,1,NA
Diagnostic Test,spartan covid-19 platform,1,2021-02-19,1,0,0,0,0,Ottawa Heart Institute Research Corporation ( 1 ),1.001,1,NA
Device,spartan covid-19 system,1,2020-07-14,1,0,0,0,0,Spartan Bioscience Inc. ( 1 ),1.001,1,NA
Other,specific exercise rehabilitation treatment,1,2020-09-10,1,0,0,0,0,Groupe Hospitalier Paris Saint Joseph ( 1 ),1.001,1,NA
Diagnostic Test,spike protein (s),1,2021-04-13,1,0,0,0,0,Baskent University ( 1 ),1.001,1,NA
Diagnostic Test,spike protein (s)/the nucleocapsid (n) of sars-cov-2,1,2021-04-13,1,0,0,0,0,Baskent University ( 1 ),1.001,1,NA
Other,spin-chat program,1,2020-04-01,1,0,0,0,0,Lady Davis Institute ( 1 ),1.001,1,1
Diagnostic Test,spirometry,1,2021-02-01,1,0,0,0,0,Johann Wolfgang Goethe University Hospital ( 1 ),1.001,1,NA
Behavioral,sse educational intervention,1,2020-06-03,1,0,0,0,0,Northwestern University ( 1 ),1.001,1,NA
Other,staff wellbeing centres,1,2020-05-22,1,0,0,0,0,University of Nottingham ( 1 ),1.001,1,2
Other,standard care/monitoring,1,2020-12-03,1,0,0,0,0,Icahn School of Medicine at Mount Sinai ( 1 ),1.001,1,NA
Other,standard interface,1,2020-04-08,1,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 1 ),1.001,1,NA
Behavioral,standard message,1,2021-04-06,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Drug,standard of care for covid-19 as per the hospital guidelines,1,2021-04-25,1,0,0,0,0,King Edward Medical University ( 1 ),1.001,1,NA
Other,standard of care non-helmet based cpap ventilation,1,2021-06-08,1,0,0,0,0,New York University ( 1 ),1.001,1,1
Other,standard oxygen delivery system,1,2020-11-13,1,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 1 ),1.001,1,NA
Behavioral,standard pcp outreach,1,2021-10-25,1,0,0,0,0,Kaiser Permanente ( 1 ),1.001,1,NA
Diagnostic Test,"standard q covid-19 ag - test, produced by sd biosensor inc.",1,2020-12-26,1,0,0,0,0,"Rigshospitalet, Denmark ( 1 )",1.001,1,NA
Behavioral,stay connected,1,2021-06-25,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Procedure,steam inhalations,1,2021-02-05,1,0,0,0,0,Meyer Children's Hospital ( 1 ),1.001,1,NA
Procedure,steroid,1,2021-08-16,1,0,0,0,0,Assiut University ( 1 ),1.001,1,NA
Other,steroid taper (prednisone),1,2021-02-25,1,0,0,0,0,Northwell Health ( 1 ),1.001,1,NA
Procedure,steroid/anticoagulants according to different protocols.,1,2021-08-16,1,0,0,0,0,Assiut University ( 1 ),1.001,1,NA
Diagnostic Test,stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,1,2020-07-02,1,0,0,0,0,University of Milan ( 1 ),1.001,1,NA
Behavioral,strength rmt/nasal breathing,1,2021-06-30,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Other,strengthening exercise,1,2021-05-06,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Behavioral,stress first aid,1,2021-01-14,1,0,0,0,0,RAND ( 1 ),1.001,1,NA
Diagnostic Test,stress test,1,2021-06-02,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Behavioral,stress/emotion management,1,2020-08-10,1,0,0,0,0,Ohio State University ( 1 ),1.001,1,NA
Behavioral,striveweekly,1,2021-06-09,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Behavioral,substance use disorders using prolonged exposure (cope),1,2021-02-10,1,0,0,0,0,University of Kentucky ( 1 ),1.001,1,NA
Dietary Supplement,sun exposure,1,2021-03-18,1,0,0,0,0,Hospital Clinica Nova ( 1 ),1.001,1,NA
Other,supervised stretching,1,2021-05-06,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,supine position,1,2020-09-08,1,0,0,0,0,"Hospital St. Joseph, Marseille, France ( 1 )",1.001,1,NA
Behavioral,support,1,2021-04-23,1,0,0,0,0,University of Toronto ( 1 ),1.001,1,NA
Behavioral,supportive therapy,1,2020-12-07,1,0,0,0,0,Drexel University ( 1 ),1.001,1,1
Behavioral,supportive therapy ssi,1,2020-11-11,1,0,0,0,0,Stony Brook University ( 1 ),1.001,1,NA
Drug,supportive/symptomatic treatment,1,2020-07-14,1,0,0,0,0,Mansoura University ( 1 ),1.001,1,NA
Other,surgical face mask use only,1,2020-11-24,1,0,0,0,0,"University of Los Andes, Columbia ( 1 )",1.001,1,NA
Other,surgical facial mask,1,2020-04-02,1,0,0,0,0,"Rigshospitalet, Denmark ( 1 )",1.001,1,2
Biological,swab,1,2020-04-28,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Behavioral,tailored best practices,1,2021-01-15,1,0,0,0,0,Massachusetts General Hospital ( 1 ),1.001,1,NA
Behavioral,tailored information,1,2021-04-13,1,0,0,0,0,"University Hospital, Akershus ( 1 )",1.001,1,NA
Behavioral,tailored recommendations,1,2020-11-25,1,0,0,0,0,Laval University ( 1 ),1.001,1,NA
Diagnostic Test,take home saliva kit,1,2021-09-20,1,0,0,0,0,The Hospital for Sick Children ( 1 ),1.001,1,NA
Behavioral,technology based social interactions,1,2020-07-19,1,0,0,0,0,Boston University ( 1 ),1.001,1,NA
Behavioral,tele-interventions related to diabetes management,1,2020-04-07,1,0,0,0,0,Federal University of Rio Grande do Sul ( 1 ),1.001,1,NA
Behavioral,telehealth/counselling,1,2020-09-08,1,0,0,0,0,UKK Institute ( 1 ),1.001,1,NA
Behavioral,telemedicine visit,1,2020-12-02,1,0,0,0,0,Cedars-Sinai Medical Center ( 1 ),1.001,1,NA
Other,telemonitoring,1,2021-03-08,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Other,telemonitoring/teleorientation,1,2021-03-08,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Procedure,telephone follow-up,1,2020-04-14,1,0,0,0,0,"Central Hospital, Nancy, France ( 1 )",1.001,1,NA
Behavioral,telepsychoeducation with personalized videos,1,2020-11-05,1,0,0,0,0,Hospital de Clinicas de Porto Alegre ( 1 ),1.001,1,NA
Behavioral,telesimulation,1,2020-08-12,1,0,0,0,0,"University of California, Davis ( 1 )",1.001,1,NA
Other,telestroke,1,2021-02-15,1,0,0,0,0,University of Minnesota ( 1 ),1.001,1,NA
Drug,tenofovir disoproxyl fumarate 300 mg,1,2021-01-07,1,0,0,0,0,Universidade Federal do Ceara ( 1 ),1.001,1,NA
Drug,tenofovir disoproxyl fumarate 300 mg oral tablet,1,2021-01-07,1,0,0,0,0,Universidade Federal do Ceara ( 1 ),1.001,1,NA
Drug,tenofovir disoproxyl fumarate 300 mg/emtricitabine 200 mg oral tablet,1,2021-01-07,1,0,0,0,0,Universidade Federal do Ceara ( 1 ),1.001,1,NA
Device,tensile strength,1,2021-02-04,1,0,0,0,0,Bangkok Metropolitan Administration Medical College and Vajira Hospital ( 1 ),1.001,1,NA
Diagnostic Test,test rt-pcr,1,2020-10-01,1,0,0,0,0,Centre Hospitalier Intercommunal Creteil ( 1 ),1.001,1,NA
Diagnostic Test,testing,1,2020-10-19,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Diagnostic Test,testing for sars-cov-2 igm/igg,1,2021-01-16,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,NA
Diagnostic Test,testing for sars-cov-2 rna,1,2021-01-16,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,NA
Other,testis pathology samples,1,2021-01-17,1,0,0,0,0,I.M. Sechenov First Moscow State Medical University ( 1 ),1.001,1,NA
Drug,tetracycline hydrochloride 3%,1,2021-01-18,1,0,0,0,0,University of Nove de Julho ( 1 ),1.001,1,NA
Behavioral,text material for psychoeducation,1,2020-10-08,1,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 1 ),1.001,1,NA
Behavioral,text material for psychoeducation/audio for relaxation techniques,1,2020-10-08,1,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 1 ),1.001,1,NA
Behavioral,text message,1,2021-09-07,1,0,0,0,0,Ascension South East Michigan ( 1 ),1.001,1,NA
Other,the management of severe covid-19 cases,1,2020-08-05,1,0,0,0,0,Surgical Systems Research Group ( 1 ),1.001,1,NA
Diagnostic Test,the nucleocapsid (n) of sars-cov-2,1,2021-04-13,1,0,0,0,0,Baskent University ( 1 ),1.001,1,NA
Behavioral,the psychosocial effects of covid-19 pandemic on dental professionals,1,2020-12-16,1,0,0,0,0,Suleyman Demirel University ( 1 ),1.001,1,NA
Device,the use of the mentalplusâ® digital game for assessment,1,2020-11-14,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Device,the use of the mentalplusâ® digital game for assessment/rehabilitation of cognitive function after remission of the symptoms of covid-19,1,2020-11-14,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Behavioral,theory-based messages,1,2021-03-23,1,0,0,0,0,University of Glasgow ( 1 ),1.001,1,1
Other,therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3),1,2021-02-05,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Other,toothpaste with sodium fluoride,1,2020-07-14,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Other,toothpaste with tin fluoride,1,2020-07-14,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Drug,tpa,1,2021-06-13,1,0,0,0,0,Grupo Mexicano para el Estudio de la Medicina Intensiva ( 1 ),1.001,1,NA
Other,tr,1,2021-03-26,1,0,0,0,0,Istituti Clinici Scientifici Maugeri SpA ( 1 ),1.001,1,NA
Procedure,tracheotomy,1,2020-05-24,1,0,0,0,0,"Sahlgrenska University Hospital, Sweden ( 1 )",1.001,1,NA
Other,training clinicians in basic critical care,1,2020-08-05,1,0,0,0,0,Surgical Systems Research Group ( 1 ),1.001,1,NA
Behavioral,"training for awareness, resilience,",1,2020-09-11,1,0,0,0,0,"University of California, San Francisco ( 1 )",1.001,1,NA
Behavioral,"training for awareness, resilience,/action (tara)",1,2020-09-11,1,0,0,0,0,"University of California, San Francisco ( 1 )",1.001,1,NA
Other,"training of youth, community health assistants",1,2020-08-05,1,0,0,0,0,Surgical Systems Research Group ( 1 ),1.001,1,NA
Other,"training of youth, community health assistants/community health workers.",1,2020-08-05,1,0,0,0,0,Surgical Systems Research Group ( 1 ),1.001,1,NA
Behavioral,training session adressing information,1,2020-06-29,1,0,0,0,0,Jacobs University Bremen gGmbH ( 1 ),1.001,1,4
Behavioral,training session adressing information/health literacy,1,2020-06-29,1,0,0,0,0,Jacobs University Bremen gGmbH ( 1 ),1.001,1,4
Behavioral,transcendental meditation,1,2020-11-11,1,0,0,0,0,Duke University ( 1 ),1.001,1,NA
Device,transcutaneous auricular vagus nerve stimulation,1,2020-05-05,1,0,0,0,0,Nemechek Technologies ( 1 ),1.001,1,NA
Diagnostic Test,transpulmonary pressure measurements,1,2020-08-18,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Behavioral,trauma informed psychotherapy,1,2020-10-29,1,0,0,0,0,University of Lethbridge ( 1 ),1.001,1,NA
Behavioral,trauma informed yoga,1,2020-10-29,1,0,0,0,0,University of Lethbridge ( 1 ),1.001,1,NA
Other,treated with hyperimmune plasma,1,2020-11-02,1,0,0,0,0,A.O. Ospedale Papa Giovanni XXIII ( 1 ),1.001,1,NA
Other,ultraprotective ventilation,1,2020-04-08,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,1
Behavioral,unavailable covid test result - hypothetical scenario,1,2020-07-05,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Behavioral,unified protocol for covid-19 parenting stress (up-covid),1,2020-06-12,1,0,0,0,0,University of Miami ( 1 ),1.001,1,NA
Other,unsupervised physical activities,1,2020-06-07,1,0,0,0,0,Federal University of Rio Grande do Sul ( 1 ),1.001,1,NA
Other,urine samples,1,2020-03-31,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,usual care control,1,2021-03-12,1,0,0,0,0,Massachusetts General Hospital ( 1 ),1.001,1,NA
Behavioral,usual care positioning with no instructions,1,2020-04-24,1,0,0,0,0,University of Utah ( 1 ),1.001,1,NA
Diagnostic Test,venous,1,2021-10-01,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Diagnostic Test,venous/capillary blood sampling,1,2021-10-01,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Device,vesta respirator,1,2020-07-19,1,0,0,0,0,University of Brasilia ( 1 ),1.001,1,NA
Device,virtual reality therapy first,1,2020-08-29,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,1
Other,virtual realty exercises,1,2021-07-28,1,0,0,0,0,Sivas Cumhuriyet University ( 1 ),1.001,1,NA
Other,virtual village,1,2021-02-03,1,0,0,0,0,"University of California, Riverside ( 1 )",1.001,1,NA
Device,viruxal oral,1,2020-04-20,1,0,0,0,0,Kerecis Ltd. ( 1 ),1.001,1,NA
Device,viruxal oral/nasal spray,1,2020-04-20,1,0,0,0,0,Kerecis Ltd. ( 1 ),1.001,1,NA
Drug,vitamin c 500 mg oral tablet,1,2021-01-07,1,0,0,0,0,Universidade Federal do Ceara ( 1 ),1.001,1,NA
Dietary Supplement,"vitamin c, vitamin b complex",1,2021-03-12,1,0,0,0,0,Hospital de la Soledad ( 1 ),1.001,1,NA
Dietary Supplement,"vitamin c, vitamin b complex/zinc acetate",1,2021-03-12,1,0,0,0,0,Hospital de la Soledad ( 1 ),1.001,1,NA
Dietary Supplement,vitamine d3 supplementation,1,2021-03-18,1,0,0,0,0,Hospital Clinica Nova ( 1 ),1.001,1,NA
Device,ward css,1,2020-10-21,1,0,0,0,0,University Hospital Bispebjerg and Frederiksberg ( 1 ),1.001,1,NA
Other,wearing surgical face mask sprayed with hypertonic saline,1,2020-07-02,1,0,0,0,0,King Faisal Specialist Hospital & Research Center ( 1 ),1.001,1,NA
Other,webex physical activity program,1,2020-05-20,1,0,0,0,0,Lawson Health Research Institute ( 1 ),1.001,1,NA
Behavioral,wellness education,1,2021-03-11,1,0,0,0,0,Saglik Bilimleri Universitesi ( 1 ),1.001,1,NA
Other,wingate exercise test/on-ice testing while wearing a sham face mask,1,2021-04-23,1,0,0,0,0,University of Saskatchewan ( 1 ),1.001,1,1
Device,withings scanwatch,1,2020-07-09,1,0,0,0,0,Ludwig-Maximilians - University of Munich ( 1 ),1.001,1,NA
Other,wofb,1,2020-11-27,1,0,0,0,0,University of Oxford ( 1 ),1.001,1,1
Behavioral,yoga group,1,2020-05-21,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,1
Other,zn,1,2021-05-24,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Biological,28),1,2020-09-21,0,1,0,0,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),1.001,1,NA
Biological,50 âµg spfn_1b-06-pl,1,2021-03-03,0,1,0,0,0,U.S. Army Medical Research and Development Command ( 1 ),1.001,1,NA
Biological,aapc,1,2020-03-05,0,1,0,0,0,Shenzhen Geno-Immune Medical Institute ( 1 ),1.001,1,NA
Drug,abbv-2b04,1,2020-11-23,0,1,0,0,0,AbbVie ( 1 ),1.001,1,NA
Biological,adcld-cov19-1,1,2021-09-14,0,1,0,0,0,"Cellid Co., Ltd. ( 1 )",1.001,1,NA
Drug,ak119,1,2020-08-13,0,1,0,0,0,Akeso ( 1 ),1.001,1,NA
Biological,alum adjuvant,1,2020-05-25,0,1,0,0,0,Clover Biopharmaceuticals AUS Pty Ltd ( 1 ),1.001,1,1
Drug,anti-sars-cov-2 igy,1,2020-09-18,0,1,0,0,0,Stanford University ( 1 ),1.001,1,NA
Biological,at-100,1,2020-12-04,0,1,0,0,0,"Airway Therapeutics, Inc. ( 1 )",1.001,1,NA
Biological,bactrl-spike,1,2020-03-31,0,1,0,0,0,Symvivo Corporation ( 1 ),1.001,1,NA
Biological,bbv154 vaccine,1,2021-02-08,0,1,0,0,0,Bharat Biotech International Limited ( 1 ),1.001,1,NA
Drug,bgb dxp593,1,2020-08-27,0,1,0,0,0,BeiGene ( 1 ),1.001,1,NA
Drug,bicalutamide 150 mg,1,2020-12-02,0,1,0,0,0,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( 1 ),1.001,1,NA
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,2020-08-16,0,1,0,0,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 1 )",1.001,1,NA
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,2020-08-16,0,1,0,0,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 1 )",1.001,1,NA
Drug,botulinum neurotoxin,1,2020-06-18,0,1,0,0,0,DeNova Research ( 1 ),1.001,1,NA
Biological,c144-ls/c-135-ls,1,2021-01-05,0,1,0,0,0,Rockefeller University ( 1 ),1.001,1,1
Biological,cd127lo,1,2021-08-26,0,1,0,0,0,"University of California, San Francisco ( 1 )",1.001,1,NA
Device,centricyte 1000,1,2020-03-26,0,1,0,0,0,"Black Tie Medical, Inc. ( 1 )",1.001,1,NA
Device,cliniporator,1,2020-11-06,0,1,0,0,0,Providence Health & Services ( 1 ),1.001,1,NA
Drug,covidir injections,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Biological,cryopreserved ex vivo expanded polyclonal cd4,1,2021-08-26,0,1,0,0,0,"University of California, San Francisco ( 1 )",1.001,1,NA
Biological,cvxga1 high dose,1,2021-06-30,0,1,0,0,0,CyanVac LLC ( 1 ),1.001,1,NA
Biological,cvxga1 low dose,1,2021-06-30,0,1,0,0,0,CyanVac LLC ( 1 ),1.001,1,NA
Drug,cytotoxic t lymphocytes,1,2021-02-19,0,1,0,0,0,Thomas Jefferson University ( 1 ),1.001,1,NA
Drug,dapsone 100 mg,1,2021-05-27,0,1,0,0,0,Hunt Regional Medical Center ( 1 ),1.001,1,NA
Diagnostic Test,diagnostic tests for covid-19 infection,1,2020-04-29,0,1,0,0,0,Texas Cardiac Arrhythmia Research Foundation ( 1 ),1.001,1,NA
Combination Product,diclofenac sodium 1gm%,1,2021-05-18,0,1,0,0,0,Sher-E-Bangla Medical College ( 1 ),1.001,1,NA
Biological,dvx201,1,2021-05-20,0,1,0,0,0,"Deverra Therapeutics, Inc. ( 1 )",1.001,1,NA
Device,electrical stimulation - sham,1,2020-12-23,0,1,0,0,0,Baylor College of Medicine ( 1 ),1.001,1,NA
Drug,emricasan,1,2021-02-12,0,1,0,0,0,Histogen ( 1 ),1.001,1,NA
Drug,fb2001,1,2021-02-04,0,1,0,0,0,Frontier Biotechnologies Inc. ( 1 ),1.001,1,NA
placebo,fb2001 placebo,1,2021-02-04,0,1,0,0,0,Frontier Biotechnologies Inc. ( 1 ),1.001,1,NA
Other,gm-csf,1,2020-12-28,0,1,0,0,0,"Aivita Biomedical, Inc. ( 1 )",1.001,1,NA
Drug,gs-441524,1,2021-04-19,0,1,0,0,0,Copycat Sciences LLC ( 1 ),1.001,1,NA
Drug,gx-i7 vehicle,1,2021-01-20,0,1,0,0,0,"Genexine, Inc. ( 1 )",1.001,1,NA
Drug,had5-sfusion/ n-etsd (oral capsule),1,2021-01-27,0,1,0,0,0,"ImmunityBio, Inc. ( 1 )",1.001,1,NA
Other,health enhancement program,1,2020-04-26,0,1,0,0,0,Lawson Health Research Institute ( 1 ),1.001,1,2
Drug,hfb30132a,1,2020-10-08,0,1,0,0,0,HiFiBiO Therapeutics ( 1 ),1.001,1,NA
Drug,intranasal spray 1%,1,2020-09-28,0,1,0,0,0,UNION therapeutics ( 1 ),1.001,1,NA
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 1, single dose, intranasal drops",1,2021-03-09,0,1,0,0,0,"Meissa Vaccines, Inc. ( 1 )",1.001,1,NA
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 2, single dose, intranasal drops",1,2021-03-09,0,1,0,0,0,"Meissa Vaccines, Inc. ( 1 )",1.001,1,NA
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal drops",1,2021-03-09,0,1,0,0,0,"Meissa Vaccines, Inc. ( 1 )",1.001,1,NA
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, two doses, intranasal drops",1,2021-03-09,0,1,0,0,0,"Meissa Vaccines, Inc. ( 1 )",1.001,1,NA
Drug,irl201104,1,2021-02-01,0,1,0,0,0,Revolo Biotherapeutics ( 1 ),1.001,1,NA
Drug,itraconazole,1,2021-07-10,0,1,0,0,0,Pfizer ( 1 ),1.001,1,NA
Biological,koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 4 âµg,1,2021-04-06,0,1,0,0,0,Kocak Farma ( 1 ),1.001,1,NA
Biological,koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 4 âµg/0.5 ml vaccine,1,2021-04-06,0,1,0,0,0,Kocak Farma ( 1 ),1.001,1,NA
Drug,lidocaine,1,2021-07-27,0,1,0,0,0,Sheikh Zayed Medical College ( 1 ),1.001,1,NA
Combination Product,"menthol 0.02%, methyl salicylate 0.05%, n- acetyl cysteine 1.2 gm%,/diclofenac sodium 1gm%",1,2021-05-18,0,1,0,0,0,Sher-E-Bangla Medical College ( 1 ),1.001,1,NA
Other,mesenchymal stromal cell-based therapy,1,2020-07-31,0,1,0,0,0,D'Or Institute for Research and Education ( 1 ),1.001,1,NA
Drug,methylene blue/ vitamin c/n-acetyl cysteine,1,2020-04-29,0,1,0,0,0,Mashhad University of Medical Sciences ( 1 ),1.001,1,2
Biological,mf59 adjuvanted sars-cov-2 sclamp vaccine,1,2020-07-13,0,1,0,0,0,The University of Queensland ( 1 ),1.001,1,1
Drug,midazolam,1,2021-08-27,0,1,0,0,0,Pfizer ( 1 ),1.001,1,NA
Biological,mrna covd19 vaccine,1,2021-04-05,0,1,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Biological,n-803,1,2020-05-07,0,1,0,0,0,"ImmunityBio, Inc. ( 1 )",1.001,1,NA
Drug,n-etsd (oral capsule),1,2021-01-27,0,1,0,0,0,"ImmunityBio, Inc. ( 1 )",1.001,1,NA
Biological,nbp2001 adjuvanted with alum (rbd 30î¼g,1,2021-02-17,0,1,0,0,0,"SK Chemicals Co., Ltd. ( 1 )",1.001,1,NA
Biological,nbp2001 adjuvanted with alum (rbd 30î¼g/dose),1,2021-02-17,0,1,0,0,0,"SK Chemicals Co., Ltd. ( 1 )",1.001,1,NA
Biological,nbp2001 adjuvanted with alum (rbd 50î¼g,1,2021-02-17,0,1,0,0,0,"SK Chemicals Co., Ltd. ( 1 )",1.001,1,NA
Biological,nbp2001 adjuvanted with alum (rbd 50î¼g/dose),1,2021-02-17,0,1,0,0,0,"SK Chemicals Co., Ltd. ( 1 )",1.001,1,NA
Drug,ntr-441,1,2021-05-04,0,1,0,0,0,Neutrolis ( 1 ),1.001,1,NA
Drug,nuvastatic,1,2020-09-06,0,1,0,0,0,Natureceuticals Sdn Bhd ( 1 ),1.001,1,NA
Biological,one covid-19 vaccine candidate (tmv-083,1,2020-07-31,0,1,0,0,0,Institut Pasteur ( 1 ),1.001,1,NA
Biological,one covid-19 vaccine candidate (tmv-083/v-591) administration - high dose,1,2020-07-31,0,1,0,0,0,Institut Pasteur ( 1 ),1.001,1,NA
Diagnostic Test,one step test,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Drug,ophtamesone,1,2020-09-29,0,1,0,0,0,University Of Anbar ( 1 ),1.001,1,1
Drug,orally suspension of cov2-ogen1,1,2021-05-14,0,1,0,0,0,Syneos Health ( 1 ),1.001,1,NA
Drug,organic brown rice,1,2021-06-21,0,1,0,0,0,"University of California, San Diego ( 1 )",1.001,1,NA
Device,patient status engine,1,2020-05-20,0,1,0,0,0,The Christie NHS Foundation Trust ( 1 ),1.001,1,NA
Drug,pf-07321332/ritonavir / midazolam,1,2021-08-27,0,1,0,0,0,Pfizer ( 1 ),1.001,1,NA
placebo,placebo multiple,1,2020-12-18,0,1,0,0,0,NP Therapeutics ( 1 ),1.001,1,NA
Drug,poly-iclc (hiltonolâ®)/placebo,1,2020-10-05,0,1,0,0,0,"Oncovir, Inc. ( 1 )",1.001,1,6
Biological,ptx-covid19-b,1,2021-02-16,0,1,0,0,0,Providence Therapeutics Holdings Inc. ( 1 ),1.001,1,NA
Biological,recombinant ndv vectored vaccine for sars-cov-2,1,2021-04-21,0,1,0,0,0,"Laboratorio Avi-Mex, S.A. de C.V. ( 1 )",1.001,1,NA
Biological,recombinant sars-cov-2 fusion protein vaccine,1,2021-09-13,0,1,0,0,0,Livzon Pharmaceutical Group Inc. ( 1 ),1.001,1,NA
Drug,rhdnase i,1,2020-05-13,0,1,0,0,0,McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 ),1.001,1,NA
Diagnostic Test,rt-pcr sars-cov-2,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Biological,sam-lnp-s-tce,1,2021-02-25,0,1,0,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),1.001,1,NA
Drug,sar443122,1,2020-06-28,0,1,0,0,0,Sanofi ( 1 ),1.001,1,NA
Drug,sarilumab prefilled syringe,1,2020-05-07,0,1,0,0,0,ASST Fatebenefratelli Sacco ( 1 ),1.001,1,NA
Biological,sars-cov-2 antigen-specific cytotoxic t-lymphocytes,1,2021-02-03,0,1,0,0,0,M.D. Anderson Cancer Center ( 1 ),1.001,1,NA
Biological,sars-cov-2 vaccine,1,2021-04-26,0,1,0,0,0,The Scientific and Technological Research Council of Turkey ( 1 ),1.001,1,4
Biological,sars-cov-2 vlp vaccine,1,2021-03-24,0,1,0,0,0,The Scientific and Technological Research Council of Turkey ( 1 ),1.001,1,NA
Biological,sars-cov2 pfizer vaccine,1,2021-06-18,0,1,0,0,0,University of Arizona ( 1 ),1.001,1,NA
Biological,sc-ad6-1,1,2021-04-07,0,1,0,0,0,Tetherex Pharmaceuticals Corporation ( 1 ),1.001,1,NA
Biological,st266,1,2021-01-21,0,1,0,0,0,"Noveome Biotherapeutics, formerly Stemnion ( 1 )",1.001,1,NA
placebo,"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",1,2020-11-17,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Biological,two covid-19 vaccine candidate (tmv-083/v-591) administrations - low dose,1,2020-07-31,0,1,0,0,0,Institut Pasteur ( 1 ),1.001,1,NA
Biological,"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",1,2020-11-17,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Biological,"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",1,2020-11-17,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Biological,"two doses of middle-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,2020-08-27,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
placebo,"two doses of placebo at the schedule of day 0, 14 #high-dose group#",1,2020-11-17,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
placebo,"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",1,2020-11-17,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Drug,uni911 inhalation 1%,1,2020-09-28,0,1,0,0,0,UNION therapeutics ( 1 ),1.001,1,NA
Drug,uni911 inhalation 1%/intranasal spray 1%,1,2020-09-28,0,1,0,0,0,UNION therapeutics ( 1 ),1.001,1,NA
Biological,v-591) administration - high dose,1,2020-07-31,0,1,0,0,0,Institut Pasteur ( 1 ),1.001,1,NA
Biological,v-591) administrations - high dose,1,2020-07-31,0,1,0,0,0,Institut Pasteur ( 1 ),1.001,1,NA
Biological,v-591) administrations - low dose,1,2020-07-31,0,1,0,0,0,Institut Pasteur ( 1 ),1.001,1,NA
Biological,v590,1,2020-09-24,0,1,0,0,0,Merck Sharp & Dohme Corp. ( 1 ),1.001,1,NA
Biological,vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,2020-08-16,0,1,0,0,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 1 )",1.001,1,NA
Drug,vib7734,1,2020-08-21,0,1,0,0,0,Viela Bio ( 1 ),1.001,1,NA
Drug,virazole,1,2020-09-15,0,1,0,0,0,"Bausch Health Americas, Inc. ( 1 )",1.001,1,NA
Behavioral,virtual family-based treatment,1,2020-12-17,0,1,0,0,0,McMaster University ( 1 ),1.001,1,1
Biological,vxa-cov2-1,1,2020-09-21,0,1,0,0,0,Vaxart ( 1 ),1.001,1,NA
Drug,xc7 200 mg multiple,1,2020-12-18,0,1,0,0,0,NP Therapeutics ( 1 ),1.001,1,NA
Other,),1,2021-01-05,1,0,0,0,0,"St. Luke's Health System, Boise, Idaho ( 1 )",1.001,1,NA
Other,0.07% cetylpyridinium chloride (cpc) in mouthwash,1,2021-02-16,1,0,0,0,0,Dentaid SL ( 1 ),1.001,1,NA
Other,1 minute sit to stand test,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Biological,10 to 14 days later,1,2020-05-05,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,1
Other,"12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",1,2020-04-20,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,16-hour pp,1,2021-08-11,1,0,0,0,0,Hospital Universitario 12 de Octubre ( 1 ),1.001,1,1
Diagnostic Test,24 hour holter ecg,1,2020-11-18,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Other,4-free app,1,2021-07-29,1,0,0,0,0,"Near East University, Turkey ( 1 )",1.001,1,NA
Other,4-free app / phn intervention,1,2021-07-29,1,0,0,0,0,"Near East University, Turkey ( 1 )",1.001,1,NA
Behavioral,5-week prevention program,1,2021-04-07,1,0,0,0,0,International Islamic University Malaysia ( 1 ),1.001,1,NA
Other,5 times sit to stand test,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Drug,5% glucose,1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Other,6-min-walk surgical mask,1,2021-03-04,1,0,0,0,0,Universitat Internacional de Catalunya ( 1 ),1.001,1,NA
Other,6-min-walk without mask,1,2021-03-04,1,0,0,0,0,Universitat Internacional de Catalunya ( 1 ),1.001,1,NA
Other,6 minute walk test,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Other,6 minutes walk test,1,2020-03-31,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,6 months later,1,2020-05-22,1,0,0,0,0,Institut Paoli-Calmettes ( 1 ),1.001,1,NA
Other,6 point likert scale,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Behavioral,a $10 survey incentive,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Behavioral,a $20 survey incentive,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Dietary Supplement,abbc1 immunoessential,1,2021-03-12,1,0,0,0,0,AB Biotek ( 1 ),1.001,1,6
Device,accuchek inform ii platform,1,2020-06-01,1,0,0,0,0,Northwell Health ( 1 ),1.001,1,NA
Behavioral,acknowledgement racial injustice ama,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Device,actigraphy,1,2020-04-24,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Behavioral,action (tara),1,2020-09-11,1,0,0,0,0,"University of California, San Francisco ( 1 )",1.001,1,NA
Other,activity list,1,2020-12-07,1,0,0,0,0,State University of New York at Buffalo ( 1 ),1.001,1,NA
Other,alcohol mouthwash (listerine) (d) mouth rinse with the solution provided,1,2020-10-21,1,0,0,0,0,Augusta University ( 1 ),1.001,1,NA
Drug,"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus",1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Drug,"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation/inhalation of vitamin c",1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Drug,"alpha-interferon, abidol, ribavirin, buzhong yiqi plus",1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Behavioral,altruism video,1,2021-06-30,1,0,0,0,0,Sir Mortimer B. Davis - Jewish General Hospital ( 1 ),1.001,1,NA
Procedure,alveolar,1,2020-04-22,1,0,0,0,0,Szeged University ( 1 ),1.001,1,1
Behavioral,ama acknowledgement drug pricing,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Other,ambulation,1,2020-09-18,1,0,0,0,0,Istanbul Medipol University Hospital ( 1 ),1.001,1,NA
Drug,amoxicillin,1,2021-09-02,1,0,0,0,0,Alexandria University ( 1 ),1.001,1,NA
Procedure,an69-oxiris,1,2020-10-03,1,0,0,0,0,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 ),1.001,1,NA
Procedure,an69-standard,1,2020-10-03,1,0,0,0,0,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( 1 ),1.001,1,NA
Other,anger message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Drug,anluohuaxian,1,2020-04-01,1,0,0,0,0,Peking University First Hospital ( 1 ),1.001,1,1
Biological,anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,1,2020-04-09,1,0,0,0,0,A.O. Ospedale Papa Giovanni XXIII ( 1 ),1.001,1,NA
Biological,anti-sars-cov-2 igt seropositivity,1,2020-06-23,1,0,0,0,0,"Central Hospital, Nancy, France ( 1 )",1.001,1,NA
Diagnostic Test,antibody test,1,2020-05-08,1,0,0,0,0,"Hospital for Special Surgery, New York ( 1 )",1.001,1,1
Diagnostic Test,antibody testing for sars-cov-2 igg,1,2021-01-16,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,NA
Procedure,anticoagulants according to different protocols.,1,2021-08-16,1,0,0,0,0,Assiut University ( 1 ),1.001,1,NA
Diagnostic Test,antigen,1,2020-04-13,1,0,0,0,0,Neuroganics LLC ( 1 ),1.001,1,NA
Behavioral,antimicrobial stewardship prospective audit,1,2021-05-17,1,0,0,0,0,University of Alberta ( 1 ),1.001,1,NA
Behavioral,antimicrobial stewardship prospective audit/feedback,1,2021-05-17,1,0,0,0,0,University of Alberta ( 1 ),1.001,1,NA
Behavioral,anxiety reduction training,1,2020-05-11,1,0,0,0,0,"Research Foundation for Mental Hygiene, Inc. ( 1 )",1.001,1,NA
Diagnostic Test,ap-23,1,2021-04-25,1,0,0,0,0,Fable Biyoteknoloji San ve Tic A.S ( 1 ),1.001,1,NA
Other,application of cdss to provide nutritional care in breast cancer patients from home,1,2021-04-27,1,0,0,0,0,"Iaso Maternity Hospital, Athens, Greece ( 1 )",1.001,1,NA
Other,apps,1,2020-09-09,1,0,0,0,0,Atrium Health ( 1 ),1.001,1,NA
Drug,aprotinin,1,2020-08-24,1,0,0,0,0,Aviron LLC ( 1 ),1.001,1,NA
Device,aptamex,1,2021-07-20,1,0,0,0,0,Achiko AG ( 1 ),1.001,1,NA
Dietary Supplement,arbox,1,2020-05-22,1,0,0,0,0,Hospital de Clinicas JosÃ© de San MartÃ­n ( 1 ),1.001,1,1
Device,arc intellicare,1,2021-10-08,1,0,0,0,0,Camlin Ltd ( 1 ),1.001,1,NA
Other,assembled mask,1,2020-05-13,1,0,0,0,0,University of Oklahoma ( 1 ),1.001,1,NA
Diagnostic Test,"assessing antibody responses, neutralizing capacity",1,2020-07-13,1,0,0,0,0,"Institute of Tropical Medicine, Belgium ( 1 )",1.001,1,NA
Diagnostic Test,"assessing antibody responses, neutralizing capacity/memory b-cell function",1,2020-07-13,1,0,0,0,0,"Institute of Tropical Medicine, Belgium ( 1 )",1.001,1,NA
Behavioral,assigned strategies: opt-in,1,2020-07-22,1,0,0,0,0,"Western University, Canada ( 1 )",1.001,1,NA
Drug,atorvastatin 80mg,1,2021-05-09,1,0,0,0,0,Penza State University ( 1 ),1.001,1,NA
Procedure,auditory evoked potentials (aep),1,2020-05-08,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Behavioral,augmented message,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Other,auricular stimulation,1,2021-01-08,1,0,0,0,0,University Medicine Greifswald ( 1 ),1.001,1,NA
Behavioral,award,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Behavioral,award advice,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Behavioral,award/covid-specific advice,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Biological,bacillus subtilis,1,2021-09-21,1,0,0,0,0,DreamTec Research Limited ( 1 ),1.001,1,NA
Behavioral,bandebereho fathers',1,2020-06-19,1,0,0,0,0,"Promundo, United States ( 1 )",1.001,1,NA
Other,baseline,1,2020-11-02,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Other,baseline blood sample,1,2020-11-02,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Other,baseline/during hospitalization blood samples,1,2020-11-02,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Behavioral,behavioral economics,1,2021-03-11,1,0,0,0,0,VA Puget Sound Health Care System ( 1 ),1.001,1,NA
Behavioral,behavioral intervention,1,2021-02-09,1,0,0,0,0,M.D. Anderson Cancer Center ( 1 ),1.001,1,NA
Behavioral,behaviour change technique intervention to improve quality of life,1,2020-05-12,1,0,0,0,0,University of Manchester ( 1 ),1.001,1,NA
Other,bereavement virtual support group,1,2020-10-08,1,0,0,0,0,Ottawa Hospital Research Institute ( 1 ),1.001,1,NA
Behavioral,best message,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Behavioral,best message alone,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Dietary Supplement,best standard of care / cardio,1,2020-07-08,1,0,0,0,0,Hofseth Biocare ASA ( 1 ),1.001,1,NA
Other,betadine (c) mouth rinse with the solution provided,1,2020-10-21,1,0,0,0,0,Augusta University ( 1 ),1.001,1,NA
Drug,betadineâ© bucal 100 mg,1,2021-01-07,1,0,0,0,0,FundaciÃ³n para el Fomento de la InvestigaciÃ³n Sanitaria y BiomÃ©dica de la Comunitat Valenciana ( 1 ),1.001,1,NA
Drug,betadineâ© bucal 100 mg/ml,1,2021-01-07,1,0,0,0,0,FundaciÃ³n para el Fomento de la InvestigaciÃ³n Sanitaria y BiomÃ©dica de la Comunitat Valenciana ( 1 ),1.001,1,NA
Dietary Supplement,bioarginina c,1,2021-06-30,1,0,0,0,0,University of Milan ( 1 ),1.001,1,NA
Other,biocollection,1,2020-10-10,1,0,0,0,0,Tourcoing Hospital ( 1 ),1.001,1,NA
Biological,biological test,1,2020-04-21,1,0,0,0,0,Centre Hospitalier Intercommunal Creteil ( 1 ),1.001,1,NA
Device,biosensor,1,2020-04-01,1,0,0,0,0,Oslo University Hospital ( 1 ),1.001,1,NA
Diagnostic Test,biozek covid-19 antigen rapid test (saliva),1,2021-06-11,1,0,0,0,0,Mach-E B.V. ( 1 ),1.001,1,NA
Diagnostic Test,blood biomarkers,1,2021-06-29,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Diagnostic Test,blood count,1,2020-11-30,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Diagnostic Test,blood group determination,1,2020-07-07,1,0,0,0,0,Brugmann University Hospital ( 1 ),1.001,1,NA
Other,blood sample analyses,1,2020-12-15,1,0,0,0,0,Intergroupe Francophone du Myelome ( 1 ),1.001,1,NA
Other,blood sample/data record,1,2020-05-04,1,0,0,0,0,CHU de Reims ( 1 ),1.001,1,NA
Biological,blood sample/salivary sample,1,2021-03-10,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Biological,blood test to describe the humoral,1,2021-06-04,1,0,0,0,0,GÃ©rond'if ( 1 ),1.001,1,NA
Biological,blood test to describe the humoral/cellular response to vaccination bnt162b2 in the elderly,1,2021-06-04,1,0,0,0,0,GÃ©rond'if ( 1 ),1.001,1,NA
Procedure,blood/nasal fluid sampling before/after covid-19 vaccination,1,2021-07-05,1,0,0,0,0,"University Hospital, Ghent ( 1 )",1.001,1,NA
Other,body odor samples,1,2021-06-16,1,0,0,0,0,HÃ´pital EuropÃ©en Marseille ( 1 ),1.001,1,NA
Dietary Supplement,bovine lactoferrin,1,2021-04-12,1,0,0,0,0,Paolo Manzoni ( 1 ),1.001,1,NA
Dietary Supplement,bovine plasma-derived immunoglobulin concentrate,1,2020-12-18,1,0,0,0,0,"Entera Health, Inc ( 1 )",1.001,1,NA
Diagnostic Test,brain mri,1,2020-08-03,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Diagnostic Test,breath sample analysis,1,2021-10-22,1,0,0,0,0,Tera Group ( 1 ),1.001,1,NA
Diagnostic Test,breath test,1,2020-07-03,1,0,0,0,0,Ancon Technologies Ltd ( 1 ),1.001,1,NA
Diagnostic Test,breath test/cheek swab,1,2020-07-03,1,0,0,0,0,Ancon Technologies Ltd ( 1 ),1.001,1,NA
Other,"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation/ambulation",1,2020-09-18,1,0,0,0,0,Istanbul Medipol University Hospital ( 1 ),1.001,1,NA
Other,breathing exercises,1,2021-06-01,1,0,0,0,0,Izmir Bakircay University ( 1 ),1.001,1,NA
Behavioral,breathing/chest mobilization exercises,1,2021-09-29,1,0,0,0,0,National Cardiovascular Center Harapan Kita Hospital Indonesia ( 1 ),1.001,1,NA
Behavioral,brief digital imagery-competing task intervention,1,2021-08-02,1,0,0,0,0,P1vital Products Limited ( 1 ),1.001,1,NA
Behavioral,brief informational infographic,1,2020-09-16,1,0,0,0,0,Indiana University ( 1 ),1.001,1,2
Behavioral,brief mindfulness based intervention,1,2020-12-04,1,0,0,0,0,Imam Abdulrahman Bin Faisal University ( 1 ),1.001,1,NA
Behavioral,brief skills for safer living,1,2020-07-23,1,0,0,0,0,Unity Health Toronto ( 1 ),1.001,1,NA
Behavioral,buddy assigned in community,1,2021-04-28,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,NA
Device,butterfly iq,1,2020-09-15,1,0,0,0,0,Bridge to Health Medical and Dental USA ( 1 ),1.001,1,NA
Other,calisthenic exercises,1,2021-06-21,1,0,0,0,0,Baskent University ( 1 ),1.001,1,NA
Diagnostic Test,capillary blood sampling,1,2021-10-01,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Diagnostic Test,capillary collection/testing,1,2020-10-19,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Diagnostic Test,cardiac magnetic resonance imaging (cmr),1,2021-03-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Diagnostic Test,cardiac pet,1,2021-06-29,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Dietary Supplement,cardio,1,2020-07-08,1,0,0,0,0,Hofseth Biocare ASA ( 1 ),1.001,1,NA
Other,cardiopulmonary exercise (centre-based),1,2021-03-01,1,0,0,0,0,The Hong Kong Polytechnic University ( 1 ),1.001,1,NA
Other,cardiopulmonary exercise (online-based),1,2021-03-01,1,0,0,0,0,The Hong Kong Polytechnic University ( 1 ),1.001,1,NA
Other,cardiopulmonary exercise training,1,2021-09-02,1,0,0,0,0,Montreal Heart Institute ( 1 ),1.001,1,NA
Other,cardiorespiratory exercise,1,2020-09-27,1,0,0,0,0,Hong Kong Baptist University ( 1 ),1.001,1,1
Other,care as usual,1,2020-06-03,1,0,0,0,0,University Ghent ( 1 ),1.001,1,NA
Other,caring contacts/introductory phone call (cc/),1,2021-01-05,1,0,0,0,0,"St. Luke's Health System, Boise, Idaho ( 1 )",1.001,1,NA
Device,carrageenan nasal,1,2020-05-28,1,0,0,0,0,Swansea University ( 1 ),1.001,1,NA
Device,carrageenan nasal/throat spray,1,2020-05-28,1,0,0,0,0,Swansea University ( 1 ),1.001,1,NA
Device,carragelose,1,2021-03-09,1,0,0,0,0,Marinomed Biotech AG ( 1 ),1.001,1,NA
Drug,"cerebrospinal fluid sampling, meningeal/brain parenchyma biopsies",1,2020-05-26,1,0,0,0,0,Fondation Ophtalmologique Adolphe de Rothschild ( 1 ),1.001,1,NA
Other,certified cloth face mask,1,2020-07-14,1,0,0,0,0,Bandim Health Project ( 1 ),1.001,1,NA
Behavioral,chain-referral,1,2021-03-24,1,0,0,0,0,New York State Psychiatric Institute ( 1 ),1.001,1,NA
Behavioral,chair-yoga program,1,2021-05-07,1,0,0,0,0,Lady Davis Institute ( 1 ),1.001,1,NA
Behavioral,chamindwell,1,2020-10-19,1,0,0,0,0,Cambridge Health Alliance ( 1 ),1.001,1,NA
Behavioral,"change in knowledge, motivation, skills, resources",1,2020-09-03,1,0,0,0,0,Charles Drew University of Medicine and Science ( 1 ),1.001,1,NA
Device,chatbot,1,2021-10-20,1,0,0,0,0,Sun Yat-sen University ( 1 ),1.001,1,NA
Other,check-list including lung ultrasound,1,2021-02-22,1,0,0,0,0,Centre Hospitalier Metropole Savoie ( 1 ),1.001,1,NA
Diagnostic Test,cheek swab,1,2020-07-03,1,0,0,0,0,Ancon Technologies Ltd ( 1 ),1.001,1,NA
Other,chemokines profiles of patients with dexmedetomidine administration,1,2020-04-21,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,chest mobilization exercises,1,2021-09-29,1,0,0,0,0,National Cardiovascular Center Harapan Kita Hospital Indonesia ( 1 ),1.001,1,NA
Other,chest physiotherapy post-covid19,1,2020-12-12,1,0,0,0,0,European University of Madrid ( 1 ),1.001,1,NA
Diagnostic Test,chest x-ray,1,2020-07-12,1,0,0,0,0,Kanuni Sultan Suleyman Training and Research Hospital ( 1 ),1.001,1,NA
Other,chlorhexidine gluconate (a) mouth rinse with the solution provided,1,2020-10-21,1,0,0,0,0,Augusta University ( 1 ),1.001,1,NA
Behavioral,choice of assignment: active choice,1,2020-07-22,1,0,0,0,0,"Western University, Canada ( 1 )",1.001,1,NA
Behavioral,choice of assignment: enhanced active choice,1,2020-07-22,1,0,0,0,0,"Western University, Canada ( 1 )",1.001,1,NA
Behavioral,choice of assignment: opt-in,1,2020-07-22,1,0,0,0,0,"Western University, Canada ( 1 )",1.001,1,NA
Behavioral,christmas holiday,1,2020-11-13,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Other,chx0.12,1,2020-09-22,1,0,0,0,0,Dentaid SL ( 1 ),1.001,1,NA
Other,chx0.12/cpc0.05 oral rinse (perioaidactive control),1,2020-09-22,1,0,0,0,0,Dentaid SL ( 1 ),1.001,1,NA
Other,cig axial,1,2020-07-14,1,0,0,0,0,October University for Modern Sciences and Arts ( 1 ),1.001,1,NA
Device,citrox,1,2020-04-15,1,0,0,0,0,Claude Bernard University ( 1 ),1.001,1,2
Drug,clarithromycin 500mg,1,2020-11-06,1,0,0,0,0,South Valley University ( 1 ),1.001,1,1
Behavioral,co-mestring (co-coping),1,2020-06-04,1,0,0,0,0,Haukeland University Hospital ( 1 ),1.001,1,NA
Behavioral,cognitive activity,1,2020-12-11,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Other,"cognitive behavior therapy (cbt), specifically using the facing your fears (fyf) curriculum",1,2020-12-11,1,0,0,0,0,"Anagnostou, Evdokia, M.D. ( 1 )",1.001,1,NA
Behavioral,cognitive behavioral brief-telepsychotherapy,1,2020-11-05,1,0,0,0,0,Hospital de Clinicas de Porto Alegre ( 1 ),1.001,1,NA
Other,"collection of blood, salivary/nasopharyngeal samples.",1,2020-11-16,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Behavioral,collective intelligence intervention,1,2021-02-21,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Drug,colloidal silver,1,2020-11-05,1,0,0,0,0,HÃ´pital Universitaire Sahloul ( 1 ),1.001,1,NA
Behavioral,combination,1,2020-05-21,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,1
Dietary Supplement,"combination of curcumin, quercetin/vitamin d",1,2021-08-11,1,0,0,0,0,Ayub Teaching Hospital ( 1 ),1.001,1,NA
Behavioral,community health worker engagement,1,2021-06-16,1,0,0,0,0,Tulane University ( 1 ),1.001,1,NA
Other,community mask,1,2021-01-26,1,0,0,0,0,Fraunhofer-Institute of Toxicology and Experimental Medicine ( 1 ),1.001,1,NA
Other,compassion exercises,1,2021-01-12,1,0,0,0,0,Radboud University ( 1 ),1.001,1,NA
Other,compassion focused intervention,1,2020-05-05,1,0,0,0,0,University of Parma ( 1 ),1.001,1,NA
Diagnostic Test,complement dosage,1,2020-04-13,1,0,0,0,0,Brugmann University Hospital ( 1 ),1.001,1,NA
Other,computerized cognitive training,1,2021-04-10,1,0,0,0,0,Yeditepe University ( 1 ),1.001,1,NA
Other,concentrated air,1,2021-05-17,1,0,0,0,0,Pulmonary Wellness Foundation ( 1 ),1.001,1,NA
Other,concentrated oxygen,1,2021-05-17,1,0,0,0,0,Pulmonary Wellness Foundation ( 1 ),1.001,1,NA
Other,concentrated rehabilitation for patients with persistent symptoms post covid-19,1,2021-03-29,1,0,0,0,0,Western Norway University of Applied Sciences ( 1 ),1.001,1,NA
Other,concert,1,2021-04-29,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,concurrent treatment of ptsd,1,2021-02-10,1,0,0,0,0,University of Kentucky ( 1 ),1.001,1,NA
Behavioral,concurrent treatment of ptsd/substance use disorders using prolonged exposure (cope),1,2021-02-10,1,0,0,0,0,University of Kentucky ( 1 ),1.001,1,NA
Diagnostic Test,conjunctival swab/nasopharyngeal swab,1,2020-06-18,1,0,0,0,0,Medical University Innsbruck ( 1 ),1.001,1,NA
Behavioral,contain covid anxiety ssi,1,2020-06-29,1,0,0,0,0,Stony Brook University ( 1 ),1.001,1,NA
Other,continuation of acei/arb,1,2020-04-14,1,0,0,0,0,"University Hospital, Gentofte, Copenhagen ( 1 )",1.001,1,NA
Device,continuous positive airway pressure (cpap) therapy using oxyjet,1,2020-12-22,1,0,0,0,0,Bangladesh University of Engineering and Technology ( 1 ),1.001,1,NA
Device,continuous vital sign monitoring - isansys patient status engine,1,2020-05-04,1,0,0,0,0,The Christie NHS Foundation Trust ( 1 ),1.001,1,NA
Other,control blend,1,2020-07-30,1,0,0,0,0,Franklin School of Integrative Health Sciences ( 1 ),1.001,1,NA
Other,control intervention,1,2021-05-10,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,control message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Device,control swab,1,2020-04-24,1,0,0,0,0,University of Virginia ( 1 ),1.001,1,NA
Other,control training group,1,2021-07-15,1,0,0,0,0,Gazi University ( 1 ),1.001,1,NA
Behavioral,controls,1,2021-01-16,1,0,0,0,0,Universidad de Murcia ( 1 ),1.001,1,NA
Behavioral,convenient scheduling link,1,2021-04-27,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Drug,conventional,1,2021-01-11,1,0,0,0,0,King Edward Medical University ( 1 ),1.001,1,NA
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",1,2020-01-28,1,0,0,0,0,Beijing 302 Hospital ( 1 ),1.001,1,1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",1,2020-01-28,1,0,0,0,0,Beijing 302 Hospital ( 1 ),1.001,1,1
Device,conventional n95 respirator,1,2020-07-19,1,0,0,0,0,University of Brasilia ( 1 ),1.001,1,NA
Other,conventional nutritional support designed by hospital nutritionists,1,2020-08-06,1,0,0,0,0,Anahuac University ( 1 ),1.001,1,7
Device,conventional therapy first,1,2020-08-29,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,1
Device,core warming,1,2020-07-29,1,0,0,0,0,Sharp HealthCare ( 1 ),1.001,1,NA
Diagnostic Test,corpus cavernosum electromyography,1,2021-07-26,1,0,0,0,0,Ankara Yildirim BeyazÄ±t University ( 1 ),1.001,1,NA
Behavioral,cosh self-help smoking cessation booklet,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Behavioral,cost-benefit frame,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Behavioral,counselling,1,2020-09-08,1,0,0,0,0,UKK Institute ( 1 ),1.001,1,NA
Behavioral,"couple hopes guided, internet-delivered, self-help intervention",1,2021-02-13,1,0,0,0,0,York University ( 1 ),1.001,1,NA
Behavioral,couples' group education,1,2020-06-19,1,0,0,0,0,"Promundo, United States ( 1 )",1.001,1,NA
Other,covid-19 antibody test,1,2021-02-17,1,0,0,0,0,Bezmialem Vakif University ( 1 ),1.001,1,4
Diagnostic Test,"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",1,2020-04-13,1,0,0,0,0,Neuroganics LLC ( 1 ),1.001,1,NA
Device,covid-19 barrier box,1,2020-04-24,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,1
Diagnostic Test,covid-19 diagnostic test,1,2020-04-01,1,0,0,0,0,Tourcoing Hospital ( 1 ),1.001,1,NA
Other,covid-19 e-package: psychological wellbeing for healthcare workers,1,2020-06-11,1,0,0,0,0,University of Nottingham ( 1 ),1.001,1,NA
Behavioral,covid-19 health education comic books,1,2021-04-16,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Behavioral,covid-19 health education comic books/videos,1,2021-04-16,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Behavioral,covid-19 informational text,1,2021-06-30,1,0,0,0,0,Sir Mortimer B. Davis - Jewish General Hospital ( 1 ),1.001,1,NA
Diagnostic Test,covid-19 rt-pcr test,1,2021-05-13,1,0,0,0,0,University of Rochester ( 1 ),1.001,1,NA
Device,covid-19 sars-cov igg,1,2021-05-21,1,0,0,0,0,Medical College of Wisconsin ( 1 ),1.001,1,NA
Device,covid-19 sars-cov igg/igm antibody rapid test,1,2021-05-21,1,0,0,0,0,Medical College of Wisconsin ( 1 ),1.001,1,NA
Drug,covid-19 standard therapy,1,2021-07-26,1,0,0,0,0,Catalysis SL ( 1 ),1.001,1,NA
Diagnostic Test,covid-19 swab,1,2020-06-17,1,0,0,0,0,St. Joseph's Healthcare Hamilton ( 1 ),1.001,1,1
Behavioral,covid-19 symptom monitoring system,1,2021-01-29,1,0,0,0,0,Johns Hopkins Bloomberg School of Public Health ( 1 ),1.001,1,NA
Biological,covid-19 vaccination,1,2021-10-06,1,0,0,0,0,Sheba Medical Center ( 1 ),1.001,1,NA
Other,covid-19 vaccine message,1,2021-05-25,1,0,0,0,0,"Children's Hospital Medical Center, Cincinnati ( 1 )",1.001,1,NA
Biological,covid-19 vaccine observation of individuals who receive the covid-19 vaccine,1,2021-06-10,1,0,0,0,0,Public health and reforms Center of Ministry of Health ( 1 ),1.001,1,NA
Behavioral,covid-specific advice,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Diagnostic Test,covid 19 serology,1,2020-07-21,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Other,covid wheld,1,2020-10-13,1,0,0,0,0,University of Exeter ( 1 ),1.001,1,NA
Device,covidfree@home,1,2020-05-06,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Biological,covishield,1,2021-03-08,1,0,0,0,0,"Institute of Liver and Biliary Sciences, India ( 1 )",1.001,1,NA
Device,covvr,1,2021-03-18,1,0,0,0,0,Ecole Polytechnique FÃ©dÃ©rale de Lausanne ( 1 ),1.001,1,NA
Device,cpap helmet,1,2021-06-08,1,0,0,0,0,New York University ( 1 ),1.001,1,1
Other,cpc,1,2021-05-24,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Other,cpc/zn,1,2021-05-24,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Other,cpc0.05 oral rinse (perioaidactive control),1,2020-09-22,1,0,0,0,0,Dentaid SL ( 1 ),1.001,1,NA
Behavioral,credible messenger,1,2021-03-24,1,0,0,0,0,New York State Psychiatric Institute ( 1 ),1.001,1,NA
Device,cri management,1,2020-06-24,1,0,0,0,0,"University of Colorado, Denver ( 1 )",1.001,1,NA
Behavioral,crisis intervention therapy,1,2020-05-03,1,0,0,0,0,Universidad Nacional Autonoma de Honduras ( 1 ),1.001,1,NA
Behavioral,critical dialogue,1,2021-02-15,1,0,0,0,0,University of Illinois at Urbana-Champaign ( 1 ),1.001,1,NA
Device,crp-apheresis,1,2021-05-20,1,0,0,0,0,"University Hospital, Essen ( 1 )",1.001,1,NA
Other,cryo lung biopsies,1,2021-02-08,1,0,0,0,0,King Faisal Specialist Hospital & Research Center ( 1 ),1.001,1,2
Diagnostic Test,ctus examination,1,2020-04-30,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Behavioral,culturally tailored pcp outreach,1,2021-10-25,1,0,0,0,0,Kaiser Permanente ( 1 ),1.001,1,NA
Other,cupping,1,2020-04-20,1,0,0,0,0,Guang'anmen Hospital of China Academy of Chinese Medical Sciences ( 1 ),1.001,1,NA
Device,current ipac-uhn ppe,1,2020-04-30,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Genetic,dalargin,1,2020-04-22,1,0,0,0,0,University Hospital Tuebingen ( 1 ),1.001,1,NA
Drug,das181,1,2020-03-25,1,0,0,0,0,Renmin Hospital of Wuhan University ( 1 ),1.001,1,NA
Diagnostic Test,data collection/rhinopharyngeal swab,1,2020-03-20,1,0,0,0,0,Centre Hospitalier Intercommunal Creteil ( 1 ),1.001,1,1
Other,data record,1,2020-05-04,1,0,0,0,0,CHU de Reims ( 1 ),1.001,1,NA
Biological,determination of covid-19 vacciantion efficacy,1,2021-06-04,1,0,0,0,0,Centre Henri Becquerel ( 1 ),1.001,1,NA
Diagnostic Test,diagnostic test covid-19,1,2020-06-10,1,0,0,0,0,Tourcoing Hospital ( 1 ),1.001,1,NA
Diagnostic Test,diagnostic test for sars-cov2 for patients,1,2020-05-18,1,0,0,0,0,Institut Cancerologie de l'Ouest ( 1 ),1.001,1,NA
Diagnostic Test,diagnostic test for sars-cov2 for patients/health staff,1,2020-05-18,1,0,0,0,0,Institut Cancerologie de l'Ouest ( 1 ),1.001,1,NA
Behavioral,dialectical behavioral therapy (dbt) skills,1,2020-09-20,1,0,0,0,0,"Rutgers, The State University of New Jersey ( 1 )",1.001,1,NA
Dietary Supplement,diet,1,2021-03-18,1,0,0,0,0,Hospital Clinica Nova ( 1 ),1.001,1,NA
Dietary Supplement,diet/sun exposure,1,2021-03-18,1,0,0,0,0,Hospital Clinica Nova ( 1 ),1.001,1,NA
Dietary Supplement,dietary supplement,1,2020-10-15,1,0,0,0,0,Terra Biological LLC ( 1 ),1.001,1,NA
Dietary Supplement,dietary supplementation in patients with covid disease admitted to hospital,1,2020-04-25,1,0,0,0,0,Hospital de Sagunto ( 1 ),1.001,1,NA
Other,difficulties lived by disabled children's parents in the period of covid-19 pandemic,1,2020-06-28,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Other,dig tilted,1,2020-07-14,1,0,0,0,0,October University for Modern Sciences and Arts ( 1 ),1.001,1,NA
Other,digital cardiac counseling,1,2020-05-11,1,0,0,0,0,Academisch Ziekenhuis Maastricht ( 1 ),1.001,1,1
Device,digital oximeter monitoring,1,2020-08-18,1,0,0,0,0,University of Sao Paulo General Hospital ( 1 ),1.001,1,NA
Behavioral,digital problem solving tool,1,2020-12-18,1,0,0,0,0,Karolinska Institutet ( 1 ),1.001,1,1
Behavioral,digital social activity video intervention,1,2021-01-29,1,0,0,0,0,Columbia University ( 1 ),1.001,1,NA
Device,digivis visual acuity app,1,2020-07-17,1,0,0,0,0,Cambridge University Hospitals NHS Foundation Trust ( 1 ),1.001,1,NA
Diagnostic Test,direct antigen tests for covid-19,1,2020-09-27,1,0,0,0,0,"E25Bio, Inc. ( 1 )",1.001,1,15
Other,discontinuation of acei,1,2020-04-14,1,0,0,0,0,"University Hospital, Gentofte, Copenhagen ( 1 )",1.001,1,NA
Other,discontinuation of arb,1,2020-04-01,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,1
Other,doppler echo,1,2020-04-23,1,0,0,0,0,Versailles Hospital ( 1 ),1.001,1,NA
Other,dressing for external use,1,2021-06-02,1,0,0,0,0,"Second Affiliated Hospital, School of Medicine, Zhejiang University ( 1 )",1.001,1,NA
Diagnostic Test,dried blood spot/venous blood collection,1,2021-05-05,1,0,0,0,0,University Ghent ( 1 ),1.001,1,NA
Other,driving pressure,1,2020-12-18,1,0,0,0,0,University of Pernambuco ( 1 ),1.001,1,NA
Other,drugs,1,2020-07-16,1,0,0,0,0,Aga Khan University ( 1 ),1.001,1,NA
Other,drugs/supportive care,1,2020-07-16,1,0,0,0,0,Aga Khan University ( 1 ),1.001,1,NA
Other,during hospitalization blood samples,1,2020-11-02,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Behavioral,duty frame,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Behavioral,early access,1,2021-03-15,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Behavioral,early occupational therapy,1,2021-04-30,1,0,0,0,0,University of Chile ( 1 ),1.001,1,NA
Device,ecco2r,1,2020-04-09,1,0,0,0,0,University of Giessen ( 1 ),1.001,1,1
Other,economic benefit message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Other,economic freedom message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Other,"educational, culturally appropriate covid-19 messages",1,2021-02-02,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Diagnostic Test,eeg,1,2020-05-26,1,0,0,0,0,"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia ( 1 )",1.001,1,NA
Other,eeg based protocol for deep sedation,1,2021-01-06,1,0,0,0,0,University of Chile ( 1 ),1.001,1,NA
Behavioral,ehealth for covid-19 prevention,1,2021-04-23,1,0,0,0,0,University of Toronto ( 1 ),1.001,1,NA
Behavioral,ehealth for covid-19 prevention/support,1,2021-04-23,1,0,0,0,0,University of Toronto ( 1 ),1.001,1,NA
Other,eit-group,1,2020-07-31,1,0,0,0,0,University of Sao Paulo General Hospital ( 1 ),1.001,1,NA
Diagnostic Test,ejaculated semen sample,1,2020-05-13,1,0,0,0,0,Universitair Ziekenhuis Brussel ( 1 ),1.001,1,NA
Device,electric pad for human external pain therapy,1,2020-04-23,1,0,0,0,0,Instituto Nacional de Perinatologia ( 1 ),1.001,1,NA
Other,electrical impedance tomography,1,2020-12-18,1,0,0,0,0,University of Pernambuco ( 1 ),1.001,1,NA
Diagnostic Test,electronic stethoscope,1,2021-02-23,1,0,0,0,0,Sanolla ( 1 ),1.001,1,NA
Diagnostic Test,elisa poct vs rt-pcr,1,2021-10-07,1,0,0,0,0,Centre Scientifique de Monaco ( 1 ),1.001,1,NA
Diagnostic Test,elispot,1,2020-12-29,1,0,0,0,0,"University Hospital, Rouen ( 1 )",1.001,1,NA
Device,elmo project at covid-19: proof of concept,1,2020-06-10,1,0,0,0,0,Escola de SaÃºde PÃºblica do CearÃ¡ ( 1 ),1.001,1,NA
Procedure,emergency surgical procedures,1,2021-02-11,1,0,0,0,0,Benha University ( 1 ),1.001,1,NA
Behavioral,emotion management,1,2020-08-10,1,0,0,0,0,Ohio State University ( 1 ),1.001,1,NA
Behavioral,emotion regulation training based on dbt,1,2021-06-12,1,0,0,0,0,British University In Egypt ( 1 ),1.001,1,NA
Behavioral,emotion regulation training via telehealth,1,2020-10-26,1,0,0,0,0,"Teachers College, Columbia University ( 1 )",1.001,1,NA
Behavioral,emotional freedom technique,1,2020-05-11,1,0,0,0,0,Istanbul Saglik Bilimleri University ( 1 ),1.001,1,NA
Behavioral,emphasis of academic researchers involvement,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Behavioral,emphasis of government involvement,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Behavioral,empower,1,2021-06-11,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Drug,emtricitabine 200 mg oral tablet,1,2021-01-07,1,0,0,0,0,Universidade Federal do Ceara ( 1 ),1.001,1,NA
Other,enamel care -cetylpyridinium chloride,1,2021-01-05,1,0,0,0,0,Queen Mary University of London ( 1 ),1.001,1,NA
Other,endotracheal intubation,1,2020-11-15,1,0,0,0,0,Evangelismos Hospital ( 1 ),1.001,1,1
Behavioral,endurance rmt,1,2021-06-30,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Behavioral,endurance rmt/nasal breathing,1,2021-06-30,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Other,enduring happiness,1,2020-10-23,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,NA
Other,enduring happiness/continued self-enhancement (enhance) for covid-19,1,2020-10-23,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,NA
Behavioral,enhanced follow through message,1,2021-02-06,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Other,eno breathe group,1,2021-03-31,1,0,0,0,0,Imperial College London ( 1 ),1.001,1,NA
Other,epic risk score display,1,2020-09-25,1,0,0,0,0,NYU Langone Health ( 1 ),1.001,1,NA
Other,eproms assessment,1,2021-03-24,1,0,0,0,0,Jessa Hospital ( 1 ),1.001,1,NA
Other,escola john talabot,1,2021-04-28,1,0,0,0,0,"FundaciÃ³n FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la PromociÃ³n de la Salud y la Ciencia ( 1 )",1.001,1,NA
Other,essence oils,1,2021-02-14,1,0,0,0,0,Universidade do Estado do ParÃ¡ ( 1 ),1.001,1,NA
Other,essential oil blend,1,2020-07-30,1,0,0,0,0,Franklin School of Integrative Health Sciences ( 1 ),1.001,1,NA
Drug,estrogen therapy,1,2020-09-03,1,0,0,0,0,"CMN ""20 de Noviembre"" ( 1 )",1.001,1,NA
Other,exercise program,1,2020-09-19,1,0,0,0,0,Universidad Politecnica de Madrid ( 1 ),1.001,1,NA
Other,exercise/nutrition,1,2020-11-30,1,0,0,0,0,University of Alberta ( 1 ),1.001,1,NA
Other,exercises,1,2021-08-06,1,0,0,0,0,Istanbul Gelisim University ( 1 ),1.001,1,NA
Other,exhaled breath sampling,1,2020-09-20,1,0,0,0,0,Gadjah Mada University ( 1 ),1.001,1,NA
Procedure,expanded hemodialysis for covid19 maintenance hemodialysis patients,1,2020-12-22,1,0,0,0,0,Universita degli Studi di Genova ( 1 ),1.001,1,NA
placebo,expiratory muscle training placebo group,1,2020-12-31,1,0,0,0,0,Universidad Complutense de Madrid ( 1 ),1.001,1,NA
Other,extra-cvd virtual care,1,2020-10-29,1,0,0,0,0,Case Western Reserve University ( 1 ),1.001,1,NA
Other,eye movement desensitisation,1,2020-06-26,1,0,0,0,0,University Hospital Southampton NHS Foundation Trust ( 1 ),1.001,1,1
Other,eye movement desensitisation/reprocessing recent traumatic event protocol,1,2020-06-26,1,0,0,0,0,University Hospital Southampton NHS Foundation Trust ( 1 ),1.001,1,1
Device,face mask / soap,1,2020-11-13,1,0,0,0,0,University of Toronto ( 1 ),1.001,1,NA
Behavioral,face mask awareness,1,2020-11-13,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Behavioral,facebook ads on the importance of staying safe during the thanksgiving,1,2020-11-13,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Device,facial mask,1,2020-04-17,1,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 1 ),1.001,1,NA
Behavioral,family nurture intervention (fni),1,2020-08-19,1,0,0,0,0,Columbia University ( 1 ),1.001,1,NA
Device,familychildcare (provisional name of app),1,2020-06-26,1,0,0,0,0,Johns Hopkins University ( 1 ),1.001,1,NA
Other,far-uvc light as an additional method of disinfection,1,2021-01-26,1,0,0,0,0,Nova Scotia Health Authority ( 1 ),1.001,1,NA
Other,fatigue severity scale,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Drug,favipiravir/tocilizumab,1,2020-03-09,1,0,0,0,0,Peking University First Hospital ( 1 ),1.001,1,NA
Radiation,fdg-pet,1,2021-08-16,1,0,0,0,0,Semmelweis University Heart and Vascular Center ( 1 ),1.001,1,NA
Radiation,fdg-pet/ct,1,2021-08-16,1,0,0,0,0,Semmelweis University Heart and Vascular Center ( 1 ),1.001,1,NA
Other,fecal sample,1,2020-03-31,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,feedback,1,2021-05-17,1,0,0,0,0,University of Alberta ( 1 ),1.001,1,NA
Dietary Supplement,ferinject,1,2021-05-28,1,0,0,0,0,Jomo Kenyatta University of Agriculture and Technology ( 1 ),1.001,1,NA
Procedure,filiform needles,1,2021-05-02,1,0,0,0,0,Indonesia University ( 1 ),1.001,1,NA
Diagnostic Test,filmarray pneumonia,1,2020-05-06,1,0,0,0,0,Cliniques universitaires Saint-Luc- UniversitÃ© Catholique de Louvain ( 1 ),1.001,1,NA
Device,filtering face piece,1,2021-09-08,1,0,0,0,0,University of the Balearic Islands ( 1 ),1.001,1,NA
Behavioral,financial incentives,1,2021-04-27,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Device,flow controlled ventilation (evone-ventilator),1,2020-05-18,1,0,0,0,0,Hamad Medical Corporation ( 1 ),1.001,1,1
Other,fluorescein,1,2020-12-03,1,0,0,0,0,Universitaire Ziekenhuizen Leuven ( 1 ),1.001,1,NA
Device,focal mask,1,2021-07-22,1,0,0,0,0,Georgia Institute of Technology ( 1 ),1.001,1,NA
Behavioral,focused,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Behavioral,focused/targeted message,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Behavioral,fresh start,1,2021-03-15,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Behavioral,gamification,1,2020-05-04,1,0,0,0,0,The University of Queensland ( 1 ),1.001,1,NA
Other,gas exchanges at different peep,1,2020-04-13,1,0,0,0,0,"Southeast University, China ( 1 )",1.001,1,1
Behavioral,general communication message,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Behavioral,general health education,1,2020-03-20,1,0,0,0,0,University of Pecs ( 1 ),1.001,1,1
Other,general lifestyle advice to breast cancer patients by phone,1,2021-04-27,1,0,0,0,0,"Iaso Maternity Hospital, Athens, Greece ( 1 )",1.001,1,NA
Behavioral,general recommendation,1,2020-11-25,1,0,0,0,0,Laval University ( 1 ),1.001,1,NA
Behavioral,generic best practices,1,2021-01-15,1,0,0,0,0,Massachusetts General Hospital ( 1 ),1.001,1,NA
Device,go2 peep mouthpiece,1,2020-03-31,1,0,0,0,0,Emory University ( 1 ),1.001,1,NA
Behavioral,gossip intervention,1,2021-04-28,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,NA
Other,grocery store gift cards,1,2020-11-30,1,0,0,0,0,Boston Medical Center ( 1 ),1.001,1,NA
Other,group a (sample collection),1,2021-02-17,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Dietary Supplement,group a: oropharygeal spray,1,2020-05-25,1,0,0,0,0,Unidad de InvestigaciÃ³n GenÃ©tica Molecular ( 1 ),1.001,1,NA
Dietary Supplement,group a: oropharygeal spray/immunostimulant emulsion,1,2020-05-25,1,0,0,0,0,Unidad de InvestigaciÃ³n GenÃ©tica Molecular ( 1 ),1.001,1,NA
Other,group b (sample collection),1,2021-02-17,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
placebo,group d:placebo oropharyngeal spray,1,2020-05-25,1,0,0,0,0,Unidad de InvestigaciÃ³n GenÃ©tica Molecular ( 1 ),1.001,1,NA
Dietary Supplement,group d:placebo oropharyngeal spray / placebo taken po,1,2020-05-25,1,0,0,0,0,Unidad de InvestigaciÃ³n GenÃ©tica Molecular ( 1 ),1.001,1,NA
Behavioral,growth mindset ssi,1,2020-11-11,1,0,0,0,0,Stony Brook University ( 1 ),1.001,1,NA
Drug,guduchi ghan vati,1,2020-09-08,1,0,0,0,0,Aarogyam UK ( 1 ),1.001,1,NA
Other,guduchi ghanvati,1,2021-06-06,1,0,0,0,0,NMP Medical Research Institute ( 1 ),1.001,1,NA
Behavioral,guided online support program,1,2020-03-26,1,0,0,0,0,International Psychoanalytic University Berlin ( 1 ),1.001,1,NA
Behavioral,hads,1,2020-04-28,1,0,0,0,0,Universitair Ziekenhuis Brussel ( 1 ),1.001,1,NA
Behavioral,handwashing stations at the public places,1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Behavioral,handwashing stations at the public places/no soap,1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Behavioral,hbcc project,1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Behavioral,hbcc project/soap,1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Device,hcfwo,1,2020-12-03,1,0,0,0,0,Icahn School of Medicine at Mount Sinai ( 1 ),1.001,1,NA
Other,hd-tdcs 2ma,1,2021-03-29,1,0,0,0,0,Federal University of ParaÃ­ba ( 1 ),1.001,1,NA
Other,hd-tdcs 4ma,1,2021-03-29,1,0,0,0,0,Federal University of ParaÃ­ba ( 1 ),1.001,1,NA
Behavioral,health warning leaflet,1,2020-05-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Behavioral,healthcare providers' communication about the covid-19 vaccine,1,2021-01-05,1,0,0,0,0,"University of Massachusetts, Worcester ( 1 )",1.001,1,NA
Other,hemodynamics changes at different peep,1,2020-04-13,1,0,0,0,0,"Southeast University, China ( 1 )",1.001,1,1
Drug,high-dose vitamin c treatment,1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Other,high-intensity aerobic training with high protein diet,1,2021-03-05,1,0,0,0,0,Cairo University ( 1 ),1.001,1,NA
Device,high flow nasal oxygen (hfno) treatment,1,2020-12-22,1,0,0,0,0,Bangladesh University of Engineering and Technology ( 1 ),1.001,1,NA
Device,high flow nasal therapy,1,2020-12-03,1,0,0,0,0,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo ( 1 ),1.001,1,NA
Behavioral,high intensity interval training,1,2020-05-21,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,1
Behavioral,high touch multi-pronged behavioral intervention,1,2021-01-27,1,0,0,0,0,Brown University ( 1 ),1.001,1,NA
Behavioral,home-based exercise training,1,2020-12-01,1,0,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Diagnostic Test,home-based sars-cov-2 test kit,1,2021-04-27,1,0,0,0,0,Montana State University ( 1 ),1.001,1,NA
Other,home-based stretching,1,2021-05-06,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,home-based stretching/strengthening exercise,1,2021-05-06,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,home based exercises,1,2021-06-14,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,home based exercises with postural,1,2021-06-14,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,home based exercises with postural/ergonomic training,1,2021-06-14,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,home exercise,1,2020-07-21,1,0,0,0,0,KoÃ§ University ( 1 ),1.001,1,2
Other,home exercise program,1,2021-10-03,1,0,0,0,0,BandÄ±rma Onyedi EylÃ¼l University ( 1 ),1.001,1,NA
Device,home pulse oximetry monitoring,1,2020-04-30,1,0,0,0,0,Swedish Hospital ( 1 ),1.001,1,NA
Diagnostic Test,"hormone levels (testosterone, fsh, lh, prolactin)",1,2021-01-17,1,0,0,0,0,I.M. Sechenov First Moscow State Medical University ( 1 ),1.001,1,NA
Other,icu recovery,1,2020-05-12,1,0,0,0,0,University of Kentucky ( 1 ),1.001,1,NA
Other,icu recovery / physical therapy,1,2020-05-12,1,0,0,0,0,University of Kentucky ( 1 ),1.001,1,NA
Diagnostic Test,igg antibody test,1,2020-04-02,1,0,0,0,0,Indiana University ( 1 ),1.001,1,3
Device,igm antibody rapid test,1,2021-05-21,1,0,0,0,0,Medical College of Wisconsin ( 1 ),1.001,1,NA
Device,iir surgical mask with filtering face piece,1,2021-09-08,1,0,0,0,0,University of the Balearic Islands ( 1 ),1.001,1,NA
Behavioral,immediate vs. delayed provision of antibody test results,1,2020-11-04,1,0,0,0,0,Indiana University ( 1 ),1.001,1,1
Dietary Supplement,immunostimulant emulsion,1,2020-05-25,1,0,0,0,0,Unidad de InvestigaciÃ³n GenÃ©tica Molecular ( 1 ),1.001,1,NA
Behavioral,increasing willingness/uptake of covid-19 testing/vaccination,1,2020-09-03,1,0,0,0,0,Charles Drew University of Medicine and Science ( 1 ),1.001,1,NA
Behavioral,independent control,1,2021-02-21,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Other,inflammatory cytokines,1,2020-04-21,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,1,2020-04-21,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,information assigned in community,1,2021-04-28,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,NA
Other,information on covid-19,1,2021-06-01,1,0,0,0,0,Izmir Bakircay University ( 1 ),1.001,1,NA
Behavioral,informational sheet,1,2021-01-29,1,0,0,0,0,Columbia University ( 1 ),1.001,1,NA
Other,informed program,1,2021-10-03,1,0,0,0,0,BandÄ±rma Onyedi EylÃ¼l University ( 1 ),1.001,1,NA
Other,inhalation of 5% sodium chloride,1,2021-02-06,1,0,0,0,0,"Clinical Hospital Center, Split ( 1 )",1.001,1,NA
Other,"inhalation of 8,4% sodium bicarbonate",1,2021-02-06,1,0,0,0,0,"Clinical Hospital Center, Split ( 1 )",1.001,1,NA
Other,inhalation of n-acetylcysteine,1,2021-02-06,1,0,0,0,0,"Clinical Hospital Center, Split ( 1 )",1.001,1,NA
Drug,inhalation of vitamin c,1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Device,injected cardiac mri,1,2021-06-02,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Other,inspiratory,1,2020-12-31,1,0,0,0,0,Universidad Complutense de Madrid ( 1 ),1.001,1,NA
Other,inspiratory / expiratory muscle training group,1,2020-12-31,1,0,0,0,0,Universidad Complutense de Madrid ( 1 ),1.001,1,NA
Other,inspiratory / expiratory muscle training placebo group,1,2020-12-31,1,0,0,0,0,Universidad Complutense de Madrid ( 1 ),1.001,1,NA
Other,inspiratory muscle training (imt),1,2021-08-24,1,0,0,0,0,Karolinska Institutet ( 1 ),1.001,1,NA
Other,inspiratory muscle training group,1,2020-12-31,1,0,0,0,0,Universidad Complutense de Madrid ( 1 ),1.001,1,NA
Behavioral,integral communication strategy (eics),1,2021-03-27,1,0,0,0,0,Pontificia Universidad Catolica de Chile ( 1 ),1.001,1,NA
Diagnostic Test,interlukein 6,1,2021-06-29,1,0,0,0,0,"Combined Military Hospital, Pakistan ( 1 )",1.001,1,NA
Diagnostic Test,interlukein 6/procalcitonin serum levels,1,2021-06-29,1,0,0,0,0,"Combined Military Hospital, Pakistan ( 1 )",1.001,1,NA
Behavioral,intermittent,1,2020-04-24,1,0,0,0,0,University of Utah ( 1 ),1.001,1,NA
Procedure,internal jugular vein cannulation,1,2021-07-04,1,0,0,0,0,Bakirkoy Dr. Sadi Konuk Research and Training Hospital ( 1 ),1.001,1,NA
Behavioral,internet-based cognitive behavioral therapy,1,2020-08-07,1,0,0,0,0,Hospital de Clinicas de Porto Alegre ( 1 ),1.001,1,1
Behavioral,internet-based guided self-help based on cbt principles,1,2020-05-13,1,0,0,0,0,Hebrew University of Jerusalem ( 1 ),1.001,1,NA
Behavioral,internet-based self-help,1,2020-05-07,1,0,0,0,0,University of Bern ( 1 ),1.001,1,1
Behavioral,internet-based self-help after 3 weeks,1,2020-05-07,1,0,0,0,0,University of Bern ( 1 ),1.001,1,1
Behavioral,internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1,2020-04-07,1,0,0,0,0,Karolinska Institutet ( 1 ),1.001,1,1
Behavioral,intervention group coronacope,1,2020-06-04,1,0,0,0,0,Linkoeping University ( 1 ),1.001,1,NA
Other,intervention group_rehabilitation program,1,2020-07-09,1,0,0,0,0,Rennes University Hospital ( 1 ),1.001,1,NA
Behavioral,intervention program,1,2020-05-13,1,0,0,0,0,Hospital Clinic of Barcelona ( 1 ),1.001,1,1
Behavioral,"intervention, tbn",1,2020-10-25,1,0,0,0,0,University of Alabama at Birmingham ( 1 ),1.001,1,NA
Behavioral,intervention. early,1,2021-03-27,1,0,0,0,0,Pontificia Universidad Catolica de Chile ( 1 ),1.001,1,NA
Behavioral,intervention. early/integral communication strategy (eics),1,2021-03-27,1,0,0,0,0,Pontificia Universidad Catolica de Chile ( 1 ),1.001,1,NA
Device,invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,1,2020-07-27,1,0,0,0,0,FundaciÃ³n Neumologica Colombiana ( 1 ),1.001,1,NA
Device,kelea water,1,2020-07-27,1,0,0,0,0,Institute of Progressive Medicine ( 1 ),1.001,1,NA
Other,ketogenic diet,1,2020-07-25,1,0,0,0,0,Ospedale Policlinico San Martino ( 1 ),1.001,1,NA
Dietary Supplement,ketogenic diet with phytoextracts,1,2020-10-31,1,0,0,0,0,University of Padova ( 1 ),1.001,1,NA
Procedure,kidney biopsy,1,2020-12-02,1,0,0,0,0,Dokuz Eylul University ( 1 ),1.001,1,NA
Other,kinesiotherapy protocol,1,2021-03-01,1,0,0,0,0,University of the State of Santa Catarina ( 1 ),1.001,1,NA
Dietary Supplement,kovir oral capsule,1,2021-09-08,1,0,0,0,0,Sunstar Joint Stock Company ( 1 ),1.001,1,NA
Behavioral,kukaa salama: mhealth intervention,1,2020-11-13,1,0,0,0,0,University of Toronto ( 1 ),1.001,1,NA
Dietary Supplement,l. reuteri dsm 17938,1,2020-12-10,1,0,0,0,0,"Ã–rebro University, Sweden ( 1 )",1.001,1,NA
Dietary Supplement,l. reuteri dsm 17938 / vitamin d,1,2020-12-10,1,0,0,0,0,"Ã–rebro University, Sweden ( 1 )",1.001,1,NA
Dietary Supplement,lactobaciltus rhamnosus gg,1,2020-05-19,1,0,0,0,0,Duke University ( 1 ),1.001,1,1
Procedure,laryngoscopy,1,2020-04-24,1,0,0,0,0,Lazarski University ( 1 ),1.001,1,NA
Device,laser acupoint stimulation(laser pen),1,2021-07-28,1,0,0,0,0,Far Eastern Memorial Hospital ( 1 ),1.001,1,NA
Other,laughter theraphy,1,2021-02-24,1,0,0,0,0,Zonguldak Bulent Ecevit University ( 1 ),1.001,1,1
Behavioral,lay telephone coaching,1,2020-10-19,1,0,0,0,0,"St. Mary's Research Center, Canada ( 1 )",1.001,1,NA
Other,let it out (lio)-c,1,2020-05-12,1,0,0,0,0,"University College, London ( 1 )",1.001,1,NA
Other,leukapheresis,1,2020-07-09,1,0,0,0,0,Seraph Research Institute ( 1 ),1.001,1,NA
Dietary Supplement,licorice extract,1,2020-07-24,1,0,0,0,0,Egyptian Biomedical Research Network ( 1 ),1.001,1,1
Device,limbix spark,1,2020-08-20,1,0,0,0,0,"Limbix Health, Inc. ( 1 )",1.001,1,NA
Procedure,"liver, lung, heart",1,2020-12-02,1,0,0,0,0,Dokuz Eylul University ( 1 ),1.001,1,NA
Procedure,"liver, lung, heart/kidney biopsy",1,2020-12-02,1,0,0,0,0,Dokuz Eylul University ( 1 ),1.001,1,NA
Radiation,lung low dose radiation,1,2020-06-01,1,0,0,0,0,Hospital Provincial de Castellon ( 1 ),1.001,1,NA
Diagnostic Test,lung ultrasound use in patients hospitalized with covid,1,2020-09-04,1,0,0,0,0,"University of Colorado, Denver ( 1 )",1.001,1,NA
Device,lus twelve area,1,2021-03-15,1,0,0,0,0,Bursa YÃ¼ksek Ä°htisas Education and Research Hospital ( 1 ),1.001,1,NA
Dietary Supplement,m capsules 148 mg,1,2021-02-11,1,0,0,0,0,Saisei Pharma ( 1 ),1.001,1,NA
Other,machine learning,1,2020-05-04,1,0,0,0,0,The Christie NHS Foundation Trust ( 1 ),1.001,1,NA
Other,machine learning/ai algorithm,1,2020-05-04,1,0,0,0,0,The Christie NHS Foundation Trust ( 1 ),1.001,1,NA
Dietary Supplement,maf capsules 148 mg,1,2021-02-11,1,0,0,0,0,Saisei Pharma ( 1 ),1.001,1,NA
Dietary Supplement,magnesium stearate),1,2020-11-05,1,0,0,0,0,Centre de recherche du Centre hospitalier universitaire de Sherbrooke ( 1 ),1.001,1,NA
Other,magnetic resonance spectroscopy (mrs).,1,2020-09-10,1,0,0,0,0,"Centre Hospitalier Universitaire, Amiens ( 1 )",1.001,1,NA
Device,magventure magpro system with brainsight neuronavigation device,1,2021-07-17,1,0,0,0,0,Weill Medical College of Cornell University ( 1 ),1.001,1,NA
Other,maintenance,1,2020-04-07,1,0,0,0,0,D'Or Institute for Research and Education ( 1 ),1.001,1,1
Device,makair,1,2020-07-15,1,0,0,0,0,Nantes University Hospital ( 1 ),1.001,1,NA
Behavioral,management by a medical student,1,2020-04-18,1,0,0,0,0,"University Hospital, Tours ( 1 )",1.001,1,NA
Dietary Supplement,manremyc,1,2020-06-25,1,0,0,0,0,Reig Jofre Group ( 1 ),1.001,1,NA
Other,maximal effort test,1,2020-04-24,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Device,mcgrath videolaryngoscope,1,2020-06-01,1,0,0,0,0,Singapore General Hospital ( 1 ),1.001,1,6
Device,mct,1,2021-03-31,1,0,0,0,0,"University of California, Davis ( 1 )",1.001,1,NA
Other,medical research council (mrc) dyspnea scale,1,2021-01-10,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Biological,mesenchymal stem cells transplantation,1,2021-05-21,1,0,0,0,0,SBÃœ Dr. Sadi Konuk EÄŸitim ve AraÅŸtÄ±rma Hastanesi ( 1 ),1.001,1,NA
Behavioral,messaging,1,2020-04-28,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Behavioral,mindfulness-based cognitive therapy,1,2020-09-04,1,0,0,0,0,University of Michigan ( 1 ),1.001,1,NA
Behavioral,mindfulness-based health promotion,1,2020-12-22,1,0,0,0,0,FundaÃ§Ã£o Bahiana de Infectologia ( 1 ),1.001,1,4
Behavioral,mindfulness-based stress reduction,1,2021-01-12,1,0,0,0,0,Radboud University ( 1 ),1.001,1,NA
Behavioral,mindfulness based cognitive therapy for resilience during covid-19,1,2020-10-19,1,0,0,0,0,Cambridge Health Alliance ( 1 ),1.001,1,NA
Behavioral,mindfulness based cognitive therapy for resilience during covid-19/chamindwell,1,2020-10-19,1,0,0,0,0,Cambridge Health Alliance ( 1 ),1.001,1,NA
Behavioral,mindfulness practice,1,2021-06-07,1,0,0,0,0,Yale-NUS College ( 1 ),1.001,1,NA
Device,miniprobe alveoflex,1,2020-06-29,1,0,0,0,0,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia ( 1 )",1.001,1,NA
Drug,"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste",1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Drug,"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation",1,2020-12-07,1,0,0,0,0,Xi'an International Medical Center Hospital ( 1 ),1.001,1,NA
Other,mobile intervention,1,2021-08-24,1,0,0,0,0,Unity Health Toronto ( 1 ),1.001,1,NA
Behavioral,mobile mental health app - 1,1,2020-08-22,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Behavioral,mobile mental health app - 2,1,2020-08-22,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Behavioral,mobile mental health app - 4,1,2020-08-22,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Other,moderate exercise training (age group 1; young adult 17 -30 years),1,2021-06-14,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,moderate exercise training (age group 2; 31 to 45 years),1,2021-06-14,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,moderate exercise training (age group 3; above 45 years),1,2021-06-14,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Biological,moderna,1,2021-05-21,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Device,mouthwashes,1,2021-05-16,1,0,0,0,0,"Cluster de Bioeconomia de Baja California, A.C ( 1 )",1.001,1,NA
Device,mouthwashes/nose rinse in a conventional way,1,2021-05-16,1,0,0,0,0,"Cluster de Bioeconomia de Baja California, A.C ( 1 )",1.001,1,NA
Diagnostic Test,mri,1,2021-06-29,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,12
Drug,mucodentol,1,2020-07-09,1,0,0,0,0,Baqiyatallah Medical Sciences University ( 1 ),1.001,1,NA
Genetic,multi-omics,1,2021-04-30,1,0,0,0,0,University Hospital Tuebingen ( 1 ),1.001,1,NA
Behavioral,multidisciplinary rehabilitation,1,2021-05-07,1,0,0,0,0,Danderyd Hospital ( 1 ),1.001,1,NA
Behavioral,multimodal teleprehabilitation,1,2021-03-01,1,0,0,0,0,McGill University Health Centre/Research Institute of the McGill University Health Centre ( 1 ),1.001,1,NA
Dietary Supplement,multivitamin with 11mg of zinc,1,2020-09-09,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Other,muscle-target oral nutritional supplementation,1,2021-02-15,1,0,0,0,0,IRCCS Policlinico S. Matteo ( 1 ),1.001,1,NA
Procedure,muscle biopsy,1,2021-01-04,1,0,0,0,0,Hasselt University ( 1 ),1.001,1,NA
Behavioral,muscle relaxation therapy,1,2020-09-04,1,0,0,0,0,University of Michigan ( 1 ),1.001,1,NA
Other,museum virtual guided tours,1,2020-10-13,1,0,0,0,0,Jewish General Hospital ( 1 ),1.001,1,NA
Other,music therapy group,1,2021-10-08,1,0,0,0,0,Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari ( 1 ),1.001,1,NA
Behavioral,my wishes,1,2021-08-24,1,0,0,0,0,University of Utah ( 1 ),1.001,1,NA
Device,n95 respirator,1,2020-03-03,1,0,0,0,0,McMaster University ( 1 ),1.001,1,NA
Device,narrow band ultraviolet b-band light,1,2021-03-24,1,0,0,0,0,"Cytokind, Inc. ( 1 )",1.001,1,NA
Behavioral,nasal breathing,1,2021-06-30,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Procedure,nasal fluid sampling before,1,2021-07-05,1,0,0,0,0,"University Hospital, Ghent ( 1 )",1.001,1,NA
Other,nasal lavage,1,2020-09-21,1,0,0,0,0,Augusta University ( 1 ),1.001,1,NA
Other,nasal spray containing anti-sars-cov-2 antibodies derived from bovine colostrum,1,2021-06-03,1,0,0,0,0,Icosagen Cell Factory ( 1 ),1.001,1,NA
Diagnostic Test,nasopharyngeal,1,2020-08-11,1,0,0,0,0,Centre Leon Berard ( 1 ),1.001,1,NA
Behavioral,nature/mindfulness,1,2021-04-14,1,0,0,0,0,National Institutes of Health Clinical Center (CC) ( 1 ),1.001,1,NA
Behavioral,navigation services,1,2021-02-15,1,0,0,0,0,University of Illinois at Urbana-Champaign ( 1 ),1.001,1,NA
Biological,nebulized platelet lysate,1,2020-07-23,1,0,0,0,0,"Regenexx, LLC ( 1 )",1.001,1,NA
Other,nebulized sterile saline,1,2020-07-23,1,0,0,0,0,"Regenexx, LLC ( 1 )",1.001,1,NA
Other,negative control,1,2021-05-24,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Procedure,neonatal resuscitation with ppe for the prevention of sars-cov-2 infection,1,2020-12-11,1,0,0,0,0,University Hospital Padova ( 1 ),1.001,1,2
Procedure,neonatal resuscitation without ppe for the prevention of sars-cov-2 infection,1,2020-12-11,1,0,0,0,0,University Hospital Padova ( 1 ),1.001,1,2
Other,neuro,1,2021-06-09,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Other,neuro -,1,2021-06-09,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Device,no personal protective equipment (ppe),1,2020-09-02,1,0,0,0,0,Institute of Mountain Emergency Medicine ( 1 ),1.001,1,NA
Behavioral,no soap,1,2021-02-11,1,0,0,0,0,BRAC University ( 1 ),1.001,1,NA
Behavioral,non-mindfulness intervention,1,2020-05-18,1,0,0,0,0,Monash University Malaysia ( 1 ),1.001,1,NA
Procedure,non-operative management,1,2021-02-05,1,0,0,0,0,The Cleveland Clinic ( 1 ),1.001,1,NA
Device,non narrow band ultraviolet b-band light,1,2021-03-24,1,0,0,0,0,"Cytokind, Inc. ( 1 )",1.001,1,NA
Device,nose rinse in a conventional way,1,2021-05-16,1,0,0,0,0,"Cluster de Bioeconomia de Baja California, A.C ( 1 )",1.001,1,NA
Other,not bravery message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Device,novottf-100l,1,2021-07-04,1,0,0,0,0,NovoCure Ltd. ( 1 ),1.001,1,NA
Behavioral,nudge,1,2020-05-04,1,0,0,0,0,Medical College of Wisconsin ( 1 ),1.001,1,NA
Behavioral,nurse-community-family partnership intervention,1,2021-04-02,1,0,0,0,0,New York University ( 1 ),1.001,1,NA
Combination Product,nutrition consult,1,2020-07-31,1,0,0,0,0,McMaster University ( 1 ),1.001,1,NA
Combination Product,nutrition consult/protein supplementation,1,2020-07-31,1,0,0,0,0,McMaster University ( 1 ),1.001,1,NA
Device,offsite pcr testing,1,2021-05-19,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Other,ointment,1,2021-06-02,1,0,0,0,0,"Second Affiliated Hospital, School of Medicine, Zhejiang University ( 1 )",1.001,1,NA
Other,ointment/dressing for external use,1,2021-06-02,1,0,0,0,0,"Second Affiliated Hospital, School of Medicine, Zhejiang University ( 1 )",1.001,1,NA
Dietary Supplement,"ol-1, high dose",1,2021-04-13,1,0,0,0,0,"Rutgers, The State University of New Jersey ( 1 )",1.001,1,NA
Other,old ppe,1,2021-01-11,1,0,0,0,0,University of Oxford ( 1 ),1.001,1,NA
Diagnostic Test,olfactometry,1,2020-08-03,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Dietary Supplement,omega dha,1,2021-03-12,1,0,0,0,0,Hospital de la Soledad ( 1 ),1.001,1,NA
Dietary Supplement,omega dha / epa,1,2021-03-12,1,0,0,0,0,Hospital de la Soledad ( 1 ),1.001,1,NA
Drug,omeprazole,1,2020-04-01,1,0,0,0,0,Imperial College London ( 1 ),1.001,1,NA
Dietary Supplement,omni-biotic pro vi 5,1,2021-03-15,1,0,0,0,0,Medical University of Graz ( 1 ),1.001,1,NA
Other,online cognitive stimulation therapy,1,2020-12-11,1,0,0,0,0,"University College, London ( 1 )",1.001,1,NA
Other,online interactive courses,1,2021-08-05,1,0,0,0,0,National Cheng Kung University ( 1 ),1.001,1,NA
Behavioral,online intervention grief covid-19,1,2020-11-19,1,0,0,0,0,Universidad Internacional de Valencia ( 1 ),1.001,1,NA
Behavioral,online intervention mental health covid-19,1,2020-07-10,1,0,0,0,0,Universidad Internacional de Valencia ( 1 ),1.001,1,2
Behavioral,online kkh sports singapore program with usual care,1,2020-02-03,1,0,0,0,0,KK Women's and Children's Hospital ( 1 ),1.001,1,NA
Behavioral,online lifestyle intervention,1,2021-02-13,1,0,0,0,0,Universidad de Sonora ( 1 ),1.001,1,NA
Behavioral,online psychological intervention for healthcare workers,1,2021-05-17,1,0,0,0,0,Universidad Internacional de Valencia ( 1 ),1.001,1,1
Behavioral,opt-in (call-back),1,2021-04-06,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,opt-in (in-bound),1,2021-04-06,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,opt-in recruitment email,1,2020-08-07,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,opt-out framing,1,2021-04-06,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,opt-out recruitment email,1,2020-08-07,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Other,oral-bâ® gum,1,2021-01-05,1,0,0,0,0,Queen Mary University of London ( 1 ),1.001,1,NA
Other,oral-bâ® gum/enamel care -cetylpyridinium chloride,1,2021-01-05,1,0,0,0,0,Queen Mary University of London ( 1 ),1.001,1,NA
Dietary Supplement,oxaloacetate medical food/dietary supplement,1,2020-10-15,1,0,0,0,0,Terra Biological LLC ( 1 ),1.001,1,NA
Behavioral,parent positive,1,2021-02-24,1,0,0,0,0,King's College London ( 1 ),1.001,1,1
Other,parent/peer presence,1,2021-08-04,1,0,0,0,0,"University Hospital, Ghent ( 1 )",1.001,1,NA
Behavioral,patient-centred advice on telephone consultation in tb patients:,1,2020-05-30,1,0,0,0,0,Health Science Center of Xi'an Jiaotong University ( 1 ),1.001,1,NA
Diagnostic Test,performance evaluation,1,2020-04-30,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Diagnostic Test,performance of the test antigenic,1,2020-10-01,1,0,0,0,0,Centre Hospitalier Intercommunal Creteil ( 1 ),1.001,1,NA
Device,performing of lung ultrasound,1,2020-06-15,1,0,0,0,0,Assistance Publique Hopitaux De Marseille ( 1 ),1.001,1,NA
Device,peripheral sealing device for surgical mask/filtering face piece,1,2021-09-08,1,0,0,0,0,University of the Balearic Islands ( 1 ),1.001,1,NA
Other,personal freedom message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Device,personal protective equipment,1,2020-07-09,1,0,0,0,0,Baqiyatallah Medical Sciences University ( 1 ),1.001,1,NA
Behavioral,personal protective measures,1,2020-11-25,1,0,0,0,0,Benha University ( 1 ),1.001,1,NA
Behavioral,personal risk messaging,1,2021-03-29,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Behavioral,phase i promotores de salud outreach,1,2021-10-15,1,0,0,0,0,University of Oregon ( 1 ),1.001,1,NA
Behavioral,phase ii promotores de salud,1,2021-10-15,1,0,0,0,0,University of Oregon ( 1 ),1.001,1,NA
Other,phn intervention,1,2021-07-29,1,0,0,0,0,"Near East University, Turkey ( 1 )",1.001,1,NA
Behavioral,phone-call screening/management by a medical student/general practitioner tandem,1,2020-04-18,1,0,0,0,0,"University Hospital, Tours ( 1 )",1.001,1,NA
Drug,phr160 spray,1,2020-07-04,1,0,0,0,0,Baqiyatallah Medical Sciences University ( 1 ),1.001,1,NA
Behavioral,physical,1,2020-12-11,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Behavioral,physical activity,1,2021-09-02,1,0,0,0,0,UniversitÃ© de MontrÃ©al ( 1 ),1.001,1,NA
Behavioral,physical/cognitive activity,1,2020-12-11,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Behavioral,physicians,1,2021-07-05,1,0,0,0,0,Seoul National University Hospital ( 1 ),1.001,1,NA
Other,physiological effects of awake prone position in covid 19 patients,1,2020-11-16,1,0,0,0,0,Assistance Publique Hopitaux De Marseille ( 1 ),1.001,1,NA
Drug,piperacillin,1,2020-05-15,1,0,0,0,0,Fundacion GenesisCare ( 1 ),1.001,1,5
Drug,piperacillin/tazobactam,1,2020-05-15,1,0,0,0,0,Fundacion GenesisCare ( 1 ),1.001,1,5
placebo,placebo (potato starch,1,2020-11-05,1,0,0,0,0,Centre de recherche du Centre hospitalier universitaire de Sherbrooke ( 1 ),1.001,1,NA
Dietary Supplement,placebo (potato starch/magnesium stearate),1,2020-11-05,1,0,0,0,0,Centre de recherche du Centre hospitalier universitaire de Sherbrooke ( 1 ),1.001,1,NA
Dietary Supplement,placebo / vitamin d,1,2020-12-10,1,0,0,0,0,"Ã–rebro University, Sweden ( 1 )",1.001,1,NA
placebo,placebo control (non-behavioral infographic),1,2020-09-16,1,0,0,0,0,Indiana University ( 1 ),1.001,1,2
placebo,placebo mini drinks,1,2021-04-13,1,0,0,0,0,Maastricht University Medical Center ( 1 ),1.001,1,NA
placebo,placebo taken po,1,2020-05-25,1,0,0,0,0,Unidad de InvestigaciÃ³n GenÃ©tica Molecular ( 1 ),1.001,1,NA
placebo,placebo videos,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Device,pneumoniacheck,1,2021-06-02,1,0,0,0,0,Emory University ( 1 ),1.001,1,NA
Other,polyester reusable mask,1,2021-06-30,1,0,0,0,0,Fundacion Clinica Valle del Lili ( 1 ),1.001,1,NA
Behavioral,position,1,2020-06-11,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Behavioral,positive feedback,1,2020-06-18,1,0,0,0,0,Cedars-Sinai Medical Center ( 1 ),1.001,1,NA
Behavioral,post-hospitalization nutritional monitoring,1,2021-05-24,1,0,0,0,0,GÃ©rond'if ( 1 ),1.001,1,NA
Device,ppg/prom,1,2021-09-13,1,0,0,0,0,Technische UniversitÃ¤t MÃ¼nchen ( 1 ),1.001,1,NA
Other,pro-sero-cov,1,2020-06-09,1,0,0,0,0,Institut BergoniÃ© ( 1 ),1.001,1,NA
Other,probiorinse,1,2020-07-01,1,0,0,0,0,Centre hospitalier de l'UniversitÃ© de MontrÃ©al (CHUM) ( 1 ),1.001,1,NA
Behavioral,problem-solving,1,2020-04-12,1,0,0,0,0,Beijing Normal University ( 1 ),1.001,1,NA
Behavioral,problem-solving/relationship improvement intervention.,1,2020-04-12,1,0,0,0,0,Beijing Normal University ( 1 ),1.001,1,NA
Procedure,procalcitonin,1,2020-04-02,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Diagnostic Test,procalcitonin serum levels,1,2021-06-29,1,0,0,0,0,"Combined Military Hospital, Pakistan ( 1 )",1.001,1,NA
Other,progressive cycling exercise test to exhaustion,1,2020-09-09,1,0,0,0,0,University of Saskatchewan ( 1 ),1.001,1,1
Other,project echo,1,2020-07-31,1,0,0,0,0,Milton S. Hershey Medical Center ( 1 ),1.001,1,NA
Other,prolectin-m; a (1-6)-alpha-d-mannopyranose class,1,2020-08-11,1,0,0,0,0,Composite Interceptive Med Science ( 1 ),1.001,1,NA
Other,prolonged proned positioning,1,2020-10-07,1,0,0,0,0,University of Alabama at Birmingham ( 1 ),1.001,1,NA
Behavioral,prosocial acts,1,2020-08-14,1,0,0,0,0,University of Toronto ( 1 ),1.001,1,NA
Other,protective ventilation,1,2020-04-08,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,1
Combination Product,protein supplementation,1,2020-07-31,1,0,0,0,0,McMaster University ( 1 ),1.001,1,NA
Device,prototype,1,2020-04-24,1,0,0,0,0,University of Virginia ( 1 ),1.001,1,NA
Other,psa value,1,2021-08-15,1,0,0,0,0,Saglik Bilimleri Universitesi ( 1 ),1.001,1,NA
Other,psg,1,2020-04-28,1,0,0,0,0,"University Hospital, Bordeaux ( 1 )",1.001,1,NA
Behavioral,psycho-education,1,2020-10-20,1,0,0,0,0,Makerere University ( 1 ),1.001,1,1
Behavioral,psychotherapy,1,2020-07-13,1,0,0,0,0,Queen's University ( 1 ),1.001,1,1
Other,public space exposure,1,2020-05-13,1,0,0,0,0,"National University, Singapore ( 1 )",1.001,1,NA
Diagnostic Test,pulmonary anomalies 4 months after documented covid-19 pneumonia,1,2020-06-05,1,0,0,0,0,"University Hospital, Toulouse ( 1 )",1.001,1,NA
Diagnostic Test,pulmonary function testing,1,2020-08-18,1,0,0,0,0,Centre Hospitalier Universitaire de Besancon ( 1 ),1.001,1,NA
Other,pulmonary physiotherapy techniques,1,2020-04-13,1,0,0,0,0,Tehran University of Medical Sciences ( 1 ),1.001,1,NA
Device,pulse oximeter,1,2020-10-07,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Diagnostic Test,pulse oximetry,1,2020-05-26,1,0,0,0,0,"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia ( 1 )",1.001,1,NA
Diagnostic Test,qualitative,1,2021-02-01,1,0,0,0,0,Johann Wolfgang Goethe University Hospital ( 1 ),1.001,1,NA
Diagnostic Test,quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,1,2021-02-01,1,0,0,0,0,Johann Wolfgang Goethe University Hospital ( 1 ),1.001,1,NA
Dietary Supplement,quercetin phytosome (qp),1,2021-04-25,1,0,0,0,0,King Edward Medical University ( 1 ),1.001,1,NA
Diagnostic Test,quidel sofia sars antigen fia,1,2020-10-27,1,0,0,0,0,Carilion Clinic ( 1 ),1.001,1,NA
Behavioral,race concordant,1,2021-04-27,1,0,0,0,0,University of Southern California ( 1 ),1.001,1,NA
Behavioral,racial,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Behavioral,racial inequality highlighted,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Behavioral,racial/ethnic frame,1,2020-09-24,1,0,0,0,0,Harvard University ( 1 ),1.001,1,NA
Device,radiofrequency therapy,1,2021-05-26,1,0,0,0,0,Clinica Gema Leon ( 1 ),1.001,1,NA
Device,rapid antigen testing,1,2021-05-19,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Device,rapid antigen testing/onsite pcr testing,1,2021-05-19,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Diagnostic Test,rapid nasopharyngeal antigen test for sars-cov-2,1,2021-04-29,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,read leaflets containing knowledge of covid-19,1,2021-08-30,1,0,0,0,0,Ningbo No. 1 Hospital ( 1 ),1.001,1,NA
Other,read leaflets containing knowledge of covid-19/vaccination.,1,2021-08-30,1,0,0,0,0,Ningbo No. 1 Hospital ( 1 ),1.001,1,NA
Behavioral,reading a book,1,2020-08-03,1,0,0,0,0,Beth Israel Deaconess Medical Center ( 1 ),1.001,1,NA
Behavioral,recharge,1,2020-08-26,1,0,0,0,0,University of Zurich ( 1 ),1.001,1,NA
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.3ml,1,2021-05-30,1,0,0,0,0,CanSino Biologics Inc. ( 1 ),1.001,1,NA
Biological,recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.5ml,1,2021-05-30,1,0,0,0,0,CanSino Biologics Inc. ( 1 ),1.001,1,NA
Behavioral,referral,1,2021-02-15,1,0,0,0,0,University of Illinois at Urbana-Champaign ( 1 ),1.001,1,NA
Behavioral,referral/digital brochure,1,2021-02-15,1,0,0,0,0,University of Illinois at Urbana-Champaign ( 1 ),1.001,1,NA
Behavioral,reframing,1,2021-01-26,1,0,0,0,0,Geisinger Clinic ( 1 ),1.001,1,NA
Other,rehabilitation,1,2020-04-26,1,0,0,0,0,Istanbul Bilgi University ( 1 ),1.001,1,NA
Other,rehabilitation-focused program,1,2020-11-09,1,0,0,0,0,VA Office of Research and Development ( 1 ),1.001,1,NA
Other,rehabilitation by concentric exercises,1,2020-09-29,1,0,0,0,0,"University Hospital, Clermont-Ferrand ( 1 )",1.001,1,NA
Other,rehabilitation by eccentric exercises,1,2020-09-29,1,0,0,0,0,"University Hospital, Clermont-Ferrand ( 1 )",1.001,1,NA
Behavioral,relaxation,1,2020-10-08,1,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 1 ),1.001,1,NA
Other,relaxation technique,1,2021-08-08,1,0,0,0,0,Beni-Suef University ( 1 ),1.001,1,NA
Behavioral,remain covid free ssi,1,2020-06-29,1,0,0,0,0,Stony Brook University ( 1 ),1.001,1,NA
Behavioral,remote cognitive behavioral therapy for insomnia,1,2020-05-28,1,0,0,0,0,Stanford University ( 1 ),1.001,1,NA
Other,remote controlled exercise,1,2020-07-21,1,0,0,0,0,KoÃ§ University ( 1 ),1.001,1,2
Behavioral,remote problem management plus,1,2020-11-02,1,0,0,0,0,The New School ( 1 ),1.001,1,NA
Other,"remote sms (short message service, also known as ""text message"") delivery",1,2021-02-08,1,0,0,0,0,Ontario Medical Association ( 1 ),1.001,1,NA
Other,removal of dead space filter,1,2020-06-07,1,0,0,0,0,Karolinska Institutet ( 1 ),1.001,1,NA
Other,reprocessing recent traumatic event protocol,1,2020-06-26,1,0,0,0,0,University Hospital Southampton NHS Foundation Trust ( 1 ),1.001,1,1
Behavioral,resistance training,1,2021-03-08,1,0,0,0,0,Universidad PÃºblica de Navarra ( 1 ),1.001,1,NA
Diagnostic Test,resp-aer-meter,1,2021-02-01,1,0,0,0,0,Johann Wolfgang Goethe University Hospital ( 1 ),1.001,1,NA
Other,respiratory,1,2020-11-30,1,0,0,0,0,Universidad Peruana Cayetano Heredia ( 1 ),1.001,1,NA
Other,respiratory activity,1,2021-10-07,1,0,0,0,0,IRCCS Policlinico S. Donato ( 1 ),1.001,1,NA
Other,respiratory/psychological rehabilitation,1,2020-11-30,1,0,0,0,0,Universidad Peruana Cayetano Heredia ( 1 ),1.001,1,NA
Other,revised home-cov score,1,2020-12-06,1,0,0,0,0,"University Hospital, Angers ( 1 )",1.001,1,NA
Behavioral,reward re-training,1,2020-12-07,1,0,0,0,0,Drexel University ( 1 ),1.001,1,1
Diagnostic Test,rhinopharyngeal,1,2020-03-20,1,0,0,0,0,Centre Hospitalier Intercommunal Creteil ( 1 ),1.001,1,1
Procedure,robot assisted percutaneous cardiovascular intervention,1,2020-04-27,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,1
Device,robotic assisted early mobilization,1,2021-02-09,1,0,0,0,0,"Charite University, Berlin, Germany ( 1 )",1.001,1,NA
Device,robotic therapy,1,2020-05-15,1,0,0,0,0,Fondazione Don Carlo Gnocchi Onlus ( 1 ),1.001,1,NA
Behavioral,routine psychological support,1,2021-03-26,1,0,0,0,0,Alexandria University ( 1 ),1.001,1,NA
Device,saline nasal/throat spray,1,2020-05-28,1,0,0,0,0,Swansea University ( 1 ),1.001,1,NA
Device,saliva assay,1,2020-10-06,1,0,0,0,0,"University of Wisconsin, Madison ( 1 )",1.001,1,NA
Diagnostic Test,saliva collected via salivette cortisol,1,2020-10-22,1,0,0,0,0,Boehringer Ingelheim ( 1 ),1.001,1,NA
Diagnostic Test,saliva sample (self-sample),1,2021-04-22,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Diagnostic Test,saliva sample/to an anterior nare self-swabbing (self-samples),1,2021-04-22,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Device,saliva test kit,1,2020-09-25,1,0,0,0,0,Stanford University ( 1 ),1.001,1,NA
Diagnostic Test,salivary test for covid19,1,2021-08-16,1,0,0,0,0,Centre Hospitalier de Cayenne ( 1 ),1.001,1,NA
Diagnostic Test,sample collection,1,2020-04-30,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Other,sampling,1,2020-06-22,1,0,0,0,0,Universitaire Ziekenhuizen Leuven ( 1 ),1.001,1,NA
Other,sampling of oropharynx,1,2020-04-20,1,0,0,0,0,Jessa Hospital ( 1 ),1.001,1,NA
Diagnostic Test,sars-cov-2 antibody test,1,2020-08-24,1,0,0,0,0,The Royal Wolverhampton Hospitals NHS Trust ( 1 ),1.001,1,NA
Other,sch intervention,1,2020-06-26,1,0,0,0,0,University of Utah ( 1 ),1.001,1,NA
Device,sd biosensor,1,2021-05-05,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,NA
Behavioral,second phase cardiac rehabilitation,1,2021-09-29,1,0,0,0,0,National Cardiovascular Center Harapan Kita Hospital Indonesia ( 1 ),1.001,1,NA
Behavioral,self-acupressure,1,2020-07-13,1,0,0,0,0,"University of California, Los Angeles ( 1 )",1.001,1,NA
Behavioral,self-compassion for chronic pain virtual group treatment program,1,2020-05-21,1,0,0,0,0,University of Manitoba ( 1 ),1.001,1,NA
Behavioral,self-management booklet (switch: stay well during covid-19),1,2020-05-26,1,0,0,0,0,King's College London ( 1 ),1.001,1,NA
Behavioral,self-questionnary,1,2020-05-27,1,0,0,0,0,Rennes University Hospital ( 1 ),1.001,1,NA
Behavioral,self study,1,2020-08-26,1,0,0,0,0,University of Zurich ( 1 ),1.001,1,NA
Device,sentinox--group a,1,2021-05-28,1,0,0,0,0,APR Applied Pharma Research s.a. ( 1 ),1.001,1,NA
Device,sentinox--group b,1,2021-05-28,1,0,0,0,0,APR Applied Pharma Research s.a. ( 1 ),1.001,1,NA
Diagnostic Test,sequence of testing.,1,2021-01-12,1,0,0,0,0,"Rigshospitalet, Denmark ( 1 )",1.001,1,1
Device,seraph,1,2020-04-29,1,0,0,0,0,ExThera Medical Europe BV ( 1 ),1.001,1,NA
Diagnostic Test,serological screening,1,2021-01-08,1,0,0,0,0,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France ( 1 )",1.001,1,NA
Diagnostic Test,serological testing for covid-19 infection,1,2020-12-29,1,0,0,0,0,"University Hospital, Rouen ( 1 )",1.001,1,NA
Behavioral,services as usual,1,2021-02-25,1,0,0,0,0,University of Oregon ( 1 ),1.001,1,NA
Dietary Supplement,sfc (5-ala,1,2020-08-16,1,0,0,0,0,Royal College of Surgeons in Ireland - Medical University of Bahrain ( 1 ),1.001,1,NA
Dietary Supplement,sfc),1,2020-08-16,1,0,0,0,0,Royal College of Surgeons in Ireland - Medical University of Bahrain ( 1 ),1.001,1,NA
Device,sham,1,2021-07-09,1,0,0,0,0,KNOWBio Inc. ( 1 ),1.001,1,NA
Other,sham acupressure group,1,2021-06-05,1,0,0,0,0,Mersin University ( 1 ),1.001,1,NA
Other,shanshamani vati plus,1,2020-11-06,1,0,0,0,0,Aarogyam UK ( 1 ),1.001,1,NA
Behavioral,shg,1,2020-06-12,1,0,0,0,0,University of Miami ( 1 ),1.001,1,NA
Behavioral,simha kriya,1,2020-08-03,1,0,0,0,0,Beth Israel Deaconess Medical Center ( 1 ),1.001,1,NA
Diagnostic Test,sit to stand test,1,2021-01-19,1,0,0,0,0,"University Hospital, Rouen ( 1 )",1.001,1,NA
Device,sledd with a l-mod,1,2020-04-07,1,0,0,0,0,Lawson Health Research Institute ( 1 ),1.001,1,3
Device,sleepio,1,2021-08-05,1,0,0,0,0,NHS Greater Glasgow and Clyde ( 1 ),1.001,1,NA
Behavioral,social norm,1,2021-10-12,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Behavioral,social proof,1,2021-01-26,1,0,0,0,0,Geisinger Clinic ( 1 ),1.001,1,NA
Diagnostic Test,specificity) for covid-19 diagnosis of the vocus ptr-tof process,1,2021-01-08,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Other,specimens specific for the study,1,2021-01-21,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Diagnostic Test,sperm test,1,2021-01-17,1,0,0,0,0,I.M. Sechenov First Moscow State Medical University ( 1 ),1.001,1,NA
Behavioral,standard charity resources,1,2020-08-12,1,0,0,0,0,King's College London ( 1 ),1.001,1,1
Other,standard guidelines,1,2021-06-06,1,0,0,0,0,NMP Medical Research Institute ( 1 ),1.001,1,NA
Procedure,stellate ganglion block,1,2020-05-22,1,0,0,0,0,West Virginia University ( 1 ),1.001,1,NA
Behavioral,stigma awareness video intervention,1,2021-01-29,1,0,0,0,0,Columbia University ( 1 ),1.001,1,NA
Other,stool analysis,1,2020-04-24,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Biological,stools,1,2020-06-10,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,strength rmt,1,2021-06-30,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Behavioral,stress,1,2020-08-10,1,0,0,0,0,Ohio State University ( 1 ),1.001,1,NA
Other,supervised rehabilitation program.,1,2021-06-01,1,0,0,0,0,Evangelismos Hospital ( 1 ),1.001,1,NA
Other,supervised stretching/strengthening exercise,1,2021-05-06,1,0,0,0,0,Riphah International University ( 1 ),1.001,1,NA
Other,supine positioning,1,2020-06-05,1,0,0,0,0,Poudre Valley Health System ( 1 ),1.001,1,NA
Other,support as usual,1,2021-01-12,1,0,0,0,0,Radboud University ( 1 ),1.001,1,NA
Other,supportive services,1,2021-01-29,1,0,0,0,0,Johns Hopkins Bloomberg School of Public Health ( 1 ),1.001,1,NA
Other,survey of acceptability of the different self-samples.,1,2021-04-22,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Other,survey of sars-cov-19 knowledge,1,2021-04-22,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Other,suspension,1,2020-04-07,1,0,0,0,0,D'Or Institute for Research and Education ( 1 ),1.001,1,1
Other,suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,1,2020-04-07,1,0,0,0,0,D'Or Institute for Research and Education ( 1 ),1.001,1,1
Other,sweat samples (covidog ancillary study),1,2020-03-31,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Other,symptom survey,1,2020-08-26,1,0,0,0,0,Lancaster General Hospital ( 1 ),1.001,1,NA
Drug,symptomatic drugs,1,2020-05-25,1,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 1 ),1.001,1,NA
Drug,symptomatic treatment,1,2020-07-14,1,0,0,0,0,Mansoura University ( 1 ),1.001,1,NA
Genetic,t-cell receptor,1,2020-04-22,1,0,0,0,0,University Hospital Tuebingen ( 1 ),1.001,1,NA
Dietary Supplement,tablets,1,2020-09-09,1,0,0,0,0,Mayo Clinic ( 1 ),1.001,1,NA
Device,tape-software,1,2020-07-28,1,0,0,0,0,RWTH Aachen University ( 1 ),1.001,1,1
Behavioral,targeted message,1,2020-09-24,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,2
Drug,tazobactam,1,2020-05-15,1,0,0,0,0,Fundacion GenesisCare ( 1 ),1.001,1,5
Device,tcc-covid mhealth,1,2020-05-21,1,0,0,0,0,"Prince of Wales Hospital, Sydney ( 1 )",1.001,1,NA
Behavioral,tele-delivered psychological intervention,1,2020-05-22,1,0,0,0,0,"Rigshospitalet, Denmark ( 1 )",1.001,1,NA
Behavioral,tele-interventions related to diabetes management/mental well-being,1,2020-04-07,1,0,0,0,0,Federal University of Rio Grande do Sul ( 1 ),1.001,1,NA
Other,tele-rheumatology,1,2021-01-06,1,0,0,0,0,University of Alabama at Birmingham ( 1 ),1.001,1,NA
Other,telegeriatric intervention,1,2021-02-06,1,0,0,0,0,"Universidad Iberoamericana A.C., Mexico ( 1 )",1.001,1,NA
Behavioral,telepsychoeducation,1,2020-11-05,1,0,0,0,0,Hospital de Clinicas de Porto Alegre ( 1 ),1.001,1,NA
Behavioral,telepsychoeducation without personalized videos,1,2020-11-05,1,0,0,0,0,Hospital de Clinicas de Porto Alegre ( 1 ),1.001,1,NA
Other,telerehabilitation-based relaxation exercise group (eg),1,2021-03-29,1,0,0,0,0,Hacettepe University ( 1 ),1.001,1,NA
Device,test group: experimental - uvc therapy applied,1,2020-11-16,1,0,0,0,0,RD Global AraÅŸtirma GeliÅŸtirme SaÄŸlik IlaÃ§ InÅŸaat Yatirimlari A.Åž. ( 1 ),1.001,1,2
Diagnostic Test,testing for sars-cov-2 igm,1,2021-01-16,1,0,0,0,0,Washington University School of Medicine ( 1 ),1.001,1,NA
Other,therapeutic exercise/education,1,2020-08-17,1,0,0,0,0,University of Malaga ( 1 ),1.001,1,NA
Behavioral,therapy intervention,1,2020-05-06,1,0,0,0,0,University of Missouri-Columbia ( 1 ),1.001,1,NA
Diagnostic Test,throat,1,2020-08-11,1,0,0,0,0,Centre Leon Berard ( 1 ),1.001,1,NA
Device,throat spray,1,2020-05-28,1,0,0,0,0,Swansea University ( 1 ),1.001,1,NA
Diagnostic Test,throat swab,1,2020-09-17,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,1
Diagnostic Test,to an anterior nare self-swabbing (self-samples),1,2021-04-22,1,0,0,0,0,Centre Hospitalier Universitaire de Saint Etienne ( 1 ),1.001,1,NA
Other,toothpaste with sodium fluoride/zinc,1,2020-07-14,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Other,toothpaste with sodium monofluorophosphate,1,2020-07-14,1,0,0,0,0,Hospital Israelita Albert Einstein ( 1 ),1.001,1,NA
Drug,traditional chinese medicine,1,2020-01-28,1,0,0,0,0,Beijing 302 Hospital ( 1 ),1.001,1,1
Other,traditional proning arm,1,2020-10-07,1,0,0,0,0,University of Alabama at Birmingham ( 1 ),1.001,1,NA
Behavioral,training,1,2021-07-04,1,0,0,0,0,Mehmet Akif Ersoy University ( 1 ),1.001,1,NA
Other,training clinicians in basic critical care/the management of severe covid-19 cases,1,2020-08-05,1,0,0,0,0,Surgical Systems Research Group ( 1 ),1.001,1,NA
Behavioral,trauma-informed yoga video recording,1,2020-06-30,1,0,0,0,0,National University of Natural Medicine ( 1 ),1.001,1,NA
Other,treadmill exercise,1,2021-05-17,1,0,0,0,0,Pulmonary Wellness Foundation ( 1 ),1.001,1,NA
Behavioral,treatment as usual,1,2021-06-25,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Drug,treatment as usual vitamin d,1,2020-08-17,1,0,0,0,0,"Cantonal Hosptal, Baselland ( 1 )",1.001,1,NA
Behavioral,trial-based cognitive therapy,1,2020-12-22,1,0,0,0,0,FundaÃ§Ã£o Bahiana de Infectologia ( 1 ),1.001,1,4
Other,trust in science message,1,2020-07-02,1,0,0,0,0,Yale University ( 1 ),1.001,1,NA
Other,tsu,1,2021-03-26,1,0,0,0,0,Istituti Clinici Scientifici Maugeri SpA ( 1 ),1.001,1,NA
Device,uexplorer,1,2021-03-31,1,0,0,0,0,"University of California, Davis ( 1 )",1.001,1,NA
Device,uexplorer/mct,1,2021-03-31,1,0,0,0,0,"University of California, Davis ( 1 )",1.001,1,NA
Behavioral,ultra brief online mindfulness-based intervention,1,2020-08-26,1,0,0,0,0,Universiti Tunku Abdul Rahman ( 1 ),1.001,1,NA
Other,upper limb training,1,2021-06-24,1,0,0,0,0,UniversitÃ© de Sherbrooke ( 1 ),1.001,1,NA
Behavioral,uptake of covid-19 testing,1,2020-09-03,1,0,0,0,0,Charles Drew University of Medicine and Science ( 1 ),1.001,1,NA
Device,usability,1,2020-06-10,1,0,0,0,0,Escola de SaÃºde PÃºblica do CearÃ¡ ( 1 ),1.001,1,NA
Other,use of facetime with child,1,2020-09-24,1,0,0,0,0,"Children's Hospital Medical Center, Cincinnati ( 1 )",1.001,1,NA
Other,use of facetime with child/parents during induction,1,2020-09-24,1,0,0,0,0,"Children's Hospital Medical Center, Cincinnati ( 1 )",1.001,1,NA
Other,usual antibiotic treatment,1,2020-04-02,1,0,0,0,0,Assistance Publique - HÃ´pitaux de Paris ( 1 ),1.001,1,NA
Behavioral,"usual care, infection control briefing",1,2021-02-25,1,0,0,0,0,The Hong Kong Polytechnic University ( 1 ),1.001,1,NA
Device,usual monitoring,1,2021-03-25,1,0,0,0,0,Assistance Publique Hopitaux De Marseille ( 1 ),1.001,1,NA
Other,usual orientations,1,2021-03-01,1,0,0,0,0,University of the State of Santa Catarina ( 1 ),1.001,1,NA
Other,usual treatments in intensive care unit according to the current state of knowledge,1,2021-02-05,1,0,0,0,0,Hospices Civils de Lyon ( 1 ),1.001,1,NA
Device,uv light treatment,1,2020-09-28,1,0,0,0,0,Cedars-Sinai Medical Center ( 1 ),1.001,1,1
Behavioral,vaccination,1,2020-09-03,1,0,0,0,0,Charles Drew University of Medicine and Science ( 1 ),1.001,1,NA
Diagnostic Test,vaccination against covid19,1,2020-12-29,1,0,0,0,0,Scentech Medical Technologies Ltd ( 1 ),1.001,1,NA
Other,vaccination.,1,2021-08-30,1,0,0,0,0,Ningbo No. 1 Hospital ( 1 ),1.001,1,NA
Other,vcpm,1,2020-09-03,1,0,0,0,0,VA Office of Research and Development ( 1 ),1.001,1,NA
Diagnostic Test,venous blood collection,1,2021-05-05,1,0,0,0,0,University Ghent ( 1 ),1.001,1,NA
Diagnostic Test,venous draw,1,2020-10-19,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Diagnostic Test,venous draw/testing,1,2020-10-19,1,0,0,0,0,LumiraDx UK Limited ( 1 ),1.001,1,NA
Diagnostic Test,venous ultrasound of lower extremity,1,2021-08-30,1,0,0,0,0,Hospital Universitari Vall d'Hebron Research Institute ( 1 ),1.001,1,NA
Device,vibrolung,1,2020-06-14,1,0,0,0,0,Astana Medical University ( 1 ),1.001,1,NA
Other,video-based intervention,1,2020-08-02,1,0,0,0,0,"Research Foundation for Mental Hygiene, Inc. ( 1 )",1.001,1,NA
Behavioral,video-based psychotherapy,1,2021-04-06,1,0,0,0,0,Indonesia University ( 1 ),1.001,1,5
Behavioral,video _ behavioral change module,1,2021-07-13,1,0,0,0,0,"Research Foundation for Mental Hygiene, Inc. ( 1 )",1.001,1,NA
Behavioral,video chat,1,2020-07-20,1,0,0,0,0,University of South Carolina ( 1 ),1.001,1,NA
Behavioral,video chat / basic feedback,1,2020-07-20,1,0,0,0,0,University of South Carolina ( 1 ),1.001,1,NA
Behavioral,video chat /personalized feedback,1,2020-07-20,1,0,0,0,0,University of South Carolina ( 1 ),1.001,1,NA
Other,video dance classes,1,2020-06-07,1,0,0,0,0,Federal University of Rio Grande do Sul ( 1 ),1.001,1,NA
Behavioral,videos,1,2021-04-16,1,0,0,0,0,University of Washington ( 1 ),1.001,1,NA
Device,vielight rx plus,1,2020-06-03,1,0,0,0,0,Vielight Inc. ( 1 ),1.001,1,NA
Behavioral,virtual-care cognitive behavioural therapy,1,2020-05-26,1,0,0,0,0,The Hospital for Sick Children ( 1 ),1.001,1,NA
Other,"virtual assistant first, then human coach",1,2020-06-09,1,0,0,0,0,"University Health Network, Toronto ( 1 )",1.001,1,NA
Other,virtual care at home,1,2020-05-29,1,0,0,0,0,Lawson Health Research Institute ( 1 ),1.001,1,NA
Behavioral,virtual elm,1,2020-11-06,1,0,0,0,0,Rush University Medical Center ( 1 ),1.001,1,NA
Behavioral,virtual group exercise,1,2020-07-31,1,0,0,0,0,McMaster University ( 1 ),1.001,1,NA
Behavioral,virtual group intervention,1,2020-05-29,1,0,0,0,0,University of British Columbia ( 1 ),1.001,1,1
Other,virtual individual cognitive simulation therapy,1,2021-03-23,1,0,0,0,0,"University College, London ( 1 )",1.001,1,NA
Behavioral,virtual meeting between patients,1,2021-07-05,1,0,0,0,0,Seoul National University Hospital ( 1 ),1.001,1,NA
Behavioral,virtual meeting between patients/physicians/caregiver,1,2021-07-05,1,0,0,0,0,Seoul National University Hospital ( 1 ),1.001,1,NA
Behavioral,virtual mindfulness meditation,1,2021-10-19,1,0,0,0,0,University of Pennsylvania ( 1 ),1.001,1,NA
Device,virtual reality,1,2020-07-03,1,0,0,0,0,Radboud University ( 1 ),1.001,1,NA
Device,volatile organic compounds analysis (e-noses),1,2021-03-15,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Device,volatile organic compounds analysis (mass spectrometry),1,2021-03-15,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Device,volatile organic compounds analysis in sweat (mass spectrometry),1,2021-03-15,1,0,0,0,0,Hopital Foch ( 1 ),1.001,1,NA
Behavioral,vr for psychoeducation,1,2020-10-08,1,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 1 ),1.001,1,NA
Behavioral,vr for psychoeducation/relaxation,1,2020-10-08,1,0,0,0,0,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta ( 1 ),1.001,1,NA
Device,vv-ecmo,1,2020-03-25,1,0,0,0,0,University Hospital Freiburg ( 1 ),1.001,1,1
Device,vv-ecmo / cytokine adsorption,1,2020-03-25,1,0,0,0,0,University Hospital Freiburg ( 1 ),1.001,1,1
Diagnostic Test,walk test,1,2021-03-19,1,0,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Other,water (e) mouth rinse with the solution provided,1,2020-10-21,1,0,0,0,0,Augusta University ( 1 ),1.001,1,NA
Device,water without an elevated level of kelea,1,2020-07-27,1,0,0,0,0,Institute of Progressive Medicine ( 1 ),1.001,1,NA
Behavioral,white sender in acknowledgement,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Behavioral,white sender in informational videos,1,2020-08-02,1,0,0,0,0,"National Bureau of Economic Research, Inc. ( 1 )",1.001,1,1
Behavioral,who recommendations (waiting condition),1,2020-03-26,1,0,0,0,0,International Psychoanalytic University Berlin ( 1 ),1.001,1,NA
Other,wingate exercise test,1,2021-04-23,1,0,0,0,0,University of Saskatchewan ( 1 ),1.001,1,1
Other,wingate exercise test/on-ice testing while wearing a face mask,1,2021-04-23,1,0,0,0,0,University of Saskatchewan ( 1 ),1.001,1,1
Behavioral,women sexual dysfunctions were screened using female sexual functioning index (fsfi),1,2021-08-23,1,0,0,0,0,Gaziosmanpasa Research and Education Hospital ( 1 ),1.001,1,NA
Behavioral,written summary of rounds,1,2020-08-04,1,0,0,0,0,Rush University Medical Center ( 1 ),1.001,1,NA
Diagnostic Test,"xiamen wiz biotech co., ltd. sars-cov-2 antigen rapid test",1,2021-03-18,1,0,0,0,0,"Sky Medical Supplies & Equipments, LLC ( 1 )",1.001,1,NA
Biological,-cd25,1,2021-08-26,0,1,0,0,0,"University of California, San Francisco ( 1 )",1.001,1,NA
Drug,0.12% chg oral rinse,1,2020-07-15,0,1,0,0,0,"University of Wisconsin, Madison ( 1 )",1.001,1,NA
Drug,100 mg/ml virazole,1,2020-09-15,0,1,0,0,0,"Bausch Health Americas, Inc. ( 1 )",1.001,1,NA
Biological,25 âµg spfn_1b-06-pl,1,2021-03-03,0,1,0,0,0,U.S. Army Medical Research and Development Command ( 1 ),1.001,1,NA
Biological,25 âµg spfn_1b-06-pl / alfq (qs21 adjuvant),1,2021-03-03,0,1,0,0,0,U.S. Army Medical Research and Development Command ( 1 ),1.001,1,NA
Biological,50 âµg spfn_1b-06-pl / alfq (qs21 adjuvant),1,2021-03-03,0,1,0,0,0,U.S. Army Medical Research and Development Command ( 1 ),1.001,1,NA
Drug,50 mg,1,2020-09-15,0,1,0,0,0,"Bausch Health Americas, Inc. ( 1 )",1.001,1,NA
Drug,50 mg/ml virazole,1,2020-09-15,0,1,0,0,0,"Bausch Health Americas, Inc. ( 1 )",1.001,1,NA
Drug,abbv-47d11,1,2020-11-23,0,1,0,0,0,AbbVie ( 1 ),1.001,1,NA
Biological,abncov2 vaccine,1,2021-03-11,0,1,0,0,0,Radboud University ( 1 ),1.001,1,NA
Biological,ad5-ncov,1,2020-09-15,0,1,0,0,0,"Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China ( 1 )",1.001,1,1
Biological,adcovid,1,2020-12-21,0,1,0,0,0,"Altimmune, Inc. ( 1 )",1.001,1,NA
Biological,adenovirus type-5 vectored covid-19 vaccine,1,2020-09-28,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Biological,adimrsc-2f,1,2020-08-12,0,1,0,0,0,Adimmune Corporation ( 1 ),1.001,1,NA
Drug,adm03820,1,2020-10-12,0,1,0,0,0,Ology Bioservices ( 1 ),1.001,1,NA
Other,aerobic exercise therapy,1,2021-03-29,0,1,0,0,0,Memorial Sloan Kettering Cancer Center ( 1 ),1.001,1,NA
Drug,agent-797,1,2020-10-06,0,1,0,0,0,Agenus Inc. ( 1 ),1.001,1,NA
Dietary Supplement,alanine,1,2021-01-06,0,1,0,0,0,Baylor College of Medicine ( 1 ),1.001,1,NA
Biological,alfq (qs21 adjuvant),1,2021-03-03,0,1,0,0,0,U.S. Army Medical Research and Development Command ( 1 ),1.001,1,NA
Drug,allogeneic mesenchymal stem cell,1,2020-08-28,0,1,0,0,0,Ina-Respond ( 1 ),1.001,1,NA
Drug,alpha one antitrypsin,1,2020-05-10,0,1,0,0,0,"Ministry of Health, Saudi Arabia ( 1 )",1.001,1,NA
Drug,anti-sars-cov-2 equine immunoglobulin f(ab')2 fragments (inosars),1,2020-08-12,0,1,0,0,0,Hospital San Jose Tec de Monterrey ( 1 ),1.001,1,NA
Drug,bempegaldesleukin,1,2020-11-14,0,1,0,0,0,Nektar Therapeutics ( 1 ),1.001,1,NA
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1,2020-08-16,0,1,0,0,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 1 )",1.001,1,NA
Biological,c-135-ls,1,2021-01-05,0,1,0,0,0,Rockefeller University ( 1 ),1.001,1,1
Biological,c144-ls,1,2021-01-05,0,1,0,0,0,Rockefeller University ( 1 ),1.001,1,1
Drug,cbd,1,2020-12-18,0,1,0,0,0,Sheba Medical Center ( 1 ),1.001,1,NA
Biological,chadv68-s,1,2021-02-25,0,1,0,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),1.001,1,NA
Biological,chadv68-s-tce,1,2021-02-25,0,1,0,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),1.001,1,NA
Biological,ck0802,1,2020-07-10,0,1,0,0,0,"Cellenkos, Inc. ( 1 )",1.001,1,NA
Biological,concentrate beetroot juice,1,2021-05-06,0,1,0,0,0,Queen Mary University of London ( 1 ),1.001,1,2
Other,control patients,1,2020-11-04,0,1,0,0,0,Hospital Reg. Lic. Adolfo Lopez Mateos ( 1 ),1.001,1,NA
Drug,convalscent plasma,1,2020-07-15,0,1,0,0,0,"Ministry of Health, Kuwait ( 1 )",1.001,1,NA
Drug,corvax,1,2020-11-06,0,1,0,0,0,Providence Health & Services ( 1 ),1.001,1,NA
Biological,covepit (ose13e),1,2021-05-07,0,1,0,0,0,OSE Immunotherapeutics ( 1 ),1.001,1,NA
Biological,covi-vac,1,2020-11-05,0,1,0,0,0,"Codagenix, Inc ( 1 )",1.001,1,NA
Biological,covid-higiv,1,2020-12-09,0,1,0,0,0,Emergent BioSolutions ( 1 ),1.001,1,NA
Biological,covid19 vaccine,1,2020-06-03,0,1,0,0,0,Vaxine Pty Ltd ( 1 ),1.001,1,NA
Drug,cpi-006,1,2020-07-07,0,1,0,0,0,"Corvus Pharmaceuticals, Inc. ( 1 )",1.001,1,NA
Biological,cryopreserved ex vivo expanded polyclonal cd4/cd127lo/-cd25/ t regulatory cells,1,2021-08-26,0,1,0,0,0,"University of California, San Francisco ( 1 )",1.001,1,NA
Biological,csl760,1,2020-11-19,0,1,0,0,0,CSL Behring ( 1 ),1.001,1,NA
Procedure,csvf,1,2020-03-26,0,1,0,0,0,"Black Tie Medical, Inc. ( 1 )",1.001,1,NA
Drug,day,1,2020-05-07,0,1,0,0,0,PharmaMar ( 1 ),1.001,1,NA
Biological,delns1-ncov-rbd laiv,1,2021-03-19,0,1,0,0,0,The University of Hong Kong ( 1 ),1.001,1,NA
Biological,dose finding phase (mtd),1,2020-05-21,0,1,0,0,0,Baylor College of Medicine ( 1 ),1.001,1,NA
Drug,double-blind nt-i7,1,2020-07-27,0,1,0,0,0,NeoImmuneTech ( 1 ),1.001,1,NA
Drug,effects in oxygenation,1,2021-05-19,0,1,0,0,0,Unidad Temporal COVID-19 en Centro Citibanamex ( 1 ),1.001,1,5
Drug,effects in oxygenation/hypoxic pulmonary vasoconstriction,1,2021-05-19,0,1,0,0,0,Unidad Temporal COVID-19 en Centro Citibanamex ( 1 ),1.001,1,5
Device,electrical stimulation,1,2020-12-23,0,1,0,0,0,Baylor College of Medicine ( 1 ),1.001,1,NA
Biological,erucov-vac,1,2020-11-14,0,1,0,0,0,Health Institutes of Turkey ( 1 ),1.001,1,NA
Drug,exo-cd24,1,2021-01-26,0,1,0,0,0,Tel-Aviv Sourasky Medical Center ( 1 ),1.001,1,NA
Drug,giga-2050,1,2021-05-04,0,1,0,0,0,"GigaGen, Inc. ( 1 )",1.001,1,NA
Biological,had5-s-fusion/n-etsd (suspension for injection),1,2021-01-27,0,1,0,0,0,"ImmunityBio, Inc. ( 1 )",1.001,1,NA
Drug,had5-sfusion,1,2021-01-27,0,1,0,0,0,"ImmunityBio, Inc. ( 1 )",1.001,1,NA
Drug,hyperpolarized xe129,1,2020-12-07,0,1,0,0,0,University of Kansas Medical Center ( 1 ),1.001,1,NA
Drug,hypoxic pulmonary vasoconstriction,1,2021-05-19,0,1,0,0,0,Unidad Temporal COVID-19 en Centro Citibanamex ( 1 ),1.001,1,5
Diagnostic Test,igg dosage,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Diagnostic Test,igm,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,4
Diagnostic Test,igm/igg dosage,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Drug,il-12 plasmid,1,2020-11-06,0,1,0,0,0,Providence Health & Services ( 1 ),1.001,1,NA
Biological,"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal spray",1,2021-03-09,0,1,0,0,0,"Meissa Vaccines, Inc. ( 1 )",1.001,1,NA
Biological,koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 6 âµg,1,2021-04-06,0,1,0,0,0,Kocak Farma ( 1 ),1.001,1,NA
Biological,koã§ak-19 inaktif adjuvanlä± covid-19 vaccine 6 âµg/0.5 ml vaccine,1,2021-04-06,0,1,0,0,0,Kocak Farma ( 1 ),1.001,1,NA
Drug,liberase enzyme,1,2020-03-26,0,1,0,0,0,"Black Tie Medical, Inc. ( 1 )",1.001,1,NA
Biological,longeveron mesenchymal stem cells (lmscs),1,2020-09-29,0,1,0,0,0,Longeveron Inc. ( 1 ),1.001,1,NA
Other,media intervention,1,2020-07-21,0,1,0,0,0,M.D. Anderson Cancer Center ( 1 ),1.001,1,1
Diagnostic Test,medical evaluation,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Procedure,meditation therapy,1,2020-07-21,0,1,0,0,0,M.D. Anderson Cancer Center ( 1 ),1.001,1,1
Combination Product,"menthol 0.02%, methyl salicylate 0.05%, n- acetyl cysteine 1.2 gm%,",1,2021-05-18,0,1,0,0,0,Sher-E-Bangla Medical College ( 1 ),1.001,1,NA
Drug,methylene blue/photodynamic therapy,1,2021-06-15,0,1,0,0,0,I.M. Sechenov First Moscow State Medical University ( 1 ),1.001,1,NA
Combination Product,monoclonal antibody,1,2020-06-06,0,1,0,0,0,"Shanghai Junshi Bioscience Co., Ltd. ( 1 )",1.001,1,1
Drug,mqfpd,1,2021-06-21,0,1,0,0,0,"University of California, San Diego ( 1 )",1.001,1,NA
Biological,mrna-1283,1,2021-03-22,0,1,0,0,0,"ModernaTX, Inc. ( 1 )",1.001,1,NA
Biological,msc,1,2020-10-29,0,1,0,0,0,Hospital Reg. Lic. Adolfo Lopez Mateos ( 1 ),1.001,1,NA
Biological,multipeptide cocktail,1,2020-08-26,0,1,0,0,0,University Hospital Tuebingen ( 1 ),1.001,1,NA
Biological,mva-sars-2-s vaccinations (days 0,1,2020-09-21,0,1,0,0,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),1.001,1,NA
Biological,mva-sars-2-s vaccinations (days 0/28),1,2020-09-21,0,1,0,0,0,UniversitÃ¤tsklinikum Hamburg-Eppendorf ( 1 ),1.001,1,NA
Dietary Supplement,n-acetyl glucosamine (nag),1,2020-12-31,0,1,0,0,0,Quantinosis.ai LLC ( 1 ),1.001,1,1
Biological,n-etsd (suspension for injection),1,2021-01-27,0,1,0,0,0,"ImmunityBio, Inc. ( 1 )",1.001,1,NA
Drug,neumifil,1,2021-09-29,0,1,0,0,0,Pneumagen Ltd. ( 1 ),1.001,1,NA
Diagnostic Test,news-2 score,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Drug,nigella,1,2021-05-28,0,1,0,0,0,HÃ´pital Universitaire Sahloul ( 1 ),1.001,1,NA
Biological,nitrate-deplete beetroot juice,1,2021-05-06,0,1,0,0,0,Queen Mary University of London ( 1 ),1.001,1,2
Drug,nitrogen gas,1,2020-08-25,0,1,0,0,0,University Hospitals Cleveland Medical Center ( 1 ),1.001,1,NA
Drug,nox66,1,2020-09-16,0,1,0,0,0,Noxopharm Limited ( 1 ),1.001,1,NA
Drug,opn-019,1,2021-08-24,0,1,0,0,0,Optinose US Inc. ( 1 ),1.001,1,NA
Biological,partially hla-matched sars-covsts,1,2020-05-21,0,1,0,0,0,Baylor College of Medicine ( 1 ),1.001,1,NA
Drug,pf-07321332/ritonavir,1,2021-07-10,0,1,0,0,0,Pfizer ( 1 ),1.001,1,NA
placebo,placebo (saline),1,2020-12-09,0,1,0,0,0,Emergent BioSolutions ( 1 ),1.001,1,NA
placebo,placebo for abbv-2b04,1,2020-11-23,0,1,0,0,0,AbbVie ( 1 ),1.001,1,NA
placebo,placebo for abbv-47d11,1,2020-11-23,0,1,0,0,0,AbbVie ( 1 ),1.001,1,NA
placebo,placebo single,1,2020-12-18,0,1,0,0,0,NP Therapeutics ( 1 ),1.001,1,NA
Drug,poly-iclc (hiltonolâ®),1,2020-10-05,0,1,0,0,0,"Oncovir, Inc. ( 1 )",1.001,1,6
Biological,primepro,1,2020-09-23,0,1,0,0,0,Thomas Advanced Medical LLC ( 1 ),1.001,1,NA
Behavioral,problem solving therapy (pst).,1,2021-05-05,0,1,0,0,0,Lawson Health Research Institute ( 1 ),1.001,1,NA
Drug,progesterone,1,2020-04-24,0,1,0,0,0,Cedars-Sinai Medical Center ( 1 ),1.001,1,1
Biological,psc-04,1,2020-07-22,0,1,0,0,0,"Sorrento Therapeutics, Inc. ( 1 )",1.001,1,1
Biological,recombinant two-component covid-19 vaccine (cho cell),1,2021-03-19,0,1,0,0,0,"Jiangsu Rec-Biotechnology Co., Ltd. ( 1 )",1.001,1,NA
Drug,ritonavir / midazolam,1,2021-08-27,0,1,0,0,0,Pfizer ( 1 ),1.001,1,NA
Other,routine care (no sars-covsts),1,2020-05-21,0,1,0,0,0,Baylor College of Medicine ( 1 ),1.001,1,NA
Biological,sab-185,1,2020-07-08,0,1,0,0,0,"SAb Biotherapeutics, Inc. ( 1 )",1.001,1,NA
Biological,sam-lnp-s,1,2021-02-25,0,1,0,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),1.001,1,NA
Biological,scb-2019 with as03 adjuvant,1,2020-05-25,0,1,0,0,0,Clover Biopharmaceuticals AUS Pty Ltd ( 1 ),1.001,1,1
Biological,scb-2019 with cpg 1018 adjuvant,1,2020-05-25,0,1,0,0,0,Clover Biopharmaceuticals AUS Pty Ltd ( 1 ),1.001,1,1
Biological,scb-2019 with cpg 1018 adjuvant/alum adjuvant,1,2020-05-25,0,1,0,0,0,Clover Biopharmaceuticals AUS Pty Ltd ( 1 ),1.001,1,1
Diagnostic Test,screening blood test,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Biological,"shingrix (zoster vaccine recombinant, adjuvanted)",1,2020-08-20,0,1,0,0,0,University of Oklahoma ( 1 ),1.001,1,NA
Drug,sir1-365,1,2020-11-03,0,1,0,0,0,"Sironax USA, Inc. ( 1 )",1.001,1,NA
Drug,sno,1,2020-08-25,0,1,0,0,0,University Hospitals Cleveland Medical Center ( 1 ),1.001,1,NA
Other,"sodium chloride, 0.9%",1,2021-02-25,0,1,0,0,0,National Institute of Allergy and Infectious Diseases (NIAID) ( 1 ),1.001,1,NA
Drug,"sodium chloride, usp, for injection (0.9% nacl)",1,2021-03-03,0,1,0,0,0,U.S. Army Medical Research and Development Command ( 1 ),1.001,1,NA
Behavioral,student-senior isolation prevention partnership (ssipp),1,2021-05-05,0,1,0,0,0,Lawson Health Research Institute ( 1 ),1.001,1,NA
Drug,sublingual methylene blue,1,2020-11-04,0,1,0,0,0,Hospital Reg. Lic. Adolfo Lopez Mateos ( 1 ),1.001,1,NA
Other,sudarshan kriya yoga (sky),1,2020-04-26,0,1,0,0,0,Lawson Health Research Institute ( 1 ),1.001,1,2
Biological,t cell derived exosom,1,2020-05-12,0,1,0,0,0,TC Erciyes University ( 1 ),1.001,1,NA
Biological,t regulatory cells,1,2021-08-26,0,1,0,0,0,"University of California, San Francisco ( 1 )",1.001,1,NA
Other,teleorientation/tooth brushing orientation,1,2021-07-09,0,1,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Biological,"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",1,2020-11-17,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Biological,"three doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 14, 28",1,2020-08-27,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Biological,"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",1,2020-11-17,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
placebo,"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",1,2020-11-17,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Drug,tl-895,1,2020-06-03,0,1,0,0,0,"Telios Pharma, Inc. ( 1 )",1.001,1,NA
Other,tooth brushing orientation,1,2021-07-09,0,1,0,0,0,University of Sao Paulo ( 1 ),1.001,1,NA
Drug,topotecan,1,2021-10-11,0,1,0,0,0,"National University Hospital, Singapore ( 1 )",1.001,1,NA
Procedure,tsvf,1,2020-03-26,0,1,0,0,0,"Black Tie Medical, Inc. ( 1 )",1.001,1,NA
Biological,two covid-19 vaccine candidate (tmv-083,1,2020-07-31,0,1,0,0,0,Institut Pasteur ( 1 ),1.001,1,NA
Biological,two covid-19 vaccine candidate (tmv-083/v-591) administrations - high dose,1,2020-07-31,0,1,0,0,0,Institut Pasteur ( 1 ),1.001,1,NA
Biological,"two doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,2020-08-27,0,1,0,0,0,Jiangsu Province Centers for Disease Control and Prevention ( 1 ),1.001,1,NA
Biological,vaccine therapy,1,2020-11-04,0,1,0,0,0,City of Hope Medical Center ( 1 ),1.001,1,NA
Biological,vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,2020-08-16,0,1,0,0,0,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. ( 1 )",1.001,1,NA
Biological,vbi-2902a,1,2021-02-24,0,1,0,0,0,VBI Vaccines Inc. ( 1 ),1.001,1,NA
Biological,vbi-2905a,1,2021-02-24,0,1,0,0,0,VBI Vaccines Inc. ( 1 ),1.001,1,NA
Diagnostic Test,who score,1,2021-06-16,0,1,0,0,0,Code Pharma ( 1 ),1.001,1,NA
Other,woebot substance use disorder,1,2020-07-01,0,1,0,0,0,"Woebot Labs, Inc. ( 1 )",1.001,1,NA
Drug,xc7 100 mg single,1,2020-12-18,0,1,0,0,0,NP Therapeutics ( 1 ),1.001,1,NA
Drug,xc7 200 mg single,1,2020-12-18,0,1,0,0,0,NP Therapeutics ( 1 ),1.001,1,NA
Drug,zotatifin,1,2020-11-12,0,1,0,0,0,Effector Therapeutics ( 1 ),1.001,1,NA
